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Abstract 
Intestinal helminth infections cause a significant global burden due to gaps in 
our translation of anti-helminth immunity. Immune responses to helminth infections are 
characterised by a balance between regulatory and effector cells, limiting immune-
driven pathology in the host whilst enabling long-term survival of the parasite. 
Functional immunity to helminths is dependent on the activation of a type-2 immune 
cascade comprised of immune and non-immune cells that coordinate to promote the 
mechanistic expulsion of the parasite. The natural murine helminth Heligmosomoides 
polygyrus establishes chronic intestinal infections that can be expelled following 
secondary infection in drug-cured mice, and provides a good experimental model to 
test mechanisms of functional immunity. Immunity to H. polygyrus is dependent on the 
differentiation of IL-4 producing CD4+ T helper 2 cells, however the exact mechanisms 
required for Th2 differentiation in vivo remain unclear.  
In this study we have identified two novel mechanisms required for Th2 
differentiation in vivo. Firstly, we identified that group 2 innate lymphoid cells (ILC2) are 
an important source of IL-4 for the differentiation of Th2 cells in vitro and in vivo during 
a chronic infection with H. polygyrus. Secondly, we have found that Foxp3+ Treg cells 
convert to Th2 cells and contribute significantly to memory Th2 responses following a 
challenge infection with Heligmosomoides polygyrus. Using a fate-reporter mouse, we 
have deleted IL-4Rα on Foxp3-expressing cells to test whether IL-4 receptor signalling 
is required for the development of ex-Foxp3 Th2 cells and whether they contribute to 
functional immune responses. In summary, we have characterised ILC2s and Treg 
cells as novel sources and targets of IL-4 required for the differentiation of Th2 cells 
and propose a model whereby ILC2-derived IL-4 provides a source of IL-4 for the 
reprogramming of Treg cells in the tissue, ultimately supporting the expulsion of H. 
polygyrus. 
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Chapter 1: Introduction 
1.1. The immune system 
1.1.1. Key players in the immune system 
The immune system is a highly evolved and tightly regulated system formed of 
diverse and specialised tissues and cells providing essential defence against invading 
pathogens. In steady-state conditions, cells of the immune system patrol the circulation 
and tissues integrating endogenous signals whilst maintaining the capacity to sense 
the presence of foreign antigen. The immune system can be broadly separated into the 
temporally distinct but inter-dependent innate and adaptive immune systems. Epithelial 
surfaces of the skin, lung and intestines are permanently exposed to environmental 
triggers and form the first line of defence against allergens and invading pathogens. 
Upon barrier breach by microorganisms, signals derived from damaged epithelial cells 
in combination with foreign antigen will activate tissue-resident innate immune cells. 
Following this, innate immune cells present foreign antigen to adaptive immune cells 
that are responsible for directing a specialised cascade of immune events. Central to 
this dichotomy is the ability of host immune cells to discern specific molecules present 
on the surface of pathogens without forming aberrant responses to self-antigens. The 
combination of innate and adaptive immune responses ultimately leads to the 
elimination of the foreign antigen whilst limiting host damage.  
Immune cells originate either from the foetal yolk sac during embryonic 
development, or haematopoietic stem cell (HSC) progenitors in the bone marrow. 
Immune cells exit the bone marrow into the circulation from where they can migrate to 
vascularised tissues. Alternatively, they form part of the lymph and migrate through 
lymphatic vessels into lymphoid organs where they continue their maturation. An early 
event in the differentiation of HSCs is the development of common myeloid progenitor 
(CMP) and common lymphoid progenitor (CLP) populations of cells (Fig. 1.1). CMP 
cells differentiate in the bone marrow into monocytes, dendritic cells (DCs), 
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granulocytes and mast cells. An important feature of CMP cells is their expression of 
specialised pattern recognition receptors (PRRs) that recognise highly specific 
pathogen associated molecular patterns (PAMPs). The largest family of PRRs are the 
Toll Like Receptors (TLRs) that are adapted for the recognition of a wide range of 
bacterial, viral and fungal antigens. For example TLR4 can recognise 
lipopolysaccharide (LPS) on the surface of gram-negative bacteria whereas 
intracellular TLR3 recognises double-stranded RNA, a replication intermediary for 
many viruses (Akira et al., 2006). In addition, innate cells express complement 
receptors and can recognise pathogen bound to complement enzymes. Granulocytes 
describe a functionally diverse group of cells (basophils, eosinophils and neutrophils) 
characterised by their cytoplasmic granules containing various enzymes, chemokines 
and growth factors. Upon infection or inflammation, granulocytes are recruited from the 
bone marrow through the circulation and into the tissue where they are activated, 
leading to their degranulation. For example, neutrophils are efficient phagocytic cells 
that kill intracellular viruses and bacteria through the release of inducible nitric oxide or 
anti-microbial peptides (reviewed in (Amulic et al., 2012)). In addition, activated 
neutrophils release neutrophil extracellular traps (NETs) recently shown to be required 
for limiting infections with larger pathogens such as the hyphal form of Candida 
albicans (Branzk et al., 2014). CMP cells can also differentiate into mast cell 
progenitors and mononuclear phagocytes. Mast cells progenitors are recruited out of 
the bone marrow through the circulation and into the tissue for their maturation. 
Mononuclear phagocytes are composed of monocytes and dendritic cells (DCs) (Fig. 
1.1). Monocytes circulate in the bone marrow, blood stream and spleen taking up 
apoptotic cells and producing inflammatory cytokines (reviewed in (Geissmann et al., 
2010)). From the circulation, monocytes get recruited to tissues and differentiate into 
macrophages. Macrophages respond to specific environmental cues to exert either 
inflammatory or regulatory functions. Classically activated macrophages (CAMΦ) 
recognise foreign antigens through toll like receptor activation to produce inflammatory 
cytokines as well as reactive oxygen species, driving a type-1 response and direct 
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killing of the bacteria. Conversely, alternatively activated macrophages (AAMΦ) 
differentiate and secrete molecules that promote wound healing and tissue-repair. In 
addition to monocyte-derived macrophages, a vast majority of tissue-resident 
macrophages originate from the foetal yolk sac during development. These cells are 
thought to be non-migratory and were recently shown to proliferate in the tissue 
(Jenkins et al., 2011). DCs are a specialised subset of mononuclear phagocytes 
otherwise defined as professional antigen-presenting cells. Immature pre-DCs exit the 
bone marrow into the circulation and migrate to the spleen or the intestine where they 
further differentiate into specialised subsets. In the tissue, invading pathogens are 
taken up by dendritic cells and processed into small peptides that are loaded onto 
major histo-compatibility (MHC) molecules and presented on the surface of DCs as 
peptide-MHC complexes.  Pathogens that are endocytosed will be processed and 
presented on MHC Class II molecules present within the endosomal compartment of 
the cell whereas cytosolic antigens are cross-presented onto MHC Class I molecules. 
Presentation of peptide-MHC complexes is fundamental for T cell recognition of 
antigen as will be discussed later.  
T- and B-lymphocytes develop from the CLP in the bone marrow and continue 
their maturation in primary lymphoid organs (Fig. 1.1). Immature T cell precursors 
migrate out of the bone marrow through the lymphatic system and into the thymus, a 
specialised and stratified primary lymphoid tissue that guides T cell maturation. B cells 
undergo the first stages of maturation in the bone marrow. Following this, B cell 
precursors migrate out of the bone marrow through the circulation and into the spleen. 
The maturation of T and B-lymphocytes requires the rearrangement of their antigen-
specific T cell receptor (TCR) and B cell receptors (BCR). Following their maturation, T- 
and B-lymphocytes migrate through the lymphatic vessels into secondary lymphoid 
organs draining the tissue, where they will encounter antigen presented by dendritic 
cells. T lymphocytes are comprised of cluster of differentiation (CD) CD4+ T helper and 
CD8+ cytotoxic T cells that recognise antigen presented on DCs and produce 
characteristic cytokines. T helper cells are required for the amplification of immune 
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responses particularly by activating other cells of the immune systems such as B cells. 
B cells are also professional antigen-presenting cells and can take up and process 
antigen through the expression of antigen-specific B cell receptor (BCR) and present it 
on their surface a peptide-MHC complexes. Antigen-specific CD4+ T cells recognise 
peptides presented on MHC Class II molecules on the surface of B cells and trigger 
their differentiation into antibody-secreting plasma B cells.  
CLP cells were recently shown to differentiate into intermediate common innate 
lymphoid progenitor cells (CILP) in the fetal liver and the bone marrow. CILP give rise 
to all innate lymphoid cell subsets (ILC) including natural killer (NK) cells and lymphoid 
tissue inducer cells (LTi cells). NK cells are cytotoxic cells that mediate cell death 
through their secretion of pro-inflammatory cytokines and granules containing perforin 
and granzymes (reviewed in (Colucci et al., 2003)). It is thought that innate lymphoid 
cells exit the bone marrow as immature progenitors and complete their maturation in 
the periphery in response to tissue-derived cytokines, as will be discussed later. 
 
1.2. αβ CD4+ T cell development 
1.2.1. Positive and negative selection in the thymus and lineage fate decisions 
As common lymphoid progenitor cells enter the thymus they lose the ability to 
differentiate towards B cells and are termed double negative (DN) (no CD4 or CD8) 
cells. DN cells undergo 4 stages of early development (DN1-DN4) in the outer cortex of 
the thymus and can be identified by their expression of CD44 and CD25, diverting 
them away from TCRγδ or NK T cell lineages. CD44–CD25+ DN3 cells upregulate the 
surrogate T cell receptor alpha chain (pre-TCRα) (Germain, 2002). Following this, the 
TCRβ chain associates with pre-TCRα as well as cytoplasmic signalling molecules 
including the CD3 co-receptors (CD3-γ/δ/ε) and TRC-ζ to form a functional αβ TCR. 
Both TCRα and TCRβ loci are composed of interchangeable coding segments, namely 
the constant, (C), variable (V), joining (J) and diversity (D) (in the TCRβ loci only) 
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genes. Random rearrangements of V and J (for TCRα) and V, D and J (for TCRβ) form 
unique complementarity determining regions (CDRs) for the recognition of a huge 
diversity of peptides presented on MHC molecules (Davis and Bjorkman, 1988). VDJ 
recombination is dependent on recombination activating genes Rag1 and Rag2 
(Dudley et al., 1994). Rag1 and Rag2-deficient mice are therefore deficient in T cells 
and B cells, whose BCR immunoglobulin receptor undergoes similar rearrangement 
(Mombaerts et al., 1992; Shinkai et al., 1992; Shinkai et al., 1993). Activation of the 
TCR leads to an arrest in TCRβ rearrangement and the upregulation of both CD4 and 
CD8 co-receptors. In the thymus, T cells are educated to a repertoire of self-antigen 
and the fate of CD4+CD8+ double-positive (DP) cells is determined by their ability to 
discriminate self-antigen through their TCR presented in discrete environments within 
the thymus. The affinity of antigen recognition by the TCR correlates with 3 main 
developmental outcomes: death by neglect, positive selection or negative selection. 
Currently, affinity selection is a well-accepted model describing a graduated 
development of cells correlating with affinity for self (Klein et al., 2014). Ultimately, the 
purpose of affinity maturation is to select functional antigen-receptive cells that can 
favour recognition of foreign versus self-peptide (Vonboehmer et al., 1989). Cortical 
thymic epithelial cells play a crucial role in T cell selection by presenting self-peptide in 
the context of MHC Class I and II molecules. Most DP cells express non-functional 
TCRs that cannot recognise MHC molecules and results in 90% of DP precursors 
undergoing death by neglect. Upon peptide engagement of a functional TCR receptor, 
intracellular lymphocyte-specific protein-tyrosine kinase (Lck) bound to the TCR 
activates a cascade of signalling events resulting in the activation of genes required for 
the functional maturation of cells. Additionally, activated Lck associates with CD4 and 
CD8 co-receptors that can selectively recognise MHC Class II and MHC Class I 
molecules. Both instructive (through strength of signalling) and stochastic (random 
interactions) events are thought to contribute to the expression of either CD4 or CD8. 
Furthermore both transcriptional and epigenetic mechanisms can control CD4 versus 
CD8 fate. Indeed, the expression of TFs ThPOK (Zbtb7b) and Runt-related 
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transcription factor 3 (Runx3) is mutually exclusive and ultimately determines CD4 
versus CD8 T cell fate (Reis et al., 2013). Furthermore, histone deacetylases 1 and 2 
(HDAC1/2) were shown to maintain the CD4 lineage by limiting the expression of the 
Runx TF complexes (including Runx3) (Boucheron et al., 2014). Similarly, a specific 
region of the Cd4 locus was specifically demethylated in CD4+ cells and required for 
the maintenance of the CD4 lineage (Sellars et al., 2015). 
 
1.2.2. Central and peripheral tolerance 
Positively selected CD4 or CD8 lymphocytes upregulate the chemokine 
receptor CCR7 and migrate to the thymic medulla where they interact with medullary 
thymic epithelial cells (mTEC) expressing peripheral-tissue-specific antigens under the 
control of the AIRE gene (autoimmune regulator) (Liston et al., 2003). In addition, they 
interact with dendritic cells cross-presenting mTEC antigens and co-receptors. These 
interactions are essential for establishing central tolerance, either by clonal deletion or 
by clonal diversion. Following positive selection, cells continue to express TCRs with a 
broad range of affinities for self. Cells expressing very high-affinity TCR have the 
potential to develop into auto-reactive cells if selected into the periphery, and undergo 
clonal deletion, which describes the combined action of negative selection or cell death 
by apoptosis. At this stage, TCR signalling also drives the expression of the TF 
Forkhead box P3 (Foxp3) in developing CD4+ T cells and the development of T 
regulatory cells (Treg) (Lee et al., 2012), as will be discussed later. As a result of TCR 
signalling in the thymus, CD4+ T cells emerge into the peripheral lymphatic system with 
low affinity to self whereas Treg cells have a repertoire skewed towards self-
recognition. Thymus-derived factors governing clonal deletion versus diversion are still 
not completely understood. 
Despite a sophisticated process of affinity maturation and clonal selection, not 
all self-reactive cells are deleted and additional mechanisms are required to 
complement negative selection. A two-step model of CD4+ T cell activation in the 
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periphery is essential for regulating the effector function of activated cells. Firstly, T 
cells encounter antigen in the context of peptide-MHC followed by stimulation with co-
stimulatory signals expressed on antigen presenting cells. When self-reactive T cells 
encounter self-antigen in the absence of co-stimulation, for example on tolerogenic 
DCs, TCR signalling causes T cells to become anergic and functionally inactive. 
Additionally, immature DCs expressing CD86 recognise CTLA-4 (cytotoxic T 
lymphocyte antigen 4) on self-reactive naïve T cells, promote their anergy (Macian et 
al., 2004) and limit their migration to tissues (Walker et al., 2002). Consequently, mice 
deficient in CTLA-4 (Teft et al., 2006) and human patients with mutations in CTLA-4 
(Schubert et al., 2014) exhibit profound immune dysregulation and the development of 
a range of autoimmune diseases. Upon infection, DCs upregulate higher levels of MHC 
and co-stimulatory molecules, which provide the necessary second signal for the 
activation of T cells and their differentiation into functional effector cells. However 
additional mechanisms of peripheral tolerance exist to limit recognition of self-antigens 
by ‘escapee’ CD4+ thymocytes, including suppression by Treg cells, as will be 
discussed later.  
 
1.2.3. CD4+ T helper cells 
Naïve CD4+ T cells emerge from the thymus into the periphery and migrate 
through the lymphatic system to tissue-resident lymph nodes (LN), such as the lung-
draining mediastinal LN (medLN) or gut-draining mesenteric LN (MLN). There are three 
fundamental signals required for T helper cell differentiation. Firstly, dendritic cells take 
up antigen in the tissue after infection and upregulate chemokine receptors, which will 
facilitate their migration to local LN. In the LN, DCs loaded with antigen enter the T-cell 
zone where they present antigen to T cells through the interaction of peptide-MHC 
complexes with the TCR. Upon functional TCR recognition of antigen presented on 
MHC Class II molecules, CD4 molecules expressed on T cells associate with the 
MHC:TCR complex and strengthen the interaction. Antigen recognition in the absence 
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of co-stimulation results in the inactivation of the cell. A second signal comes from T-
cell associated CD28 interactions with CD80/86 receptors on the antigen presenting 
cell which initiates the activation and proliferation of the cell. Activated T cells rapidly 
produce IL-2 and further upregulate IL-2Rα on their surface, providing a positive 
feedback loop (Busse et al., 2010) and promoting their proliferation. DCs or other 
resident innate cells that have been primed by recognition of specific pathogens and 
tissue-derived alarmins provide the third signal, usually a cytokine signal, that dictate 
the differentiation of CD4+ T cells into specialised subsets of cells called CD4+ T helper 
(Th) cells. In addition, T cells express CTLA-4, which has a high affinity for CD80 and 
CD86, and therefore competes with CD28 to bind to DCs, indirectly limiting the 
proliferation or infiltration of T cells into the tissue (Yokosuka et al., 2010). Alternatively, 
CTLA-4-expressing T cells were shown to endocytose CD80/CD86, thereby limiting the 
availability of ligands for CD28 and indirectly inhibiting the activation of T cells (Qureshi 
et al., 2011).  
Following cytokine signalling, the differentiation of T helper cells requires 
coordinated transcriptional and epigenetic changes, which facilitate heritable 
differentiation programs. T helper cell subsets develop through the coordinated 
expression of distinct signal transducer and activator of transcription (STAT) and 
transcription factors (TFs), ultimately leading to the secretion of characteristic cytokines 
such as interleukins (IL). Th1 cells express the TF T-box transcription factor (Tbx21) 
and secrete interferon gamma (IFN-γ) and are primarily required for the control of 
intracellular pathogens. Th2 cells express the TF GATA binding protein 3 (Gata3) and 
secrete interleukin 4 (IL-4), IL-5 and IL-13 required for anti-helminth defence but also 
responsible for driving allergic inflammation. Th17 cells express the TF RAR-related 
orphan receptor C (Rorct) and produce IL-17, which provides protection from bacterial 
and fungal infections. IL-9-producing Th9, IL-22-producing Th22 cells and T follicular 
helper cells are subsets of cells with polyvalent roles in infection and disease (Fig. 1.1).  
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1.2.3.1. T helper cell differentiation 
Th1 and Th2 cells were originally described by Mosmann and Coffman as 
clonal populations of T cells capable of secreting distinct cytokines in vitro (Mosmann 
et al., 1986), later identified as IFN-γ and IL-4, respectively (Cherwinski et al., 1987). In 
vivo, the development of Th1 or Th2 cells was shown to correlate with susceptibility to 
Leishmania infection suggesting the cell types had distinct effector functions (Heinzel 
et al., 1989). In addition, the development of Th cells in vivo was strongly dictated by 
the nature of the infection suggesting distinct antigens and/or signalling molecules 
induced in response to specific pathogens could mediate the development of T cell 
subsets (O'Garra, 1998).  
The study of T cell differentiation in vitro has been invaluable for our 
understanding of differentiation requirements and requirements for the maintenance of 
T helper subsets. Both TCR and CD28 engagement on T cells drive the expression of 
TFs such as nuclear factor of activated T cells (NFAT) and nuclear factor kappa-light-
chain-enhancer of activated B cells (NFκB), which directly promotes Il2 expression 
(Peng et al., 2001; Raab et al., 2001). IL-2 acts in an autocrine manner through STAT5 
to initiate the proliferation of the cell (Northrop et al., 1994). In the context of an 
infection with intracellular pathogens, NK cells and APCs secrete IFN-γ and IL-27, 
which activate STAT1 phosphorylation and expression of the TF T-bet (Tbx21) (Szabo 
et al., 2000; Lighvani et al., 2001). Following this, Tbx21 associates with co-factors 
such as H2.0-Like Homeobox (Hlx) and Runx3 leading to the upregulation of surface 
IL-12Rβ2 (Afkarian et al., 2002). Consequently, macrophage- or APC-derived IL-12 
(Hsieh et al., 1993) signals through the IL12Rβ2 to activate STAT3 and STAT4 
(Jacobson et al., 1995), which cooperate with Runx3, HLX and T-bet to drive increased 
expression of IFN-γ (Ifng) (Mullen et al., 2002; Djuretic et al., 2007). Thus, secreted 
IFN-γ acts in an autocrine manner through phosphorylated STAT1 to reinforce Tbx21 
expression and stabilise IFN-γ production, thus promoting the maintenance of the Th1 
lineage through a positive regulation loop (O'Garra, 1998). The differentiation of Th2 
cells will be described in more detail later. Briefly, signalling downstream of the IL-4Rα 
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and Notch1 receptor lead to the indirect (via STAT6) or direct activation of Gata3 and 
Il4 (Amsen et al., 2007). Following this, GATA-3 promotes expression of the TF c-maf 
(maf) and together they further enhance the expression of Il4, Il5 and Il13 (Zhu, 2010). 
Autocrine IL-4 signalling and auto-activation of GATA-3 ensure stability of the Th2 
lineage (Ouyang et al., 2000) (Fig. 1.2).  
Following the differentiation of Th cells, the maintenance of Th lineages occurs 
through TF cross-regulation by active silencing of TFs. In Th1 cells, T-bet reduces the 
expression of Gata3 (Usui et al., 2006) and cooperates with Runx3 to inhibit the 
expression of Il4 (Djuretic et al., 2007), limiting the development of Th2 cells. 
Conversely, GATA-3 and STAT-6 bind to the Ifng promoter to inhibit IFN-γ secretion 
(Chang and Aune, 2007). Maintenance of T-bet and GATA-3 is therefore crucial for the 
stability of Th1 and Th2 subsets, respectively. As discussed later in the context of Treg 
development, methylation of DNA is an epigenetic modification of DNA that dictates its 
accessibility to TF binding, and correlates with stable gene expression (Wilson et al., 
2009). GATA-3 and T-bet bind to the demethylated promoter regions of Ifng and Il4 
genes in order to promote their expression (Agarwal and Rao, 1998). Furthermore, the 
Ifng locus remains methylated in Th2 cells, and the Gata3 locus methylated in Th1 
cells, providing an additional mechanism of stability (Agarwal and Rao, 1998).  
As well as coordinating the maintenance of T helper cell subsets, TF cross-
regulation can also dictate the development of Th subsets. In particular, transforming 
growth factor beta 1 (TGF-β) was shown to promote the expression of Rorct, required 
for Th17 development, as well as the Foxp3, required for Treg development (Zhou et 
al., 2008). Furthermore, Foxp3 expression was shown to directly bind to, and inhibit 
Rorct expression and Th17 differentiation (Zhou et al., 2008). However, in the 
presence of IL-6, phosphorylated STAT3 can directly inhibit Foxp3 expression and 
instead, promote the expression of Il21 (Veldhoen et al., 2006; Dardalhon et al., 2008). 
Following this, autocrine IL-21 drives further STAT3 phosphorylation and induces the 
expression of Rorct, Il17a and IL-23R (Gaffen et al., 2014). IL-23 signalling further 
stabilises the expression of Il17a and Rorct and promotes Il17f and Il22 expression in 
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pathogenic Th17 cells (Gaffen et al., 2014). Similarly, although IL-4 alone drives Th2 
differentiation, cells cultured in the presence of IL-4 and TGF-β were shown to lose the 
ability to produce IL-4 and secrete IL-9 (Veldhoen et al., 2008). Th9 cells are thought to 
share common transcriptional requirements with Th2 cells (Stat6, Gata3 and Irf4) and 
express TFs such as Spi1 (PU.1), Batf and Bcl6, important for their effector function in 
vivo (Schmitt et al., 2014). Finally, the cytokine IL-22 is part of the IL-10 family of 
cytokines and can be secreted both by Th17 cells and by Th22 cells in a STAT3-
dependent manner, downstream of IL-23, IL-6 and IL-21 signalling (Ahlfors et al., 
2014). Although Rorct is not sufficient to confer IL-22 capacity to T cells, Roct–/– cells 
have severely impaired IL-22 production (Ouyang et al., 2011).  
Many cytokines typically associated with T helper cells are secreted by other 
immune subsets including γδ T cells and ILCs. Indeed, a high proportion of γδ T cells 
were shown to secrete IL-17 in naïve mice (Hirota et al., 2011). Furthermore, two 
recent studies showed ILCs were the predominant source of IL-22 (Ahlfors et al., 2014) 
and IL-9 (Turner et al., 2013) in the intestinal tract and lung tissue respectively. 
Furthermore, under some conditions such as infections with the intestinal helminth N. 
brasiliensis, ILC2s were shown to be the major IL-13 producing population (Neill et al., 
2010). With emerging evidence of an effector role for ILCs, it will be important to 
address the relative contribution of T cell- and ILC-derived cytokines. Furthermore, 
ILCs secrete cytokines at steady state in the tissue, in the absence of an infection 
(Turner et al., 2013). This suggests they could present novel mechanisms of cell-
intrinsic or extrinsic cytokine regulation.  
 
1.2.3.2. Molecular mechanisms of Th2 differentiation 
Both CD4+ T cells and IL-4Rα expression on T cells are essential for protective 
immune responses to intestinal helminths (Allen and Sutherland, 2014) and therefore 
understanding the molecular mechanisms of Th2 differentiation in vivo is of significant 
importance. In vivo, Th2 cells develop in response to a diversity of antigens, ranging 
Chapter 1 – Introduction  
 25 
from microscopic pollen allergens to macroscopic helminthic parasites. Th2 cells 
differentiate from naïve CD4+ T cells in response to TCR stimulation and IL-4 signalling 
to secrete canonical cytokines including IL-4, IL-5, IL-13 and IL-9. The nature, strength 
and duration of TCR signalling following antigen recognition dictates the fate of naïve T 
cells differentiation towards distinct T helper subsets (van Panhuys et al., 2014) and 
low signal strength is thought to promote the differentiation of Th2 cells (Yamane and 
Paul, 2013). Concurrent to TCR engagement, IL- 4 binds to the high affinity IL-4Rα 
chain, which heterodimerises with the common gamma chain (γc) (a subunit of the IL-
2, IL-4, IL-7, IL-9, IL-15, and IL-21 receptors (Rochman et al., 2009)) to form the type-1 
IL-4 receptor. The IL-4Rα chain can also heterodimerise with the IL-13Rα chain to form 
the type-2 IL-13 receptor, ubiquitously expressed on immune and non-immune cells 
(Junttila et al., 2008) including Th17 cells (Newcomb et al., 2009). Consequently, CD4-
specific deletion of IL-4Rα impairs IL-4 and IL-13 signalling (Barner et al., 1998). 
Following IL-4 engagement, cytoplasmic domains of the IL-4Rα chain are 
phosphorylated by activated kinases Janus Kinase 1 (Jak1) and Jak3 (Witthuhn et al., 
1994). As a consequence, insulin receptor substrates 1 and 2 (IRS1/2) bound to the 
Tyr motifs on the cytoplasmic domains of the IL-4Rα are phosphorylated (Keegan et 
al., 1994). Following this, STAT6 which is bound to the SH2 motif on Tyr domains is 
phosphorylated, forms dimers and translocates to the nucleus where it binds specific 
DNA motifs essential for the differentiation as well as the proliferation of Th2 cells 
(Kaplan et al., 1996; Takeda et al., 1996; Nelms et al., 1999). For example STAT6 
directly binds to, and promotes the expression of Gata3 (Zhu et al., 2001). GATA-3 
subsequently binds to the Il4 locus to reinforce Il4 expression (Zheng and Flavell, 
1997). Indeed, enforced expression of both STAT6 (Kurata et al., 1999) and GATA-3 
(Zhu et al., 2003) resulted in IL-4 secretion in CD4+ Th1 cells. Furthermore, ectopic 
expression of GATA-3 could restore Il4 expression in STAT6 deficient cells and IL-4 
could directly induce GATA-3 expression in a STAT6-independent manner, suggesting 
that GATA-3 is sufficient to promote Th2 differentiation in the absence of STAT6 
Chapter 1 – Introduction  
 26 
(Ouyang et al., 2000). Indeed, Il4 activation and high levels of IL-4 production were 
shown to establish a positive feedback loop through the autoactivation of GATA-3, 
reinforcing the differentiation of Th2 cells (Ouyang et al., 2000). A potential mechanism 
of GATA-3-independent activation occurs through signalling downstream of Notch1 
interactions with Jagged1 on APCs resulting in STAT-6 independent IL-4 production 
(Amsen et al., 2004). Mechanistically, both GATA-3 and STAT-6 were shown to 
facilitate long-range interactions forming between Il4, Il5 and Il13 loci required to 
maintain accessible conformation for TF binding and gene expression (Spilianakis and 
Flavell, 2004; Ansel et al., 2006). Consequently, GATA-3 was termed the ‘master 
regulator’ of Th2 cells (Fig. 1.2).  
GATA-3 has since been shown to be expressed at low levels in naïve T cells 
and plays important roles in the development of many immune cells including CD4+ T 
regulatory cells and ILC2s (Tindemans et al., 2014). Gata3 deficiency is embryonically 
lethal and Gata3-deficient CD4 T cells do not develop in the thymus (Pai et al., 2003). 
Therefore the role of GATA-3 in CD4+ T cells has been studied using mice where 
GATA-3 was specifically deleted in differentiated T cells, such as under the control of 
the distal Lck promoter expressed in late stage thymocytes or under the control of the 
OX40 promoter expressed in peripheral CD4+ T cells (Tindemans et al., 2014). CD4-
specific GATA-3 deficiency completely abrogated IL-5 and IL-13 production by T cells 
and partially inhibited IL-4 secretion in vitro (Zhu et al., 2004). Furthermore, IL-4 
production was not significantly different in cells cultured for multiple rounds of in vitro 
polarisation suggesting that GATA-3 is required for Il5 and Il13 expression but that 
additional mechanisms promote the expression of Il4 (Zhu et al., 2004). Indeed, the 
TFs c-maf (Maf) and JunB (Junb) were two TFs found to be highly expressed in Th2 
cells. CD4-restricted deletion of Maf specifically impaired Il4 expression (Kim et al., 
1999) and c-maf transgenic mice showed enhanced Th2 differentiation in vitro (Ho et 
al., 1998). Furthermore, c-maf was shown to co-operate with JunB to promote IL-4 
expression by directly binding to the Il4 locus (Ansel et al., 2006). Another important 
transcription factor involved in Th2 differentiation is the family of NFAT transcription 
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factors (reviewed in (Ansel et al., 2006)). In particular, NFAT2 was shown to synergise 
with the TF interferon regulatory factor (Irf4) for optimal production of IL-4 (Rengarajan, 
2002) and stabilise a complex containing GATA-3, STAT6 and c-maf at the Il4 locus to 
promote Il4 transcription (Kock et al., 2014).  
A critical role for STAT6 and GATA-3 for the differentiation of Th2 cells in vivo 
has also been demonstrated. Th2 responses were impaired in the absence of IL-4-
receptor or STAT6 following N. brasiliensis infection (Kopf et al., 1993) and H. 
polygyrus infection (Finkelman et al., 2000; Perona-Wright et al., 2010). Similarly, 
GATA-3 deficient peripheral CD4+ T cells were impaired in their production of IL-4, IL-
13 and IL-5 following N. brasiliensis infection, resulting in impaired class-switching and 
therefore reduced serum IgE levels, as well as impaired worm expulsion (Zhu et al., 
2004). Transgenic GATA-3 dominant-negative mice that display attenuated levels of 
Gata3 expression had reduced type-2 allergic inflammation after ovalbumin (OVA) 
immunisation and localised airway challenge (Zhang et al., 1999). Conversely, GATA-3 
transgenic mice that overexpressed Gata3 under the control of the Lck promoter 
displayed heightened IL-5 and IL-13 production by T cells and increased eosinophilia 
following H. polygyrus infection (Watanabe et al., 2003) and N. brasiliensis infection 
(Ozawa et al., 2005). Many other transcription factors are required for Th2 
differentiation through promoting or stabilising the expression of GATA-3 and its 
associated TFs, including Nfκβ (Das et al., 2001) and Dec2 (Yang et al., 2009). 
Additionally, TFs such as GRAIL were shown to regulate Th2 differentiation through 
negative regulation of STAT6 (Sahoo et al., 2014).  
As previously mentioned, both IL-4 and IL-2 signalling coordinate for the 
optimal differentiation of Th2 cells in vitro (Ben-Sasson et al., 1990; Le Gros et al., 
1990; Zhu, 2010). The IL-2 receptor is composed of IL-2Rβ (CD122) and γc (CD132) 
readily found on naïve T cells. IL-2 is captured by IL-2Rα (CD25), which subsequently 
associates with IL-2Rβ and γc to form a functional receptor. IL-2 signalling through the 
IL-2 receptor leads to the phosphorylation of STAT5 and downstream gene activation, 
including positive regulation of Il2ra resulting in increased surface expression of CD25 
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and IL-2 signalling, required for the proliferation of the cells (Malek and Castro, 2010). 
Although early IL-4 signalling in naïve T cells could increase surface IL-4Rα expression 
independently of IL-2 (Perona-Wright et al., 2010), IL-2 secreted following TCR 
activation was shown to feed back on differentiating T cells to increase the expression 
of IL-4Rα (Liao et al., 2008) through direct binding of STAT5 to the Il4ra locus (Liao et 
al., 2008). Consequently, STAT5 deficiency or IL-2 neutralisation impaired IL-4 
secretion in vitro and in vivo (Yamane et al., 2005). Mechanistically, IL-2 activated 
STAT5 to induce epigenetic changes at the Il4 locus and cooperated with GATA-3 for 
Il4 expression (Cote-Sierra et al., 2004). IL-2 is therefore fundamentally required for IL-
4 production by Th2 cells.  
Although the TFs required for cytokine production are well characterised, the 
differentiation of mature Th2 cells in vivo is likely to be far more complex, resulting in 
diverse and specialised subsets of Th2 cells. Indeed, transcriptional profiling of Th2 
populations revealed significant gene expression variation between Th2 populations 
isolated from in vitro cultures, H. polygyrus infection or the inflamed lungs of house 
dust mite (HDM)-challenged mice (Okoye et al., 2014). Furthermore, Liang et al made 
use of cytokine reporter mice (Il4KN2/4getIl13Smart/+) expressing huCD2 under the control 
of the Il4 promoter and huCD4 under the control of the Il13 promoter to identify sub-
populations of Th2 cells secreting either or both cytokines in the context of N. 
brasiliensis infection (Liang et al., 2012). One major finding was that a sub-population 
of CD4+ T cells secreting IL-4 and not IL-13 were expressing markers characteristic 
with T follicular helper (Tfh) suggesting there are unique subsets of IL-4- and IL-13-
secreting CD4+ T cells (Liang et al., 2012). Furthermore, single-cell sequencing of a 
purified Il13-GFP+ cells isolated from N. brasiliensis infected Il13-GFP reporter mice 
identified of a subpopulation of steroidogenic suppressor cells expressing the lipid 
enzyme Cyp11a1 (Mahata et al., 2014) highlighting the heterogeneity of Th2 cells in 
vivo.  Thus, although we understand molecular mechanisms behind the differentiation 
of Th2 cells, these studies highlight the fascinating diversity of T effector cells in vivo, 
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suggesting there are many additional signals required for their effector function in 
diverse contexts. 
The studies above describe a clear role for IL-4 in the differentiation of Th2 
cells, however studies using Il4–/–, Il4ra–/– and Stat6–/– mice have shown that T cells can 
differentiate into Th2 cells independently of IL-4 or IL-4 signalling, in vitro and in vivo 
(Bouchery et al., 2014). In the context of helminth infections, Il4ra–/– cells could both 
proliferate and secrete IL-4 in response to helminth antigens ex-vivo (Jankovic et al., 
2000) and Il4ra–/– mice developed functional Th2 responses in vivo during S. mansoni 
infection (Jankovic et al., 1999). However Th2 responses in Il4ra- and Stat6-deficient 
mice were dramatically reduced in comparison to WT mice and insufficient to promote 
granuloma formation surrounding eggs in the liver (Jankovic et al., 1999). Furthermore, 
the differentiation and development of memory Th2 cells and functional immunity to N. 
brasiliensis was shown to be independent of STAT6 (van Panhuys et al., 2008; Van 
Panhuys et al., 2013). However this could be explained by the finding that TCR-
signalling promotes GATA-3 expression in the absence of STAT6 leading to STAT6-
independent IL-4 production (Ouyang et al., 2000). Alternatively, peptide activation of 
CD4+ naïve T cells in vitro induced sufficient concentrations of IL-4 to support Th2 
differentiation of neighbouring T cells in the absence of an exogenous source of IL-4 
(Noben-Trauth et al., 2000), suggesting T cells may require IL-4, however not from an 
exogenous source. 
Taken together these studies suggest that IL-4 signalling is not always required 
for the differentiation of Th2 cells however it is required for the optimal development of 
a functional population of Th2 cells. Finally, IL-4 may not be required for the 
maintenance of Th2 cells in vivo following the observation that sustained activation of 
Th2 cells through the TCR results in the downregulation of IL4Rα (Perona-Wright et al., 
2010).  
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1.3. CD4+ Foxp3+ Treg cell development and function 
In addition to the mechanisms of central tolerance described above, the 
development of a specialised subset of CD4+Foxp3+ T regulatory cells (Treg) is 
required for the maintenance of peripheral tolerance and immune homeostasis in 
steady state and disease contexts. 
 T regulatory cells were first identified in the 1980’s by several laboratories as a 
sub-population of CD4+ lymphocytes expressing activation markers CD5+ and 
CD45RBlow and capable of limiting the development of autoimmune disease caused by 
the proliferation of self-reactive CD4+ T cells (Sakaguchi et al., 2001). In a seminal 
series of experiments, the transfer of CD45RBhigh cells to lymphodeficient mice resulted 
in the development of spontaneous autoimmune disease in multiple organs and 
wasting, which could be prevented by the co-transfer of CD45RBlow cells (Powrie et al., 
1993). CD45RBlow cells were further characterised as expressing the high affinity IL-2 
receptor CD25 (IL2Rα) (Sakaguchi et al., 1995). CD4+ cells depleted of CD25+ cells 
(approximately 10% of the CD4+ T cell pool) could also induce colitis in lymphodeficient 
recipients, which was prevented when CD25+CD4+ T cells were co-transferred. 
Additionally, CD25+CD4+ T cells were able to limit autoimmune development in 
thymectomised mice. Antibody-mediated depletion of CD25+ cells in wild-type mice 
resulted in the development of a similar disease (Sakaguchi et al., 1995; Asano et al., 
1996). These experiments demonstrated the existence of self-reactive T cells capable 
of mediating autoimmune disease that were controlled by a population of CD25+ cells. 
The development of CD25+ Treg cells was later shown to be dependent on the 
expression of the Foxp3 (Fontenot et al., 2003; Hori et al., 2003; Khattri et al., 2003). 
Indeed, mutations in the Foxp3 locus abolished the development of CD25+ T cells 
resulting in a severe lymphoproliferative disorder in mice, called Scurfy disease 
(Brunkow et al., 2001; Fontenot et al., 2003) and in humans, called immune 
dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome (Bennett et 
al., 2001).  
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1.3.1 Treg cell development 
 It is currently widely accepted that Treg cells develop in response to instructive 
signals in the thymus (tTregs) and periphery (pTreg). tTregs develop in the thymus 
from CD4+ SP precursors in response to high-affinity TCR recognition of self-peptide. 
The generation of tTreg cells was directly correlated to the affinity of the TCR for self-
peptide, as shown using a panel of TCRs recognising OVA-peptide with different 
affinity (Lee et al., 2012). Additionally, the levels of self-antigen expressed in the 
thymus correlate with tTreg development, as shown using transgenic mice expressing 
varying amounts of HA mRNA in the thymus (Weissler and Caton, 2014). Combined, 
these studies suggested that the recognition of low abundance self-antigens in the 
thymus was required for Treg development. Indeed the Treg TCR repertoire was 
shown to have considerable overlap with the escapee self-reactive T cells (Hsieh et al., 
2006). A two-step model has been proposed for the development of tTreg cells in the 
thymus. Firstly, high-affinity TCR signalling in CD4+ SP cells leads to the upregulation 
of high levels of CD25 and binding of NFAT, AP1, CREB, ATF, Runx1 and Foxo family 
members Foxo1 and Foxo3 (Ouyang et al., 2012) to the Foxp3 promoter and enhancer 
elements. Additionally NFκB signalling downstream of the TCR stimulates c-rel binding 
to Foxp3, enhancing Foxp3 expression (Long et al., 2009; Barbi et al., 2014). IL-2 
signalling on the CD25+ precursors drives phosphorylation of STAT5 and expression of 
Foxp3 (Lio and Hsieh, 2008). Treg cells fail to develop in IL-2 and IL-2Rβ-deficient 
mice that develop systemic autoimmune disease, demonstrating a fundamental 
requirement for IL-2 signalling in combination with TCR signalling (Zorn et al., 2006; 
Burchill et al., 2007). Transfer of WT Treg cells to IL2rb–/– mice prevented the onset of 
autoimmune disease (Malek et al., 2002) Additionally, IL-2 was required for Treg 
maintenance in the periphery, as treatment with IL-2 neutralising antibody significantly 
reduced the population of Treg cells (Setoguchi et al., 2005), as well as the 
maintenance of Foxp3 expression in vivo (Oldenhove et al., 2009). Importantly though, 
Treg cells do not secrete any IL-2, and IL-2 hypoproduction is absolutely essential for 
their suppressive function (Marson et al., 2007). Chromatin immuno-precipitation 
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(ChIP) revealed that as well as directly regulating Il2 expression, Foxp3 targets genes 
of the TCR pathway, including cell surface molecules and signalling components such 
as Zap70 (Marson et al., 2007), suggesting an early step in early differentiation of Treg 
cells is the suppression of excessive TCR signalling which could mediate cell death as 
well as initiate TCR-activation-dependent immune effector responses. Foxp3 therefore 
acts as an independent regulatory mechanism determining the outcome of TCR 
signalling and promoting cell survival and tTreg development over clonal deletion.  
 Naïve CD4+ T cells can be induced to express Foxp3 in vitro (iTreg) in response 
to IL-2 and TGF-β signalling (Davidson et al., 2007). Additionally, the vitamin A 
metabolite retinoic acid (secreted in high levels in the intestine) was shown to enhance 
TGFβ signalling and Foxp3 expression in iTregs (Liu et al., 2015). Evidence for the 
upregulation of Foxp3 in vivo was seen when T cells isolated from TCR transgenic 
Rag1-deficient mice deficient in Treg cells were able to upregulate Foxp3 expression 
after their adoptive transfer into WT mice (Apostolou and von Boehmer, 2004). Indeed 
Foxp3+ cells can develop from conventional T cells in the periphery (pTregs) in 
response to antigens including microbial antigens. Recent work has shown intestinal 
commensal bacteria digest specific components in our diet and secrete immunogenic 
metabolites. One of these, butyrate, was shown to directly stimulate Foxp3 expression 
and suppression (Arpaia et al., 2013; Furusawa et al., 2013). As described in the 
context of helminth infections, Foxp3+ pTreg cells develop in response to foreign 
antigens and may play a different role to tTreg cells in the context of an infection. 
Additional stimuli were shown to support pTreg development, such as the vitamin a 
metabolite retinoic acid, highly expressed in gut-associated lymphoid tissues (Sun et 
al., 2007). Gene expression analysis revealed tTreg cells expressed unique genes 
differentiating them from other Treg populations (Sugimoto et al., 2006). Two 
molecules Helios (Thornton et al., 2010) and Neuropilin (Weiss et al., 2012; Yadav et 
al., 2012) were identified as markers preferentially expressed on thymic Treg cells, in 
an effort to distinguish tTreg cells in the periphery (Fig. 1.1). 
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1.3.2. Mechanisms of Treg suppression 
As described above, CTLA-4 is essential for promoting anergy in self-reactive 
peripheral CD4+ T cells after TCR stimulation. CTLA-4 is constitutively expressed on all 
Treg subsets and crucial for their suppressor function (Walker and Sansom, 2015). 
Treg cell-specific CTLA-4 deficiency impairs their suppressive function in vitro and in 
vivo (Wing et al., 2008) and blockade of CTLA-4 in vivo impairs suppressive activity of 
Treg cells leading to the development of disease (Read et al., 2006). Treg cells were 
shown to form long-lasting interactions with dendritic cells and suppress their function, 
indirectly resulting in limiting the differentiation of CD4+ T helper cells (Onishi et al., 
2008). One potential contact-dependent mechanism is the interaction of CTLA-4 with 
CD80/86 on APCs, triggering their secretion of IDO, which degrades tryptophan 
thereby limiting T cell growth (Fallarino et al., 2003). Conversely, depletion of DCs or 
DC-specific deletion of MHC Class II expression led to a loss of Treg cells, suggesting 
DCs promote Treg maintenance thereby enhancing the suppressive environment in a 
feedback regulatory loop and limiting the expansion of effector cells (Darrasse-Jeze et 
al., 2009). Other surface molecules shown to support Treg-mediated suppression 
include GITR (Shevach and Stephens, 2006), CD39, OX40 (Griseri et al., 2010) and 
CD73 (Morikawa and Sakaguchi, 2014) however deficiency in these molecules does 
not impair peripheral homeostasis as much as deficiencies in Foxp3 and CTLA-4. In 
the periphery, Treg cells form long-lasting interactions DCs, inhibiting their maturation 
(Onishi et al., 2008). Conversely, DCs were shown to maintain the Treg population, in 
a regulatory feedback loop (Darrasse-Jeze et al., 2009). IL-10 and TGF-β are 
immunosuppressive cytokines secreted by many cells of the innate and adaptive 
immune response including both Foxp3+ and Foxp3–Treg cells (Tr1), and a proportion 
of Foxp3+ Treg cells. Il10–/– Treg cells were unable to limit the development of colitis 
after adoptive transfer of CD45RBhigh T cells into Rag2–/– mice (Asseman et al., 1999). 
Additionally, Treg-specific deletion of IL-10 leads to systemic autoimmunity and 
particularly severe colitis (Rubtsov et al., 2008). Furthermore, IL-10 signalling on Treg 
cells was required for Treg-mediated suppression of Th17 cells (Chaudhry et al., 2011) 
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and for limiting the development of colitis. In addition to cell-contact mechanisms, IL-
10, TGFβ and IL-35 production by Foxp3+ Treg cells was shown to maintain DCs in an 
immature state, thus indirectly limiting T cell activation (Collison et al., 2007; Collison et 
al., 2010).  
Many other mechanisms of suppression are likely to exist and remain unknown. 
Recently however, Treg cells were shown to secrete miRNA-containing exosomes, 
which could directly target Th1 cells in vitro and suppress their proliferation (Okoye et 
al., 2014). Both miRNA- and exosome-deficient Treg cells had impaired suppressive 
function in vitro and in vivo as assessed by their ability to limit the development of 
colitis when co-transferred with CD45RBhigh cells (Okoye et al., 2014).  
It remains unclear whether the ability of Treg cells to suppress auto-reactive T 
effector cells is dependent on the expression of similar self-antigen on the surface of 
APCs or if it is through bystander activation. Many studies show Treg suppression of T 
effector cells in vitro was not dependent on their expression of a TCR with the same 
affinity (Thornton and Shevach, 2000). In vivo, adoptively transferred H. polygyrus-
primed Treg cells were able to suppress allergic airway inflammation (Wilson et al., 
2005) and adoptive transfer of polyclonal but not not clonotypic Treg cells controlled 
the spontaneous development of arthritis in TS1 transgenic mice that express the S1 
peptide (derived from a PR8 influenza strain) (Oh et al., 2012). Thus it seems likely that 
antigen-specificity is not required for their suppressor function, however recognition of 
self-antigen may be important in the context of Treg instability, as discussed later. 
Furthermore, Treg suppression mechanisms are likely to be context-dependent and 
increasing evidence shows suppressor function correlates with the expression of 
unique transcriptional profiles, as discussed later. 
 
1.3.3. Transcriptional requirements for Treg development  
Foxp3 expression is fundamentally required for Treg suppressor function, and 
has historically been described as the master regulator TF for Treg cells. Indeed, 
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ectopic expression of Foxp3 is able to confer in vivo and in vitro suppressive activity to 
conventional T cells (Fontenot et al., 2003; Hori et al., 2003). An essential role for 
Foxp3 is to regulate the functional features of Treg cells through the simultaneous 
activation and repression of genes (Zheng and Rudensky, 2007). Experiments using 
Foxp3-GFP knockin mice highlighted the role of Foxp3 for Treg maintenance. Indeed, 
the IRES-GFP inserted into the Foxp3 locus was shown to disrupt Foxp3 function, 
inducing global transcriptional changes in their profile (Darce et al., 2012), resulting in 
their instability in vivo and the acquisition of effector cytokine production (Bettini et al., 
2012). As described above, TCR signalling induces the expression of many genes, 
including the CD25 receptor. IL-2 signals through CD25 to phosphorylate STAT5 and 
activate Foxp3 expression (Marson et al., 2007). Experiments in Foxp3-null mice with 
impaired Foxp3 expression highlighted the role for Foxp3 in regulating the gene 
expression of key functional molecules such as CD25 and CTLA-4 whilst limiting the 
expression of Il2 and pro-inflammatory cytokines such as Il4 and Ifng (Gavin et al., 
2007; Marson et al., 2007; Zheng et al., 2007). However these studies revealed many 
differentially expressed genes were not direct targets of Foxp3, suggesting other 
transcription factors were required for the Foxp3-dependent transcriptional profile. 
Indeed, two seminal studies have since characterised self-reinforcing transcriptional 
networks associated with Foxp3, and required for maintenance of Foxp3 expression, 
defined as the ‘Foxp3 interactome’ (Fu et al., 2012; Rudra et al., 2012). Firstly, a 
proteomic approach characterised large protein complexes formed around Foxp3 and 
containing transcription factors as well as chromatin-remodelling complexes, all 
containing Foxp3 binding sites (Rudra et al., 2012). Using a computational approach, a 
‘quintet’ of 5 transcription factors (Eos, Gata1, Irf4, Lef1 and Stab1) was shown to co-
operate with Foxp3 in a redundant manner to induce the Treg transcriptional program 
(Fu et al., 2012). Indeed, Eos had been previously shown to promote Foxp3-dependent 
gene silencing and maintain the stability of the Treg lineage (Pan et al., 2009). Both 
studies identified regulatory feedback loops and suggested the Treg interactome was 
required for the maintenance of a stable subset of Treg cells, which also suggests that 
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changes in the association of Foxp3 and co-factors could impact the stability of the 
Treg cell. One example of an essential Foxp3 co-factor is the transcription factor 
GATA-3, typically associated with the differentiation of Th2 cells (Ouyang et al., 2000). 
Through genome-wide sequencing analysis, recent studies have shown GATA-3 forms 
a complex with Foxp3, through the mutual presence of binding sites on both genes 
(Rudra et al., 2012). Furthermore, Treg-specific deletion of GATA-3 impaired their 
suppressor function and homeostasis of the cells resulting in the spontaneous 
development of disease (Wang et al., 2011) and their inability to control colitis after 
adoptive transfer of CD45RBhigh cells into lymphodeficient mice (Wohlfert et al., 2011). 
Many more studies have highlighted the role of specific TFs for the maintenance of 
Treg function, including the recent description of Bach2, which stabilises iTreg 
development by directly repressing the expression of genes associated with T helper 
function such as Irf4, Gata3 and IL12Rb1 (Roychoudhuri et al., 2013).  
 
1.3.4. Epigenetic regulation of Treg development and stability 
              Foxp3 expression has been shown to be transiently upregulated in both 
human and mouse CD4 T cells following TCR activation, however these cells lacked 
any other Treg features (Pillai et al., 2007; Wang et al., 2007; Miyao et al., 2012), 
suggesting that transient Foxp3 expression is not sufficient for Treg development or 
function. Conversely, cells can possess Treg function without expressing Foxp3, as 
seen in Foxp3-null Treg cells (Barbi et al., 2014). Therefore the vast majority of studies 
agree that the sustained levels of Foxp3 are necessary for Treg function (Williams and 
Rudensky, 2007). Stability of gene expression is largely regulated by epigenetic 
modifications of the DNA that alter the accessibility of the gene and facilitate binding of 
transcription factors. Some examples of DNA modifications shown to play an important 
role in Treg development are histone modifications and DNA methylation, both 
heritable through cell divisions (Huehn and Beyer, 2015). Histones can be modified by 
acetylation, methylation and phosphorylation, all of which are reversible, indicating 
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epigenetic changes are dynamic. For example, TCR stimulation induced histone H3 
lysine 4 dimethylation (H3-K4me2) and trimethylation (H3-K4me3) on the promoter 
regions of Foxp3 and Il2ra, and further enhanced by TGF-β and RA signalling in vitro 
(Lu et al., 2011). In addition, recent work has described an essential role for the 
chromatin-remodelling methyltransferase enhancer of zeste homolog 2 (Ezh2) for the 
maintenance of Treg function and stability. Ezh2 functions to stabilise the Foxp3 
transcriptional program by promoting the repression of its target genes (Arvey et al., 
2014). Ezh2-deficiency in Foxp3-expressing cells therefore resulted in the development 
of systemic autoimmunity due to the uncontrolled expansion of T effector cells 
(DuPage et al., 2015). Furthermore, DNA methylation of cytosines is the predominant 
modification of mammalian DNA and occurs early in the development of a cell. 5’-CpG-
3’ dinucleotides are bound by factors such as DNA-methyl-binding domains (Mbd) and 
targeted for methylation through the recruitment of histone deacetylases (HDACs) and 
DNA methyl transferases (DNMTs) such as DNMT3a and DNMT3b (reviewed in (Smith 
and Meissner, 2013)). Most mammalian cytosines found at CpG dinucleotides are 
methylated, however CpG islands found at the promoter of many developmentally 
regulated genes remain hypomethylated, which confers accessibility to the gene locus 
for the binding of transcription factors, ultimately leading to the enhancement of 
transcription (Thurman et al., 2012). This is stably maintained throughout subsequent 
differentiation processes through DNMT1, which copies methylation patterns during 
cell division (Lee et al., 2001). Demethylation can occur passively via DNMT1, or 
actively through the modification of methylated cytosines (methylcytosine 
hydroxylation) by the ten-eleven translocation (TET) family of proteins (Ito et al., 2011). 
Thus, changes in methylation can be dynamically regulated throughout the lifetime of a 
cell, and lead to epigenetic reprogramming of a cell (Wu and Zhang, 2010). In the 
context of T helper cell differentiation, CpG methylation was shown to regulate the 
proliferation and differentiation of CD4 T helper cells by maintaining hypomethylation at 
specific cytokine gene loci. Indeed, methylation of the Il4 locus is progressively lost 
during Th2 cell polarisation in vitro, correlating with increased Il4 transcription (Lee et 
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al., 2002). Furthermore, Dnmt-deficient CD4+ T cells were shown to simultaneously 
secrete multiple cytokines including IL-4 and IFN-γ, highlighting the importance of 
methylation for lineage specification (Lee et al., 2001). More recently, genome-wide 
analysis of 5’-methylcytosines revealed a unique pattern of methylation in both human 
and mouse Treg cells compared to conventional T cells (Floess et al., 2007; Wei et al., 
2009; Ohkura et al., 2012). These studies identified Treg-specific demethylation 
regions (TSDRs) located in several key Treg-related genes such as IL2ra, Tnfrsf18 
(GITR), Ikzf2 (Helios), Ikzf4 (Eos) and Foxp3 itself that were uniquely demethylated in 
Treg cells (Schmidl et al., 2009). Three conserved non-coding regions (CNS1, CNS2 
and CNS3) were the primary targets of DNA methylation in the Foxp3 locus and play 
important roles in Treg development and function (Zheng et al., 2010). 
Hypomethylation of CNS3 was required for Foxp3 expression in the thymus whereas 
hypomethylation of CNS1 was required for de novo expression of Foxp3 in peripheral 
CD4+ T cells, through direct binding by TGF-β-elicited Smad2 and retinoic acid 
receptor (Zheng et al., 2007). In contrast, hypomethylation of CNS2, although not 
important for the induction of Foxp3 expression, was crucial for the maintenance of 
Treg function (Zheng et al., 2010; Feng et al., 2014). Indeed, CNS2-deficient mice 
display reduced proportions of Foxp3-expressing cells (Zheng et al., 2010) correlating 
with an observed decrease in Treg suppressor function in mice with compromised 
CNS2 methylation (Mouly et al., 2010). Demethylation of the Foxp3 locus and Treg 
enhancer regions occurred in CD4+CD25+ thymic Treg precursors upon TCR signalling 
and prior to their expression of Foxp3 (Ohkura et al., 2012; Toker et al., 2013), thus 
establishing an epigenetic landscape accessible to the binding of Foxp3 and its co-
factors (Samstein et al., 2012). As a consequence, the methylation of the Foxp3 locus 
gives a good indication of the stability of the Treg lineage. Interestingly, iTreg cells that 
develop in vitro in response to TFG- β and IL-2 express Foxp3 but fail to induce 
hypomethylation at the Foxp3 CNS2, correlating with the rapid loss of Foxp3 
expression upon re-stimulation in comparison to CD25+ Treg cells isolated ex vivo 
(Floess et al., 2007). Conversely, tTreg cells have been shown to maintain a 
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methylated Foxp3 CNS2 following TCR activation in vitro or after transfer into 
lymphodeficient hosts (Ohkura et al., 2012; Toker et al., 2013). In vivo, a small 
population of cells was shown to lose Foxp3 expression but maintained a partially 
demethylated CNS2 locus (Miyao et al., 2012). These cells were able to readily re-
express Foxp3 upon TCR stimulation in vitro suggesting that CNS2 demethylation 
correlates with epigenetic memory of a Treg past, independently of Foxp3 expression 
(Miyao et al., 2012). Conversely, another population of cells had also lost Foxp3 
expression and secreted T helper cell cytokines, which correlated with a methylated 
Foxp3 CNS2, suggesting that functional reprogramming of Treg cells correlates with 
the re-methylation of the Foxp3 locus (Miyao et al., 2012). Given that inflammatory 
cytokines can directly promote the re-methylation of Foxp3 CNS2 (Feng et al., 2014), it 
is conceivable that these cells underwent de novo methylation of their Foxp3 locus 
following cytokine signalling. 
 Together these studies demonstrate that methylation, and not Foxp3 expression, 
correlates with Treg function. Indeed, Foxp3-null cells exhibited a very similar 
methylation pattern despite lacking Foxp3 protein (Gavin et al., 2007) highlighting the 
importance of TFs other than Foxp3 for the function of Treg cells (Morikawa and 
Sakaguchi, 2014), as previously described. However, some genes are regulated by 
Foxp3 as well as by DNA methylation, such as Il2ra, Ctla4 and Foxp3 itself. It is 
therefore likely that DNA methylation controls the expression of a limited number of 
genes, which in turn, drive the expression of a more diverse complex of TFs. This 
complex level of regulation may reflect an ancient evolutionary developmental pathway 
that enables maintenance and heritability of their Tregs and survival of the host. 
 
1.3.5. Post-transcriptional and post-translational regulation of Treg 
differentiation and function  
Post-transcriptional mechanisms of regulation such as micro-RNAs (miRNAs) 
also play an important part in the development and function of Treg cells. Treg cells 
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deficient in the miRNA-processing enzyme Dicer could develop in the thymus, however 
in the periphery, they lost Foxp3 expression and started to produce T helper cell-
related cytokines such as IL-4 and IFN-γ (Zhou et al., 2008). As a consequence, mice 
with a Treg-specific deletion of Dicer developed lymphoproliferative disease similar to 
that seen in Foxp3–/– mice (Zhou et al., 2008). Although many miRNAs were found to 
be highly upregulated in Treg cells, not much is known about the function of specific 
miRNAs. miR-155 is a well characterised miRNA which plays many important 
physiological functions including in immune cells (Vigorito et al., 2013). Foxp3-
dependent miR-155 expression was required for the maintenance of Treg cells by 
heightening their sensitivity to IL-2 (Lu et al., 2009). In addition, miR-17-92 was critical 
for the accumulation of Treg cells and IL-10-mediated suppression of experimental 
autoimmune encephalitis (EAE) (de Kouchkovsky et al., 2013). Furthermore, miR-182 
and miR-10a were required for the targeted suppression of Th2 and Th1 cells, 
respectively (Kelada et al., 2013). Combined, these results suggest that miRNAs 
contribute to the maintenance, specialisation and suppressor function of Treg cells, 
however more work need to be done to identify functions of unique miRNAs expressed 
in Treg cells. 
Posttranslational mechanisms of regulation have received considerably less 
attention, however increasing evidence suggests they play an important role in 
regulation of Foxp3 and associated TFs required for Treg suppressor function (Barbi et 
al., 2014). For example, the Ubc13/Ikk axis was required for the expression of 
functional Treg-associated genes such as Il10 and Socs1 (Chang et al., 2012). More 
specifically, a recent study found that TCR signalling could induce the transcription of 
the protein kinase casein kinase 2 (CK2), which in turn phosphorylates up to 300 
downstream target proteins including the inhibitory receptor ILT3, required Treg 
suppression of Th2 cells (Ulges et al., 2015). Thus, Treg-specific deletion of CK2 
resulted in the spontaneous development of Th2 lymphoproliferative disease (Ulges et 
al., 2015). Additionally, Foxp3 stability can be positively and negatively regulated by 
acetylation of its lysine residues (van Loosdregt et al., 2010) and negatively regulated 
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through proteosomal degradation by ubiquitination (Barbi et al., 2014). For example, 
the E3 ubiquitin ligases TRAF-6 (Muto et al., 2013) and ITCH (Jin et al., 2013) were 
required for Treg suppression of Th2 cells.  Similarly, Treg-specific deletion of the E3 
ubiquitin ligase VHL (von Hippel-Landau) resulted in the loss of Foxp3 expression in 
Treg cells and secretion of IFN-γ (Lee et al., 2015). Surprisingly, a single 
deubiquitinating enzyme (DUB) USP7 was sufficient to stabilise Foxp3 protein by 
inhibiting its upiquitination (van Loosdregt et al., 2013) and DUBs were also shown to 
stabilise GATA-3 protein, critical for Foxp3 maintenance (as described previously) 
(Barbi et al., 2014). Taken together, these studies suggest that post-translational and 
post-transcriptional mechanisms are required to maintain Treg function in the 
periphery, and confer Treg cells with the specific ability to suppress subsets of T 
effector cells. 
 
1.3.6. Influence of the environment on Treg stability  
In the periphery, Treg cells are exposed to a huge variety of triggers, including 
antigen, cytokines, metabolites and lipid mediators, all of which could potentially impact 
the stability and survival of the cell. TCR signalling plays an essential role for the 
development and function of Tregs. Although previous studies found that TCR 
signalling was only required early in Treg development (Thornton and Shevach, 2000), 
more recent evidence has found that continuous TCR signalling is essential for the 
effector function of Treg cells in vivo and in vitro (Levine et al., 2014), through the 
maintenance of a signature of genes required for Treg function such as Irf4 (Ahyi et al., 
2009; Cretney et al., 2011; Vasanthakumar et al., 2015). This suggests that any 
disruption in TCR signalling in the periphery could impact the stability of Treg cells. 
Similarly, cytokines play important roles in the development and maintenance of Treg 
cells. Indeed, IL-2 is critically important for the development and maintenance of Treg 
cells in the thymus (Fontenot et al., 2005). Furthermore, IL-10 acts on peripheral Tregs 
to increase their suppressor function and limit Th17 responses (Chaudhry et al., 2011). 
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Although cytokines can shape Treg function and enhance their ability to suppress T 
effector populations (as discussed later), in some contexts pro-inflammatory cytokines 
have been shown to impair Treg function. Indeed, levels of IL-6 can dictate the balance 
between the development of TGF-β-dependent Treg and Th17 cells (Veldhoen et al., 
2006). Furthermore, IL-4 impairs Treg function by reducing Foxp3 expression levels in 
vitro (Feng et al., 2014) and in vivo in the context of food allergy (Noval Rivas et al., 
2015). In addition, Treg cells cultured with synovial fluid isolated from rheumatoid 
arthritis patients and containing high levels of TNFα, maintained Foxp3 expression but 
lost their suppressive potential (Nie et al., 2013). More recently, IL-1β, TNFα and 
bacterial LPS were shown to reduce Foxp3 protein levels by stimulating increased 
expression of E3 ubiquitin ligase Stub1, resulting in the targeting of Foxp3 for 
proteosomal degradation (Chen et al., 2013). Collectively, this data suggests that TCR 
stimulation, combined with signalling from appropriate cytokines, are required for the 
development and maintenance of Treg cells, both of which can be disrupted in the 
context of inflammation and infection.  
 
1.3.7. Treg cell specialisation  
As discussed above, Treg cells are highly sensitive to changes in their 
environment. Tregs upregulate chemokine receptors and genes for their migration into 
tissues, where they express unique transcriptional signatures required for their 
maintenance and function (Feuerer et al., 2010) (Fig. 1.5). For example the 
transcription factor PPAR-γ was required for the accumulation of Tregs into the VAT of 
ageing mice and for limiting obesity-induced inflammation (Cipolletta et al., 2012). VAT-
Treg cells were later shown to express Batf and Irf4, which could promote the 
expression of Pparg as well as high levels of Il1rl1 (IL-33R) (Vasanthakumar et al., 
2015). IL-33 signalling was shown to promote the proliferation and accumulation of 
Treg cells to the VAT (Vasanthakumar et al., 2015), as well enhance their expression 
of CD25 and suppressor function (Molofsky et al., 2015). IL-33R was also highly 
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expressed on colonic Treg cells where it was shown to be required for Treg-mediated 
control of intestinal inflammation (Schiering et al., 2014). As part of their adaptation to 
their microenvironment, both murine (Burzyn et al., 2013) and human (Duhen et al., 
2012) Treg cells have been shown to up-regulate TFs associated with the development 
of T helper cell subsets, enabling them to specifically regulate immune responses. For 
example, Foxp3+ cells isolated from the Peyer’s patches expressed surface CXCR5 
and the TF Bcl6, both of which are associated with Tfh development, and were shown 
to specifically suppress Tfh cells (Tfr) (Chung et al., 2011; Linterman et al., 2011). Tfr 
cells were essential to control late stage germinal centre reactions (Chung et al., 2011), 
thereby limiting the development of non-antigen-specific affinity matured B cells 
(Linterman et al., 2011). Furthermore, Irf4, which forms part of ‘the quintet’ of genes 
required for Foxp3 maintenance and is critically required for IL-4 production by Th2 
cells (Rengarajan, 2002), was required for Treg suppression of Th2 cells. Indeed, Irf4-
deficient Treg cells were selectively impaired in their ability to suppress Th2 cells, 
resulting in the development of an inflammatory disease characterised by elevated 
levels of serum IgG1 and IgE (Zheng et al., 2009). Furthermore, Treg cells up-
regulated the TF Tbx21 (T-bet) associated required for Th1 differentiation in response 
to IFN-γ stimulation (Koch et al., 2009). Consequently, Tbx21-deficient Treg cells failed 
to rescue Th1 cell-mediated inflammation in scurfy mice or limit type-1 responses 
during Mycobacterium tuberculosis infection (Koch et al., 2009). In addition, Treg cells 
were shown to upregulate T-bet and CXCR3 in response to IL-27 signalling, which was 
required for their migration to the intestine during infection with Toxoplasma gondii 
(Hall et al., 2012) as well as respond to T-cell derived IFN-γ and specifically suppress 
IFN-γ+ Th1 cells in response to Toxoplasma gondii infection (Hall et al., 2012). In 
addition to responding to IFN-γ signalling, Foxp3+ cells were shown to secrete IFN-γ in 
a model of graft versus host disease (GVHD) and during infection with L. 
monocytogenes (Koenecke et al., 2012) and Ifng–/– Treg cells were unable to prevent 
the development of GVHD (Koenecke et al., 2012). Similarly, Foxp3+ Treg cells were 
shown to migrate to the LP and secrete IFN-γ in response to microbial stimuli and IL-12 
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signalling, leading to their suppression of intestinal inflammation (Feng et al., 2011). 
Lastly, Treg-specific STAT-3 deficiency resulted in a selective increase in pathogenic 
Th17 cells. Stat3–/– Treg cells were able to control T cell proliferation in vitro but unable 
to limit Th17 responses in vivo, resulting in the development of intestinal inflammation 
(Chaudhry et al., 2009). Taken together, these studies found that co-opting both TF 
and cytokine potential confers Treg cells with the specific ability to suppress T effector 
cells.  In addition to expressing diverse TFs, Treg cells isolated from different infection 
settings expressed distinct miRNA profiles that can dictate their suppressor function. 
Indeed, miR-146a was shown to target STAT1 in Treg cells and was critical for Treg-
mediated suppression of Th1 responses (Lu et al., 2010). In addition, IFN-γ-dependent 
miR-10a expression and IL-4-dependend miR-182a expression correlated with the 
ability of Tregs to suppress Th1 and Th2 responses in L. major and S. mansoni 
infections, respectively (Kelada et al., 2013). More recent studies have shown that 
bacterial metabolites could directly target Treg cells and maintain their suppressive 
potential in the small intestine (Murai et al., 2010; Arpaia et al., 2013) suggesting that 
immune and non-immune parameters are required to drive Treg specialisation. 
Taken together, these studies suggest Treg populations are heterogeneous and 
can adapt to their local environment to enhance their suppressive specificity. Further 
research is required to better characterise the nature of local cytokines and tissue-
derived molecules that can shape specialised Treg responses, in order to provide 
insight into directed Treg therapy. Preliminary evidence for cytokines and receptors 
involved in specialisation highlight the existence of control mechanisms ensuring the 
maintenance of the Treg phenotype in the context of a strong polarising environment, 
and inhibiting their conversion to T helper phenotypes. 
 
1.3.8. Therapeutic potential of Treg cells  
As discussed, understanding the mechanisms regulating stability and 
suppression in Treg cells is of considerable therapeutic interest. Indeed, many groups 
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are currently investigating the use of adoptively transferred Treg cells to control the 
development of T-cell mediated inflammatory diseases such as rheumatoid arthritis 
(Miyara et al., 2014), and indeed, clinical trials are showing positive results for the 
control of type-1 diabetes by adoptively transferred Treg cells (Marek-Trzonkowska et 
al., 2014). Patient Treg cells can either be expanded or differentiated from conventional 
CD4+ T cells into Treg cells in vitro before their transfer (Miyara et al., 2014), and 
therefore determining the stability of Treg cells in this context is important. 
Alternatively, Treg cells can be expanded in vivo by with recombinant IL-2 treatment, 
which is known to stabilise Foxp3 expression in the context of inflammatory cytokines 
(Feng et al., 2014). The complex of IL-2 and anti-IL-2 antibody (clone JES61-A12) (IL-
2c) stabilises the half-life of IL-2 and targets IL-2 to cells expressing high levels of 
CD25 (Boyman et al., 2006) and IL-2c treatment was shown to dramatically increase 
the proportion of Foxp3-expressing cells in naïve mice (Boyman et al., 2006) as well as 
reduce allergic lung inflammation (Wilson et al., 2008), allograft rejection and severity 
of EAE (Webster et al., 2009). However recent evidence has shown that IL-2 complex 
can also dramatically expand ILC2s (Roediger et al., 2013; Oliphant et al., 2014), 
which suggests IL-2c treatment may have undesired effects on other CD25-expressing 
cells. Indeed, IL-2c treatment was shown to drive eosinophilia and increased allergic 
symptoms (Van Gool et al., 2014), as well as increase the permeability of the 
vasculature through its effect of CD25-expressing endothelial cells, leading to internal 
bleeding (Krieg et al., 2010).  A stable fusion of both IL-2 and anti-IL-2 antibody, the 
‘superkine’ was shown to promote similar effects at a much lower concentration, which 
could be a safer application (Levin et al., 2012). Indeed, low-dose IL-2 treatment is 
already approved in the clinic for the treatment of cancer, however the impact of IL-2 
on the stability of Treg cells has not been well studied in this setting. 
The stability of Foxp3+ Treg cells is critical for the maintenance of immune 
homeostasis and survival of the host. Which is why since their discovery 20 years ago, 
diverse cellular and molecular mechanisms have been identified to regulate their 
development and function. In addition, these studies have highlighted the impact of 
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environmental signals such as cytokines on the stability of the cells, in particular in the 
context of inflammation and infection. Therefore it remains critically important to 
understand how different immune contexts can impact the stability of the Treg cell and 
impact the outcome of disease.  
 
1.4. Innate lymphoid cell (ILC) development and function 
As mentioned previously, ILCs differentiate from the CLP in the bone marrow, 
and differentiate into a diverse family of cells predominantly located in mucosal tissues 
such as the lung and small intestine. Both through their developmental requirements as 
well as their cytokine profile, ILCs largely mirror CD4+ T helper cell (Th) counterparts. 
They are distinguished from Th cells by their expression of the haematopoietic marker 
CD45 and the thymocyte marker Thy1.2 (CD90) as well as through their lack of 
expression of lineage markers commonly expressed on lymphocytes such as 
somatically rearranged antigen receptors. In addition, they can be identified by the co-
expression of the high affinity subunit of the IL-2 receptor IL-2Rα (CD25) and IL-7Rα 
(CD127). Furthermore, ILC2s have been shown to express the IL-33 receptor (ST2) to 
varying levels depending on the tissue (Roediger and Weninger, 2015). The ILC family 
include group 1 (ILC1), group 2 (ILC2) and group 3 (ILC3) innate lymphoid cells (which 
include lymphoid tissue inducer (LTi) cells) and conventional natural killer cells (NK). 
As their surface markers suggest, ILCs develop independently of recombination 
activating genes (Rag1 or Rag2), and there is currently no evidence that ILCs express 
any antigen or pattern recognition receptors such as TLRs (Fig. 1.3).  
 
1.4.1. Development of ILCs 
All ILCs including conventional NK (cNK) cells and LTi cells develop from a 
common innate lymphoid progenitor (CILP) expressing the TF E4bp4 (NFIL3) (Geiger 
et al., 2014) and the cell-surface integrin α4β7. In addition, the TF TOX (thymocytes 
selection-associated high-mobility group box protein), directly regulated by NFIL3 (Yu 
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et al., 2014), was required for the differentiation of all ILC subsets from the CILP 
(Seehus et al., 2015).  Further downstream, the expression of Gata3 (Yagi et al., 2014) 
and high levels of Id2 (inhibitor of DNA binding) (Moro et al., 2010; Klose et al., 2014) 
gives rise to group 1, 2 and 3 ILCs, excluding cNK cells, although the upregulation of 
Id2 was required at later stages for the development of cNK cells (Diefenbach et al., 
2014). Further expression of the transcription factor (TF) Plzf (promyelocytic leukaemia 
zinc finger protein) in Id2+ precursors was required for the development of group 1-3 
ILCs excluding group 3 LTi cells (Constantinides et al., 2014; Di Santo, 2014). Notch 
expression was required for the additional lineage specification of Rorct-expressing 
ILCs (Possot et al., 2011). Unlike conventional natural killer cells (cNK) cells, ILCs 
developed independently of IL-15 and of the low affinity receptor shared between IL-2 
and IL-15 (Moro et al., 2010) however their development was dependent on the 
expression of the common gamma chain (γc) and IL-7Rα, suggesting that IL-7 plays a 
crucial role for the development and function of ILCs and that IL-4, IL-9 or IL-21 may 
also be involved (Moro et al., 2010; Satoh-Takayama et al., 2010; Hoyler et al., 2012). 
Indeed, recombinant IL-7 was shown to maintain ILC populations in vitro (Neill et al., 
2010) and recombinant IL-2 promotes enhanced cytokine production by ILC2s in vitro 
(Moro et al., 2010) (Fig. 1.3). 
Similar to their CD4+ Th cell counterparts, the final stage of development of 
ILCs results in their functional specialisation mediated by cytokine signalling and the 
expression of specific transcription factors (Robinette et al., 2015). IL-23, IL1β and aryl 
hydrocarbon receptor (AHR) ligands were shown to stimulate RORγt+ ILC3s leading to 
their production of IL-22, IL-17A and GM-CSF. Furthermore, ILC3s were shown to play 
an important role in the maintenance of intestinal homeostasis and lymphoid tissue 
development (Cornelissen et al., 2011; Sawa et al., 2011). IL-12, IL-15 and IL-18 were 
shown to stimulate T-bet+ ILC1s leading to their production of IFN-γ and TNFα. ILC1s 
play an important role in the control of intracellular bacteria and protozoa. Interestingly, 
both Gata3 (Serafini et al., 2014) and Tbx21 expression were also required for the 
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development of a population of intestinal RORγT+ ILC3s, distinguished by the surface 
expression of NKP46 and secretion of IL-22 (Sciume et al., 2012). ILC2s can be 
distinguished from Rorct-expressing ILC3s by their expression of retinoic acid receptor 
alpha (Rora), which is required for their development (Halim et al., 2012; Wong et al., 
2012), as will be discussed later (Fig. 1.3).  
Due to their localisation in mucosal surfaces, ILCs are in close proximity to the 
epithelium and to commensal microbiota and many studies describe a strong influence 
of gut-derived signals on the function of ILCs (Sonnenberg and Artis, 2012; Kamada 
and Nunez, 2013; Philip and Artis, 2013). Recently, bacteria-derived metabolites were 
shown to directly stimulate intestinal Foxp3+ Treg cells, and therefore they may also 
play a role in stimulating TLR-deficient ILC3s (Arpaia et al., 2013; Furusawa et al., 
2013). Furthermore, diet-derived micronutrients were shown to directly impact ILC 
function (Veldhoen and Brucklacher-Waldert, 2012). For example vitamin A signalling 
influenced the ratio of ILC subsets in the small intestine in favour of ILC2 development, 
enhancing resistance to T. muris helminth infection (Spencer et al., 2014). Additionally, 
mice deficient in the aryl hydrocarbon receptor (AHR) of which one of the ligands is 
highly abundant in cruciferous vegetables, were deficient in IL-22 producing ILC3s (Lee 
et al., 2012). Finally, the indirect diet supplementation via maternal intake of retinoic 
acid was shown to influence foetal development of LTi cells (van de Pavert et al., 
2014). Taken together, these studies demonstrate a diversity of signals are required for 
ILC function and highlight the need to identify unique upstream regulators to promote 
ILC function. 
 
1.4.2. Differentiation of ILC2s 
ILC2s were first described as natural helper cells, nuocytes or innate helper 
type 2 cells and were only later given the uniform nomenclature of group 2 innate 
lymphoid cells (ILC2s) (Spits et al., 2013) following the characterisation of the broader 
group of innate lymphoid cells. They were originally identified in the mesenteric fat, the 
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lungs and the small intestine (Moro et al., 2010; Neill et al., 2010; Price et al., 2010; 
Saenz et al., 2010) and have now been described to populate tissue-draining lymph 
nodes, the dermis and visceral adipose tissue (Artis and Spits, 2015). As a result of 
their diverse localisations, ILC2s are likely to be heterogeneous cells and their 
developmental requirements and effector functions may vary from organ to organ. 
Differentiated ILC2s express the IL-25 receptor (Il17rb) and IL-33 receptor (ST2/Il1rl1) 
as well as high levels of the high affinity IL-2 receptor chain CD25 (Il2ra) (Moro et al., 
2010). Other cell-surface markers have been used to characterise ILC2s, however their 
functional impact on ILC2s is less clear. Sca-1 and KLRG1 expression correlate with 
GATA-3 expression in ILC2s and have been used as surface markers to distinguish 
ILC2s (Hoyler et al., 2012). In addition, ILC2s express MHC Class II (Neill et al., 2010) 
and are thought to have antigen-presentation functions (Oliphant et al., 2014). Both 
Rora expression and (Wong et al., 2012) the maintenance of high levels of Gata3 
expression (Klein Wolterink et al., 2013) are required for the development and lineage 
specification of ILC2s (Spits and Di Santo, 2011; Hoyler et al., 2012; Mjosberg et al., 
2012). Additional transcription factors have recently been shown to be required for 
ILC2 development, including factors required for T lymphocyte development such as T 
cell factor 1 (TCF-1; Tcf7) (Yang et al., 2013) which promotes Il17rb and Il1rl1 
expression, B cell lymphoma 11b (Bcl11b) (Walker et al., 2015; Yu et al., 2015) and 
GRF-interacting factor 1 (Gfi1; Gfi1) which regulates Il1rl1, Il2ra and Il7ra whilst 
suppressing the expression of Rorct and Il17a (Spooner et al., 2013), although it 
remains unclear how these TFs interact during the development of ILC2s (Fig. 1.3). 
ILC2s can be distinguished from other ILCs by their secretion of canonical type-
2 cytokines IL-13 and IL-5 (Moro et al., 2010). Furthermore, ILC2s are major producers 
of IL-9 in the lung (Wilhelm et al., 2011) and were shown to contribute to tissue-repair 
following N. brasiliensis infection (Turner et al., 2013). In addition, both murine and 
human ILC2s were shown to secrete IL-4 following PMA and ionomycin (P+I) 
stimulation (Moro et al., 2010) or stimulation with IL-33, IL-2, TSLP (Mjosberg et al., 
2012) and IL-33 and IL-25 (Xue et al., 2014). ILC2s were also shown to secrete IL-2 
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following P+I stimulation in mouse ILC2s (Molofsky et al., 2013) or TLR4 stimulation in 
human ILC2s (Mjosberg et al., 2012) however the secretion of IL-4 and IL-2 has 
generally received less attention. Recently in-depth transcriptomics were performed on 
ILC populations isolated from the spleen, liver and small intestine (SI). SI lamina 
propria ILC2s were shown to express high levels of Il5, Il13 and Il9 similarly to previous 
transcriptional arrays of ILC2s isolated from the lung (Motomura et al., 2014) as well as 
Il4 and Il2 (Robinette et al., 2015). Interestingly, both TCF-1 and Gfi1 promote the 
expression of Gata3, which is known to regulate Il5 and Il13 expression in Th2 cells 
(Zhu et al., 2004) suggesting TFs such as c-maf may be required for ILC2-derived IL-4 
secretion, similarly to Th2 cells (Kim et al., 1999). 
Although signalling via the IL-25 receptor (Il17rb–/–) or IL-33 receptor (Il1rl1–/–) 
(Neill et al., 2010) was not required for the development of ILC2s, epithelial-cell derived 
alarmins IL-25 and IL-33 appear to be important for stimulating ILC2 effector function. 
Indeed, treatment of ILC2s with combinations of IL-25, IL-33 (Neill et al., 2010) and 
TSLP (Mjosberg et al., 2011; Kim et al., 2013; Molofsky et al., 2015) induced IL-5 and 
IL-13 secretion by ILC2s in vitro. In addition, IL-25 (Fallon et al., 2006) and IL-33 (Price 
et al., 2010) treatment in vivo promotes the proliferation of ILC2s and increased 
secretion of IL-5 and IL-13. Furthermore, IL-2 was shown to enhance cytokine 
production by ILC2s in vitro in the presence of IL-25 and IL-33 (Moro et al., 2010). In 
particular, IL-2 was required for optimal IL-9 secretion by ILC2s in vitro and in vivo 
(Wilhelm et al., 2011). Neither the low affinity IL-2 receptor (Il2/Il15rb–/–) IL-4R (Il4ra–/–) 
(Fort et al., 2001), Il4–/– (Kim et al., 2014) or Il9r–/– mice (Turner et al., 2013) were 
required for the development or function of ILC2s and for their expansion following IL-
25 treatment (Fallon et al., 2006). Instead, these cytokines are increasingly thought to 
promote the effector function of ILC2s. Indeed, Il9r-deficient ILC2s secreted lower 
levels of IL-5 and IL-13 in the lung during N. brasiliensis infection (Turner et al., 2013) 
and culturing ILC2s with IL-9 in vitro led to increased cytokine production, suggesting 
autocrine IL-9 production maintains ILC2 function (Turner et al., 2013). In addition, 
basophil-derived IL-4 was shown to promote the effector function and proliferation of 
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ILC2s in the lungs (Kim et al., 2014) and skin (Kim et al., 2014; Motomura et al., 2014). 
Many more cytokines and growth factors are likely to play a role. For example the TNF 
superfamily member, TL1A, which binds to its receptor DR3 on ILC2s was shown to 
promote their effector function, proliferation and survival (Yu et al., 2014). Combined, 
these studies suggest cytokines play a major role for the development and function of 
ILC2s. Because most of these signals impact ILC2 populations in the lung and small 
intestine, identifying signals that are tissue-specific would enhance the design of 
immunotherapies targeting ILCs.  
 
1.4.3. Effector function of ILC2s 
Although the tools to specifically delete ILC2 cells are limited, a combination of 
genetic and cytokine/antibody treatments have been used to test the function of ILC2s 
in vivo in the context of allergic inflammation and anti-helminth immunity. Increasing 
evidence shows ILC2s play a key role in the initiation of immune responses to intestinal 
helminths. To date, the majority of studies have investigated the role of ILC2s in 
response to the mouse-adapted helminth N. brasiliensis, which has been extremely 
valuable for understanding the effector function of ILC2s. Il25–/– mice, deficient in ILC2s 
(then identified as IL-5, IL-13 and IL-4 producing non-B, non-T, c-kit+, FCεR1- cells) 
were impaired in their ability to expel N. brasiliensis, which is normally cleared from WT 
mice within 12 days (Fallon et al., 2006). In a separate approach, recombinant IL-25 
treatment increased numbers of ILC2s correlating with a rapid clearance of N. 
brasiliensis in susceptible Rag1–/– mice (Price et al., 2010) but not in mice deficient in 
type-2 cytokines  (Il4–/–Il5–/–Il13–/–Il9–/–) (Fallon et al., 2006) suggesting ILC2 production 
of type-2 cytokines was sufficient to mediate N. brasiliensis expulsion. Additionally, 
recombinant IL-25 treatment led to enhanced eosinophilia and serum IgG1 and IgE in 
WT but not Il4ra–/– mice (Fort et al., 2001), suggesting IL-13 was particularly important 
for driving effector responses downstream of ILC2s. Taken together these early 
experiments concluded that an innate, IL-25-responsive and Rag-dependent cell 
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produced type-2 cytokines and was sufficient to drive anti-helminth immunity (Fallon et 
al., 2006; Koyasu et al., 2010; Neill and McKenzie, 2011). 
In addition to their role in promoting anti-helminth immunity, ILC2s have been 
shown to be major players in the development of allergic lung inflammation in multiple 
laboratory models (Halim et al., 2012; Pishdadian et al., 2012; Salmond et al., 2012; 
Scanlon and McKenzie, 2012) however currently this has not been shown in the 
context of asthma. Conversely, ILC2s have been implicated in mediating lung damage 
repair following viral or helminth infections, through their secretion of amphiregulin and 
IL-9, respectively (Monticelli et al., 2011; Turner et al., 2013). In addition, recent 
transcriptional profiling revealed ILC2s express many genes involved in lipid 
metabolism (Robinette et al., 2015). Indeed, ILC2s were shown to regulate tissue 
metabolism through their cooperation with eosinophils, resulting in the beiging of white 
adipose tissue (Brestoff et al., 2015; Lee et al., 2015). Furthermore, ILC2s are 
increasingly thought to cooperate with other innate and adaptive cells of the immune 
system, including AAMΦ and eosinophils (Molofsky et al., 2013; Nussbaum et al., 
2013), γδ CD4+ T cells and neutrophils (Van Dyken et al., 2014), and most recently 
Treg cells in the VAT (Molofsky et al., 2015).  
 
1.4.4. ILC2-T cell crosstalk 
Although some studies suggest ILC2s are sufficient to drive anti-helminth 
immunity, increasing evidence is pointing towards the cooperation between ILC2s and 
other immune cells for the development of optimal type-2 responses (Fig. 1.3). For 
example, ILC2-derived IL-5 was shown to maintain eosinophil populations in the 
adipose tissue (Molofsky et al., 2013). Furthermore, ILC2s were recently shown to 
promote the accumulation of Treg cells in the VAT through ICOSL-ICOS interactions 
(Molofsky et al., 2015). Similarly, ILC2s were an important source of IL-13 for the 
activation of alternatively activated macrophages in the adipose tissue (Nussbaum et 
al., 2013). Recent studies have focused on the co-operation between ILC2s and T 
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cells. Indeed, early experiments showed the adoptive transfer of WT and Il13–/– ILC2s 
to IL-25R-deficient mice infected with N. brasiliensis restored the ability of T cells to 
make IL-13 (Neill et al., 2010) suggesting ILC2s contribute to T cell differentiation in an 
IL-13-independent manner. The identification of ILC2-deficient mice has provided more 
definitive evidence of compromised immune responses in ILC2 deficiency. Indeed, 
RORαsg/sg mice were shown to be specifically deficient in ILC2s (Wong et al., 2012) 
and had dramatically reduced immune infiltrate in the bronchioalveolar spaces 
following papain challenge (Halim et al., 2012) suggesting type-2 responses were 
impaired in the absence of ILC2s. Following these observations, several studies have 
now shown that Th2 differentiation is impaired in RORαsg/sg mice, correlating with 
reduced type-2 inflammation in the skin and lungs after allergen challenge (Drake et 
al., 2014; Gold et al., 2014; Halim et al., 2014; Liu et al., 2015) and not due to a T cell 
intrinsic role for RORα (Yang et al., 2008; Gold et al., 2014). One proposed mechanism 
is that ILC2-derived IL-13 was required for the migration of DCs to draining lymph 
nodes for efficient T cell priming (Halim et al., 2014). To date, these observations have 
been mostly limited to models of allergic inflammation. However a recent study found 
Th2 differentiation was impaired in RORαsg/sg mice infected with N. brasiliensis, 
resulting in the delayed expulsion of the parasite (Oliphant et al., 2014), suggesting 
that although IL-25-expanded ILC2 cells are sufficient to promote immunity to N. 
brasiliensis, optimal immune responses require ILC2-T cell co-operation. 
Mechanistically, ILC2s were shown to stimulate T cell proliferation in vitro in an MHC 
Class II-dependent and contact-dependent manner (Mirchandani et al., 2014). 
Furthermore, transferred WT but not MHC Class II deficient ILC2s could promote 
expulsion of N. brasiliensis in Il13–/– mice (Oliphant et al., 2014). IL-2 is another 
essential cytokine for the development of Th2 cells (Cote-Sierra et al., 2004) and 
human ILC2s isolated form nasal polyps were shown to produce IL-2 in response to 
TLR stimulation (Crellin et al., 2010). Furthermore, a recent study suggests ILC3-
derived IL-2 may support ILC2 function in the context of eosinophilic crystalline 
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pneumonia (ECP) (Roediger et al., 2015). Although the role of ILC2-derived IL-2 
remains unclear, it is possible that it could act in a paracrine or autocrine manner to 
enhance the proliferation of cells. Together, these studies suggest that ILC2s may play 
a role in the priming and differentiation of Th2 cells, however a direct role of ILC2-
derived cytokines in this process remains unclear. 
Conversely, T cells may promote ILC2 function. Indeed, ILC2s numbers 
negatively correlated with the presence T and B cells when comparing WT and Rag2–/– 
mice (Wilhelm et al., 2011). In addition, ILC2 numbers in the MLN of N. brasiliensis 
infected mice were not maintained in Rag2–/– mice (Neill et al., 2010). In light of the in 
vitro data showing IL-2 promotes cytokine production (as discussed above), T-cell 
derived IL-2 was hypothesised to promote ILC2 function (Wilhelm and Stockinger, 
2011). Although traditionally used for the expansion of CD25-expressing Treg cells, IL-
2c treatment was shown to dramatically expand numbers of ILC2s in the mesenteric 
lymph nodes of Rag–/– mice, resulting in the expulsion of N. brasiliensis (Oliphant et al., 
2014). Additionally, IL-2c expanded dermal ILC2s increased their secretion of IL-5, and 
IL-13, leading to increased skin inflammation and eosinophilia (Roediger et al., 2013). 
In vivo treatment of Rag1–/– mice with recombinant IL-2 restored lung IL-9 
concentrations to normal levels (Wilhelm et al., 2011). Furthermore, blocking IL-2 
following papain challenge reduced IL-9 concentrations in lung homogenates but not 
IL-4, IL-5 and IL-13, suggesting T-cell derived IL-2 may be required for the production 
of specific cytokines such as IL-9 (Wilhelm et al., 2011). Indeed, ILC-derived IL-9 was 
later shown to mediate lung damage repair following N. brasiliensis infection (Turner et 
al., 2013). These two studies suggest T cell derived IL-2 may play a specific role in 
driving IL-9 in the context of immune inflammation and damage, rather than in the 
initiation of immune responses. Given the similarity between ILC2s and their Th2 
counterparts, more work is required to understand their relative contribution to 
pathogenic and protective type-2 immune responses such as anti-helminth immunity.  
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1.5. Immunity to helminth parasites 
Type-2 immunity is a specialised immune response whose initiation is largely 
dependent on CD4+ T cells secreting the cytokine interleukin-4 (IL-4) and driving a 
multi-cellular cascade of events combining immune and structural cells. Type-2 
immune responses are evolutionarily ancient and are important both for protective 
responses to chronic infections with multi-cellular helminths and for the regulation of 
tissue repair following damage caused by invading helminths (Gause et al., 2013; Allen 
and Sutherland, 2014). Like all immune responses, the type-2 immune cascade is 
tightly regulated. Excessive type-2 responses can lead to inflammation as seen in the 
lungs of allergic individuals following sensitisation to allergens or in the liver of 
individuals chronically infected with the nematode Schistosoma mansoni (S. mansoni).  
 
1.5.1. Soil-transmitted helminths  
Helminth infections form a large part of the 17 neglected tropical diseases 
(NTDs) and remain a huge global burden, with devastating economic and health 
impacts due to the infection of both animals and humans. The World Health 
Organisation (WHO) estimated that around 880 million pre-school or school-aged 
children from low socioeconomic backgrounds in tropical and sub-tropical countries 
were infected by one or more soil-transmitted helminths (STH) in 2013 (WHO, 2015). 
The most prevalent human species are the roundworm (Ascaris lumbricoides), the 
hookworms (Necator americanus, Ancyslostoma duodenale) and the whipworm 
(Trichuris trichiura). The morbidity associated with infection is directly correlated with 
the high burden and recurrence of infection due to limited access to treatment and poor 
hygiene. Hookworm infection alone caused a global loss of 3.2 million disability-
adjusted life years (DALYs) in 2010 (Hotez et al., 2014). Hookworms feed on the 
intestinal mucosa, submucosa and blood, causing abdominal pain, blood and protein 
loss and growth retardation due to compromised nutrient absorption (Hotez et al., 
2004). These can result in severe long-term consequences such as stunted growth and 
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impaired intellectual development (Hotez et al., 2004). Although antihelminthic 
treatment is relatively inexpensive, widely available and effective, only 35% of children 
in need of treatment received deworming treatment in 2013 (WHO, 2015). Vaccination 
is arguably the best solution to eradicate helminthiasis, however the mechanisms of 
natural or vaccine-associated immunity to human hookworm are relatively unclear and 
therefore major efforts are being made to understand how best to heighten protective 
responses. Combined progress in genomics, proteomics and transcriptomics are 
contributing to significant advances for the identification of helminth-derived molecules 
as both vaccine candidates and for use as novel anti-inflammatories. Recent 
sequencing of a wide array of human and lab-strains of nematode species 
(WormBase) including N. Americanus (Tang et al., 2014) will provide new insight into 
similarities between species and guide therapeutic strategies. In addition, proteomic 
studies are profiling the highly immunogenic helminth excretory/secretory proteins, or 
“secretome”, that contain immunodulatory proteins involved in invasion (such as 
proteases) and evasion (Loukas et al., 2011). Phase 1 clinical trials are underway for a 
human hookworm vaccine directed against two adult N. americanus antigens thought 
to be involved in degradation of host hemaglobin, including the secreted Glutathione S-
transferase Na-GST-1 (Hotez et al., 2013). Many lab-adapted strains of parasites exist 
for modelling helminth infections in mice, including the hookworm Nippostrongylus 
brasiliensis, which is a parasite of rats adapted for use in mice, the gastro-intestinal 
whipworm Trichuris muris, and the roundworm Heligmosomoides polygyrus. 
 
1.5.2. Heligmosomoides polygyrus: a model of intestinal helminth infection 
In contrast to other laboratory-adapted parasite models, the nematode 
Heligmosomoides polygyrus is a natural murine intestinal parasite which is commonly 
used in the laboratory to model chronic intestinal human hookworm infection in mice. 
The lifecycle of H. polygyrus is strictly enteric, making it a suitable model for studying 
the natural development of intestinal immune responses. Free-living L3 larval stages 
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are orally ingested, migrate to the small intestine and invade the submucosa and 
muscularis externa within 24 hours. There they undergo 2 developmental moults and 
emerge into the lumen as L5 larvae 8-10 days post-infection where they attach to the 
villi of the intestine and mature into adults. From approximately day 14 post-infection, 
sexually mature male and female worms mate and release eggs into the faeces that 
are consequently released into the environment. In favourable conditions, L1 larvae 
hatch from the eggs and develop into L2 larvae, then free-living L3 larvae.  A new host 
will ingest L3 larvae in contaminated food or water, perpetuating the lifecycle (Johnston 
et al., 2015). Laboratory strains of mice have differing susceptibilities to the infection 
correlating with the strength of a type-2 immune response (Filbey et al., 2014). 
C57BL/6 mice are intermediate responders and infection can last 8-20 weeks. When a 
primary infection with H. polygyrus is cleared with a pyrantel-based anthelminthic drug, 
C57BL/6 mice develop highly protective immunity to secondary infections resulting in 
larval killing in the intestinal wall (Reynolds et al., 2012). H. polygyrus 
excretory/secretory (HES) products have been extensively characterised and most 
recently shown to contain both immunomodulatory proteins and vesicle-associated 
miRNAs thought to support parasite invasion (Buck et al., 2014). Characterisation of 
various lifecycle stages has revealed that larval and adult stages have distinct 
secretomes containing highly immunogenic components. Immunisation with both L4-
derived HES and adult-derived HES was able to confer sterile immunity to re-infection 
with H. polygyrus (Hewitson et al., 2013). Furthermore, in-depth proteomics revealed 
that both HES fractions contained large amounts of acetylcholinesterase proteins, 
including ACE-1, which was strongly recognised by antibodies in the immunised 
animals, suggesting they may constitute promising vaccine candidates (Hewitson et al., 
2013). Thus, the natural murine helminth Helimgosomoides polygyrus, which 
establishes chronic infections in inbred mice similar to its human counterpart, provides 
an appropriate experimental system to study co-evolved host-pathogen interactions 
(Fig. 1.4).  
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1.5.3. Type-2 immune responses to intestinal helminths 
1.5.3.1. Intestinal epithelial cell secretion of alarmins following helminth 
infections 
The gut-associated lymphoid tissue includes the Peyer’s patches, lamina 
propria lymphocytes and intra-epithelial lymphocytes. Intestinal epithelial cells form the 
largest environmentally exposed surface in the body, composed of specialised cells 
providing both physical and anti-microbial defence mechanisms (Peterson and Artis, 
2014). Intestinal epithelial cells are colonised with a large number of commensal 
microbes and have evolved to secrete a plethora of anti-microbial peptides such as 
defensins, C-type lectins and RNAses. This confers a natural chemical barrier limiting 
the interaction of pathogenic bacteria with epithelial cells (Gallo and Hooper, 2012). At 
steady state, tissue-resident dendritic cells extend trans-epithelial dendrites to sense 
luminal antigens and establish a tolerant relationship between commensal microbes 
and the immune system (Chieppa et al., 2006) through promoting the development and 
maturation of innate immune cells residing in the intestine (Hooper et al., 2012). 
However pathogens have evolved to disrupt barrier functions of the epithelium and can 
penetrate the epithelial barrier through direct receptor binding or by causing damage to 
epithelial cells, rendering them permissive to infection. Upon infection with an intestinal 
nematode, damaged intestinal epithelial cells secrete alarmins including the cytokines 
IL-33, IL-25 and TSLP that act on both innate and adaptive immune cells and are 
required for the initiation of type-2 immune responses (Saenz et al., 2008). As 
previously described, Il25–/– mice fail to expel N. brasiliensis due to the reduced 
activation of ILC2s (Fallon et al., 2006), and recombinant IL-25 treatment promoted 
type-2 immune responses and functional immunity to Trichuris muris (Owyang et al., 
2006). In addition, IL-25 was shown to have a partial role in the development of type-2 
responses to primary infection with H. polygyrus (Zaiss et al., 2013) and Il33–/– mice 
were susceptible to primary and secondary infection with N. brasiliensis (Hung et al., 
2013). Furthermore, Tslpr–/– mice were unable to clear an infection with T. muris 
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(Siracusa et al., 2011) however functional immune responses to H. polygyrus and N. 
brasiliensis were not impaired (Massacand et al., 2009), suggesting their requirement 
may vary depending on the infection. Furthermore, epithelial-cell derived trefoil factor 2 
(Tff2) promotes IL-33 production by lung epithelial cells following N. brasiliensis 
infection and consequently lung epithelial cells from Tff2–/– mice expressed lower levels 
of Il33 resulting in impaired Th2 responses in the lung and delayed expulsion of N. 
brasiliensis (Wills-Karp et al., 2012). Additionally, epithelial-cell derived Act1 was 
shown to regulate IL-25 secretion by intestinal epithelial cells and consequently K18-
CreAct1fl/fl mice with a specific deletion in epithelial Act1 had impaired Th2 responses 
in the mesenteric lymph nodes following N. brasiliensis infection and following IL-25 
treatment, resulting in compromised worm expulsion (Kang et al., 2012). Taken 
together, these studies highlight the essential role of the intestinal epithelium for the 
initiation of type-2 immune responses following helminth infection.  
 
1.5.3.2. Innate type-2 responses to helminths 
Following infections with intestinal helminths, intestinal epithelial cell-derived IL-
25, IL-33 and TSLP act on tissue-resident innate cells to enhance their function and 
promote type-2 responses, for example for the activation of ILC2s, as previously 
described (Saenz et al., 2013). In addition, DCs cultured in vitro with IL-25 and TSLP 
upregulated OX40L, which resulted in their ability to drive more proficient Th2 
differentiation (Ito et al., 2005). Furthermore, IL-33 was shown to induce IL-13 
production by bone marrow derived macrophages (BMDMs) and adoptive transfer of 
IL-33-activated BMDMs resulted in the expulsion of H. polygyrus following a primary 
infection (Yang et al., 2013). Innate cells themselves were shown to regulate IL-25 and 
IL-33 secretion and influence the development of the type 2 responses. For example, 
mast cells could promote IL-25, IL-33 and TSLP production in the small intestine, and 
consequently, mast-cell deficient mice had impaired Th2 responses to H. polygyrus 
(Hepworth et al., 2012). Conversely, the secretion of IL-1β from intestinal epithelial 
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cells and macrophages following H. polygyrus infection inhibited IL-25 and IL-33 
secretion in the small intestine, resulting in decreased ILC2 activation (Zaiss et al., 
2013). As a consequence Il1b–/– mice exhibited increased immunity to primary infection 
(Zaiss et al., 2013). Combined, these studies suggest IL-25 and IL-33 are crucial for 
activating cells of the innate immune system following H. polygyrus infection.  
As described previously, innate phagocytic cells such as neutrophils and 
macrophages are generally associated with the control of intracellular pathogens such 
as bacteria and viruses. Due to their macroscopic size, helminth parasites evade 
phagocytic mechanisms and the precise role for neutrophils and macrophages in anti-
helminth defence is unclear. However in the context of a helminth infection, monocytes 
get recruited to the tissue and differentiate towards AAMΦ in response to IL-4 and IL-
13 (Kreider et al., 2007). Furthermore, IL-4 stimulated the proliferation of tissue-
resident macrophages in the pleural cavity of mice infected with the helminth 
Litosomoides sigmondontis (Jenkins et al., 2013). Although Th2 cells were always 
described as an important source of IL-4 and IL-13 for AAMΦ activation, ILC2s are also 
major producers of these cytokines and therefore it is likely they play a major role in 
driving AAMΦ during a helminth infection given their tissue localisation. AAMΦ produce 
characteristic molecules such as arginase-1, resistin-like molecule alpha (Fizz1/Relma) 
and chitinase-like protein 3 (Ym1/Chil3) associated with functions such as wound 
healing and immune regulation (Allen and Sutherland, 2014). In addition, it is thought 
that AAMΦ contribute to the regulation of excessive type-2 responses by limiting the 
expansion of Th2 cells through the depletion of arginine sources (Pesce et al., 2009). 
Although AAMΦ play an important regulatory role, they were also shown to promote 
the larval killing of H. polygyrus following secondary challenge, however the 
mechanisms remain unclear (Anthony et al., 2006). There are many examples of 
neutrophils accumulating in the tissue surrounding helminths in the context of 
challenge infection. For example, neutrophils were rapidly recruited around the 
encysted larvae following H. polygyrus challenge infection (Morimoto et al., 2004). 
Furthermore, neutrophils accumulated in the lung tissue following secondary challenge 
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with N. brasiliensis and were shown to secrete IL-13 leading to the activation of 
AAMΦs (Chen et al., 2014). Consequently, depletion of neutrophils in a secondary but 
not primary inoculation with N. brasiliensis resulted in impaired AAMΦ differentiation 
and accumulation of the parasite in the lung (Chen et al., 2014). In addition, there is 
emerging evidence for novel roles for neutrophils and macrophages in the context of a 
type-2 response (Allen et al., 2015). Indeed, early recruitment of neutrophils to the 
lungs following N. brasiliensis infection was shown to be dependent on chitinase-like 
protein Chil3 (Ym1) secreted by macrophages (Sutherland et al., 2014). Macrophage-
dependent recruitment of neutrophils was shown to promote tissue damage and as a 
consequence, limit the establishment of the parasite (Sutherland et al., 2014). Taken 
together, this data suggests there is a strong cooperation between neutrophils and 
macrophages early in infection with intestinal helminths and that ILC2s may be an 
important source of type-2 cytokines for the development of early type-2 responses in 
the tissue. 
 
1.5.3.3. Initiation of the adaptive immune response 
As the evidence above suggests, innate cells can be sufficient to drive 
proficient type-2 responses to helminths independently of the adaptive immune system. 
However Th2 cells are fundamentally required for the amplification of immune 
responses to some intestinal helminths, such as H. polygyrus (Urban et al., 1991). For 
example, early type-2 responses to H. polygyrus including the differentiation of AAMΦ, 
occurs in the absence of CD11c+ DCs, suggesting adaptive immune responses were 
not required (Smith et al., 2012). However the development of IL-4 and IL-13-producing 
CD4+ Th2 cells, which are required for the functional expulsion of H. polygyrus (Urban 
et al., 1991) was severely compromised in the absence of CD11c+ DCs (Smith et al., 
2011). DCs play a crucial role for both the priming and maintenance of Th2 cells in vivo 
(Hammad et al., 2010; Phythian-Adams et al., 2010; Leon et al., 2012; Plantinga et al., 
2013; Hussaarts et al., 2014). Both pathogen derived and epithelial cell-derived 
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molecules are thought to stimulate DC function in the tissue before they migrate to the 
local lymph node to prime the differentiation of Th2 cells. Unlike our understanding of 
DC recognition of specific bacterial and viral ligands, a role for TLR recognition of 
helminth-derived antigens is less clear. The H. polygyrus secretome contains 
glycoproteins and lipids that are likely to be recognised by TLRs (Hewitson et al., 
2009). Indeed, the trematode Schistosoma mansoni secretome contains a 
phosphorylcholine (S. mansoni ES-62) that stimulated TLR4 signalling on DCs and 
impaired their ability to make IL-12p40 in response to LPS stimulation (Goodridge et 
al., 2004). Furthermore, immunity to H. polygyrus was shown to require MyD88 adaptor 
protein, part of the signalling pathway downstream of TLRs. Surprisingly, neither Tlr2, 
Tlr4, Tlr5 or Tlr9-deficient mice phenocopied the Myd88–/– mouse (Reynolds et al., 
2014) suggesting that TLRs may signal redundantly to maintain H. polygyrus 
susceptibility (Reynolds et al., 2014). Other pattern recognition receptors are thought to 
recognise helminth-derived molecules, such as C-type lectin receptors (CLR) that were 
shown to recognise S. mansoni egg antigen (reviewed in (Everts et al., 2010)). Specific 
populations of DCs have been described to prime the development of Th2 cells in the 
lung and skin. CD103+ DCs and not CD11bhigh DCs purified from cockroach or house 
dust mite challenged mice promoted the differentiation of Th2 cells in vitro, and 
deletion of CD103+ DCs using Ccr7–/– mice resulted in impaired Th2 differentiation 
(Nakano et al., 2012). Furthermore, two independent studies identified CD301b+ (Mgl2) 
DCs as important drivers of Type-2 immunity in the skin and lung respectively (Gao et 
al., 2013; Kumamoto et al., 2013). CD301b+ cells were shown to be Irf4-dependent and 
express PDL2, a marker associated with the regulation of Th2 differentiation. Deletion 
of CD301b+ DCs using conditional knockout mice (Cd11ccreIrf4fl/fl) or following the 
inducible deletion of Mgl2 upon diphtheria toxin treatment (Mgl2DTR mice) resulted in 
a reduced proportion of Th2 cells in the lung draining lymph nodes of mice in response 
to both lung allergen challenge as well as N. brasiliensis infection (Gao et al., 2013; 
Kumamoto et al., 2013). Furthermore, the differentiation of Th2 cells during H. 
polygyrus infection was dependent on B-cell stimulated CXCL13 production, which 
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regulated the co-localisation of T cells with a population of CXCR5+ DCs in B cells 
zones. This interaction was essential for the differentiation of Th2 cells (Leon et al., 
2012). Taken together, this data suggests that DCs respond to helminth antigens to 
promote the differentiation of Th2 cells in vivo. Furthermore, this data highlights the 
essential role of IL-4 for Th2 differentiation in vivo following H. polygyrus infection and 
for the functional expulsion of H. polygyrus (Urban et al., 1991). However the source of 
IL-4 required for Th2 differentiation in vivo remains unclear. 
 
1.5.3.4. Sources of IL-4 for the differentiation of Th2 in vivo 
The study of bicistronic 4get (Il4-GFP) cytokine reporter mice has been 
invaluable for the characterisation of the cellular sources and regulation of Il4 
expression in vivo (Croxford and Buch, 2011). Il4-GFP mice were developed by 
targeting an IRES-eGFP (internal ribosome entry site-enhanced green fluorescent 
protein) construct to the 3’-UTR of the endogenous Il4 locus resulting in the 
transcription of Il4-IRES-eGFP and translation of IL-4 and eGFP from the same locus 
(Mohrs et al., 2001). Furthermore, comparisons of Il4-GFP expression with Il4 mRNA 
expression confirmed the knockin hadn’t disrupted IL-4 expression and that IL-4 
function was intact (Mohrs et al., 2001). In order to determine whether Il4-GFP 
expression was faithful to IL-4 protein secretion, Il4-GFP mice were crossed to KN2 
mice, where exons 1 and 2 of the Il4 locus contain a huCD2-encoding sequence 
(Mohrs et al., 2005). Analysis of these mice revealed that huCD2 expression on the 
surface of CD4+ T cells faithfully reported IL-4 protein secretion rather than Il4 
expression, particularly in the MLN, Peyer’s patches and lamina propria of mice 
infected with H. polygyrus (Mohrs et al., 2005). Following H. polygyrus infection, Il4-
GFP+ cells were systemically dispersed throughout lymphoid and non-lymphoid 
tissues, with the highest proportions in gut-draining lymph nodes (Mohrs et al., 2005). 
In addition, these mice revealed that a proportion of the Il4-GFP+ cells in draining 
lymph nodes during H. polygyrus infection and in SEA immunised mice co-localised to 
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the B cell follicles and expressed CXCR5 and PD-1, characteristic of Tfh cells 
(Glatman Zaretsky et al., 2009; King and Mohrs, 2009). Furthermore, IL-4-secreting Tfh 
cells were shown to contribute to the generation of mature, high-affinity IgG1 
antibodies during N. brasiliensis infection (Reinhardt et al., 2009). This data suggested 
that many cell types have the capacity to secrete IL-4. Given that IL-4 is required for 
Th2 polarisation in vitro (as discussed), these results prompted a continuing debate on 
the cellular source of IL-4 required for the differentiation of Th2 cells in vivo. Indeed, 
several innate cells were shown to be capable of producing IL-4, such as mast cells, 
eosinophils and NK T cells (Voehringer et al., 2004; Gessner et al., 2005; Mohrs et al., 
2005). TCR activation of NK T cells in vitro stimulated IL-4 production, which was 
maintained in vivo in the absence of IL4Rα signalling (Noben-Trauth et al., 1997) 
however the function of NK T cell-derived IL-4 is unclear. Several studies have 
described basophils as a dominant source of IL-4 (Min et al., 2004; Voehringer et al., 
2006; van Panhuys et al., 2011) that can process and present antigen to CD4+ T cells 
for their priming and differentiation into Th2 cells during allergic inflammation and 
helminth infections (Perrigoue et al., 2009; Sokol et al., 2009; Yoshimoto et al., 2009). 
However, experiments in basophil-deficient mice (Mcpt8–/– mast cell protease 8 
deficient mice), basophil antibody-depleted mice (Phythian-Adams et al., 2010; Smith 
et al., 2012) and mice with a basophil-specific deletion in IL-4 revealed that basophils 
had a minimal role for the development of Th2 cells in vivo (Ohnmacht et al., 2010; 
Sullivan et al., 2011). In the context of H. polygyrus infection, basophils and eosinophils 
were shown to express and secrete IL-4 (Mohrs et al., 2005), however Th2 
differentiation was not impaired in basophil-deficient mice, basophil-depleted mice or 
mice given anti-IL-5 to deplete eosinophils (Herbst et al., 2012; Smith et al., 2012; 
Schwartz et al., 2014). Instead, CD4+ T cells were shown to stimulate IL-4 production 
by basophils in vitro (Sullivan et al., 2011) and in vivo (van Panhuys et al., 2011) 
following N. brasiliensis infection. Although dispensable for the priming of Th2 
responses, basophils were shown to contribute to chronic type-2 responses such as 
allergic dermatitis, as well as proficient immunity to secondary infection with N. 
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brasiliensis (Ohnmacht et al., 2010) and H. polygyrus (Herbst et al., 2012), suggesting 
that they serve important functions other than their secretion IL-4. Taken together, this 
data suggests basophils play important roles for the development of chronic type-2 
immune responses to H. polygyrus, but are redundant for the early differentiation of 
Th2 cells during H. polygyrus infection.  
Both murine and human ILC2s have been shown to transcribe Il4 (Fallon et al., 
2006; Price et al., 2010; Molofsky et al., 2013; Robinette et al., 2015) and secrete IL-4 
in vitro (Mjosberg et al., 2012; Doherty et al., 2013; Drake et al., 2014; Mirchandani et 
al., 2014). In vivo, increases in Il4-GFP+ ILC2s in the lung of N. brasiliensis infected 
mice preceded the major expansion of IL-4 producing CD4+ T cells suggesting they 
could provide the IL-4 required for Th2 differentiation (Fallon et al., 2006). However IL-
4 was undetectable by ELISPOT assay following the re-stimulation of Il4-GFP-
expressing ILC2s isolated from the MLN of N. brasiliensis infected mice (Fallon et al., 
2006). Furthermore, following the infection of KN2 mice with N. brasiliensis, Il4-GFP+ 
lineage negative cells in the spleen, mediastinal lymph nodes and lung were negative 
for KN2 suggesting they were not secreting IL-4 in vivo (Price et al., 2010). Similarly, a 
proportion of ILC2s in the VAT were Il4-GFP+KN2– (Molofsky et al., 2013) suggesting 
ILC2s are poised for Il4 secretion but may not secrete IL-4 in vivo. Early studies 
characterising the KN2 mice show that global Il4-GFP expression induced following H. 
polygyrus infection correlated the highest with KN2 expression in the gut associated 
lymphoid tissue (GALT) (MLN, PP, IEL and LP) highlighting the importance of looking 
at site-specific expression of cytokines in the context of different infections (Mohrs et 
al., 2005). IL-4 production by intestinal ILC2s has not yet been reported. 
Although the signals required for IL-5 and IL-13 secretion by ILC2s are well 
characterised (as discussed above), the signals driving IL-4 secretion in vivo remain 
unclear. Basophil-derived IL-4 was shown to support ILC2 activation and proliferation 
in the skin (Kim et al., 2014) and ILC2 cytokine production in allergic lungs (Motomura 
et al., 2014) however it remains unclear whether basophil-derived IL-4 is required for 
ILC2-derived IL-4. Interestingly two members of the arachidonic pathway, PGD2 and 
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LTD4, known to directly enhance human Th2 cytokine production (Xue et al., 2012), 
stimulated increased IL-4 secretion by human (Xue et al., 2014) and mouse ILC2s 
(Doherty et al., 2013) respectively. Furthermore, human ILC2s isolated from nasal 
polyps were shown to produce IL-4 in response to TSLP and IL-33 (Mjosberg et al., 
2012). Still, the functional role of ILC2-derived IL-4 remains unclear. In vitro, one study 
reported reduced IL-5 and IL-13 measured in the supernatants following the co-culture 
of T cells with Il4–/– ILC2s compared to WT ILC2s (Drake et al., 2014) suggesting either 
ILC2-derived IL-4 was required for their own secretion of IL-5 and IL-13 or for T cells to 
secrete IL-5 and IL-13. Furthermore, blocking IL-4 in vitro reduced the total numbers of 
IL-13+ ILC2s and IL-13+ T cells, suggesting that either T cell or ILC2 derived IL-4 was 
required for the maintenance or activation of ILC2 cells (Oliphant et al., 2014). In vivo, 
one study showed that IL-4 was not required for the differentiation of Th2 cells in 
response to papain challenge in the lung, and concluded ILC2-derived IL-4 was not 
significant, however the role of IL-4 has not been tested in the context of an IL-4 
dependent model (Halim et al., 2014).  
Taken together, these studies suggest that the importance of any of these 
sources of IL-4 is most likely to depend on the tissue, and location of the infection, and 
highlight a gap in our knowledge on the function of ILC2-derived IL-4. 
 
1.5.3.5. Type 2 effector responses downstream of type-2 cytokines 
Following the initiation of the adaptive immune response to infection, Th2-
derived IL-4, IL-13 and IL-5 promote a positive feedback loop by stimulating increased 
activation of the early intestinal immune and non-immune effector cells. For example, 
IL-4 and IL-13 serve to further amplify the alternative activation of macrophages, for 
example during memory responses to H. polygyrus when AAMΦ infiltrate the 
granuloma forming around the larvae resulting in larval trapping and killing (Anthony et 
al., 2006). Consequently, clodronate-dependent deletion of phagocytes (including 
macrophages) was shown to reduce immunity to H. polygyrus in the genetically 
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resistant strain of SJL mice (Filbey et al., 2014), highlighting the importance of effector 
responses for functional immunity to helminths. Indeed, the treatment of mice with IL-4 
complex (IL-4c), known to prolong the in vivo half-life of IL-4 (Finkelman et al., 1993) 
was sufficient to drive expulsion of N. brasilensis in lymphodeficient SCID mice (Urban 
et al., 1995). Although IL-4 acts primarily on haematopoietic cells, both IL-4 and IL-13 
can act on non-immune cells particularly intestinal epithelial cells expressing the IL-
4Rα to promote the expulsion of helminths (Reinecker and Podolsky, 1995). Goblet 
cells are specialised epithelial cells synthesising mucin glycoproteins that assemble to 
form a protective mucus layer. Upon infection, goblet cells proliferate and diversify their 
composition of mucin proteins and type-2 cytokines are able to directly enhance this 
process. Indeed, IL-13 could directly increase the expression levels of Muc2 and 
Muc5ac in the small intestine following N. brasiliensis infection (Hasnain et al., 2011). 
Consequently, expulsion of both Trichuris muris and N. brasiliensis was delayed in 
mice deficient in Muc2 or Muc5ac (Hasnain et al., 2010; Hasnain et al., 2011). In 
addition to their ability to secrete mucus, goblet cells were shown to secrete resistin-
like beta (Relmβ/Retnlb) in response to IL-13, which was essential for proficient 
immunity to H. polygyrus (Herbert et al., 2009). Treatment with recombinant Relmβ in 
vitro and in vivo had a direct impact on parasite fecundity and viability (Herbert et al., 
2009) and consequently, Retnlb-deficient mice failed to expel H. polygyrus following 
secondary infection or IL-4c treatment of primary infected mice (Herbert et al., 2009).  
In addition to promoting goblet cell proliferation, type-2 cytokines promote 
intestinal epithelial cell turnover and smooth muscle cell contractility, which co-
ordinately mediate a ‘weep and sweep’ mechanism resulting in functional expulsion of 
the pathogen. IL-13 but not IL-4 were required for intestinal cell turnover during 
Trichuris muris infection (Cliffe et al., 2005) and both IL-4 and IL-13 were required for 
intestinal smooth muscle contractility during infection with N. brasiliensis (Zhao et al., 
2003). Consequently, Il4ra-deficiency in smooth-muscle cells resulted in a delayed 
expulsion of N. brasiliensis (Horsnell et al., 2007; Horsnell et al., 2011). Furthermore, 
type-2 cytokines promote changes in epithelial cell function including increased 
Chapter 1 – Introduction  
 68 
mucosal permeability, which is thought to participate in the expulsion of H. polygyrus 
(Shea-Donohue et al., 2001; Madden et al., 2002). Conversely, epithelial cell derived 
alarmins can directly stimulate Th2 cells and also amplify type 2 immune responses. 
Indeed, TSLP was shown to promote proliferation and survival of Th2 cells in allergic 
asthma (Kitajima et al., 2011) however its role in stimulating helminth-elicited Th2 cells 
has not been tested. Furthermore, IL-33 stimulates type-2 cytokine secretion from Th2 
cells cultured in vitro (Schmitz et al., 2005) and IL-5 from memory Th2 cells in vivo 
(Endo et al., 2015). 
An important role for Th2-derived cytokines in promoting functional effector 
responses is the stimulation of B cell class switching by IL-4. Indeed, IL-4 was required 
for B cell class switching to IgG1 and IgE-producing plasma cells (Kuhn et al., 1991) 
and increased type-2 responses correlated with an increase in polyclonal IgE and IgG1 
in a primary infection with H. polygyrus (McCoy et al., 2008). Although antibodies do 
not play a role in limiting the establishment of a primary infection with H. polygyrus, 
passive transfer of polyclonal IgG antibodies impaired the fecundity of adult parasites 
(as measured by egg output) (McCoy et al., 2008). Furthermore, antigen-specific IgE 
and IgG1 antibodies directed against larval stages of the parasite were highly elevated 
in H. polygyrus secondary infection (McCoy et al., 2008). Consequently, µMT mice 
lacking B cells were unable to expel secondary infection with H. polygyrus 
(Wojciechowski et al., 2009) as were Aicda–/– mice (activation-induced cytodine 
deaminase) deficient in the production of class-switched antibodies (McCoy et al., 
2008). Although B cells can feed-back on Th2 cells to support their activation 
(Wojciechowski et al., 2009), B-cell deficiency resulted in impaired immunity to H. 
polygyrus without affecting Th2 memory responses themselves, suggesting B-cell 
dependent mechanisms including antibody production are required rather than an 
indirect role for B cell help to T cells (Liu et al., 2010). Furthermore, two studies 
describe a new role for antibodies in promoting tissue repair after H. polygyrus 
secondary infection. Antigen-specific antibodies were shown to directly bind to and 
mediate the accumulation of macrophages in the granulomas around invading L4 
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larvae (Esser-von Bieren et al., 2013). This correlated with the ability of antibody to 
bind to FcRγ receptors expressed on macrophages and stimulate their secretion of 
arginase-1, leading to larval immobilisation in vitro (Esser-von Bieren et al., 2013). In 
addition, this interaction was found to promote would-healing around the invading 
larvae (Esser-von Bieren et al., 2015).  
Although the secretion of IL-4, IL-13 and IL-5 by CD4+ T cells is required for 
fully functional type-2 responses, emerging data suggests that many other T helper 
cell-associated cytokines play important roles for the control of helminth infections 
(Bouchery et al., 2014). For example, Th2 cells are an important source of IL-21, which 
was shown to act on macrophages to enhance their arginase activity (Pesce et al., 
2006) as well as promote class-switching of B cells. Consequently, Il21r–/– mice 
displayed impaired Th2 responses during H. polygyrus infection including decreased 
eosinophilia, IgE and IgG1 antibody production and reduced antigen-specific Th2 
cytokine production (Frohlich et al., 2007). Furthermore, both innate and adaptive cells 
secrete IL-9 during helminth infections including Th2 cells. IL-9 mRNA and protein 
were significantly increased during infection with N. brasiliensis and Il9–/– mice 
exhibited reduced type-2 responses (Licona-Limon et al., 2013) resulting in delayed 
worm expulsion (Turner et al., 2013). More surprisingly, Th17-derived IL-17 was shown 
to synergise with IL-13 and exacerbate lung inflammation following HDM challenge 
(Lajoie et al., 2010). Furthermore, IL-17 production by γδ T cells was hypothesised to 
mediate the recruitment of neutrophils to the lung following N. brasiliensis infection, 
leading to the production of Ym1 by macrophages required for lung damage repair and 
functional helminth expulsion (Sutherland et al., 2014).  
In conclusion, structural cells of the small intestine secrete alarmins following 
helminth infections leading to the recruitment of innate cells, which secrete and 
respond to type-2 cytokines. Furthermore, antigen-presenting cells such as DCs deliver 
antigen to naïve T cells that differentiate into Th2 cells secreting characteristic IL-5, IL-
13 and IL-4. Th2 cells are required to support and amplify innate mechanisms resulting 
in the development of a diversified type-2 immune response required for immunity to 
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the complex multi-cellular pathogens.  Central to these responses are the cytokines IL-
4 and IL-13 that are secreted by both innate and adaptive cells. The dominance of a 
certain cell type is likely to be tissue and context-dependent, and therefore deciphering 
the relevant sources of cytokines will be of huge importance for the design of effective 
and targeted therapeutic strategies. 
 
1.5.4. Immunoregulation by intestinal helminths 
Intestinal helminths have generated great interest as potential therapeutic tools 
to treat autoimmune and inflammatory diseases due to their potent immunoregulatory 
properties. For example, helminth-derived ES proteins were shown to directly induce 
the differentiation of Foxp3+ Treg cells (Grainger et al., 2010) and H. polygyrus-elicited 
Treg cells were shown to suppress the development of allergic lung inflammation 
following HDM challenge (Wilson et al., 2005). Conversely, OVA-restricted Treg cells 
were expanded following H. polygyrus infection (Grainger et al., 2010) suggesting that 
Treg cells could efficiently suppress cells specific for a different antigen.  Furthermore, 
the development of Th2 responses can suppress the development of inflammatory 
type-1 responses, due cross-regulatory nature of the CD4+ Th2 and Th1 differentiation 
programs. Thus, parasite-derived antigens have been shown to limit the development 
of Th1-mediated autoimmune diseases (Harnett and Harnett, 2010). For example, H. 
polygyrus infection was shown to reduce the development of colitis in susceptible Il10–
/– mice (Elliott et al., 2004). Furthermore, ingestion of Trichuris suis eggs can 
dramatically reduce intestinal inflammation in patients suffering from inflammatory 
bowel disease (IBD) (Summers et al., 2003) and Crohn’s disease (Summers et al., 
2005). However, helminth-induced inhibition of type-1 responses could also have 
detrimental effects on immune responses to viruses and bacteria. Indeed, 
epidemiological data suggests that helminth-elicited type-2 responses negatively 
impact protective immune responses to co-infections including malaria (Coomes et al., 
2015), HIV (Cassol et al., 2009) and tuberculosis (Potian et al., 2011) (reviewed in 
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(Salgame et al., 2013)). Furthermore, increases in hygiene in developing countries as 
well as advances in medicine have had a consequence on the global distribution of the 
burden of helminth infections, correlating with a rise in asthma and allergy, indicative of 
the dominant regulatory environment established following helminth infection. The 
hygiene hypothesis proposes that reduced prevalence of intestinal helminths in 
developed countries has led to exacerbated type-2 immune responses normally kept in 
check by a regulatory environment in the context of helminth infections (Maizels, 2005). 
Excessive type 2 responses include the formation of obstructive granulomas in the liver 
of Schistosoma mansoni infected individuals (Gause et al., 2013) or hypersensitivity to 
food allergens causing severe vomiting and diarrhoea (Burton et al., 2014).  
Tregs are thought to play a dominant regulatory role in the control of Th2 
immune responses and immune-mediated pathology in response to helminth 
infections. Indeed, transient Treg depletion using DEREG mice preferentially expanded 
Th2 cells during T. muris infection (Sawant et al., 2014) and primary H. polygyrus 
infection (Rausch et al., 2009), suggesting that Treg cells were negatively regulating 
protective Th2 responses in these models. Similarly, concomitant antibody-mediated 
blockade of CD25-expressing cells and stimulation of GITR+ cells following infection 
with Litomosoides sigmondontis, led to the expulsion of established worms and 
increased type-2 cytokine production by CD4+ T cells in vitro after co-culture with APCs 
(Taylor et al., 2005), suggesting Treg cells limit functional expulsion of helminths. 
Conversely, Tregs limit the development of Th2-mediated pathology. For example, 
Treg cells were shown to accumulate in colonic granulomas surrounding S. mansoni 
eggs, and reduce the accumulation of immune cells and Th2-mediated fibrosis (Turner 
et al., 2011).  
H. polygyrus induces an early increase in Foxp3+ Treg cells in a primary 
infection (Finney et al., 2007; Rausch et al., 2008), in the face of a strong Th2 
response (Grainger et al., 2010). Treatment of naïve CD4+ T cells with HES, containing 
TGF-β homologs, results in the induction of Foxp3 expression and proliferation of 
Foxp3+ cells in vitro in a TGF-β-dependent way (Grainger et al., 2010). Furthermore, in 
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vivo blockade of TGF-β reduced worm burden in chronically infected mice (Grainger et 
al., 2010) demonstrating a role for parasite antigens in promoting a regulatory 
environment and limiting mechanisms of natural immunity. Another mechanism by 
which Treg cells may develop following H. polygyrus infection is through Treg 
stimulation by bacterial products such as LPS and lipoproteins that infiltrate the tissue 
following epithelial damage (Caramalho et al., 2003). Indeed, there is evidence that 
Treg cell numbers are impaired in the absence of TLR2 signalling (Reynolds et al., 
2014) following H. polygyrus infection. In addition, a tolerogenic population of CD11clow 
DCs were shown to preferentially generate Foxp3+ Treg cells in vitro in the presence of 
TGF-β, and depletion of CD11chigh cells led to a reduction in effector but not Treg 
responses (Smith et al., 2011), suggesting that H. polygyrus could either directly or 
indirectly (via DCs) promote Treg differentiation. In addition, non-canonical cytokines 
have been shown to promote Treg cells. For example, IL-6 was shown to limit Th2 
responses by promoting the expression of Foxp3, Helios and GATA-3 in CD4+ T cells 
(Smith and Maizels, 2014). Thus Il6–/– mice display an altered Treg phenotype and 
heightened Th2 responses, resulting in the expulsion of a primary infection with H. 
polygyrus (Smith and Maizels, 2014). In addition, H. polygyrus-elicited IL-1β was 
shown to impair the development of Th2 responses and promote chronicity of infection 
and therefore IL-1β-deficient mice expelled primary infection with H. polygyrus (Zaiss et 
al., 2013). 
Taken together, these studies highlight a diversity of mechanisms induced 
either directly or indirectly by intestinal helminths that result in the development of an 
immunoregulatory environment and the establishment of chronic infections. 
 
1.6. T cell plasticity  
1.6.1. T helper cell plasticity 
Although differentiated T helper cells were historically described as stable 
cellular lineages, many studies have highlighted a significant degree of plasticity 
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between T helper cells in vitro and in vivo (Bluestone et al., 2009). As previously 
discussed, the expression of TFs in response to cytokine signalling is required for the 
cross-regulation of different T helper cell subsets and their development. What this 
implies is that the balance in the expression of certain TFs and cytokines can dictate 
cell fate and promote the reversibility of lineages in vitro. For example, Th1 or Th2 cells 
generated in vitro were shown to readily co-express the opposing cytokine when 
exposed to the appropriate polarising environment (Krawczyk et al., 2007). This system 
has widely been used to manipulate T cell fate and provided valuable knowledge on 
transcriptional networks required for cytokine production. However more definitive 
evidence for the flexibility of T helper cells has emerged from studies in vivo. Indeed, 
many studies have reported the existence of hybrid cells co-expressing one or more 
characteristic T helper cell marker. For example, IL-4+IFN-γ+ (Krawczyk et al., 2007) 
and T-bet+Gata-3+ (Peine et al., 2013) cells were identified in vivo. IL-4+IFN-γ+ cells 
were found to develop following infection with the Th1-driving LCMV (Lymphocytic 
Choriomeninigitis virus) in response to interferon and IL-12 signalling and could provide 
protection against viral persistence as well as immunity to challenge infection (Lohning 
et al., 2008; Hegazy et al., 2010). The flexibility of Th17 cells and their conversion to 
Th1 cells has been widely reported in the context of autoimmunity and inflammation. 
For example, in vitro generated Th17 cells were shown to upregulate IFN-γ in response 
to IL-12 stimulation and mediate colitis following adoptive transfer (Mukasa et al., 2010; 
Feng et al., 2011).  A seminal study made use of fate-reporter mouse to track cells that 
have expressed IL-17 and demonstrated that the majority of CD4+IFN-γ+ cells isolated 
during EAE but not Candida albicans infected mice originated from IL-17-expressing 
cells (Hirota et al., 2011). Using this fate-reporter, Th17 were also shown to convert to 
T follicular helper cells in the Peyer’s patches following adoptive transfer, and 
contribute to the generation of class-switched mucosal IgA (Hirota et al., 2013). The 
characterisation of cytokine reporter mice has been valuable for increasing our 
understanding of the migration and fate of T helper cells. Indeed, in vitro generated 
Th2 cells (CD4+Il4-GFP+) cells were shown to convert to functional CD4+Ifng-YFP+ cells 
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and secrete IFN-γ during an infection with Plasmodium chabaudi, thereby controlling 
parasitemia levels (Coomes et al., 2015). Furthermore, although Ifng-YFP+ ex-Il4-GFP+ 
cells were transcriptionally re-wired, they were still able to produce IL-5 and IL-13 
following stimulation ex vivo, suggesting they maintained epigenetic memory of their 
Th2 past. It remains to be determined whether the flexible relationships described in 
vitro are functionally relevant in vivo. Furthermore, the extent of T helper cell plasticity 
in the context of infection and co-infection remains relatively unexplored. In this latter 
study, TCR engagement, IFN-γ and IL-12 signalling were required for Th2 to Th1 
conversion, which correlated with impaired Th2 responses and impaired immunity to H. 
polygyrus in mice co-infected with P. chabaudi (Coomes et al., 2015) suggesting Th 
conversion could be detrimental in the context of a co-infection with pathogens 
promoting polarised immune responses.  
It is interesting to speculate that the flexibility of T helper cells is evolutionarily 
advantageous in the context of co-infections with pathogens whose elimination is 
dependent on opposing T helper cell responses. In addition, emerging data suggests 
that protective immune responses to helminths are associated with multiple T helper 
cell lineages such as IL-4 and IL-17 suggesting certain infections may promote mixed T 
effector profiles.  
 
1.6.2. Treg plasticity  
As previously described, Treg cells develop independently to naïve T cells, and 
have always been thought to maintain stable expression of Foxp3. Although many 
mechanisms exist for the maintenance of Treg cells in vivo, recent studies have 
identified that both mouse and human Treg cells are unstable in vitro and in vivo in the 
context of inflammation and can lose Foxp3 expression to acquire pathogenic 
properties (Zhou et al., 2009; McClymont et al., 2011). Given that the TCR repertoire of 
Treg cells is so similar to auto-reactive T cells, Treg instability was shown to result in 
their differentiation into auto-reactive T cells that have the potential to contribute to the 
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development of disease. Understanding diverse disease and infection settings where 
Treg instability occurs is of significant therapeutic relevance as Treg-based therapies 
move closer to the clinic.  
 
1.6.2.1. Treg plasticity in vitro  
As previously discussed, Foxp3 mRNA and Foxp3 protein are maintained 
through tightly regulated and diverse stabilising mechanisms including through cytokine 
signalling with IL-2 (Fontenot et al., 2005) and IL-10 (Chaudhry et al., 2011). Indeed, 
the IL-2/STAT5 axis was shown to play an important role in the maintenance of Foxp3 
expression in the presence of inflammatory cytokines (Feng et al., 2014) suggesting 
that Treg cells have control mechanisms limiting loss of Foxp3 in response to 
cytokines, and that any change in CD25 expression or IL-2 levels have a significant 
impact on the stability of Treg cells. Therefore, recent work has focused on elucidating 
the impact of inflammatory cytokines on the stability of Treg cells, as purified Treg cells 
stimulated with inflammatory cytokines in vitro were shown to readily lose Foxp3 
expression (Feng et al., 2014). As previously described, a cross-regulatory relationship 
exists between Th17 and Treg cells during their development. Indeed, Treg cells 
cultured in the absence of TGF-β, which is required for their maintenance in vitro (Xu et 
al., 2007), and in combination with pro-inflammatory cytokines such as IL-6 were 
shown to lose Foxp3 expression (Veldhoen et al., 2006) and convert to IL-17-secreting 
cells (Yang et al., 2008). Furthermore, in vitro stimulation of Treg cells with both IL-6 
and IL-4 reduced Foxp3 expression and promoted type-2 cytokine secretion by 
Foxp3+CD25– cells (Komatsu et al., 2009). Furthermore, Treg-specific ablation of 
Ubc13 ubiquitin-conjugating enzyme resulted in their production of IL-17 and IFN-γ 
(Chang et al., 2012). In addition, Bach2-deficient Treg cells were able to secrete T 
helper cell cytokines in vitro (Roychoudhuri et al., 2013). Together, these studies 
support the fact that cytokines can promote Treg instability as well as their conversion 
to cytokine-secreting T helper cells.  
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1.6.2.2. Treg plasticity in vivo 
Evidence for instability of Foxp3 expression in vivo stems from recent 
observations demonstrating that the transfer of purified Foxp3+ Treg cells into a 
lymphodeficient host resulted in the loss of Foxp3 expression and acquisition of T 
effector cytokine production. Indeed, up to 90% of cells lost Foxp3 expression and 
started to produce effector cytokines including IL-4, IFN-γ and IL-2 following adoptive 
transfer into T-cell deficient or Rag2-deficient mice (Duarte et al., 2009; Komatsu et al., 
2009). Additionally, adoptively transferred Treg cells were shown to lose Foxp3 
expression and convert to Tfh cells in the Peyer’s patches (Tsuji et al., 2009) although 
it remains unclear whether this has any functional relevance, such as driving antibody 
class-switching (Hirota et al., 2013). In one previously discussed study, Foxp3+ Treg 
cells were shown to migrate to the LP and secrete IFN-γ whilst maintaining their 
suppressor function (Feng et al., 2011). Furthermore, these specialised Foxp3+IFN-γ+ 
Treg cells were later shown to lose Foxp3 expression and contribute to the pathogenic 
Th1 pool driving intestinal inflammation (Feng et al., 2011). This study suggests there 
may be a tipping point between the specialisation of Treg cells and their conversion to 
cytokine-producing T effector cells (Fig. 1.5). 
Taken together, these studies provided evidence that Treg cells had the 
potential to lose Foxp3 expression, previously thought to be a stable and heritable Treg 
marker. However there are caveats associated with Treg adoptive transfer models, 
including the risk of transferring small proportions of Foxp3– contaminants that may 
preferentially expand and differentiate into T effector cells. Additionally, the 
environment in lymphodeficient hosts is vastly different to that of WT mice, in particular 
due to the low levels of circulating IL-2 (normally secreted by proliferating T effector 
cells), required for Foxp3 maintenance (Fontenot et al., 2005). Indeed, the co-transfer 
of Foxp3– T cells with Foxp3+ Treg was shown to reduce the proportion of cells that lost 
Chapter 1 – Introduction  
 77 
Foxp3 expression (Komatsu et al., 2009) suggesting the lymphodeficient environment 
is promoting exaggerated Foxp3 loss. 
Support for the functional loss of Foxp3 expression in vivo stemmed from 
studies performed in the context of infection and inflammation where the dramatic 
reduction in Treg numbers correlated with increased T-cell mediated disease. For 
example, the frequencies of islet-cell resident Treg cells were shown to decline during 
the development of Type 1 diabetes in favour of increased pathogenic T effector cells 
(Tang et al., 2008). Thus, IL-2 treatment was employed to maintain a functional Treg 
population and control of pathogenic islet-cell reactive CD4+ T cells (Liston et al., 
2007). Similarly, frequencies of Foxp3+ Treg cells were dramatically decreased during 
an infection with Toxoplasma gondii, correlating with increased proportions of Th1 cells 
and reduced availability of IL-2 (Oldenhove et al., 2009). Furthermore, this correlated 
with increased expression of Tbx21 and secretion of IFN-γ by the remaining T cells, 
suggesting a proportion of the Treg population had lost Foxp3 expression and acquired 
a Th1 phenotype (Oldenhove et al., 2009). Indeed, the rescue of Treg numbers using 
IL-2c resulted in reduced immune-mediated pathology and disease (Oldenhove et al., 
2009). Taken together, these studies described environments where the proportion and 
absolute numbers of Treg cells reduce significantly to give way to a strong T effector 
population, and suggested that ex-Foxp3 cells may be contributing to the pathogenic T 
effector population.  
One way to test these observations and identify ex-Foxp3 cells in vivo is to use 
a mouse fate-mapping approach. Recent studies have taken advantage of fate-reporter 
mice to track the fate of Foxp3-expressing cells in various disease settings and to 
identify cells that have lost Foxp3 expression in vivo (ex-Foxp3 cells). For example, 
one study generated Foxp3 fate-reporter mice by crossing knockin BAC transgenic 
mice expressing GFP-Cre under the control of the Foxp3 promoter with ROSA-LSL-
YFP mice (Zhou et al., 2009). Using these mice, the authors were able to determine 
that 10-15% of peripheral CD4+ T cells were GFP–YFP+ suggesting they had lost 
Foxp3 expression (Zhou et al., 2009). The proportion of ex-Foxp3 cells secreting IFN-γ 
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and IL-17A was increased in the pancreatic lymph nodes of diabetic mice. Additionally, 
ex-Foxp3 cells were pathogenic after adoptive transfer (Zhou et al., 2009), suggesting 
that ex-Foxp3 cells were functional T effector cells. Similarly, Treg cells were shown to 
lose Foxp3 expression during the development of EAE (Bailey-Bucktrout et al., 2013). 
Ex-Foxp3 cells isolated from the spinal fluid of diseased mice had a demethylated 
Foxp3 CNS2 locus suggesting they had derived from bona-fide Treg cells. 
Furthermore, ex-Foxp3 cells were reactive to myelin oligodendricyte glycoprotein 
(MOG), secreted IFN-γ and were able to induce EAE in recipient mice following 
adoptive transfer (Bailey-Bucktrout et al., 2013). In a separate study, ex-Foxp3 cells 
were shown to accumulate in the synovial fluid of the joints during autoimmune arthritis 
and develop into IL-17-secreting cells (Komatsu et al., 2014). In contrast to the 
previous study, ex-Foxp3 cells displayed a methylated Foxp3 CNS2 locus suggesting 
there may have been de novo methylation of the Foxp3 locus. Functionally, IL-17+ ex-
Foxp3 cells were shown to promote osteoclatogenesis following adoptive transfer 
suggesting they may contribute to the pathogenesis of disease (Komatsu et al., 2014). 
Taken together these studies demonstrate that ex-Foxp3 cells can develop in vivo and 
that their proportion increases in the context of disease. Furthermore, these studies 
found that ex-Foxp3 T cells were pathogenic and contributed to the development of 
disease. Together, these in vitro and in vivo studies suggest that inflammatory 
cytokines could be promoting the loss of Foxp3, however the role of cytokines on Treg 
instability has not been investigated in these studies (Fig. 1.5).  
 There have been conflicting reports on Treg stability using fate-reporter mice. 
Another study generated fate-reporter mice by inserting a GFP-Cre-ERT2 vector into 
the Foxp3 locus and crossing the mice to ROSA-LSL-YFP reporter mice. This system 
allowed for the temporal expression of ROSA-LSL-YFP following tamoxifen treatment 
allowing the authors to track the loss of Foxp3 in mature Treg cells rather than 
throughout their development (Rubtsov et al., 2010). In contrast to previous strategies, 
the authors found that very few cells lost Foxp3 expression (around 5%) either at 
steady state or in the context of autoimmune inflammation or infection with Listeria 
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monocytogenes (Rubtsov et al., 2010) suggesting that Foxp3 cells do not lose Foxp3 
expression following their development. In a third study, a GFP-Cre vector was 
inserted into the endogenous Foxp3 locus and the mice were crossed to ROSA-LSL-
RFP mice. The authors describe the accumulation of ex-Foxp3 cells throughout life that 
had lost Treg-associated markers and were secreting inflammatory cytokines (Miyao et 
al., 2012). Further characterisation and lineage tracking of these cells revealed they 
were a small proportion of the total Treg pool expressing low levels of the fate-mark 
RFP and low levels of CD25, correlating with a methylated Foxp3 locus. Together, 
these results suggested that a proportion of newly developed Foxp3+ thymocytes were 
transiently expressing Foxp3 (Miyao et al., 2012). Indeed, this population was also 
identified in a separate study where the authors found that a fraction of peripheral cells 
lost Foxp3 expression but maintained a demethylated Foxp3 locus, termed 
‘epigenome+ cells’. Together, these studies suggest that the demethylation of the 
Foxp3 locus rather than Foxp3 expression itself correlated with a Treg phenotype, 
highlighting the separate nature of these events and the redundancy of Foxp3 
expression (Ohkura et al., 2012). To rectify many of the above discrepancies, the 
authors defined a ‘heterogeneity model’ of Treg development. In this model, it was 
proposed that a proportion of peripheral CD4+ T cells activate Foxp3 in response to 
TCR signalling without remodelling the CNS2 region of the Foxp3 locus or other Treg 
specific demethylated regions (Ohkura et al., 2012). These transiently expressing ex-
Foxp3 cells are later thought to differentiate into cytokine-producing effector cells. 
Importantly, this model also suggests that a proportion of the peripheral cells have truly 
lost Foxp3 expression in vivo. One caveat of these studies is the insertion of fusion 
proteins such as GFP-Cre into the Foxp3 locus, which was previously shown to disrupt 
Foxp3 function and its genomic signature, including the stability of Foxp3 expression 
(Bettini et al., 2012; Darce et al., 2012). Despite this, fate-mapping tools have provided 
a sophisticated method to identify Foxp3 instability in vivo, which will be important to 
test in diverse settings of immunity and infection.  
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1.6.3. Plasticity between Treg and Th2 cells 
Treg cells are important for the control of pathogenic Th2 responses in the 
context of allergic disease (Fyhrquist et al., 2012). In particular, extra-thymically 
derived Treg cells are thought to be important suppressors of Th2 responses and limit 
commensal-induced development of mucosal allergic disease (Josefowicz et al., 2012). 
Furthermore, helminth infections can promote de novo peripheral Treg differentiation 
and suppress the early differentiation of Th2 responses (Taylor et al., 2005; Taylor et 
al., 2009) and consequently Treg deletion during a primary infection restores Th2 
responses (Sawant et al., 2014). Recent work has described specific transcription 
factors associated with Foxp3 that are required for the regulation of Th2 responses by 
Treg cells (Zheng et al., 2009; Sawant et al., 2012). In addition, many studies describe 
Treg cells that have reduced or lost Foxp3 expression or are deficient in a co-factor 
associated with Foxp3 can preferentially acquire a Th2 effector phenotype (Wan and 
Flavell, 2007; Wang et al., 2010), indicating that there is a cross-inhibitory relationship 
between Treg and Th2 cells. Indeed, many studies have reported cross-regulation 
between Foxp3 and IL-4 in vitro (Pace et al., 2005; Skapenko et al., 2005; Mantel et 
al., 2007; Wei et al., 2007; Takaki et al., 2008; Hadjur et al., 2009; Pillemer et al., 2009; 
Chapoval et al., 2010; Tran et al., 2012), however the role of IL-4 signalling on Foxp3+ 
Treg cells in vivo is less clear.  
 
1.6.3.1. Cross-regulation between Treg and Th2 cells 
As mentioned above, the cross regulation between Treg and Th2 cells has 
been well documented in vitro. Mechanistically, Foxp3 was shown to regulate IL-4 
expression by inhibiting the translocation of NfκB to the nucleus as well as modifying 
the chromatin structure and accessibility of the Il4 locus (Kwon et al., 2008). 
Furthermore, TGF-β signalling was shown to activate the adaptors Ndfip1 and TF JunB 
and inhibit IL-4 expression, thereby promoting iTreg differentiation (Beal et al., 2012). 
Similarly, the TF Sox4, expressed upon TGF-β signalling, was shown to directly bind to 
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Gata3 and the Il5 promoter, thereby inhibiting Th2 function through two independent 
mechanisms (Kuwahara et al., 2012).  Conversely, both the Th1 and Th2 differentiation 
programs were shown to inhibit iTreg formation in vitro. Indeed, IL-4 could directly 
inhibit the differentiation of Treg cells through STAT6 activation (Wei et al., 2007). 
Furthermore, enforced GATA-3 expression in naïve T cells rendered the cells resistant 
to Foxp3 expression following their culture in iTreg conditions (Wei et al., 2007). 
Indeed, GATA-3 was shown to directly bind to the Foxp3 promoter and reduce iTreg 
frequency in vitro (Mantel et al., 2007). More recently, IL-4 induced pSTAT6 was 
shown to directly bind Dnmt1 DNA methyltransferases, leading to reduced mRNA 
expression of Foxp3 in vitro, which suggests that IL-4 signalling can directly interfere 
with the epigenetic status of the of the Foxp3 locus (Feng et al., 2014). Indeed, IL-4-
elicited STAT6 was shown to compete with IL-2 elicited STAT6 for Foxp3 binding 
(Feng et al., 2014). Evidence in vivo stems from a correlative study showing that 
treatment with IL-4c resulted in reduced numbers of Foxp3-expressing cells, 
suggesting that IL-4 directly regulates the Treg population (Mantel et al., 2007). In 
addition, STAT6-deficient mice had elevated frequencies of Foxp3+ cells after OVA 
challenge suggesting IL-4 acts through STAT6 and GATA3 to limit the expansion of 
Treg cells (Chapoval et al., 2011). Furthermore, the development of type-2 immune 
responses was shown to impair Treg function. Indeed, Th2-induced IgE was shown to 
promote Treg tolerance to oral allergens resulting in exacerbated disease (Burton et 
al., 2014). Furthermore, transgenic mice expressing a mutant IL-4Rα chain with 
increased signalling activity (IL4raF709) showed impaired iTreg formation and impaired 
suppressor function in the context of OVA sensitisation (Noval Rivas et al., 2015). In 
summary, the differentiation of Treg or Th2 cells is tightly controlled by the cross-
regulation of TFs downstream of cytokine signalling. Consequently, changes in the 
cytokine environment and activation of TFs have the potential to skew the balance 
towards either of the two populations.  
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1.6.3.2. Conversion of Treg to Th2 cells 
In the aforementioned study, increased IL-4 signalling in transgenic IL4raF709 
Treg cells was shown to promote Treg reprogramming to Th2 effector cells, correlating 
with the development of enhanced allergic disease following oral challenge (Noval 
Rivas et al., 2015). This study provides evidence of a direct role for IL-4 inhibition of 
Treg stability and function in vivo. This may be surprising given the observation that 
Treg cells increase dramatically despite the development of a polarised Th2 response 
following infections with diverse intestinal helminths (Taylor et al., 2009; Grainger et al., 
2010). However, it has been shown that the proportion of Treg cells was markedly 
reduced in the context of even stronger Th2 responses, for example following 
secondary infection with H. polygyrus (Liu et al., 2010), suggesting that high levels of 
IL-4 may be inhibiting Treg formation in the context of intestinal helminth infections. 
Furthermore, it is conceivable that Treg cells could be reprogramming to Th2 cells and 
contributing to memory Th2 cells, similarly to the observed conversion of Treg to Th1 
cells during Toxoplasma gondii infection (Oldenhove et al., 2009). Indeed, there is 
some evidence that Treg cells can convert to Th2 cells in vivo. FILIG (Foxp3-IRES-
luciferase-IRES-eGFP) mice were generated by knocking in IRES-eGFP cassette into 
the 3’-untranslated region of the endogenous Foxp3 locus, leading to Foxp3 mRNA 
destabilisation. Consequently, although FILIG mice displayed normal proportions of 
Treg cells, Foxp3+ cells had attenuated levels of Foxp3 expression and a reduced 
suppressive function, which resulted in the development of spontaneous autoimmune 
disease (Wan and Flavell, 2007). Interestingly, cells that exhibited reduced Foxp3 
levels were shown to secrete functional levels of the canonical Th2 cytokines IL-4, IL-
13 and IL-10 (Wan and Flavell, 2007) that could promote the differentiation of naïve T 
cells into Th2 cells in vitro (Wang et al., 2010). Th2 cytokine production by FILIG+ cells 
occurred independently of IL-4/STAT6 signalling but was dependent on GATA-3 (Wang 
et al., 2010). As previously described, Th2 differentiation can occur in a STAT6 
independent manner and similar mechanisms may be at play here (Wang et al., 2010). 
Similarly, a population of human CD45Ra– Treg cells was shown to readily lose Foxp3 
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expression in vitro, correlating with increased expression of Gata3 and the secretion of 
IL-4 and IL-13 (Hansmann et al., 2012). More recently, mice with a Treg-specific 
deficiency in Itch were shown to develop systemic inflammation and increased death 
due to dysregulation of Th2 responses (Jin et al., 2013). Itch-deficient Treg cells were 
shown to secrete IL-4, IL-5 and IL-13 and induce type-2 inflammation in response to 
OVA challenge (Jin et al., 2013). In addition, Bcl6-deficient Treg cells expressed higher 
levels of GATA-3 and Th2-related genes, indicating Bcl6 acts to suppress the 
development of a Th2 program in Treg cells (Sawant et al., 2012). Furthermore, Traf6-
deficient mice were shown to be prone to Type-2 autoimmune disease and Traf6-
deficient Treg cells were shown to lose Foxp3 expression in lymphopenic conditions 
and secrete IL-4 (Muto et al., 2013). Finally, Treg-specific deletion in the protein kinase 
Ck2 led to dysregulated Th2 responses and the development of allergic disease (Ulges 
et al., 2015). 
In summary, these studies demonstrate a close link between Treg and Th2 cells 
and suggest that discrete transcriptional, post-transcriptional and post-translational 
mechanisms limit Treg to Th2 conversion. This suggests that Treg to Th2 conversion 
could readily be disrupted in vivo, and furthermore, could be manipulated to promote 
the development of type-2 responses in the context of helminth infections.  
 
1.7. Thesis aims 
IL-4 producing CD4+ Th2 cells are required for functional immunity to the 
natural murine intestinal helminth H. polygyrus (Urban et al., 1991; Urban et al., 1991), 
however the cellular sources of IL-4 required for Th2 differentiation in vivo remain 
unclear. ILC2s have been shown to secrete type-2 cytokines in response to tissue-
derived alarmins or inflammatory mediators following intestinal helminth infections, 
including IL-5, IL-13, IL-4 and IL-2. Although ILC2s have been shown to be sufficient 
for the expulsion of some helminths, it is increasingly thought that they support the 
development of downstream type-2 responses, including the activation of T cells, 
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however the role for ILC2-derived cytokines for Th2 differentiation is unclear. In this 
thesis, we hope to characterise a role for ILC2-derived IL-4 in driving the differentiation 
of Th2 cells in vitro and in vivo during a chronic infection with H. polygyrus. 
Furthermore, ILC2s secrete IL-2 and are responsive to IL-2 signalling in vitro and in 
vivo, however the role of autocrine or paracrine IL-2 for the effector function of ILC2s 
has not been well characterised. In this thesis, we investigate the role of IL-2, including 
ILC2-derived IL-2 on the development and effector function of ILC2s. We hypothesise 
that ILC2s are an important source of IL-4 required for Th2 differentiation and immunity 
to H. polygyrus.  
Intestinal helminth infections promote a strong regulatory environment through 
the induction of CD4+Foxp3+ Treg cells, which limit the development of Th2 cells and 
proficient immunity. Functional expulsion of H. polygyrus occurs following secondary 
challenge, and correlates with a shift in the ratio of Treg to Th2 cells, resulting in the 
activation of a cascade of effector cells required for immunity. Diverse regulatory 
mechanisms control the maintenance of Treg cells and consequently maintain immune 
homeostasis and host survival. However in the context of inflammatory diseases, 
Foxp3+ Treg cells have been shown to lose Foxp3 expression and convert to 
pathogenic T helper cells. Whether Treg cells can convert to protective T helper cells 
and participate in pathogen clearance is currently unknown. In the second part of this 
thesis, we aim to test whether Treg cells can convert to Th2 cells and contribute to 
immunity to H. polygyrus. Furthermore, we aim to test the requirement of IL-4 signalling 
for the development and plasticity of Treg cells. Lastly, we would like to test the impact 
of Treg conversion to Th2 cells on functional immune responses.  
By studying the function of ILC2-derived IL-4 and the role of IL-4 signalling for 
Treg to Th2 conversion, we hope we can uncover two new pathways required for the 
differentiation of Th2 cells in vivo and functional immunity to H. polygyrus.  
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Figure 1.1. B- and T-lymphocyte development and differentiation. Schematic diagram of 
CD4+ T cell development and differentiation. Abbreviations: HSC (haematopoietic stem cell), 
CLP (common lymphoid progenitor), CILP (common innate lymphoid progenitor), DN (double 
negative), Treg (T regulatory cell), Th (T helper). CD4+ T cells, CD8+ T cells, B cells and CILP 
develop from the CLP in the bone marrow. DN T cells migrate to the thymus where they 
differentiate into γδ T cells or further differentiate into TCRαβ+ CD4- or CD8-expressing mature 
T cells. Immature B cells migrate to the spleen and lymph nodes where they undergo class 
switching upon activation to produce a diverse library of antibodies. In the thymus, T cells then 
undergo positive selection, negative selection or death by neglect, depending on the affinity of 
the TCR for self-antigen. Positively selected naive CD4+ T cells exit into the periphery where 
they migrate through the lymphatics to tissue-draining lymph nodes. In the thymus, 
CD4+TCRαβ+ with a strong recognition for self can further differentiate into CD25highFoxp3+ 
Treg cells. In the context of infection and inflammation, the presence of specific cytokines will 
drive the differentiation of naïve CD4+ T cells into Th1, Th2, Th17, Th22, Th9, Tfh or pTreg cells 
that secrete characteristic cytokine required for the development of proficient immune 
responses.   
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Figure 1.2. Molecular mechanisms of Th2 differentiation. Schematic diagram of the 
signalling pathways required for the differentiation of CD4+ Th2 cells. Both IL-4 and IL-2 
signalling (through the Type-1 IL-4R and IL-2R, respectively) are required for the differentiation 
of Th2 cells. Following TCR engagement and the activation of NFAT and NF-κB, IL-2 is 
secreted from activated cells and signals through STAT5 to activate Il4 as well as increase the 
expression of Il2ra and Il4ra. Following this, IL-4 signals through STAT6 to promote the 
expression of Gata3. Both STAT6 and GATA-3 can bind to the Th2 locus, comprised of Il4, Il13 
and Il5 loci and enhance their expression. Furthermore, Gata3 establishes a positive feedback 
loop by binding to its own promoter. Although Gata3 is fundamental for Il5 and Il13 expression, 
the TF c-maf is required for optimal expression of Il4, and occurs following Gata3 expression. In 
addition, the TF Irf4 stabilises the complex of STAT6, GATA-3 and c-maf. Thus, GATA-3 is 
fundamentally important for the differentiation and maintenance of Th2 cells.  
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Figure 1.3. Development and effector function of ILC2s. Schematic diagram of ILC2 
development and effector function. Abbreviations: HSC (haematopoietic stem cell), CLP 
(common lymphoid progenitor), CILP (common innate lymphoid progenitor), NK (natural killer), 
LTi (lymphoid tissue inducer), ILC (innate lymphoid cell), AAMΦ (alternatively activated 
macrophage), DC (dendritic cell). ILCs develop from the CILP in response to IL-7 signalling, and 
further mature in peripheral tissues. Group 2 ILCs (ILC2s) form part of the wider ILC family, 
which includes NK cells, group 1 (ILC1) and group 3 (ILC3) ILCs. ILC2s develop from CD25-, 
Sca-1-, CD127-expressing progenitor cells in the bone marrow, and are dependent on the 
expression of Gata3, Rora, Tcf7, Bcl11b and Gfi1. In the tissue, mature ILC2s express IL-25R, 
ST2 (IL-33R) and KLRG1 and secrete characteristic cytokines such as IL-13 and IL-5 in 
response to IL-25 and IL-33 signals. Furthermore, ILC2s secrete IL-9, IL-4, IL-2 and 
amphiregulin. ILC2s form functional relationships with other immune and non-immune cells 
through their cytokine production and expression of MHC Class II molecules. Thus, ILC2s have 
been implicated in the development of allergic disease as well as promoting wound healing and 
worm expulsion following infections with intestinal helminths.  
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Figure 1.4. Type-2 immune responses to the intestinal helminth Heligmosomoides. 
polygyrus. Schematic diagram of immune responses to Heligmosomoides polygyrus. 
Abbreviations: Hp (Heligmosomoides polygyrus), 1°/2° (primary/secondary), L3/4/5 (larval 
stages) HES (Hp excretory/secretory proteins), AAMΦ (alternatively activated macrophage), 
TSLP (thymic stromal lymphopoietin), Bas (basophil), Eos (eosinophil). Upon a 1° infection with 
Hp, activated and antigen-loaded DCs, migrate from the small intestine to the mesenteric lymph 
nodes and in the presence of IL-4, stimulate the differentiation of CD4+ Th2 cells secreting the 
characteristic cytokines IL-4, IL-13 and IL-5. Th2-derived IL-4 promotes class-switching of B cell 
to IgE and IgG1-secreting plasma cells. Th2 cells migrate back to the tissue and activate a 
variety of immune and non-immune effector cells. After challenge infection (2°) in drug-cured 
mice, a large granuloma composed of AAMΦ, DCs, eosinophils and Th2 cells forms around the 
invading larvae, creating a distinct granulomatous structure ultimately killing Hp larvae before 
their maturation. Extensive research has identified key immune pathways required for functional 
immunity to H. polygyrus, however the initial pathogen-derived triggers and the early events 
crucial for the development of CD4+ Th2 cells are still incompletely understood, including the 
role of ILC2s for the priming of Th2 cells in the MLN. 
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Figure 1.5. Treg specialisation and plasticity. Schematic diagram of Treg specialisation and 
plasticity. Foxp3+ Treg cells express TFs that are required for the stability of Foxp3 expression. 
For example, upon Treg-specific deletion of Itch, Bach2, Traf6 and Ck2 expression, Treg cells 
lose Foxp3 expression fail to limit the development of type-2 inflammatory disease. 
Furthermore, Treg cells can upregulate TFs associated with the development and differentiation 
of T helper cell subsets, enabling more specialised suppression. For example, IL-4 stimulated 
the expression of miR-182, which was required for their suppression of Th2 cells. Finally, 
cytokines can also promote loss of Foxp3 expression and conversion of Treg to T helper cells. 
For example, IL-4 was shown to stimulate the loss of Foxp3 expression in vitro and in vivo and 
result in the reprogramming of Foxp3+ cells to IL-4-expressing Th2 cells in the context of oral 
allergy.  
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Chapter 2: Materials and Methods 
2.1. Animals  
All mice used in this study were bred and maintained under specific pathogen-
free conditions at the Mill Hill Laboratory, Francis Crick Institute. Strains used include: 
C57BL/6, B6/CD45.1, C57BL/6 Rag2–/–(Shinkai et al., 1992), SJL Rag2–/–Il2–/– crossed 
with C57BL/6 at the Mill Hill Laboratory, Tcra–/–, TRE-IL-7R.BrtTA.ChuCD2Il7r–/– (Buentke 
et al., 2006) and DEREG (Lahl et al., 2007) mice. Double-reporter mice (Il4-
GFPFoxp3-RFP) were established by crossing Il4-GFP (4get) (Mohrs et al., 2001) mice 
with Foxp3-RFP (FIR) (Wan and Flavell, 2005) mice. Fate-reporter mice (Foxp3YFP-
CreIl4-GFPR26RFP635) were established by crossing Foxp3YFP-Cre (Rubtsov et al., 2008) 
mice with Il4-GFP (4get) (Mohrs et al., 2001) mice and R26RFP635 (Coomes et al., 
2015) mice. Il4ra–/– fate-reporter mice (Foxp3YFP-CreIl4-GFPR26RFP635Il4rafl/fl) were 
established by crossing Foxp3YFP-CreIl4-GFPR26RFP635 fate-reporter mice with C57BL/6 
Il4raflox/flox (Herbert et al., 2004) mice (backcrossed onto the C57BL/6 background by 
Judi Allen, University of Edinburgh). Bone marrow from the following strains were used 
for the generation of bone marrow chimeras: C57BL/6 Il4ra–/– (Jenkins et al., 2013), 
C57BL/6 Il4–/– (backcrossed onto the C57BL/6 background by Judi Allen, University of 
Edinburgh), Foxp3–/– (Fontenot et al., 2003) and RORαsg/sg (Sidman et al., 1962). 
Animal experiments were performed according to institutional guidelines and following 
UK Home Office regulations (project license 80/2506) and were approved by the UK 
National Institute for Medical Research Ethical Review Panel. Mouse strains were 
genotyped by PCR analysis of tail DNA and using Transnetyx Automated Genotyping.  
 
2.2. Heligmosomoides polygyrus infection 
The Heligmosomoides polygyrus lifecycle was maintained at Mill Hill 
Laboratory, The Francis Crick Institute. C57BL/6 lifecycle mice were infected with 200 
H. polygyrus larvae. Faeces from mice with established infections (day 14-30 post-
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infection) were spread on to damp filter paper and covered with activated charcoal. The 
filter paper was placed into a petri dish containing Milli-Q purified water and in a damp 
box protected from light exposure. From around day 7-10, infective third stage larvae 
(L3) accumulated in the purified water. The larvae were collected into 50ml tubes, 
filtered through 100μm filters (Fisher), spun at 200g for 5 minutes and adjusted to the 
appropriate concentration before use. Experimental mice were infected with 200 H. 
polygyrus L3 larvae by oral gavage. For some experiments, mice were treated with 
2.5mg/mL Pyrantel Embonate (Pfizer) on day 14 and 15 post-infection and 
subsequently given a challenge infection with 200 H. polygyrus larvae on day 28.  
 
2.3. Worm counts  
The small intestine was isolated from infected mice and opened longitudinally in 
PBS. The dissected small intestine was laid out lumen side up and adult worms were 
removed one at a time and counted using a stereoscopic microscope (SMZ-2B; Nikon). 
For worm counts at d9, the intestine was laid out lumen down in a petri dish and L5 
larvae were counted in the outer wall of the intestine before counting luminal worms as 
described above.  
 
2.4. IL-2 complex and antibody treatments 
Where indicated, mice were treated with IL-2 complex (IL-2c) i.p. IL-2c was 
formed of recombinant IL-2 (R&D) and anti-IL-2 antibody (clone JES6-1A12; BioXcell). 
They were prepared at a 1:10 ratio of IL-2:anti-IL-2 in sterile PBS for i.p delivery. 3 
doses were used in this study, IL-2chigh (5μg:50μg), IL-2cmed (2.5μg:25μg) and IL-2clow 
(0.5μg:5μg). For each experiment, 3 treatments are delivered to the mice every other 
day, on days 0, day 2 and day 4 (as specified in figure legends). For depletion of ILCs, 
Rag2–/– mice were injected with 300µg of anti-Thy1.2 antibody (clone 30H12; BioXCell) 
every other day for 5-6 treatments (as detailed in the specific figure legends) starting 
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one day before infection with H. polygyrus. Control mice received 300µg of isotype 
control antibody (clone LTF-2; BioXCell) at the same time-points.  
 
2.5. Preparation of single-cell suspensions 
2.5.1. Isolation of cells from the spleen, mesenteric lymph nodes and Peyer’s 
patches 
The spleen, mesenteric lymph nodes (MLN) and Peyer’s patches (PP) were 
dissected from mice and kept on ice in cIMDM (complete Iscove’s Modified Dulbecco’s 
Medium (Gibco) containing 1% FBS, 1mM EDTA, 100 U/mL Penicillin and 100 µg/mL 
Streptomycin (Gibco), 8 mM L-glutamine (Gibco), and 0.05 mM 2-mercaptoethanol 
(Gibco)). Single cell suspensions were prepared by gently mashing the organ through 
a 40µM filter (ThermoScientific) using a 5mL syringe plug. Cells were washed using 
PBS and centrifuged the cells at 1500pm (450g for 5min). Splenic red blood cells were 
lysed using ACK lysis buffer (Life Technologies; 1mL per spleen for 2min), washed with 
10mL PBS and centrifuged (1500prm, 5min). Cells were resuspended in cIMDM and 
prepared for Fluorescence Activated Cell Sorting (FACS) analysis or FACS sorting. 
 
2.5.2. Isolation of lamina propria cells  
For the isolation of lamina propria cells, the small intestine (SI) was dissected 
from mice making sure to remove all the mesenteric fat and PP. In a petri dish placed 
on ice, intestines were opened up longitudinally and the faecal contents were shaken 
out in PBS, twice. Intestines were cut into approximately 2-inch segments. Using a 
scalpel blade, the mucus layer was gently scraped off the lumen of the intestine 
avoiding damage to the lamina propria. Intestines were washed in PBS, resuspended 
in PBS containing 5% FBS and 25mM HEPES (Lonza) and centrifuged (1500rpm, 
3min). The IEL fraction was separated by incubating the intestines in PBS containing 
10% FBS, 15mM HEPES, 5mM EDTA (Life Technologies) and 1mM Dithiothreitol 
Chapter 2 – Materials and Methods  
 94 
(Sigma) for 25min in a bacterial shaker at 37°C. IEL fractions were discarded through a 
wide mesh into a beaker. To obtain the lamina propria fraction, the tissue was washed 
2-3 times in PBS containing 5% FBS and 25mM HEPES, centrifuged (1500rpm, 3min) 
and incubated in cIMDM containing 0.5mg/ml Liberase TL (Roche) and 60µg/ml DNAse 
(Roche) for 25-30min in a 37°C shaker. The digested tissue was passed through a 
100μm filter and centrifuged (1500rpm, 5min). To separate lymphocytes from the 
digested tissue, the cells were layered onto 40% isotonic Percoll (GE Healthcare) in 
cIMDM and centrifuged (2000rpm, 20min with applied breaks). Cells were resuspended 
in cIMDM and prepared for FACS analysis or sorting. 
 
2.5.3. Cell counting 
Aliquots of single-cell suspensions were diluted in cIMDM (1:5, 1:10, 1:20) and 
mixed at a 1:1 ratio in Trypan blue (Sigma). Live cells were counted using a cell 
counting haemocytometer (Hawksley) and a LED inverted light microscope (Leica).  
 
2.5.4. Cytospins 
FACS purified cells were fixed onto a slide using a Cytospin 4 cytocentrifuge 
(Thermo Scientific) and stained with a modified Giemsa stain (Sigma). Slides were 
scanned using a scanning light microscope. Pictures were taken at 60X with oil 
immersion using an Olympus IX71 inverted microscope (Olympus), captured with a 
Camera QIClick colour CCD camera (QImaging) and processed using Image Pro-Plus 
software (Media Cybernetics). Scanned images were analysed using Fiji (Open 
Source). 
 
2.6. Cell sorting and Flow Cytometry 
Cell sorting was performed using a FACS Aria II (BD Biosciences) or Influx (BD 
Biosciences). When sorting CD4+ T cells, CD4-expressing cells were first enriched 
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using MACS CD4 (L3T4) positive selection Microbeads and a MACS column (Miltenyi 
Biotech) according to the manufacturer’s instructions. Single cell suspensions were 
incubated on ice for 15 minutes with CD4 Microbeads in sterile PBS containing 0.5% 
FBS and 0.5mM EDTA. Cells were passed through magnetic selection columns and 
magnetically labelled cells were flushed into a 15mL flacon tube and centrifuged 
(1500rpm, 5min). When sorting ILCs from the MLN or lamina propria, single cell 
suspensions were obtained (as described above) and stained directly. Antibodies were 
made up to concentrations as indicated in Table 1 in PBS containing 2% FBS. Cells 
were stained in antibody mix for 25 min at 4°C, washed, centrifuged (1500rpm, 5min) 
and diluted in phenol-red free cIMDM for sorting. Sorted fractions were collected into 
phenol-red free cIMDM containing 20% FBS. FACS analysis was performed using a 
LSR II (BD Biosciences) or LSR Fortessa (BD Bioscience) FACS analyser. For FACS 
analysis, antibodies were made up to concentrations as indicated in Table 1 in PBS 
containing 2% FBS. 2-6x106 cells were stained in 100µl of antibody mix for 25 min at 
4°C, washed, centrifuged (1500rpm, 5min) and resuspended in PBS containing 2% 
FBS. Cells were sometimes fixed in 4% Formaldehyde (Sigma) for 20 min at 4°C for 
FACS analysis. For intra-cellular cytokine staining, cells were restimulated in cIMDM 
containing PMA (0.05 mg/mL phorbol 12-myristate 13-acetate (PMA) (Promega) and 
0.1 mg/mL ionomycin (Sigma) in the presence of GolgiStop (BD) and GolgiPlug (BD) 
for 6 hours at 37°C. Cells were washed, centrifuged and fixed using the Fix/Perm kit 
(eBioscience) as per the manufacturer’s instructions, or with PBS containing 2% 
Formaldehyde (Sigma) for 20min at 4°C. Cells were permeabilised in 1X 
permeabilisation buffer (eBioscience) for 30min at 4°C followed by FACS antibody 
staining in permeabilisation buffer for 25 min at 4°C. For all FACS sorting and analysis, 
viability of the cells was determined using the LIVE/DEAD Fixable Yellow or 
LIVE/DEAD Fixable Blue kit (Life Technologies).  
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2.7. Adoptive cell transfer model 
Specified reporter mice were infected with 200 H. polygyrus larvae for 14 days. 
CD4+TCRβ+Foxp3-RFP+Il4-GFP-CD25high (HpTR) cells were FACS-purified (as 
described above) from CD4-enriched spleens and MLNs of H. polygyrus infected 
reporter mice day 14 post-infection. In some experiments, cells were FACS-purified as 
CD4+TCRβ+Foxp3-RFP+Il4-GFP-CD25low (as specified in the figure legend). 
CD4+TCRβ+Foxp3-RFP-Il4-GFP-CD25-CD44low naïve T cells (nT) were sorted naïve 
double-reporter mice. Sort purified T cells were counted (as described above) and 
diluted in sterile PBS for intra-venous (i.v) delivery. For each experiment, 0.5x106 to 
1.5x106 HpTR or nT cells were injected into Tcra–/– mice infected with 200 H. polygyrus 
larvae on the day of transfer. Recipient mice were drug-cured and infected with a 
secondary H. polygyrus infection (as described above).  
 
2.8. In vitro cell cultures and stimulation assays 
2.8.1. T helper cell polarisation 
Mice were infected with 200 H. polygyrus larvae for 14 days. 
CD4+TCRβ+Foxp3-RFP+Il4-GFP-CD25high  (HpTR) cells were FACS-purified (as 
described above) from CD4-enriched spleens and MLNs of H. polygyrus infected 
reporter mice day 14 post-infection. CD4+TCRβ+Foxp3-RFP-Il4-GFP-CD25-CD44low nT 
cells were FACS-purified from naïve double-reporter mice. Sort purified cells were 
resuspended in cIMDM at a concentration of 1x106/mL. 1x105 HpTR or nT cells were 
plated onto tissue-culture treated flat-bottom 96-well plates coated with CD3 (BioXCell; 
1µg/mL) and CD28 (BioXCell; 10µg/mL) antibody at 37°C for 2-3 hours. A mix of 
recombinant IL-4 (Peprotech; 20ng/mL) and recombinant IL-2 (R&D; 20ng/mL) was 
added to the wells (final concentration of cells 1x105, final concentration of cytokine 
10ng/mL). At day 3, cells were removed from the plate and transferred to a round-
bottom plate. Cells were harvested at day 7 for FACS analysis.  
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2.8.2. T cell-ILC2 co-cultures 
CD45+Lin-Thy1.2+KLRG1+Sca1+ (ILC2) cells were sort purified from the LP or 
MLN as described above. Cells were counted, centrifuged (1500rpm, 5min) and 
resuspended at a final concentration of 5x104 cells per 50μl. ILC2s were cultured in 
cIMDM containing PMA (0.05 mg/mL phorbol 12-myristate 13-acetate (PMA) 
(Promega) and Ionomycin (0.1 mg/mL) (Sigma) for 24H. For some experiments (as 
specified in figure legends), the cell cultures were centrifuged after 3H and the 
supernatant containing PMA+I was replaced with fresh cIMDM for the remaining 21H. 
Supernatants were harvested 24H post-stimulation and stored at -20°C. 
CD4+TCRβ+Foxp3-RFP-Il4-GFP-CD25-CD44low nT cells were FACS-purified from naïve 
double-reporter mice. Sort purified cells were resuspended in cIMDM at a concentration 
of 1x106/mL. 1x105 nT cells were plated onto tissue-culture treated flat-bottom 96-well 
plates coated with CD3 (1μg/mL) and CD28 (10μg/mL) antibody (BioXCell) at 37°C for 
2-3 hours. Cells were resuspended in 50μl ILC2-derived supernatant with or without the 
addition of 10μg/ml of anti-IL-4 antibody (BioXCell). 
 
2.8.3. Macrophage differentiation and culture  
Bone marrow (BM) cells were flushed from the femur of male C57BL/6 mice, 
filtered through a 40µM filter and centrifuged (1500rpm, 5min). Cells were lysed in ACK 
lysis buffer (Life Technologies; 2mL per mouse for 1.5min), washed and centrifuged 
(1500rpm, 5min). Cells were counted and 5x106 cells were plated in petri dishes in 
conditioned media (Dulbecco’s Modified Eagle Medium with GlutaMAX (Life 
Technologies), 20% L-cell 929 (in-house media kitchen, Mill Hill Laboratory), 10% FBS, 
10mM HEPES, 100 U/mL Penicillin and 100µg/mL Streptomycin (Gibco), 2.7mM L-
glutamine (Gibco), 0.05mM 2-mercaptoethanol (Gibco), and 1mM Sodium Pyruvate 
(Lonza)). Additional conditioned media was added at day 4. Adherent cells, defined as 
bone-marrow derived macrophages (BMDMs), were harvested at day 7 and 
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resuspended in 1% DMEM with GlutaMAX (Life Technologies), 1% FBS, 10mM 
HEPES, 100 U/mL Penicillin and 100µg/mL Streptomycin (Gibco), 2.7mM L-glutamine 
(Gibco), 0.05 mM 2-mercaptoethanol (Gibco), and 1mM Sodium Pyruvate (Lonza). 
1x106 BMDMs were plated in 24-well flat bottom tissue-culture treated plates and left to 
rest for 24 hours. 1x105 FACS-purified T cells were resuspended in 1% DMEM 
containing soluble CD3 (1μg/mL) and soluble CD28 (10μg/mL) antibody (BioXCell) and 
cultured with the BMDMs for 24H. As a control, BMDMs were co-cultured in the 
presence of recombinant IL-4 (Peprotech; 20ng/mL) and IL-13 (Peprotech; 20ng/mL) or 
media alone. Non-adherent cells were washed off after 24H and adherent activated 
BMDMs were harvested for downstream analysis.  
 
2.8.4. Treg suppression assay 
CD4+TCRβ+CD25–CD44low nT cells were FACS-purified from CD45.2 C57BL/6 
mice. CD4+TCRβ+Il4-GFP–Foxp3-RFP+ (HpTRà Foxp3-RFP+), CD4+TCRβ+Il4-GFP–
Foxp3-RFP– (HpTRà DN) or CD4+TCRβ+Il4-GFP+Foxp3-RFP– (HpTRà Il4-GFP+) cells 
were FACS-purified from the spleen and MLN of Tcra–/– mice day 42 following adoptive 
transfer. nT were counted, centrifuged (1500rpm, 5min) and resuspended in PBS 
containing Cell Tracker Violet (CTV) (5mM, Life Technologies). The cells were 
incubated for 20 min at 37°C (final cell density 1x106/mL, final CTV concentration, 
5µM). Following this, nT cells were quenched in pre-warmed PBS, centrifuged 
(1500rpm, 5min) and resuspended in cIMDM. nT cells were cultured alone or with an 
equal number of FACS-purified HpTRà Foxp3-RFP+, HpTRà DN or HpTRà Il4-GFP+  
cells at varying ratios (1:1, 1:5 and 1:10) in the presence of CD3/CD28 activator 
Dynabeads (Life Technologies) and harvested after 64h for FACS analysis. 
 
2.8.5. Generation of bone marrow chimeric mice 
BM cells were isolated by flushing adult femurs or by gently crushing bones 
isolated from juvenile RORαsg/sg and Foxp3–/– mice using a pestle and mortar. BM cells 
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were filtered through a 40µM filter and centrifuged (1500rpm, 5min). BM cells were 
lysed in ACK lysis buffer (Life Technologies; 2mL per mouse for 1.5min), washed, 
centrifuged (1500rpm, 5min) and stored in 90% FBS with 10% DMSO in liquid nitrogen 
until needed. To set up bone-marrow chimeras, cells were thawed and counted (as 
described above). The cells were mixed at the required ratios and diluted in sterile PBS 
for i.v delivery. Tcra–/– or TRE-IL-7R.BrtTA.ChuCD2Il7r–/– mice were irradiated with 900 
RADs. 3-5x106 BM cells (depending on the experiment) were transferred intravenously 
to mice. Mice were fed antibiotics for 3 weeks and the BM cells were left to reconstitute 
for 7-8 weeks before the start of the experiment.  
 
2.9. RNA extraction and gene expression analysis 
2.9.1. RNA extraction from tissue samples 
Tissue samples were harvested and frozen in RNAlater® at -20°C. Tissue 
samples were homogenised in 500µl Qiazol (Qiagen) using a Precellys Homogeniser 
(Precellys). 200µl chloroform was added and the samples were shaken and left at 
room temperature for 10min. The samples were spun in a table-top microcentrifuge at 
maximum speed for 15min. Supernatants were added to EtOH and samples were 
processed using the RNAeasy kit (Qiagen) according to the manufacturer’s instructions 
and eluted in 30-50µl RNAse/DNAse-free water (5 Prime). 
 
2.9.2. RNA extraction from cells 
Sort purified cells were harvested and stored in RLT lysis buffer (Qiagen) at -
20°C. The RNeasy kit (Qiagen) was used to perform RNA extractions according to the 
manufacturer’s instructions and eluted in 30-50µl of RNAse/DNAse-free water (5 
Prime). For quantitative real-time polymerase chain reaction (qRT-PCR), RNA 
concentrations were quantified using a Nanodrop 1000 (Thermo Scientific).  
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2.9.3. Real-Time PCR 
RNA concentrations were quantified using a Nanodrop 1000 (Thermo 
Scientific). 0.1-1µg RNA was reverse transcribed using the Qiagen Quantitect Reverse 
Transcription kit (Qiagen) according to the manufacturer’s instructions. For some 
experiments, the cDNA produced was diluted with RNAse/DNAse-free water before 
proceeding. cDNA was used for real-time PCR analysis using Power SYBR® Green 
Master Mix and analysed using an Applied Biosystems 7900HT Fast Real-Time PCR 
System (both Applied Biosystems). The PCR conditions were as follows: 95°C for 
15min, 40 cycles of 94°C for 30s, 55°C for 30s, 70°C for 30s followed by a melting step 
of 95°C for 15s, 60°C for 15s, 95°C for 15s. Gene expression was normalised to the 
house-keeping gene hypoxanthine-guanine phosphoribosyl transferase (HPRT). In 
some experiments gene expression was expressed as fold-change relative to naïve or 
PBS treated mice (as specified in the figure legends). Sequences for the primers used 
are listed in Table 2. All primers were used at 1pmol/mL.  
 
2.9.4. Microarray analysis and IPA analysis 
CD4+TCRβ+Foxp3-RFP+Il4-GFP-CD25high  (HpTR) cells were FACS-purified 
from CD4-enriched spleens and MLNs of H. polygyrus infected reporter mice day 14 
post-infection. CD4+TCRβ+Foxp3-RFP-Il4-GFP-CD25-CD44low nT cells were FACS-
purified from naïve double-reporter mice. CD4+TCRβ+Il4-GFP–Foxp3-RFP+ (HpTRà 
Foxp3-RFP+), CD4+TCRβ+Il4-GFP–Foxp3-RFP– (HpTRà DN) or CD4+TCRβ+Il4-
GFP+Foxp3-RFP– (HpTRà Il4-GFP+) were FACS-purified from HpTR Tcra–/– recipients 
and CD4+TCRβ+Il4-GFP–Foxp3-RFP+ (nTà Foxp3-RFP+), CD4+TCRβ+Il4-GFP–Foxp3-
RFP– (nTà DN) or CD4+TCRβ+Il4-GFP+Foxp3-RFP– (nTà Il4-GFP+) were FACS-
purified from nT Tcra–/– recipients day 42 following adoptive transfer. RNA was 
extracted from the FACS-purified populations and concentrated using a MiVac DNA 
concentrator (Barnstead, Genevac). The Systems Biology Unit at Mill Hill Laboratory, 
The Francis Crick Institute processed samples for microarray analysis. RNA quality 
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was determined using a 2100 Bioanalyzer (Agilent). RNA concentrations were 
determined using a Qubit 2.0 Fluorometer (Life technologies). cDNA was amplified 
from 20ng total RNA using the Ovation® Pico WTA system (version 2) (NuGEN) . 
Amplified cDNA was fragmented and labelled using the Encore Biotin Module 
(NuGEN). Labelled cDNA was hybridised to an Affymetric GeneChip® mouse Genome 
430A 2.0 microarray using the GeneChip® Hybridization, Wash and Stain Kit 
(Affymetrix) and ran on the 450 Affymetrix GeneChip Fluidics Station (Affymetrix) 
followed by scanning on the 3000 7G Affymetrix GeneChip Scanner (Affymetrix). 
Microarray data was analysed using the GeneSpring software (Agilent). Samples were 
normalised using the Affymetrix MicroArray Suite 5 method (MAS5) and filtered by 
Flags and expression (20-100 percentile). Differentially expressed genes were 
determined using unpaired T-tests relative to nT control cells. Genes with false 
discovery rate-corrected P values <0.05 and fold change values ≥2.0 were considered 
significant. 3 biological replicates of each sample were used. Each biological replicate 
contains cells pooled from 3-4 mice. 3-4 way comparative analyses and hierarchical 
clustering were performed on significantly expressed genes using GeneSpring 
(Agilent). Predicted upstream regulators were determined using Ingenuity Pathways 
Analysis (Ingenuity systems). 
 
2.10. Bisulphite modification of DNA and sequencing  
2.10.1. Bisulphite modification of DNA  
 CD4+TCRβ+Foxp3-RFP+Il4-GFP-CD25high  (HpTR) cells and 
CD4+TCRβ+Foxp3-RFP–Il4-GFP+ (Il4-GFP+) cells were FACS-purified from CD4-
enriched spleens and MLNs of H. polygyrus infected reporter mice day 14 post-
infection. CD4+TCRβ+Foxp3-RFP-Il4-GFP-CD25-CD44low nT cells were FACS-purified 
from naïve double-reporter mice. CD4+TCRβ+Il4-GFP–Foxp3-RFP+ (HpTRà Foxp3-
RFP+), CD4+TCRβ+Il4-GFP–Foxp3-RFP– (HpTRà DN) or CD4+TCRβ+Il4-GFP+Foxp3-
RFP– (HpTRà Il4-GFP+) were FACS-purified from HpTR Tcra–/– recipients day 42 
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following adoptive transfer. Foxp3-YFP-Cre+Il4-GFP– (Foxp3-YFP-Cre+) Foxp3-YFP-
Cre–Il4-GFP+ (Il4-GFP+) Foxp3-YFP-Cre–Il4-GFP+FP635+ (Il4-GFP+FP635+) cells were 
sorted form the spleen and MLN of fate-reporter mice day 7 following secondary 
infection. Sorted cells were centrifuged (2500 rpm, 5min) and cell pellets were digested 
in 1X TE buffer containing proteinase K (200µg/ml) and 0.5% sodium dodecyl sulphate 
(SDS, Life Technologies) at 55°C for 3-4 hours. DNA was extracted using 
Phenol/Chloroform (Sigma), centrifuged (13,000rpm, 10min) and washed in 100% 
chloroform (Sigma). The aqueous phase was removed and added to 100% ethanol for 
DNA precipitation. For large quantities of DNA, the DNA was fished using a glass 
pipette, washed in 70% ethanol and eluted in 30-40µl dH2O. DNA concentrations were 
measured using a Nanodrop 1000 (Thermo Scientific). For smaller quantities, the DNA 
was precipitated in 100% ethanol at -20°C for 20min, then centrifuged (13,000rpm, 
10min). Supernatant was gently removed and the pellet was eluted in 30-40µl dH2O. 
DNA concentrations were measured using the Quant-iT™ PicoGreen® dsDNA Assay 
Kit (Life technologies). Bisulphite modification was performed as described previously 
(Clark et al., 1994). Briefly, 1µg of DNA was denatured in a final concentration of 0.3M 
NaOH at 37°C for 15min. 2M Meta Bisulphite (Sigma) and 100mM Hydroquinione 
(Sigma) were made up in distilled water and the pH was adjusted to 4.5-5. Denatured 
DNA was modified in Bisulphite (6.14 x VDNA) containing 0.5mM Hydroquinone. The 
sample was gently mixed, overlayed with mineral oil and incubated at 55°C overnight 
(16-20hours). DNA was recovered from under the mineral oil and purified using ChIP 
DNA Clean & Concentrator kit (Zymo Research) according to the manufacturer’s 
instructions and eluted in 50µl elution buffer. Freshly prepared NaOH was added to a 
final concentration of 0.3M at 37°C for 15min. The solution was neutralised with 3M 
Ammonium acetate. DNA was ethanol precipitated as described above and eluted in 
20-50µl dH2O. DNA concentrations were measured using the Quant-iT™ PicoGreen® 
dsDNA Assay Kit (Life technologies). Efficiency of DNA modification was assessed by 
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qRT-PCR with methylation specific primers (see Table 2) designed on UroGene (Li and 
Dahiya, 2002). 
 
2.10.2. Cloning and sequencing 
PCR reactions were performed on MasterCycler Gradient S PCR cycler 
(Eppendorf) in a final volume containing 1X PCR buffer, 0.5U Taq Polymerase 
(Thermo Scientific), 0.4mM dNTPs, 0.2-1pmol each of forward and reverse primers 
and 0.1µg DNA. The amplification conditions were 94°C for 3min, 10 cycles of 94°C for 
30s, 63°C down to 53°C for 40s (touchdown), 72°C for 45s, 40 cycles of 94°C for 30s, 
53°C for 30s and 72°C for 45s, and a final extension step of 72°C for 5min. Primers 
used for amplification of bisulphite modified DNA for sequencing (see Table 2) were 
designed based on previous studies (Floess et al., 2007) using MethPrimer primer 
design software (Li and Dahiya, 2002). PCR products were gel purified using QiaQuick 
Gel Extraction Kit (Qiagen) according to the manufacturer’s instructions. Purified DNA 
was concentrated using a speed vacuum concentrator. DNA was cloned into OneShot 
TOP10 Chemically competent E. coli according to the manufacturer’s instructions and 
cells were plated on ampicillin plates (100mg/L) with X-gal (20mg/ml). Clones were 
cultured overnight in LB Broth (in-house media kitchen, Mill Hill Laboratory, The 
Francis Crick Institute) containing 0.1mg/mL ampicillin (Sigma). 10-16 clones were sent 
for sequencing (Source Bioscience). Sequencing results were analysed using 
Seqbuilder and online Quantification Tool for Methylation Analysis (QUMA) (Kumaki et 
al., 2008).   
 
2.11. Cytokine measurements 
2.11.1. ELISA  
 IL-5 and IL-13 were measured in cell culture supernatants using DuoSet 
ELISA kits, according to the manufacturer’s instructions (R&D systems – Biotechne). 
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2.11.2. Flow Cytomix 
IL-4, IL-2, IL-5 and IL-13 were measured in cell culture supernatants using the 
FlowCytomix™ flow cytometry multi analyte detection system according to the 
manufacturer’s instructions (eBioscience).   
 
2.12. Western Blot  
For immunoblotting, cells were lysed in 1X RIPA buffer (500mM Tris HCl Ph2.5, 
150mM NaCl, 2mM EDTA, 0.1% SDS, 0.5% deoxycholate, 1% Nonidet-P40) 
containing protein inhibitors as per the manufacturer’s instructions (diluted 1:50; 
Roche), 5mM NaF, 1mM Na3VO4, 100nM Okadoic acid, 2mM Na4P2O7 and MilliQ 
water. Cell lysates were normalised to equal total protein content using the Pierce BCA 
Protein Assay Kit (Life Technologies) and resolved on 10% CriterionTM TGXTM Gels 
(Biorad). Separated proteins were transferred onto Trans-Blot® TurboTM PVDF transfer 
(Biorad) membranes. Membranes were blocked in 0.1% PBST (Sigma) containing 20% 
milk (Sigma) and then incubated with primary (pSTAT6, STAT6; Cell Signalling, 
αTubulin; in-house) and secondary (Rabbit IgG; GE Healthcare) antibodies in 0.1% 
PBST (Sigma) containing 10% milk (Sigma). Membranes were washed in PBST and 
specific bound antibodies were visualised by chemiluminescence (Immobilon; Merck 
Millipore). 
 
2.13. Statistical analysis 
Data sets were compared by unpaired t-tests (two-tailed Mann Whitney test) 
using GraphPad Prism (V.5.0). Some graphs were analysed using one-tailed Mann 
Whitney test (as specified in the figure legends).  Differences were considered 
significant at *P ≤ 0.05. 
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2.14. FACS antibodies and FACS-sorting staining panel 
Marker Clone Conjugate [C] µg/mL 
CD4 RM4-5 APC, BioL; eFluor 450, eBio 0.5-1.0 
CD4 MCD0430 Pacific Orange, Invitrogen 0.5 
CD8 53-6.7 APC, BioL 0.5 
CD3 145-2C11 APC, BioL 1.0 
TCRαβ H57-597 PeCy7, PerCPCy5.5, BioL; APC, eBio 0.5-1.0 
TCRγδ GL3 APC, BioL 1.0 
CD44 IM7 PeCy7, Pacific Blue, BioL; PerCPCy5.5 eBio  1.0-2.5 
CD25 PC61 APCCy7, BioL; PerCPCy5.5 eBio 1.0 
CD103 2E7 APC, eBio 1.0 
CD49b DX5 APC, BioL; PB, eBio 1.0-2.0 
CD11c N418 APC, BioL; PeCy7, eBio 1.0 
CD11b M1/70 APC, BioL 0.1 
CD19 6D5 APC, BioL 0.5 
CD45.1 A20 APC, eBio 1.0 
CD45.2 104 PeCy7, BioL 1.0 
CD45 30-F11 APCCy7, BioL; FITC eBio 0.5-1.0 
CD69 H1-2F3 PB, eBio 1.0 
CTLA-4 UC10-4B9 APC, BioL 1.0 
GITR ebioAITR eFluor 450, eBio 1.0 
Foxp3 FJK-16S PE, eBio 1.0 
IL-13 eBio13A Alexa Fluor 288, eBio 2.5 
IL-4 11B11 PE, eBio 1.0 
IL-5 554396 APC, BD Biosciences 1.0 
Thy1.2 53-2.1 PeCy7, BioL 0.5 
KLRG1 2F1 PErCPe710, eBio 1.0 
IL7Ra A7R34 PE, BioL 1.0 
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FCER1 MAR-1 APC, BioL 1.0 
NK1.1 PK136 APC, BioL 1.0 
Sca1 E13-161.7 PB, eBio 2.5 
Siglec-F E50-2240 PE, BioL  
c-kit 2B8 PerCPCy5.5, BioL 1.0 
Gr-1 RB68C5 APC, BioL 0.5 
Ter119 TER-119 APC, BioL 1.0 
CXCR5 2G8 Biotin, BD Biosciences 2.5 
PD-1 29F.1.A12 PeCy7, BioL 1.0 
ILC2 sorting panel: Live, lymphocytes, CD45+, Lineage–(CD3, CD4, CD8, CD19, 
CD11c, CD11b, NK1.1, TCRβ, TCRγδ, Gr-1, CD49b, Ter119), Thy1.2+, KLRG1+, 
Sca1+ 
HpTR sorting panel: Live, lymphocytes, CD4+, TCRβ+, Il4-GFP–, Foxp3-RFP+, 
CD25high 
 
2.15. PCR primers  
RT-PCR Primers 
 
 Forward 
 
Reverse 
Hprt GCCCTTGACTATAATGAGTACTTCAGG TTCAACTTGCGCTCATCTTAGG 
Il4 ACGAGGTCACAGGAGAAGGGA AGCCCTACAGACGAGCTCACTC 
Il5 TGACAAGCAATGAGACGATGAGG ACCCCCACGGACAGTTTGATTC 
Il13 CCTCTGACCCTTAAGGAGCTTAT CGTTGCACAGGGGAGTCTT 
Arg1 GGAAAGCCAATGAAGAGCTG GCTTCCAACTGCCAGACTGT 
Ym1 CATGAGCAAGACTTGCGTGAC GGTCCAAACTTCCATCCTCCA 
Retnla CCCTCCACTGTAACGAAGACTC CACACCCAGTAGCAGTCATCC 
Retnlb ATGGGTGTCACTGGATGTGCTT AGCACTGGCAGTGGCAAGTA 
Muc5ac CAGGACTCTCTGAAATCGTACCA AAGGCTCGTACCACAGGGA 
Mcl3a3 CATCGCCATAGACCACGACG TTCCAGCTCTCGGGAATCAAA 
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Il9 ATGTTGGTGACATACATCCTTGC TGACGGTGGATCATCCTTCAG 
Il22 GTGAGAAGCTAACGTCCATC GTCTACCTCTGGTCTCATGG 
Il17A ACCCTGGACTCTCCACCGCAA GGCTGCCTGGCGGACAATCG 
Rorct GGAGCTCTGCCAGAATGACC CAAGGCTCGAAACAGCTCCAC 
Gata3 CGGGTCGGCCAGGCAAGATG AGGGGACCTCCCAGCAGGC 
Il10 ATGCTGCCTGCTCTTACTGACTG CCCAAGTAACCCTTAAAGTCCTGC 
Il4ra TCCCATTTTGTCCACCGAAT GTTTCTAGGCCCAGCTTCCA 
Il2 CTAGGCCACAGAATTGAAAGATCT GTAGGTGGAAATTCTAGCATCATCC 
Il33 CACATTGAGCATCCAAGGAA AACAGATTGGTCATTGTATGTACTCAG 
Foxp3 GTGGGCACGAAGGCAAAG CCTTGTTTTGCGCTGAGAGTCT 
   
Bisulphite sequencing primers  
2a TGGGTTTTTTTGGTATTTAAGAAAG AAAAAACAAATAATCTACCCCACAA 
2b2 GAAATTTGTGGGGTAGATTATTTGT AACTAACCAACCAACTTCCTACACTAT 
3 TTTTAAGTTTAAAATTAGTTTGGTTAA CTCAAATCCTTTTTCTATCAAAAATAT 
 
Methylation specific primers  
Mod TGATTTTTTTAAAATATAAAGAAATACGG TCCCAAATACTAAAATCAAAAACA TACG 
Unmod TGATTTTTTTAAAATATAAAGAAATATGG  TCCCAAATACTAAAATCAAAAACATACAC 
Gen TGACTCTTCTAAAACACAAAGAAACACGG TCCCAAGTGCTGGGATCAAAGGCATGCG 
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Chapter 3: IL-4-secreting ILC2s are essential for the differentiation of Th2 cells 
following helminth infection 
3.1. Introduction 
ILC2s have emerged as key players in the development of type 2 immune 
responses. Gain and loss of function experiments have demonstrated that ILC2s were 
both sufficient and necessary for the functional expulsion of acute infection with the 
intestinal helminth, N. brasiliensis (Oliphant et al., 2014). However the function of 
ILC2s in a model of chronic intestinal infection such as an infection with the natural 
murine helminth Heligmosomoides polygyrus remains unclear. ILC2 numbers were 
shown to expand early following H. polygyrus infection (Mackley et al., 2015) and 
correlated with genetic resistance to H. polygyrus (Filbey et al., 2014). In addition, 
ILC2s co-localise with CD4+ T cells in the mesenteric lymph nodes (Mackley et al., 
2015). In light of recent work demonstrating antigen-dependent co-operation between 
ILC2 and T cells for the development of type-2 responses (Oliphant et al., 2014), we 
wanted to test whether ILC2s contributed to the differentiation of Th2 cells following 
infection with H. polygyrus, and whether this was through their ability to secrete Th2-
associated cytokines.  
ILC2s secrete type-2 cytokines such as IL-13, IL-5 and IL-9 in response to epithelial 
cell-derived alarmins (Moro et al., 2010), with ILC2-derived IL-13 being particularly 
important for immunity to N. brasiliensis. Transfer of WT, but not IL-13-deficient ILC2s 
resulted in the expulsion of N. brasiliensis in lymphodeficient mice (Neill et al., 2010). 
Furthermore, IL-13 production by ILC2s was shown to be required for the recruitment 
of CD40+ DCs to the local draining lymph nodes and differentiation of Th2 cells 
resulting in N. brasiliensis clearance (Halim et al., 2014). However in addition to IL-13, 
IL-5 and IL-9, both murine and human ILC2s have been shown to secrete IL-4 
(Mjosberg et al., 2012; Doherty et al., 2013) and IL-2 (Crellin et al., 2010; Molofsky et 
al., 2013), however the role of these cytokines from ILC2s has not been reported. Both 
IL-4 and IL-2 are essential for the differentiation of Th2 cells in vitro (Liao et al., 2008), 
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however the contribution of ILC2-derived IL-4 or IL-2 to Th2 differentiation remains 
unknown. 
A variety of innate cells secrete IL-4 however their relative contribution to Th2 
differentiation in vivo is still debated. Following the observation that ILC2s secrete IL-4, 
we hypothesised that ILC2-derived IL-4 may be an important early source of IL-4 for 
Th2 differentiation. IL-4 blockade in vitro (Oliphant et al., 2014) and in vivo (Halim et 
al., 2014) did not impair ILC2 effector function and IL-13 production in the context of N. 
brasiliensis or papain lung challenge respectively, however immunity to N. brasiliensis 
does not require IL-4 (Lawrence et al., 1996; Halim et al., 2012) suggesting that this 
may not be the most appropriate model for studying ILC2-derived IL-4. Conversely, IL-
4 is both necessary (Urban et al., 1991) and sufficient (Urban et al., 1995; Herbert et 
al., 2009) for immunity to H. polygyrus. For these reasons we decided to test the role 
for ILC2-derived IL-4 in the context of H. polygyrus infection. 
In this chapter, we tested the requirement of ILC2-derived IL-4 for the differentiation 
of Th2 cells during primary infection with H. polygyrus. Although ILC2s were increased 
following infection and following treatment with IL-2 complex (IL-2c), they were 
insufficient to mediate expulsion of H. polygyrus in the absence of T cells. Instead, we 
hypothesised that ILC2s cooperated with T cells and that ILC2-derived IL-4 was 
required for the differentiation of Th2 cells in vivo. We found that ILC2s isolated from 
the small intestine of H. polygyrus infected mice expressed Il4-GFP and secreted IL-4 
protein in vitro. Furthermore, ILC2-derived IL-4 was sufficient to drive Th2 
differentiation in vitro and ILC2s were required for the development of Th2 responses 
in vivo. In addition, we identified that the ILC2s did not require IL-2 for their 
development or effector function suggesting that in the context of early Th2 
differentiation, ILC2s provide help to adaptive immune cells and not vice-versa.  
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3.2. Results 
3.2.1. ILC2 expansion correlated with the development of type-2 responses 
during primary infection with H. polygyrus 
3.2.1.1. Development of type-2 immune responses early following primary 
infection with H. polygyrus 
We infected C57BL/6 mice with H. polygyrus and measured the gene 
expression of key type-2 response genes at days 5, 7, and 10 post-infection in the 
small intestine by qRT-PCR. We observed a significant elevation of the type-2 
response as early as day 5 (d5) following infection in comparison to naïve mice (d0) 
(Fig. 3.1) including elevated levels of Il13, Il5 and Il4 throughout the timecourse (Fig. 
3.1). Furthermore, the expression of epithelial-cell derived IL-33 (Il33), known to 
promote type-2 responses and activate ILC2s, was significantly elevated from day 3 
post-infection. In addition, goblet cell-derived Relmβ (Retnlb), which is secreted 
downstream of IL-13 signalling, was significantly upregulated from d5 in comparison to 
uninfected mice (d0). Finally, the expression of genes associated with AAMΦ following 
IL-4 and IL-13 exposure such as Relmα (Retnla) and Arginase (Arg1), were 
significantly increased at day 5 post-infection, and followed the same pattern 
thereafter. Increased expression of type-2 genes also correlated with heightened 
mucus production by intestinal goblet cells as assessed by period acid-Schiff (PAS) 
staining, particularly at d7 and d10 (Fig 3.1.B), correlating with the highest expression 
of type-2 cytokines.  
 
3.2.1.2. Expansion of ILC2s day 5 following primary infection with H. polygyrus. 
Killer lectin-like receptor 1 (KLRG1) is an e-cadherin receptor (Henson and 
Akbar, 2009) expressed on many cells of the immune system including NK cells 
(Blaser et al., 1998) and activated CD4+ T cells (Voehringer et al., 2002). Within the 
ILC population, GATA-3+ ILC2s were shown to uniquely express KLRG1 (Hoyler et al., 
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2012), permitting its use as a marker for ILC2s for FACS-based analysis. FACS-based 
gating strategies for identifying ILC2s had previously defined them as Sca1+ (Moro et 
al., 2015) however because all KLRG1+ cells also co-expressed Sca-1, throughout this 
study we chose to identify the ILC2 subset as either KLRG1+ or KLRG1+Sca1+. In this 
study we defined KLRG1– cells containing a mixture of group-1 ILCs (ILC1) and group-
3 ILCs (ILC3) as ILCs (Hoyler et al., 2012).  
ILC2s have been shown to expand and produce cytokines such as IL-13 and 
IL-5 in response to IL-33 signalling (Artis and Spits, 2015). Following the observation 
that Il33, Il13 and Il5 expression were all significantly elevated at day 5 post-infection 
(Fig. 3.1), we hypothesised that ILC2 numbers would be increased at day 5 both in the 
tissue and local draining lymph node. We infected wild-type mice with H. polygyrus and 
observed a significant increase in the proportion and total number (Fig 3.1.D) of 
CD45+Lin–Thy1.2+KLRG1+ ILC2s in the lamina propria (LP) of mice infected with H. 
polygyrus, as shown in representative FACS plots of the lamina propria (Fig.3.1 C) and 
graphically (Fig 3.1.D). We also saw a significant expansion of the ILC2s in the MLN at 
day 5 following infection (Fig.3.1.E). In addition, we saw a significant increase in the 
number of KLRG1– ILCs in the LP at d5 (Fig. 3.1 F), as previously reported (Mackley et 
al., 2015). 
 
3.2.1.3. Expansion of ILC2s correlated with the differentiation of Th2 cells  
CD4+ Th2 cells play an essential role in promoting early type-2 effector 
responses to intestinal helminths (Allen and Maizels, 2011). We therefore measured 
type-2 cytokine production by intracellular cytokine staining in CD4+ T cells in both local 
(MLN) and peripheral (spleen) lymphoid organs at days 5, 7 and 10 post-infection. In 
the spleen, we saw a significant increase in the proportion and total number of 
CD4+CD44+IL-4+ (Fig.3.2 A and B) and CD4+CD44+IL-13+ Th2 cells (Fig.3.2 C and D) 
as early as day 5 post-infection and a further significant increase at day 7 (Fig 3.2 A 
and C). In the MLN, the proportion of IL-4- (Fig.3.2 E) and IL-13-producing Th2 cells 
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(Fig.3.2 G) was higher than in the spleen, with up to 10% of CD4+ T cells producing IL-
4 (Fig.3.2 E) and 6% of CD4+ T cells producing IL-13 at d10 (Fig 3.2. G). The 
proportion and total number of CD4+CD44+IL-4+ (Fig.3.2 E and F) and CD4+CD44+IL-
13+ Th2 cells in the MLN (Fig.3.2 G and H) were significantly increased from day 5 
following infection. 
In summary, a characteristic type-2 response developed early following H. 
polygyrus infection, as exemplified by the expression of genes and cytokines 
associated with the activation of AAMΦ, Th2 cells and ILC2s. The proportion and 
absolute numbers of ILC2s increased at day 5 post-infection in the tissue and 
peripheral lymphoid organs, correlating with the differentiation of Th2 cells and the 
initiation of a polarised type-2 response in the intestinal tissue.  
 
3.2.2. ILC2s are a major source of IL-4 in the tissue following H. polygyrus 
infection 
3.2.2.1. Phenotyping intestinal KLRG1+ ILC2s  
To further characterise H. polygyrus-elicited ILC2s we FACS-purified CD45+Lin–
Thy1.2+KLRG1+Sca1+ ILC2s from the LP of Rag2–/– mice and measured the expression 
of several genes known to be related to ILC2 development and function. As a control, 
we purified CD45+Lin–Thy1.2+KLRG1–Sca1+/– ILCs.  Purified KLRG1+ ILC2s expressed 
high levels of Gata3 and type-2 cytokines Il13 and Il5 in comparison to KLRG1– ILCs 
(Fig 3.3 A). Conversely, purified KLRG1– ILCs expressed high levels of Rorct, Il17 and 
Il22, characteristic of the ILC3 phenotype (Fig 3.3 A). Purified ILC2s were 
morphologically similar to previously published images (Moro et al., 2010; Robinette et 
al., 2015) and similar to purified Il4-GFP+ CD4+ T cells (Th2), indicative of their 
lymphoid origin (Fig 3.3 B). Concordant with the mRNA expression, in vitro re-
stimulated KLRG1+ ILC2s but not KLRG1– ILCs secreted high concentrations of IL-13 
and IL-5 protein following re-stimulation with PMA and Ionomycin or with IL-2/IL-25/IL-
33, as measured by FlowCytomix™ (Fig. 3.3 C). 
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3.2.2.2. ILC2s express Il4-GFP, Il4 and Il2 mRNA and secrete IL-4 and IL-2 protein  
In addition to secreting IL-13, IL-5 and IL-9 ILC2s have been shown to secrete 
other type-2 cytokines including IL-4 and IL-2 (Artis and Spits, 2015). Indeed, following 
H. polygyrus infection, purified ILC2s expressed Il4 and Il2 (Fig. 3.4 A) and secreted 
high concentrations of both IL-4 and IL-2 after re-stimulation with PMA and Ionomycin 
ex vivo (Fig. 3.4 B). To identify factors required for IL-4 secretion, we stimulated ILC2s 
with IL-2/IL-25/IL-33 or leukotriene D4 (LTD4), a member of the arachidonic pathway 
previously shown to induce IL-4 production by ILC2s (Doherty et al., 2013). IL-4 
secretion, in contrast to IL-13 and IL-5, was not induced in response to IL-2/IL-25/IL-33 
(Fig. 3.4 C), however we found that LTD4 could induce IL-4 secretion by ILC2s in a 
dose-dependent manner (Fig. 3.4 C), as previously described (Doherty et al., 2013). 
We also infected Il4-GFPFoxp3-RFP mice and found that the majority of KLRG1+ ILC2s 
were Il4-GFP+Foxp3-RFP–. Indeed, ILC2s constitutively expressed Il4-GFP both in 
naïve and H. polygyrus infected mice (Fig. 3.4 D). Consequently, the absolute number 
of Il4-GFP-expressing ILC2s significantly increased in the LP at d5 post-infection (Fig. 
3.4 E). 
 
3.2.2.3. ILC2s are a dominant cellular source of Il4-GFP in the LP of H. polygyrus 
infected mice 
 A diversity of immune cells have been reported to express Il4-GFP early in 
ontogeny (Gessner et al., 2005) however their relative contribution to Th2 
differentiation in vivo is still not clearly understood. In particular, basophils are thought 
to play an essential role for the differentiation of Th2 cells in vivo (Voehringer, 2013). 
However basophil-deficiency (Schwartz et al., 2014) or basophil depletion (Smith et al., 
2012) had no impact on the development of Th2 cells in a primary infection with H. 
polygyrus. Instead, basophils were required for functional expulsion of H. polygyrus in 
a secondary infection (Herbst et al., 2012). To characterise the dominant cellular 
sources of IL-4 during a primary H. polygyrus infection, we determined the composition 
Chapter 3 – Results  
 114 
of Il4-GFP+ cells at day 5 post-infection in the lamina propria and local gut draining 
MLN. We identified CD4+ T cells as Il4-GFP+CD4+CD49b–, ILC2s as Il4-GFP+CD4–
CD49b–lineage–Thy1.2+KLRG1+ and basophils as Il4-GFP+CD4–CD49b+ (Fig 3.5 A). 
Furthermore, we identified a large proportion of Il4-GFP+ cells as non-basophil, non-
CD4, non-ILC, FSC-HlowSSC-Ahigh cells, suggesting they could be eosinophils (Fig. 3.5 
A). We saw significantly higher numbers of Il4-GFP+ ILC2s than basophils in the lamina 
propria at day 5 post-infection (Fig. 3.5 B), and CD4+ T cells formed the major part of 
the Il4-GFP+ population in the MLN (Fig. 3.5 B).  
 
3.2.3. ILC2s develop and function in the absence of IL-2 
As described above, ILC2s isolated from the lamina propria of H. polygyrus 
infected mice expressed Il2 mRNA and secreted IL-2, confirming previous findings 
from mouse and human studies (Crellin et al., 2010; Moro et al., 2010; Monticelli et al., 
2011; Molofsky et al., 2013). Furthermore, ILC2s expressed the high affinity IL-2 
receptor CD25 (IL-2Rα) (Moro et al., 2010). Many studies report that IL-2 can increase 
cytokine production by ILC2s in vitro, when compared with IL-25 and IL-33 alone (Moro 
et al., 2010). Furthermore, IL-2 has been shown to be sufficient to drive IL-9 secretion 
by ILC2s (Wilhelm et al., 2011), and IL-9 further promotes IL-5 and IL-13 secretion 
(Turner et al., 2013; Mohapatra et al., 2015). These studies suggest IL-2 is important 
for the effector function of ILC2s, however the absolute requirement of exogenous or 
autocrine IL-2 for ILC2 development and function have not been studied.  
To address this question, we made use of Il2–/–Rag2–/– mice that lack T and B 
cells and are deficient in any source of IL-2, and compared them to Rag2–/– mice (Moro 
et al., 2010). We saw no significant differences in the proportion (Fig. 3.6 A) or 
absolute number (Fig. 3.6 B) of KLGR1+ ILC2 (black bars) or KLRG1– ILCs (white 
bars) in the lamina propria or MLN between the two groups. In addition, we saw no 
significant impact of IL-2 deficiency on the expansion of ILC2s at day 5 post-infection 
with H. polygyrus (black bars) in the LP or MLN (Fig. 3.7 A). Furthermore, a high 
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proportion of Il2–/– ILC2s secreted IL-5 and IL-13 (Fig. 3.7 B) and were actively 
proliferating at day 5 post-infection, as measured by Ki-67 staining (Fig. 3.7 C), similar 
to IL-2-sufficient ILC2s. Overall, these experiments demonstrate that ILC2s are not 
dependent on IL-2 for their development, proliferative capacity or cytokine secretion. 
 
3.2.4. ILC2s are insufficient to drive sterile immunity to H. polygyrus  
3.2.4.1. IL-2 complex treatment expands ILC2s in the tissue and mesenteric 
lymph nodes 
As discussed, ILC2s express high levels of CD25 and secrete significant 
amounts of type-2 cytokines in response to IL-2 stimulation in vitro. To determine 
whether ILC2s were sufficient to control H. polygyrus, we made use IL-2c, which has 
been shown to expand and activate ILC2s in vivo (Roediger et al., 2013; Oliphant et 
al., 2014; Van Gool et al., 2014). Treatment of Rag2–/– mice with a dose of IL-2c 
previously used in lymphocomplete mice (Boyman et al., 2006) caused severe 
haemorrhaging resembling vascular leakage syndrome (Klatzmann and Abbas, 2015) 
and ultimately resulting in their death. Consequently, we treated Rag2–/– mice with 
lower doses of IL-2c (IL-2clow [0.5µg:5µg] and IL-2cmed [2.5µg:25µg]) on days 0, 2 and 4 
post-infection, when L4 larvae are establishing in the intestinal wall. We characterised 
lineage–Thy1.2+ cells at day 5 post-infection, as shown in the representative FACS 
plots of the MLN (Fig 3.8 A). Treatment with both IL-2clow and IL-2cmed doses led to a 
significant expansion in the proportion and absolute number of ILC2s in the LP (Fig. 
3.8 B). Because we had previously seen that the majority of lineage–Thy1.2+ cells in 
the MLN of Rag2–/– mice were ILC2s (Fig. 3.6 A), IL-2c treatment did not significantly 
impact the proportion of ILC2s (Fig. 3.8 C), however the absolute number of ILC2s in 
the MLN was significantly increased following both IL-2clow and IL-2cmed treatments 
(Fig. 3.8 B). In accordance with these results, the proportion of Ki-67+ proliferating 
ILC2s was increased following IL-2c treatment (Fig. 3.9 C). Furthermore, IL-2c 
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treatment further increased CD25 expression on ILC2s (Fig. 3.9 A), but not on KLRG1- 
ILCs (Fig. 3.8 B).  
 
3.2.4.2. IL-2 complex treatment impairs H. polygyrus larval development resulting 
in reduced adult worm establishment  
We hypothesised that IL-2c-mediated expansion of ILC2s would lead to an 
increased type-2 response in the tissue and impair the development of invading larvae. 
To test this, we infected Rag2–/– mice, treated them with IL-2cmed or PBS at days 0, 2 
and 4 and harvested the mice at day 9 post-infection when adult worms have normally 
emerged into the lumen (Reynolds et al., 2012). At day 9 post-infection, the majority of 
adult worms had emerged into the lumen of PBS treated mice (black bars) and only a 
small number were still trapped in the wall (white bars) (Fig. 3.10 A). Strikingly, IL-
2cmed treatment resulted in a large number of larvae trapped in the intestinal wall (white 
bars) and a significant reduction in the emergence of adult worms in the lumen (Fig. 
3.10 A and B). Following an identical treatment regimen, we looked at a later time-
point following infection to assess whether IL-2c treatment early during infection merely 
reflected a delay in the emergence of worms, or whether the tissue-embedded larvae 
were killed. We saw a significant reduction in the total number of adult worms in the 
lumen at day 22, with little evidence of any worms still trapped in the wall (Fig. 3.10 A), 
suggestive of IL-2c-mediated larval killing.  
To identify potential mechanisms of larval killing, we measured the expression 
of type-2 effector genes in the small intestine of IL-2c treated mice 5 days post-
infection. IL-2cmed treatment increased the expression of Il5, Il13 and Il4 in the whole 
tissue (Fig. 3.10 C), correlating with the expansion of ILC2s (Fig. 3.8 B). IL-2cmed 
treatment also resulted in the increased expression of Retnlb, Retnla, Arg1 and 
increased expression of the goblet-cell proliferation marker Mclca3 (Gob5) (Fig. 3.10 
C).  
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3.2.4.3. Depletion of ILC2s partly impairs IL-2c-mediated larval killing  
To test the role of ILC2s in promoting larval killing following IL-2c treatment, we 
depleted ILC2s from Rag2–/– mice using an anti-Thy1.2 antibody (as previously 
published (Turner et al., 2013)) and determined whether larval killing occurred in the 
absence of ILC2s (see model, Fig. 3.11 A). As we had previously shown (Fig. 3.8), IL-
2c treatment led to a significant increase in the absolute number of ILC2s in the MLN of 
IL-2c-treated mice co-treated with isotype control, but not anti-Thy1.2 antibody (Fig. 
3.11 B), suggesting the anti-Thy1.2 treatment efficiently depleted ILC2s. As expected, 
a significant number of larvae were trapped in the intestinal wall of IL-2c treated mice 
at day 9 post-infection (Fig. 3.11 C). Surprisingly, the majority of worms also remained 
trapped in ILC2-depleted mice, (Fig. 3.11 C) suggesting that IL-2c treatment promoted 
larval killing in an ILC2-independent manner. In conclusion, IL-2c mediated expansion 
of ILC2s correlated with increased type-2 responses in the tissue but only partial 
immunity to H. polygyrus, suggesting they have limited anti-helminth potential against 
H. polygyrus. We therefore explored whether ILC2s were influencing adaptive immune 
mechanisms. 
 
3.2.5. ILC2s promote the differentiation of nT cells to Il4-GFP+ cells in vitro in an 
IL-4 and IL-2-dependent manner 
To test whether ILC2-derived IL-4 was required for Th2 differentiation, we 
designed an in vitro assay to measure Th2 polarisation (normally dependent on IOL-4 
and IL-2 in vitro) by ILC2-derived supernatant (see model, Fig. 3.12 A). To obtain 
sufficient numbers of ILC2s, we expanded ILC2s in vivo with IL-2c. Rag2–/– or Il2–/–
Rag2–/– mice were infected with H. polygyrus and treated with IL-2c on days 0, 2 and 4. 
At day 5 post-infection, IL-2c-expanded ILC2s were FACS-purified and re-stimulated 
with P+I for 3 hours. Following this 3-hour stimulation, ILC2s were washed to remove 
the P+I and resuspended in fresh cIMDM for a remaining 21 hours before harvesting 
the supernatant. Similarly to ILC2s obtained from the lamina propria of WT mice (Fig. 
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3.3 and 3.4), ILC2s isolated from the MLN of Rag2–/– mice secreted large 
concentrations of IL-13, IL-5, IL-4 and IL-2 (white bars, Fig. 3.12 B). Furthermore, Il2–/– 
ILC2s secreted similar concentrations of IL-13 and IL-5 as WT ILC2s, and as expected, 
secreted undetectable levels of IL-2 (black bars, Fig. 3.12 B). Surprisingly however, 
Il2–/– ILC2s secreted lower levels of IL-4 than WT ILC2s (Fig. 3.12 C) which was not 
due to increased cell death (Fig. 3.12 D). To test whether IL-2 was required for ILC2-
derived IL-4, we purified ILC2s from the LP of Rag2–/– and Il2–/–Rag2–/– mice and re-
stimulated them with P+I in vitro. Compared to MLN-derived ILC2s, we saw no 
differences in IL-4 production by LP-derived ILC2s (Fig. 3.12 C) suggesting that ILC2s 
form the MLN may have a greater dependence on IL-2 for IL-4 production. 
To test whether ILC2-derived supernatant could support Th2 differentiation, we 
purified naïve CD4+Il4-GFP–Foxp3-RFP–CD25–CD44– T cells (nT) from Il4-GFPFoxp3-
RFP mice and cultured them with the supernatant of re-stimulated WT ILC2 or Il2–/– 
ILC2 in the presence of anti-CD3 and anti-CD28 for 4 days. In addition, we tested 
whether ILC2-derived IL-4 contributed to Th2 differentiation by adding anti-IL-4 
blocking antibody to some of the cultures. As a positive and negative control, we 
cultured nT cells with recombinant IL-4 or media alone, respectively. After 4 days in 
culture we measured Il4-GFP expression as an indication of Th2 commitment. 
Strikingly, up to 90% of the cells cultured with ILC2 supernatant were Il4-GFP+, in 
comparison to 50% of cells cultured with recombinant IL-4 alone (Fig. 3.12 E). 
Furthermore, the proportion of Il4-GFP+ cells was significantly reduced in samples 
cultured with supernatant from Il2–/– ILC2 cultures (Fig. 3.12 E). The addition of anti-IL-
4 to the supernatants of either WT ILC2 or Il2–/– ILC2 cultures entirely inhibited the 
differentiation of Il4-GFP+ cells (Fig. 3.12 E). Furthermore, differentiation of nT cells 
into Il4-GFP+ cells correlated with increased concentrations of ILC2 supernatant (Fig. 
3.12 F). Neither the addition of IL-2 to the cultures or varying concentration of IL-4 
could rescue the difference in the proportion of Il4-GFP+ cells seen between WT and 
Il2–/– cultures. 
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3.2.6. IL-4 production by ILC2s is required for early development of Th2 cells 
Following the observation that ILC2s could promote Th2 differentiation in vitro, 
we tested whether ILC2-derived IL-4 supported Th2 differentiation in vivo during the 
development of a Th2 response to H. polygyrus. To test this, we used a mixed bone 
marrow chimera approach to restrict IL-4 deficiency to ILC2s. To do this, we used 
lethally irradiated Il7r-deficient mice that are deficient in ILC1, ILC2 and ILC3 (Hoyler et 
al., 2012) and Rora-deficient mice (RORαsg/sg mice), which are specifically deficient in 
ILC2s (Halim et al., 2012; Wong et al., 2012). We reconstituted Il7r-deficient mice with 
100% Rora-deficient bone marrow creating a mouse that is specifically deficient in 
ILC2 cells. In addition, we reconstituted a cohort of mice with 80% Rora–/– bone marrow 
and 20% WT or Il4–/– bone marrow. In these chimeric mice, all ILC2s were either WT 
(80% Rora–/–:20% WT) or Il4-deficient (80% Rora–/–:20% Il4–/–), with the majority (80%) 
of other haematopoietic cells being IL-4-sufficient (see model, Fig. 3.13 A).  
 
3.2.6.1. Il4–/– ILC2s fail to develop in bone-marrow chimera 
Following 8 weeks of reconstitution, we infected the chimeric mice with H. 
polygyrus and assessed the development of ILC2s and Th2 cells at day 7 post-
infection. We checked for reconstitution by FACS-staining for congenically marked WT 
bone-marrow (data not shown) however we were unable to distinguish the CD45.2+ IL-
4Rα-deficient bone marrow from the CD45.2+ RORα group. There were no defects in 
the proportion of lineage–Thy1.2+ cells between the different groups (Fig. 3.13 B) 
however as expected, there were significantly fewer KLRG1+ ILC2s in mice 
reconstituted with 100% Rora–/– bone marrow alone (–) in comparison to mice 
reconstituted with 80% Rora–/– and 20% WT bone marrow (WT) (Fig. 3.13 C). 
Surprisingly, we observed significantly fewer ILC2s in the lamina propria in chimeric 
mice given 80% Rora–/– and 20% Il4–/– bone marrow (Il4–/–) (Fig. 3.13 C).  
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3.2.6.2. ILC2-deficiency correlates with the impaired development of Th2 
responses 
To measure the impact of ILC2-deficiency on Th2 differentiation we measured 
cytokine production from splenic T cells by intra-cellular cytokine staining. We saw no 
significant differences in the proportion and number of CD4+TCRβ+ cells suggesting 
Rora-deficiency did not grossly impact the development of CD4+ T cells (Fig. 3.13 D). 
However we saw a reduced proportion of IL-4+, IL-13+ CD4+ T cells and a significantly 
reduced proportion of IL-5+ CD4+ T cells in mice reconstituted with Rora–/– bone 
marrow alone (–) compared to mice with ILC2s (WT) (Fig. 3.13 E). Strikingly, this 
resulted in significantly fewer absolute numbers of IL-4+, IL-13+ and IL-5+ CD4+ T cells 
(Fig. 3.13 F). Similarly, there was a reduced proportion of IL-4+, IL-13+ and IL-5+ CD4+ 
T cells in mice reconstituted with Il4–/– ILC2s (Il4–/–) compared to mice with ILC2s (WT) 
(Fig. 3.13 E). Consequently, this resulted in fewer absolute numbers of IL-4+ CD4+ T 
cells and significantly fewer IL-13+ and IL-5+ CD4+ T cells (Fig. 3.13 F), even though 
absolute numbers of CD4+ T cells were unchanged (Fig. 3.13 D). Overall, these results 
demonstrate that ILC2s are required for Th2 differentiation in vivo during primary 
infection with H. polygyrus and that ILC2-derived IL-4 can drive Th2 differentiation in 
vitro. However it remains unclear whether ILC2-derived IL-4 is required for Th2 
differentiation in vivo.   
 
3.3. Discussion 
IL-4 is critical for the differentiation of Th2 cells following primary infection with 
the intestinal helminth H. polygyrus (Urban et al., 1991; Urban et al., 1991) and is 
required for the functional expulsion of H. polygyrus following a secondary challenge 
infection (Urban et al., 1991; Urban et al., 1995). Conventional CD11c+ DCs were 
shown to be critically required for the initiation of Th2 responses following H. polygyrus 
infection (Gause et al., 1996; Smith et al., 2012) but are not thought to be a source of 
IL-4 themselves (MacDonald and Pearce, 2002). Although stimulation of naïve T cells 
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by dendritic cells was sufficient to promote IL-4 secretion by T cells in vitro in the 
presence of antigen and in the absence of any supplemented IL-4 (Jankovic et al., 
2000; Noben-Trauth et al., 2000), the differentiation of Th2 cells in vivo was almost 
completely abolished in mice lacking IL-4Rα (Noben-Trauth et al., 1997) indicating that 
IL-4 plays a central role in Th2 differentiation in vivo. Taken together, these studies 
indicate that DCs and IL-4 are critical for Th2 differentiation in vivo, however the source 
of IL-4 required for optimal differentiation of Th2 cells in the context of H. polygyrus 
infection is still unclear. NKT cells, basophils and eosinophils have all been described 
to produce IL-4 but none of these cells appear to be required for Th2 differentiation 
following H. polygyrus infection (Voehringer et al., 2004; Mohrs et al., 2005).  
ILC2s are characterised by their secretion of IL-5 and IL-13 however they have 
also been shown to transcribe Il4 and Il2 in vivo using cytokine reporters (Fallon et al., 
2006; Price et al., 2010; Molofsky et al., 2013; Roediger et al., 2015) and to secrete IL-
4 and IL-2 following re-stimulation ex vivo (Molofsky et al., 2013). The function of ILC2-
derived IL-4 and IL-2 has not been tested, and in this chapter, we aimed to determine 
whether ILC2-derived IL-4 and IL-2 could promote the differentiation of Th2 cells in 
vitro and in vivo. Using Il2-deficient mice, we found that neither paracrine or autocrine 
IL-2 was required for the optimal expansion of and function of ILC2s in vivo. 
Furthermore, we found that ILC2s were not sufficient to mediate expulsion of primary 
infection with H. polygyrus in the absence of an adaptive immune response, as has 
been suggested in the context of other helminth infections. Instead, we found that 
ILC2-derived IL-4 could promote the differentiation of naïve T cells to Th2 cells in vitro 
and in vivo, identifying a novel role for ILC2s in anti-helminth immunity.  
 H. polygyrus has a strictly enteric lifecycle and induces a strong polarised type-
2 response early in infection (Reynolds et al., 2012). It has previously been observed 
that the absolute number of ILC2s correlated with the strength of the type-2 response 
in mice with varying genetic susceptibilities to H. polygyrus (Filbey et al., 2014; 
Mackley et al., 2015). Furthermore, the absolute number of ILC2s have been reported 
to increase in the spleen and MLN of C57BL/6 mice at days 6, 7 and 10 post-infection 
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(Zaiss et al., 2013; Filbey et al., 2014; Mackley et al., 2015). These studies suggest 
that ILC2s are dynamically regulated and may play a role in immune responses to 
primary infection with H. polygyrus. We were particularly interested in determining the 
role for ILC2s at early time-points following infection when H. polygyrus larvae were 
embedded in the intestinal sub-mucosa (Fig. 3.1 B) and are known to secrete highly 
immunogenic products (Hewitson et al., 2013). Furthermore, we had observed 
increased gene expression of cytokines known to promote ILC2s or to be secreted by 
ILC2s in the intestinal tissue of mice as early as day 5 post-infection (Fig. 3.1 A). We 
also found that ILC2s expanded early following infection in the tissue as well as the 
local draining LN, correlating with the differentiation of Th2 cells (Fig. 3.3 A-H). This is 
the first description of increased ILC2 numbers in the intestinal tissue rather than MLN 
following H. polygyrus infection, perhaps due to the difficulty in obtaining live 
preparations of cells from inflamed tissue (Moro et al., 2015). For technical reasons, we 
were limited to studying immune responses between days 0 and 7 following primary H. 
polygyrus infection, as cells isolated after day 7 were not reliably recoverable. ILC2 
expansion was previously shown to precede the expansion of Th2 cells in the context 
of N. brasiliensis infection (Fallon et al., 2006), however both ILC2 and Th2 cells were 
concomitantly increased at day 5 post-infection. A more detailed kinetic analysis in 
local tissue and draining lymph nodes following H. polygyrus infection would be 
required to determine whether ILC2s precede Th2 cell differentiation in this setting, 
which would support the hypothesis that ILC2s promote Th2 differentiation.  
 
3.3.1. Identifying a role for neglected ILC2-derived cytokines 
A recently published transcriptional array identified that ILC2s purified from the 
small intestine of naïve mice express Il4 and Il2 (Robinette et al., 2015). We confirmed 
this in ILC2s isolated from H. polygyrus mice and found that LP-derived ILC2s 
expressed Il4 and Il2 as well as the canonical cytokines Il5 and Il13. Importantly, the 
authors of this study purified ILC2s from the small intestine of mice using a similar 
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staining strategy as ours (containing anti-KLRG1 antibody, as described in chapter 2). 
Il4 expression was not reported in transcriptional arrays of lung-derived ILC2s following 
allergic inflammation (Motomura et al., 2014) or viral infection (Monticelli et al., 2011), 
however there have been many reports of Il4-GFP expression by lung ILC2s following 
N. brasiliensis infection (Fallon et al., 2006; Price et al., 2010; Molofsky et al., 2013), 
suggesting there are either disparities between the methods used to analyse Il4 
expression, or that expression of Il4 is highly context dependent. Alternatively, this 
suggests that Il4 expression in lung ILC2s is induced following infection with helminths 
rather than constitutively expressed. We characterised Il4-GFP expression in LP-
derived ILC2s and found that the majority of ILC2s in both naïve and H. polygyrus 
infected mice expressed Il4-GFP, suggesting they were genetically primed to secrete 
IL-4 (Fig. 3.4 C and D). Previously published work using Il4-GFP mice crossed with 
KN2 mice (expressing huCD2 under the control of the IL-4 promoter to identify cells 
that secrete IL-4) indicated that the highest correlation of Il4-GFP expression with IL-4 
protein production occurred in gut-associated tissues such as the MLN and LP (Mohrs 
et al., 2005). Therefore we hypothesise that a high proportion of Il4-GFP-expressing 
ILC2s could be secreting IL-4 protein in vivo.  
ILC2s secrete IL-5 and IL-13 in response to stimulation with combinations of IL-
2, IL-25, IL-33 and TSLP (Artis and Spits, 2015). We confirmed these findings and 
showed that ILC2s stimulated with IL-25, IL-33 and IL-2 secreted IL-5 and IL-13, but 
not IL-4. Indeed, IL-4 was only seen following PMA and Ionomycin or LTD4, as 
previously reported (Doherty et al., 2013). We found that ILC2s but not KLRG1– ILCs 
expressed and secreted IL-2 in response to P+I, in contrast to a recently published 
study suggesting that ILC3s formed the dominant IL-2-expressing cells in the lung 
(Roediger et al., 2015). Again, the differences may be explained by the apparent 
heterogeneity between ILC populations isolated from the lung and the LP, or to sorting 
strategies. To definitively test whether Il4-GFP+ ILC2s produce IL-4 protein in vivo and 
increase upon infection, we could infect Il4-GFP/KN2 mice and measure huCD2 
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expression on the surface of Il4-GFP+ ILC2s in naïve mice and following H. polygyrus 
infection.  
Many cells including NKT cells, eosinophils and mast cells have been described 
to express Il4-GFP (Gessner et al., 2005; Mohrs et al., 2005), however their role in the 
differentiation of Th2 cells is not clear. Basophils (Perrigoue et al., 2009) and CD4+ T 
cells themselves (Noben-Trauth et al., 2000) have been proposed to be potential 
sources of IL-4 for Th2 differentiation in various settings. Following our observation that 
purified ILC2s expressed Il4 and secreted IL-4 in vitro, we wanted to characterise Il4 
expression in vivo and determine the relative contribution of ILC2s to Il4-expressing 
cells (Mohrs et al., 2001). We found higher numbers of Il4-GFP+ ILC2s than CD4 cells 
and basophils in the LP but not the MLN, suggesting ILC2s may play a role in priming 
T cells in the tissue but not the MLN. Alternatively, very low numbers of ILC2s could be 
sufficient to drive the differentiation of Th2 cells in the MLN. Recent imaging of the 
MLN following H. polygyrus infection showed 30% of lamina propria ILC2s migrate 
from the small intestine to the MLN following infection (Mackley et al., 2015), 
suggesting that ILC2s may be recruited to the MLN for the activation of T cells. 
Similar to previously published data (Voehringer et al., 2004), we found that the 
majority of Il4-GFP+ cells were phenotypically characteristic of eosinophils. However, 
eosinophils are not thought to contribute to the differentiation of Th2 cells following N. 
brasiliensis (Voehringer et al., 2006) or S. mansoni (Swartz et al., 2006) infection. 
Furthermore, depletion of eosinophils had no impact on the production of IgE following 
primary infection with H. polygyrus (Urban et al., 1991) suggesting that eosinophils are 
not required for Th2 development during H. polygyrus infection. Instead, eosinophils 
may be an important source of IL-4 for the amplification of type-2 immune responses.  
IL-2 has been shown to enhance cytokine production by ILC2s in vitro (Moro et 
al., 2010) and expand ILC2s in vivo (Roediger et al., 2013; Oliphant et al., 2014), 
however it remained unclear whether ILC2s require IL-2 for their development or 
function. The best way to test this would be to characterise ILC2s isolated from IL-2-
deficient mice, however these mice succumb to T-cell mediated inflammation due to a 
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deficiency in the development of Treg cells (Sadlack et al., 1993). We therefore chose 
to compare the development of ILC2s in T-cell deficient mice to limit the development 
of disease. We compared Rag2-deficient and IL-2-deficient mice on a Rag2-deficient 
background and found IL-2 was not fundamentally required for the development, 
expansion or cytokine-producing function of ILC2s. Furthermore, given that ILC2s are a 
source of IL-2 themselves, these results suggested that ILC2-derived IL-2 was not 
required in an autocrine manner. However these studies were restricted to T and B cell 
deficient Rag2–/– mice, and it is conceivable that in a wild-type setting ILC2-derived IL-2 
is required to stimulate IL-2-responsive cells such as T cells. For example, Treg cells 
express CD25 and are critically dependent on IL-2 for their development and 
maintenance, however they do not produce IL-2 (Setoguchi et al., 2005; Marson et al., 
2007). ILC2-derived IL-2 may exert an indirect regulatory role by promoting Treg 
maintenance in the tissue. In addition, ILC2-derived IL-2 could be promoting NK cell 
proliferation for example in the context of early immune responses to LCMV (Biron et 
al., 1990), although the role of NK cells in protective anti-helminth immune responses 
is currently unclear. To characterise the kinetics of IL-2 secretion by ILC2s in the small 
intestine we could use Il2Cre fate-reporter mice (Yamamoto et al., 2013) that were 
recently used to determine Il2 expression by ILCs in the inflamed lungs (Roediger et 
al., 2015). Furthermore, to test whether ILC2-derived IL-2 influenced T cell responses, 
we could restrict IL-2 deficiency to ILC2s by generating mixed bone marrow chimeras 
of 80% Rorasg/sg and 20% Il2–/–Rag–/– bone marrow and studying the generation and 
maintenance of T cells, in particular the generation of Treg cells. 
The sensitivity of ILC2s to IL-2 has been manipulated in vivo by treating Rag-
deficient mice with IL-2:anti-IL-2 complexes (IL-2c) (Boyman et al., 2006) to activate 
and expand ILC2 cells. IL-2c treatment resulted in systemic eosinophilia (Van Gool et 
al., 2014), exacerbated atopic dermatitis (Roediger et al., 2013), enhanced lung 
inflammation during eosinophilic crystalline pneumonia (ECP) (Roediger et al., 2015) 
and expulsion of N. brasiliensis from susceptible Rag2–/– mice (Oliphant et al., 2014), 
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correlating with the expansion of ILC2s. We also observed a dose-dependent 
expansion in the number of ILC2s in the LP and MLN of Rag2-deficient mice following 
IL-2c treatment. Furthermore, high doses of IL-2c led to the increased expression of 
surface CD25, indicative of an IL-2 positive feedback loop described following IL-2c 
stimulation of Treg cells (Spangler et al., 2015). Taken together these results suggest 
that although IL-2 was not fundamentally required for ILC2 function it can promote the 
expansion and activation of ILC2s, which could impact the amplification of immune 
responses. Indeed, T cells secrete high levels of IL-2 upon activation (Seder et al., 
1994), and have been previously suggested to provide a source of IL-2 for ILC2 
expansion in vivo (Wilhelm and Stockinger, 2011). Alternatively, NK cells were recently 
shown to deplete IL-2 from the microenvironment thereby modulating Treg numbers 
(Gasteiger et al., 2013), which could also be the case for ILC2s. 
Another effect of IL-2 on ILC2s could be the induction of cytokine production. 
For example, IL-2 was shown to be required for IL-9 secretion by ILC2s (Wilhelm et al., 
2011) and consequently for efficient lung repair following N. brasiliensis infection 
(Turner et al., 2013). Furthermore, Il4 expression was detectable in inflamed lungs of 
ECP-diseased Rag2–/– mice following IL-2c treatment, suggesting that IL-2 could 
promote IL-4 production by non-T cells in the lung, perhaps from ILC2s (Roediger et 
al., 2015). Indeed, IL-2 is required for optimal IL-4 production by T cells (Ben-Sasson et 
al., 1990) by promoting accessibility of the Il4 locus (Cote-Sierra et al., 2004) 
suggesting it may be required for ILC2-derived IL-4 production. However, we found that 
in vitro stimulation of ILC2s with IL-2 alone or in the presence of IL-25 and IL-33 did not 
promote IL-4 secretion. Furthermore, we only observed reduced concentrations of IL-4 
from ILC2s isolated from the MLN of IL-2 deficient mice but not LP-derived ILC2s. 
Whether there are differential requirements for IL-2 signalling between ILC2 
populations in the tissue compared to ILC2s in lymphoid organs is currently unclear. 
Taken together, these results suggest that IL-2 is not fundamentally required for IL-4 
production by ILC2s, in contrast to T cells, highlighting an interesting divergence in the 
transcriptional and post-transcriptional regulation of IL-4 mRNA. As mentioned, NKT 
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cells (Stetson et al., 2003) constitutively express Il4 and were found to contain pre-
formed cytokine transcripts correlating with permissive chromatin modifications at the 
Il4 locus (Stetson et al., 2003). Similarly, pre-formed IFN-γ transcripts are retained in 
the nucleus of NK cells following transcription, and released upon secondary 
stimulation (Hodge et al., 2002). Following the observation that ILC2s constitutively 
express Il4-GFP, it is conceivable that they are transcriptionally regulated in a similar 
way to NK T cells and contain pre-formed Il4 mRNA transcripts. ILC2s could be primed 
for the rapid production of IL-4 and represent a biologically important source of IL-4 for 
the differentiation of Th2 cells. Experiments using the transcriptional inhibitor 
actinomycin D could be done to determine whether pre-formed Il4 transcripts are 
stored in ILC2s for rapid translation and secretion.   
Although IL-2 was not fundamentally required for ILC2 function, Th2 
differentiation was impaired in cells cultured with Il2–/– ILC2s. This may not be due to 
reduced IL-4 secretion by Il2–/– ILC2s, as culturing nT cells with a range of IL-4 
concentrations (1-15ng/µl) to account for the differences measured in the Il2–/– ILC2 
supernatants made little impact on the proportion of CD4+Il4-GFP+ cells. Furthermore, 
the differences did not occur as a direct consequence of an IL-2 deficiency, as 
exogenous IL-2 did not rescue Th2 differentiation. Instead, ILC2-derived IL-2 may play 
an indirect role on promoting Th2 differentiation, via an autocrine feedback loop 
supporting the secretion of an unidentified cytokine or growth factor from ILC2s. For 
example, ILC2s have been shown to express Il6 (Robinette et al., 2015), which can 
promote early IL-4 secretion by Th2 cells (Rincon et al., 1997). Whether ILC2-derived 
IL-6 could be promoting Th2 differentiation by ILC2s in addition to IL-4 is unclear. 
Further characterisation of ILC2-derived cytokines using multi-analyte detection 
systems or mass spectrometry may uncover a role for novel molecules in promoting 
Th2 differentiation. 
In summary, both the function of ILC2-derived IL-2 as well as the requirement 
for IL-2 signalling on ILC2s for optimal immune responses is still unclear and requires 
further investigation. 
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3.3.2. Regulation of cytokine production by ILC2s    
The signals required for IL-4 secretion by murine ILC2s are not well defined. 
We have shown that ILC2s produce IL-4 in response to P+I in vitro but not in response 
to IL-2, IL-33 and IL-25. In T cell cultures, PMA stimulates enhanced PKC activation, 
mimicking Nf-κb activation downstream of the TCR (Visekruna et al., 2012) however 
ILCs do not express antigen receptors such as the TCR, suggesting PMA mimics PKC 
activation downstream of another receptor such as a cytokine receptor.  
ILC2s have been shown to express genes associated with lipid metabolism 
including Alox5, a lipoxygenase that catalyses the synthesis of leukotriene A4 
(Robinette et al., 2015). Two separate studies identified the expression of the surface 
receptor CysTLR1 (Cystlr1) on ILC2s (Doherty et al., 2013; Robinette et al., 2015), 
which recognises cysteinyl leukotrienes including LTC4, LTD4 and LTE4 that are 
derived from arachidonic acid through Alox5 catalysis (Ford-Hutchinson et al., 1994). 
Leukotrienes are known to play a pathophysiological role in asthma and Alox5 
polymorphisms are associated with increased leukotriene production and reduced lung 
function (Mougey et al., 2013). As such, leukotriene antagonists are therefore used to 
control chronic asthma in patients (Montuschi, 2010). Similar to a previous report 
(Doherty et al., 2013), we found that LTD4 could promote IL-4 production by LP-derived 
ILC2s following H. polygyrus infection to similar levels as P+I stimulation. Mast cells 
are known to secrete proteins including leukotrienes and prostaglandins in the context 
of helminth infections (Rogerio and Anibal, 2012). Furthermore, mast cells are 
activated early following H. polygyrus infection (Hepworth et al., 2012), and are 
required for early Th2 differentiation following H. polygyrus infection (Hepworth et al., 
2012). Indeed, the supernatant from IgE-activated mast cells was sufficient to stimulate 
IL-4-secretion from Th2 cells (Xue et al., 2012). Finally, mast cells and ILC2s form 
close associations in vivo (Roediger et al., 2013), supporting a model of mast cell-
derived LTD4 stimulating IL-4 secretion by ILC2s. To test the role for mast cells in 
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promoting ILC2-derived IL-4, we could measure IL-4 production by ILC2s isolated from 
mast-cell deficient mice KitW/KitW-v (Hepworth et al., 2012). Prostaglandin D2 (PGD2), a 
lipid mediator derived from arachidonic acid pathway and known to promote Th2 
responses (Kalinski et al., 1997), could also stimulate IL-4 production by lung-derived 
ILC2s in vitro (Xue et al., 2014), however its role in promoting IL-4 production by LP-
derived ILC2s is still unclear. Interestingly, helminth-derived excretory/secretory 
products contain proteins that resemble members of the arachidonic pathway (Maizels 
and Yazdanbakhsh, 2003). It is therefore conceivable that H. polygyrus-secreted 
proteins act directly on ILC2s to promote IL-4 production. To test this, we could culture 
ILC2s with H. polygyrus excretory/secretory proteins (HES) isolated from larval stages 
to test whether helminth secretions can simulate IL-4 production. 
Basophil-derived IL-4 was proposed to stimulate the function of ILC2s in the 
skin and the lung (Kim et al., 2014; Motomura et al., 2014), suggesting that IL-4 from 
other cellular sources may drive the production of IL-4 by ILC2s. Indeed, IL-4Rα was 
highly expressed on ILC2s in the lung (Motomura et al., 2014), however Il4ra 
expression on ILC2s isolated from the small intestine was not significantly different 
than on other ILC subsets (Robinette et al., 2015) suggesting that intestinal ILC2s may 
not require IL-4 for their activation. To conclusively test this, we could isolate ILC2s 
from the small intestine of basophil-deficient (Mcpt8–/–) or Il4ra-deficient mice and 
measure IL-4 production. Furthermore, NKT cells (Stetson et al., 2003), basophils and 
eosinophils (Voehringer et al., 2004) have all been shown to constitutively express Il4 
mRNA in a STAT6-independent manner, which suggests that IL-4 may not be required 
for ILC2-derived Il4 expression. To test this we could characterise Il4-GFP expression 
by ILC2s in Il4-GFP/Stat6–/– mice (Voehringer et al., 2004). 
 
3.3.3. Determining a wider impact of ILC2s for anti-helminth immunity 
H. polygyrus establishes chronic infections in susceptible hosts, despite the 
development of strong Th2 responses (Reynolds et al., 2012). Treatment with 
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supraphysiological levels of IL-4 using IL-4c was sufficient to mediate the expulsion of 
a primary infection (Urban et al., 1995; Herbert et al., 2009), suggesting that the 
amplification of type-2 responses is sufficient to promote expulsion of the parasite. 
Similarly, IL-2c treatment was shown to significantly expand IL-5 and IL-13-producing 
ILC2s resulting in the expulsion of N. brasiliensis in susceptible lymphodeficient mice 
(Oliphant et al., 2014). We investigated the impact of IL-2c treatment on the 
establishment of H. polygyrus, and found that IL-2c treatment resulted in the trapping 
of larvae in the intestinal wall, correlating with the expansion of ILC2s and enhanced 
type-2 responses. This phenotype was similar to that observed during immune 
responses to secondary infection with H. polygyrus (Reynolds et al., 2012), however 
we saw no significant cellular infiltrate around the embedded larvae suggesting that IL-
2c may not be promoting a similar mechanism of expulsion. Although the depletion of 
ILCs significantly reduced IL-2c-mediated larval killing, a large number of worms 
remained trapped in the wall. Collectively, these results suggest IL-2c treatment 
promotes partial immunity to H. polygyrus but is insufficient to mediate the complete 
expulsion seen following IL-4c treatment (Urban et al., 1995; Herbert et al., 2009). 
These results also suggest that IL-2c mediates larval killing in an ILC-independent 
manner, however it remains unclear how. To conclusively test the requirement for ILCs 
in this system, we could infect ILC-deficient mice such as Il7–/–Rag2–/– mice (Moro et 
al., 2010) and measure worm burden following IL-2c treatment. This would allow us to 
directly test the impact of ILCs on the larval killing and exclude the role of other Thy1.2-
expressing cells that may have been depleted following anti-Thy1.2 antibody treatment, 
such as NK cells and basophils.  
To date, the role of ILC2-derived cytokines in mediating expulsion following IL-
2c treatment has not been tested. Adoptively transferred IL-13 competent but not Il13–/– 
ILC2s could mediate N. brasiliensis expulsion from Rag2–/– mice (Neill et al., 2010), 
which suggests IL-13 may play an important role for ILC2-mediated expulsion of N. 
brasiliensis. To test whether ILC2-derived cytokines mediate larval killing following IL-
2c treatment, both in the context of H. polygyrus or N. brasiliensis infection, it would be 
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interesting to cross existing cytokine-deficient mice such as Il13–/– and Il4–/– mice onto a 
lymphodeficient background and assess H. polygyrus expulsion following IL-2c 
treatment. In this way we could address whether ILC2-derived cytokines are required 
to promote downstream immune responses in the absence of T cells, by stimulating 
the alternative activation of macrophages or the recruitment of eosinophils as has been 
previously shown in wild-type mice (Molofsky et al., 2013; Nussbaum et al., 2013). 
 
3.3.4. Teaming-up: ILC2s as an early trigger of Th2 differentiation   
Although there are situations where ILC2s may play a role in the absence of the 
adaptive immune system, it’s increasingly thought that ILCs provide crucial signals to T 
cells either through their presentation of antigen (Hepworth et al., 2013; Oliphant et al., 
2014) or cytokine production (Halim et al., 2014). In particular, ILC2s have been shown 
to be important for optimal Th2 differentiation and development of type-2 responses in 
vivo (Halim et al., 2012; Wong et al., 2012; Gold et al., 2014; Halim et al., 2014; 
Mirchandani et al., 2014; Oliphant et al., 2014). Furthermore, ILC2s promoted T cell 
proliferation and increased type-2 cytokine production in vitro (Mirchandani et al., 2014) 
in a contact- and antigen-dependent manner (Oliphant et al., 2014). Mechanistically, 
ILC2-derived IL-13 was shown to promote the recruitment of DCs to the tissue-draining 
lymph nodes, thus indirectly promoting Th2 differentiation (Oliphant et al., 2014), 
however whether ILC2-derived cytokines have a direct role on Th2 cells remains 
unclear. We have shown that ILC2s secrete IL-4 and IL-2 in vitro, which are two 
fundamental requirements for Th2 differentiation (Paul, 2010). In contrast to previous 
experiments that describe an essential role for ILC expression of MHC Class II for 
ILC2-mediated T cell help, (Mirchandani et al., 2014; Oliphant et al., 2014) our 
experiments suggest ILC2-derived cytokines were sufficient to mediate Th2 
differentiation in the presence of TCR stimulation. Given the importance of CD11c+ 
cells for the differentiation of Th2 cells in the context of H. polygyrus infection (Smith et 
al., 2012), it is conceivable that CD11c+ dendritic cells provide TCR engagement and 
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co-stimulation, while ILC2s provide IL-4 for the differentiation of Th2 cells in vivo. 
Indeed, both CD11c+ DCs (Leon et al., 2012) and ILC2s (Mackley et al., 2015) were 
shown to migrate from the lamina propria into the MLN early following H. polygyrus 
infection. Interestingly, both ILC2s and CD11c+CXCR5+ DCs localised in the 
interfollicular spaces of the lymph node rather than the T cell zones (Leon et al., 2012; 
Mackley et al., 2015). This unusual localisation of DCs was required for the 
differentiation of Th2 and TfH cells in response to H. polygyrus (Leon et al., 2012). 
Given the similar localisation of ILC2s, it is conceivable that ILC2s are an important 
source of IL-4 for the priming of Th2 cells in the MLN. Furthermore, ILC3s, which 
possess antigen-presentation capacity (Hepworth et al., 2013) and migrate to the MLN 
following H. polygyrus infection (Mackley et al., 2015), were shown to express 
significant levels of CXCR5 (Robinette et al., 2015) suggesting they could directly 
provide antigen and co-stimulation to T cells in the interfollicular spaces. Thus, it is also 
conceivable that expanded ILC3s migrate to the MLN and provide antigen and TCR 
engagement whilst ILC2s provide the IL-4.  
We found that the differentiation of Th2 cells was significantly impaired in ILC2-
deficient mice, indicating that ILC2s are required for the differentiation of Th2 cells. 
This confirms previously published data showing impaired Th2 cells in response to N. 
brasiliensis (Oliphant et al., 2014) and constitutes the first report of a functional role for 
ILC2s in the context of H. polygyrus infection. Although IL-4 was not required for the 
development of ILC2s in the BM or skin (Kim et al., 2014), we found that Il4–/– ILC2s 
were compromised in their ability to migrate or repopulate the lamina propria, 
suggesting that ILC2-derived IL-4 may play a role in the survival or maintenance of 
ILC2s. As a consequence of ILC2 deficiency seen in Il4–/– mice, Th2 responses were 
severely compromised, similarly to that seen in ILC2-deficient mice. We can therefore 
conclude that the number of ILC2s in the lamina propria correlated with the 
development of Th2 responses to H. polygyrus, similarly to that described in mice of 
differing genetic backgrounds (Filbey et al., 2014). To further address the role of ILC2-
derived IL-4 in vivo, we could generate mice with an ILC2-specific deletion in IL-4 using 
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Rora-IRES-Cre knock-in mice (Wu et al., 2010) crossed with Il4/Il13flox mice 
(Voehringer et al., 2009), however ILC2-derived IL-13 was also shown to be required 
for the differentiation of Th2 cells (Oliphant et al., 2014). A better system would be to 
cross Rora-IRES-Cre mice to Il4flox mice instead, however these mice are not currently 
available. In summary, as a consequence of the impaired reconstitution of ILC2s from 
Il4–/– BM, we weren’t able to specifically test a role for ILC2-derived IL-4. 
Taken together, these results highlight an important role for ILC2s early in the 
development of Th2 responses to primary H. polygyrus infection however whether 
ILC2s also influence memory Th2 cells is currently unclear. Indeed, re-activation of 
memory Th2 cells is required for functional expulsion (Urban et al., 1991; Finkelman et 
al., 2000) and does not depend on DCs (Gause et al., 1996). It is conceivable that 
ILC2s may be involved in the reactivation of memory responses through antigen-
presentation or by directly promoting type-2 responses through their cytokine 
production. However given that IL-4 is not required for the activation of memory Th2 
cells, as discussed in the next chapter, it’s unlikely that ILC2-derived IL-4 is 
contributing at that stage. To test whether ILC2 cells are required for the reactivation of 
memory Th2 responses we would need to temporally and selectively delete ILC2 cells 
following the diphtheria toxin treatment of Rora-Cre/DTR mice, however these mice are 
not currently available.  
 
3.3.5. Requirement for improved mouse models for the study of ILC2s 
Studying ILC2 function in vivo is currently hindered by the lack of available tools 
to specifically delete ILC2s, highlighting gaps in our knowledge of unique molecules 
and TFs required for ILC2 development. An explanation for this is that these TFs may 
have evolved in innate cells before being co-opted by T cells (Roediger and Weninger, 
2015). Indeed, TFs such as Gata3, Tcf7, Gfi1 and Bcl11b are uniquely expressed in 
the group-2 ILCs and not other ILC subsets, however they are also important in the 
development of CD4+ T cells or the differentiation of T helper cells. Although Rora-
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deficient Th2 cells were not impaired in their ability to differentiate into Th2 cells in vitro 
(Halim et al., 2012), it is conceivable that RORα plays a role in Th2 cell function in vivo. 
Furthermore, Th17 cells (Yang et al., 2008) and some subsets of Tregs (Feuerer et al., 
2010) were also shown to express RORα, suggesting the deletion of Rora may have 
non-specific effects on other immune cells in addition to ILC2s. Furthermore, RORα 
plays a critical role during neurological development and RORαsg/sg mice develop 
severe neurological disease within a few weeks of birth (Sidman et al., 1962). The role 
of RORα has therefore been characterised using BM reconstituted mice (in our study 
and others), or through conditional deletion of Rora under the control of the IL-7 
receptor promoter (Il7r-Cre), which limited Rora deletion to T cells and ILCs (Oliphant 
et al., 2014). Furthermore, Oliphant et al also generated a second ILC2-deficient 
mouse model by deleting Icos (expressed on T helper cells and ILC2s and required for 
T helper cell function) specifically in ILC2 cells. To do this, a floxed Dtx receptor (DTR) 
sequence was introduced within the Icos locus under the control of the CD4 promoter 
(Oliphant et al., 2014), which meant that upon diphtheria toxin treatment, the target 
sequence was deleted in CD4 cells and not ILC2s leading to disrupted Icos function 
specifically in non-CD4 expressing ILC2s (Oliphant et al., 2014). Additionally, Il5-Cre or 
Il13-Cre mice were crossed to ROSA-DTA mice and subsequently treated with 
diphtheria toxin to eliminate IL-5 and IL-13-expressing cells (Molofsky et al., 2013; Van 
Dyken et al., 2014; Molofsky et al., 2015). Although ILC2s are important producers of 
these cytokines, DT treatment would result in the deletion of other innate and adaptive 
immune cells secreting IL-5 and IL-13 such as CD4+ T cells, and therefore these mice 
are an imperfect model for studying the relationship between ILC2 and Th2 cells.  
In summary, although currently available tools have demonstrated there are 
important relationships between ILC2s and the immune system, the identification of 
TFs unique to the development or function of ILC2s will be necessary to definitively test 
the requirement and involvement of ILC2s for the development of immunity or disease. 
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Figure 3.1. ILC2 expansion correlates with the development of type-2 responses 
following primary infection with H. polygyrus. C57BL/6 mice were infected with 200 H. 
polygyrus larvae and harvested at days 0, 5, 7 and 10 post-infection. A) Il33, Retnla, Retnlb, 
Arg1, Il13, Il5 and Il4 gene expression in the small intestine, expressed as fold change relative 
to day 0. B) Mucus staining (AB-PAS) of small intestine sections taken at days 0, 5, 7 and 10 
post-infection. C) Representative FACS plots of small intestine lamina propria (LP) cells 
showing the frequency of KLRG1+ cells within the Lineage–Thy1.2+ gate. D) Frequency and 
absolute number of KLRG1+ cells in the LP at days 0 (white bars) and 5 (black bars) post-
infection. E) Absolute number of KLRG1+ cells in the mesenteric lymph nodes (MLN) at days 0 
(white bars) and 5 (black bars) post-infection. F) Absolute number of KLRG1– cells in the LP at 
days 0 (white bars) and 5 (black bars) post-infection. Data are representative of 3 independent 
experiments with 4-5 mice per group. Statistical test applied Mann-Whitney, two-tailed, * 
denotes p<0.05.  
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Figure 3.2. Timecourse of Th2 differentiation following primary infection with H. 
polygyrus. C57BL/6 mice were infected with 200 H. polygyrus larvae and harvested at days 0, 
5, 7 and 10 post-infection. Frequency (A and C) and total number (B and D) of splenic CD44+IL-
4+ cells and CD44+IL-13+ cells as measured by intra-cellular cytokine staining. Frequency (E 
and G) and total number (F and H) of CD44+IL-4+ cells and CD44+IL-13+ cells in the MLN as 
measured by intra-cellular cytokine staining. Statistical test applied Mann-Whitney, two-tailed, * 
denotes p<0.05. 
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Figure 3.3. Intestinal KLRG1+ ILC2s express characteristic type-2 cytokines. Rag2–/– mice 
were infected with 200 H. polygyrus larvae and harvested at day 5 post-infection. A) Expression 
of key innate lymphoid cell associated genes (Gata3, Il13, Il5, Rorct, Il17, and Il22) in FACS-
purified LP ILCs (Lin–Thy1.2+KLRG1-) and ILC2s (Lin-Thy1.2+KLRG1+), expressed relative to 
Hprt. Data is representative of 3 independent experiments and cells were pooled from 4-6 mice. 
B) Cytospins of FACS-purified ILC2 cells isolated from Rag2–/– mice day 5 post-infection and 
CD4+TCRβ+Il4-GFP+ (Th2) cells isolated from Il4-GFP mice infected for 14 days with H. 
polygyrus. C) Quantification of IL-5 and IL-13 production by LP FACS-purified ILCs (white bars) 
and ILC2s (black bars) re-stimulated with PMA and ionomycin or IL-2/IL-25/IL-33 for 24h, as 
measured by Flow Cytomix. Data is representative of 2 independent experiments and cells were 
pooled from 4-6 mice.  
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Figure 3.4. ILC2s express and secrete IL-4 and IL-2, and constitutively express Il4-GFP. 
Rag2–/– mice were infected with 200 H. polygyrus larvae and harvested at day 5 post-infection. 
A) Il4 and Il2 gene expression in FACS-purified LP ILCs and ILC2s, expressed relative to Hprt. 
Cells were pooled from 4-6 mice. B) Quantification of IL-4 and IL-2 production by FACS-purified 
LP ILCs and ILC2s re-stimulated with PMA and ionomycin for 24h, as measured by Flow 
Cytomix. C) Quantification of IL-4 production by FACS-purified MLN ILC2s re-stimulated with 
PMA and ionomycin, IL-2/IL-25/IL-33 or LTD4 for 24h. Il4-GFPFoxp3-RFP mice were infected 
with 200 H. polygyrus larvae and harvested at day 5 post-infection. D) Representative FACS 
plots of small intestine LP cells showing the frequency of KLRG1+Il4-GFP+ cells within the 
Lineage–Thy1.2+ gate. E) Total number of KLRG1+Il4-GFP+ cells in the LP and MLN at days 0 
(white bars) and 5 (black bars) post-infection. Data are representative of 3 independent 
experiments with 4 mice per group. * denotes p<0.05. 
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Figure 3.5. ILC2s form a significant part of the Il4-GFP+ population in the LP at day 5 
post-infection. Il4-GFPFoxp3-RFP mice were infected with 200 H. polygyrus larvae and 
harvested at day 5 post-infection. A) Representative FACS plots of small intestine LP cells 
showing the frequency of CD4+, CD49b+ CD4–CD49b- cells within the Il4-GFP+ gate, and all 
non-CD4, non-CD49b, non-CD4–CD49b– cells. Representative FACS showing the frequency of 
FSC-HlowSSC-Ahigh cells within the non-CD4/non-CD49b/non-CD4–CD49b– gate. B) Total 
number of CD4+ Th2 cells (black bar; CD45+Il4-GFP+CD4+), basophils (grey bar; CD45+Il4-
GFP+CD49b+) and ILC2s (white bar; CD45+Il4-GFP+CD4–CD49b–Thy1.2+KLRG1+) in the LP 
and MLN at days 0 and 5 post-infection. C) Total number of ILC2s (CD45+Il4-GFP+CD4–CD49b–
Thy1.2+KLRG1+) and CD4+ Th2 cells (CD45+Il4-GFP+CD4+) in the LP and MLN at day 5 post-
infection. Data are representative of 3 independent experiments with 4 mice per group. * 
denotes p<0.05. 
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Figure 3.6. ILC2s develop normally in the absence of IL-2. A) Frequency and total number 
(B) of ILCs (white bars; Lin–Thy1.2+KLRG1–) and ILC2s (black bars; Lin–Thy1.2+KLRG1+) in the 
LP and MLN of naïve Rag2–/– and Il2–/–Rag2–/– mice. Data are representative of 3 independent 
experiments with 3-5 mice per group.  
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Figure 3.7. IL-2 is not required for the expansion, cytokine production or proliferation of 
ILC2s. Rag2–/– or Il2–/–Rag2–/–mice were infected with 200 H. polygyrus larvae and harvested at 
day 5 post-infection. A) Absolute number of ILC2s (Lin–Thy1.2+KLRG1+) in the LP and MLN of 
naïve Rag2–/– (white bars) and infected Rag2–/– and Il2–/–Rag2–/– mice (black bars) day 5 post-
infection. Data are representative of 3 independent experiments with 3-5 mice per group. B) 
Frequency of IL-5+IL-13+ ILC2s (Lin–Thy1.2+KLRG1+) in the MLN of naïve Rag2–/– (white bars) 
and infected Rag2–/– and Il2–/–Rag2–/– mice (black bars) day 5 post-infection. C) Frequency of 
Ki-67+ ILC2s (Lin–Thy1.2+KLRG1+) in the MLN of naïve Rag2–/– (white bars) and infected Rag2–
/– and Il2–/–Rag2–/– mice (black bars) day 5 post-infection. Data are representative of 3 
independent experiments with 3-5 mice per group. 
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Figure 3.8. IL-2 complex (IL-2c) treatment expands ILC2s in the tissue and mesenteric 
lymph nodes. Rag2–/– were infected with 200 H. polygyrus larvae and treated with low-dose IL-
2c (IL-2clow) and medium-dose (IL-2cmed) or with PBS as a control. Mice were harvested 5 days 
post-infection. A) Representative FACS plots of MLN cells showing the frequency of lineage–
Thy1.2+ cells following treatment. Frequency and total number of ILC2s (Lin–Thy1.2+KLRG1+) in 
the LP (B) and MLN (C) of treated mice. Data are representative of 3 independent experiments 
with 3-4 mice per group. * denotes p<0.05. 
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Figure 3.9. IL-2c treatment increases the surface expression of CD25 on ILC2s and their 
proliferation. Rag2–/– were infected with 200 H. polygyrus larvae and treated with low-dose IL-
2c (IL-2clow) and medium-dose (IL-2cmed) or with PBS as a control. Mice were harvested day 5 
post-infection. A) Representative FACS plots of MLN cells showing the frequency of Lineage–
Thy1.2+ cells following treatment. Frequency and total number of ILC2s (Lin–Thy1.2+KLRG1+) in 
the LP (B) and MLN (C) of IL-2c-treated mice. Data are representative of 3 independent 
experiments with 3-4 mice per group. * denotes p<0.05. 
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Figure 3.10. IL-2c treatment impairs larval development resulting in reduced adult worm 
development. Rag2–/– were infected with 200 H. polygyrus larvae and treated with IL-2cmed or 
PBS as a control. A) Worm count of H. polygyrus larvae in the wall (black bars) and adult worms 
in the lumen (white bars) of mice at day 9 and day 22 post-infection. B) Immune cell infiltration 
(H&E) in small intestine histological sections. Arrows point to wall-embedded and luminal 
worms. C) Il5, Il13, Il4, Retnla, Retnlb, Arg1 and Mcl3a3 (Gob5) gene expression in the small 
intestine of IL-2c treated mice, day 5 post-infection, expressed as fold change relative to PBS 
treated mice. Data are representative of 3 independent experiments with 3-4 mice per group. * 
denotes p<0.05 
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Figure 3.11. Depletion of ILC2s partly impairs IL-2c-mediated larval killing.  
A) Experimental system: Rag2–/– were pre-treated with anti-Thy1.2 or an isotype control. 
Following this, the mice were infected with H. polygyrus and treated with anti-Thy1.2 or isotype 
control as well as IL-2c as illustrated. B) Absolute number of ILC2s (Lineage–NK1.1–
KLRG1+CD25+) in the LP of IL-2c and anti-Thy1.2 antibody treated mice day 9 post-infection. C) 
Worm count in the intestinal wall of IL-2c and anti-Thy1.2 antibody treated mice day 9 post-
infection. Data are representative of 2 independent experiments with 4-6 mice per group. * 
denotes p<0.05. 
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Figure 3.12. ILC2s drive the differentiation of naïve T cells in vitro in an IL-4 and IL-2-
dependent manner. A) Experimental model: ILC2 cells were expanded using IL-2 complex and 
FACS-purified from the MLN of 3-4 Rag2–/– or Rag2–/–Il2–/– mice. Following this the cells were 
stimulated with PMA + Ionomycin for 3H, washed and resuspended in complete media and 
harvested at 24H. B) Quantification of IL-13, IL-5 and IL-2 as well as C) IL-4 production in the 
supernatant of re-stimulated ILC2s or Il2–/– ILC2s (3-24H) measured by Flow Cytomix. D) Live 
cell count after 24H in culture. Error bars represent individual wells. Naïve T cells (nT; 
CD4+TCRβ+Il4-GFP–Foxp3-RFP–CD44–CD25–) were FACS-purified from Il4-GFPFoxp3-RFP 
mice and cultured with the supernatant from either ILC2 or Il2–/– ILC2 cultures, in the presence 
or absence of anti-IL-4 blocking antibody. Cells were cultured with recombinant IL-4 (10ng/ml) 
and IL-2 (10ng/ml) or cIMDM as controls. Cells were pooled from 2-3 mice and error bars 
represent individual wells. E) Frequency of Il4-GFP+ cells in the CD4+TCRβ+ gate as assessed 
by FACS. Data are representative of 3 independent experiments. nT cells were sorted from Il4-
GFPFoxp3-RFP mice and cultured with supernatant ILC2 cultures at indicated dilutions (F) or 
with the addition of recombinant IL-2 (G). nT cells were sorted from Il4-GFPFoxp3-RFP mice 
and cultured with recombinant IL-4 at the indicated concentrations. Data is representative of 1 
experiment. * denotes p<0.05. 
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Figure 3.13. ILC2s are required for the development of Th2 cells during primary infection 
with H. polygyrus. A) Experimental system: Il7ra–/– mice were sub-lethally irradiated and 
reconstituted with Rora–/– (RORαsg/sg) ILC2-deficient bone marrow or a mix of 80% Rora–/– bone 
marrow and 20% C57BL/6 (WT) or 20% Il4–/– (IL-4KO) bone marrow. 7-weeks post-
reconstitution, chimeric mice were infected with 200 H. polygyrus larvae and harvested at day 7 
post-infection. Frequency of ILCs (Lineage-Thy1.2+) (B) and ILC2s (Lineage-Thy1.2+KLRG1+) 
(C) in the LP of RORαsg/sg (–), RORαsg/sg:WT (WT) or RORαsg/sg:IL-4KO (Il4–/–) mice d7 post-
infection as assessed by FACS. D) Frequency and total number of CD4+TCRβ+ cells in the 
spleen of chimeric mice as assessed by FACS. E) Frequency of IL-4+, IL-13+ and IL-5+ of the 
CD4+CD44+ cells in the spleen of chimeric mice as assessed by intra-cellular cytokine staining 
and FACS. F) Absolute number of IL-4+, IL-13+ and IL-5+ of the CD4+CD44+ cells in the spleen 
of chimeric mice as assessed by intra-cellular cytokine staining and FACS. Data are 
representative of 2 experiments with 6-7 mice per group. * denotes p<0.05. 
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Chapter 4: Foxp3+ cells adopt a Th2 phenotype, contributing to protective type-2 
immunity against Heligmosomoides polygyrus. 
4.1. Introduction 
Foxp3+ CD4+ Treg cells are suppressive cells essential for the maintenance of 
immune homeostasis (Bennett et al., 2001; Brunkow et al., 2001) and prevention of 
excessive immune responses to infection (reviewed in (Belkaid, 2007)). The stability of 
the Treg population is maintained through the co-ordination of diverse mechanisms 
including cytokine signalling, transcription factor expression, post-transcriptional and 
post-translational modifications (Barbi et al., 2014). Despite this, many studies have 
identified that CD4+ Treg cells can lose the expression of Foxp3 in vitro or after transfer 
into lymphopenic hosts (Coomes et al., 2013). Additionally, the use of fate-mapping 
tools has identified a population of ex-Foxp3 cells that previously expressed, but have 
subsequently down-regulated Foxp3 expression in vivo in the context of autoimmune 
disease (Bailey-Bucktrout et al., 2013; Komatsu et al., 2014) and allergic inflammation 
(Noval Rivas et al., 2015). Furthermore, a significant fraction of ex-Foxp3 cells 
acquired T helper cell function and contributed to disease pathogenesis. To date, it is 
unclear whether ex-Foxp3 cells contribute to protective rather than pathogenic immune 
responses, in particular in the context of infection. In addition, due to a limited 
understanding of the mechanisms driving Treg to T effector cell conversion, the 
contribution of Treg conversion to functional immune responses remains unclear. 
The immune response to the intestinal helminth H. polygyrus is characterised 
by the simultaneous development of a polarised type-2 response, orchestrated by 
CD4+ Th2 cells, and immune-regulatory mechanisms, including the expansion of CD4+ 
Foxp3+ T regulatory cells. The balance established between these responses is 
thought to limit host damage, but as a consequence permits the survival, establishment 
and chronicity of infection and subsequent disease morbidity (Gause et al., 2013).  
CD4+ Th2 cells secrete cytokines that activate a cascade of downstream type-2 
effector responses and promote functional immunity to intestinal helminths (Allen and 
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Maizels, 2011). Emerging evidence suggests Th2 cells are required for sterile immunity 
to re-infection following anti-helminth vaccination (Hewitson et al., 2015). Interestingly, 
Th2 cells have contrasting pathogenic and regulatory roles within the immune 
response, possibly depending upon the time and requirements of the immune 
response. For example Th2 cells contribute to the development of allergic inflammation 
and can also promote wound healing and tissue repair during the resolution of 
inflammation (Wynn, 2015). Despite their important role as orchestrators of type-2 
responses, the factors driving Th2 differentiation in vivo remain unclear. A better 
understanding of the cellular and molecular pathways leading to Th2 differentiation in 
vivo is therefore required for the improved design of effective vaccines and new 
therapeutics and to identify new molecular targets to prevent Th2-mediated allergic 
reactions.  
In the previous chapter we identified a novel role for IL-4-secreting ILC2s in the 
differentiation of Th2 cells during acute H. polygyrus infection. In this chapter, we 
asked whether CD4+ Foxp3+ T regulatory cells convert to Th2 cells during H. polygyrus 
infection and contribute to the protective type-2 response. Many studies have shown a 
close relationship between Treg and Th2 cells and loss of Foxp3 expression has often 
been associated with the spontaneous acquisition of a Th2 phenotype (Sawant et al., 
2012; Muto et al., 2013). In addition, IL-4, which is required for Th2 differentiation in 
vivo (Kopf et al., 1993), can suppress Foxp3 expression in vivo (Noval Rivas et al., 
2015) and directly lead to the re-methylation of the Foxp3 locus in vitro, thereby 
compromising Treg stability (Feng et al., 2014).   
We hypothesised that canonical IL-4 signalling drives Treg conversion to Th2 
cells and that ex-Treg cells contribute to the memory Th2 response during a 
secondary, challenge infection with H. polygyrus. To test this hypothesis, we generated 
Il4-GFPFoxp3-RFP double-reporter mice to simultaneously monitor Th2 and Treg 
responses. Using these mice, we demonstrated that Foxp3-RFP+CD25high cells could 
lose Foxp3 expression and acquire Il4-GFP expression following adoptive transfer into 
lymphodeficient mice infected with H. polygyrus. To determine the frequency of Th2 
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cells that had derived from a Treg-past in vivo, we used a Foxp3 fate-reporter system 
crossed with Il4-GFP reporter mice (Foxp3YFP-CreIl4-GFPR26RFP635) and identified a 
population of Il4-GFP+R26RFP635+ cells in vivo which were currently transcribing Il4 and 
were fate-marked (FP635+) indicating that they had derived from a Foxp3-expressing 
past. The proportion and number of these Il4-GFP+ ex-Foxp3 cells expanded during a 
secondary infection with H. polygyrus. Finally, we have deleted IL-4R signalling 
specifically on Foxp3-expressing Treg cells, using recently generated Foxp3YFP-CreIl4-
GFPR26RFP635Il4rafl/fl mice, to test the Treg cell-intrinsic requirement of IL-4 signalling 
for Treg conversion. These mice will also be used to test the functional importance of 
IL-4Rα signalling on Treg cells during H. polygyrus expulsion.  
 
4.2. Results  
4.2.1. Secondary infection with H. polygyrus correlates with increased type-2 
responses and larval killing 
To study the conversion of CD4+ Foxp3+ T cells to CD4+ Th2 cells following 
infection with H. polygyrus, we generated double-reporter mice by crossing existing 
fluorescent cytokine reporter strains Foxp3-RFP mice (Wan and Flavell, 2005) and Il4-
GFP mice (Mohrs et al., 2001). Il4-GFPFoxp3-RFP mice enabled us to simultaneously 
monitor Th2-commited and Treg cells based on their expression of lineage-defining 
factors Foxp3 and Il4 and to FACS-purify live Th2 or Treg cells for adoptive transfer 
studies.  
H. polygyrus establishes a chronic infection in C57BL/6 mice lasting between 8-
20 weeks (Reynolds et al., 2012) however drug-cured mice develop a highly protective 
memory response resulting in killing of subsequent invading larvae (Reynolds et al., 
2012). Using this system and with the same genetic background of mice, we can 
compare the immune response during a primary infection (Hp 1°), which leads to a 
chronic infection, with the immune response during a secondary challenge infection 
(Hp 2°), which leads to rapid killing of invading larvae.  To do this, we infected Il4-
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GFPFoxp3-RFP mice with H. polygyrus, drug-treated them on day 14 and 15 post-
infection and subsequently gave them a secondary, challenge infection on day 28 (Hp 
2°) and analysed the immune response at d35 or d42 (model; Fig. 4.1 A). We infected 
a second group of Il4-GFPFoxp3-RFP mice and analysed the immune response at day 
7 or 14 following a primary infection (Hp 1°) (model; Fig. 4.1 A), which could otherwise 
lead to a chronic infection. Validating this model system in my hands, we observed 
significantly fewer adult worms in the lumen of immune Hp 2° mice compared to 
susceptible Hp 1° mice 14 days post-infection (Fig. 4.1 B). Immunity to secondary 
infection correlated with increased mucus staining on intestinal sections (as visualised 
by AB-PAS stain) and increased accumulation of immune cells around the H. polygyrus 
larvae in the intestinal wall (as assessed by H&E staining) at day 7 post-infection in 
secondary infected mice (Fig. 4.1 C). In addition, immunity to secondary infection 
correlated with a significant increase in the expression of several genes associated 
with type-2 effector responses such as Retnlb, Retnla, Arg1 and Gob5 in the small 
intestine (Fig. 4.1 D). 
 
4.2.2. Characterising Treg and Th2 cells during H. polygyrus infection 
4.2.2.1. Shift from a regulatory to an effector T cell response during secondary 
infection with Heligmosomoides polygyrus  
We characterised the frequency of Il4-GFP-expressing and Foxp3-RFP-
expressing CD4+ T cells in mice with a primary or secondary infection by FACS 
analysis. We observed an increased proportion of CD4+Foxp3-RFP–Il4-GFP+ Th2 cells 
in Hp 1° mice compared to naïve mice, which was further increased during a 
secondary infection (Hp 2°), as shown in the representative FACS plots of the MLN 
(Fig. 4.2 A). CD4+Foxp3-RFP–Il4-GFP+ Th2 cells were significantly increased in the PP 
and the MLN (Fig. 4.2 C and D) of Hp 1° mice compared to naïve mice, and further 
significantly increased in Hp 2° mice compared to Hp 1° mice in the spleen, MLN and 
PP (Fig. 4.2 A, B and C). There were no significant changes in the proportion of 
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CD4+Foxp3-RFP+Il4-GFP– Treg cells in the spleen or MLN (Fig. 4.2 A and B) however 
Treg cells were increased in the PP of Hp 1° mice in comparison to naïve and Hp 2° 
mice (Fig. 4.2 D). Using this data we calculated the ratio of Il4-GFP expression over 
Foxp3-RFP expression and observed a significant increase in the ratio of Th2 to Treg 
cells between Hp 1° and Hp 2° mice in the spleen, MLN and PP (Fig. 4.2 E). Taken 
together this data indicated that immunity to H. polygyrus following secondary infection, 
correlated with a dominant CD4+ Th2 effector population in systemic, secondary and 
tissue-associated lymphoid organs.  
 
4.2.2.2. IL-2c treatment during H. polygyrus infection leads to the expansion of 
Treg and Th2 cells and cannot be used to preferentially expand Treg cells 
As previously discussed in chapter 3, the complex of IL-2 and IL-2 antibody 
(JES6-1A12 clone), or IL-2 complex (IL-2c), has been shown to preferentially expand 
CD4+Foxp3+ cells (Boyman et al., 2006) and has been extensively used to manipulate 
the balance between Treg and T effector populations in the context of inflammation. 
For example, IL-2c was shown to restore Treg numbers and limit Th1-mediated islet 
cell damage during the development of type-1 diabetes in NOD mice (Tang et al., 
2008) and to expand Treg numbers and limit Th2-mediated airway allergy (Wilson et 
al., 2008). Furthermore, IL-2c treatment was shown to restore Treg numbers following 
Toxoplasma gondii infection and limit a pathogenic Th1 response (Oldenhove et al., 
2009). In light of our data showing IL-2c expansion of CD25-expressing ILC2s (chapter 
3), we wanted to investigate the impact of IL-2c treatment on CD4+ T cell responses 
following H. polygyrus infection, with the aim of promoting Th2 cells and H. polygyrus 
expulsion. We treated naïve and H. polygyrus infected mice (at days 12, 14 and 16 
post-infection) with a previously published dose of IL-2c (IL-2chigh; 5:50µg) and 
observed a significant expansion in the proportion of Foxp3-RFP+ Treg cells in the 
spleen of both naïve and H. polygyrus infected mice (Fig. 4.3 A). Furthermore, we saw 
a two-fold expansion in the proportion of Il4-GFP+ cells in naïve and H. polygyrus 
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infected mice (Fig. 4.3 A). Due to the high levels of CD25 expression on Treg cells 
(Sakaguchi et al., 1995), lower doses of IL-2c have been shown to preferentially 
expand Treg cells over T effector cells (Tang et al., 2008; Klatzmann and Abbas, 
2015). Therefore, we wanted to test whether we could use variable doses of IL-2c to 
modulate the balance between Treg and Th2 cells. We treated H. polygyrus infected 
mice with IL-2chigh (5:50µg) and IL-2clow (0.5:5µg) doses. We found that treatment with 
IL-2clow did not induce a significant expansion of either Treg or Th2 cells compared to 
PBS treated mice (Fig. 4.3 C). From these experiments we concluded that IL-2c can 
stimulate the expansion of diverse CD25-expressing cells including CD4+ Th2 and Treg 
cells, however we were unable to test whether differing doses of IL-2c led to the 
preferential expansion of Treg or Th2 cells and would need to test an intermediate 
dose in any future experiments.  
 
4.2.2.3. The Il4-GFPFoxp3-RFP reporter faithfully reports Il4 and Foxp3 mRNA 
expression  
Throughout these experiments, we identified a population of CD4+Il4-
GFP+Foxp3-RFP+ double-positive cells (DP) in both naïve and H. polygyrus infected 
mice (Fig. 4.2 A). We FACS-purified DP cells, single-positive Il4-GFP+ (Th2) and 
Foxp3-RFP+ (Treg) cells from the spleen and MLN of Hp 1° mice and analysed their 
expression of characteristic Th2 and Treg associated genes (Il4, Foxp3, Il4ra, Il2ra, 
Gata3 and Il10).  DP cells expressed Il4, albeit at lower levels than Th2 cells (Fig. 4.4), 
correlating with a lower Il4-GFP mean fluorescence intensity (MFI) observed by FACS 
analysis (Fig. 4.2). DP cells expressed similar levels of the Th2 master TF GATA-3 as 
Th2 cells. GATA-3 was also slightly increased in Treg cells compared to naïve T cells, 
in line with its essential role in the development of all CD4+ T cell subsets (Wang et al., 
2011; Wohlfert et al., 2011). DP cells expressed similar levels of Foxp3 as Treg cells 
(Fig. 4.4), correlating with their similar Foxp3-RFP MFI levels (Fig. 4.4). Although Treg 
cells expressed similar levels of Il4ra to naïve T cells, Il4-GFP+ cells expressed much 
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lower levels (Fig. 4.4), in accordance with the previously reported downregulation of IL-
4Rα on differentiated Th2 cells in vivo (Perona-Wright et al., 2010). DP cells expressed 
intermediate level of Il4ra (Fig. 4.4) and Il2ra in comparison to Foxp3-RFP+ cells and 
Il4-GFP+ cells (Fig. 4.4). Interestingly, DP cells expressed significantly higher levels of 
Il10 than both Foxp3-RFP+ cells and Il4-GFP+ cells. Taken together, these results show 
that Il4-GFP+Foxp3-RFP+ DP cells display a distinct gene expression profile. In 
addition, this data highlights the utility of Il4-GFPFoxp3-RFP mice to faithfully identify 
characteristic CD4+ T cell lineages and identify sub-populations of cells co-expressing 
lineage-specific TFs and cytokines. 
 
4.2.3. Foxp3-RFP+CD25high Treg cells convert to Il4-GFP+ cells and are 
transcriptionally re-wired following adoptive transfer into H. polygyrus infected 
TCRα-deficient mice 
4.2.3.1. Foxp3-RFP+CD25high Treg cells convert to Il4-GFP+ cells during secondary 
H. polygyrus infection  
IL-4 can directly inhibit Foxp3 expression in vitro (Feng et al., 2014) and in vivo 
(Noval Rivas et al., 2015). Furthermore, a proportion of Foxp3+ cells can lose Foxp3 
expression and their suppressive potential in the context of inflammation (Barbi et al., 
2014). Foxp3+ cells expressing high levels of CD25 were shown to have a 
demethylated Foxp3 locus, correlating with their functional stability in vitro (Komatsu et 
al., 2009) and in vivo following adoptive transfer (Miyao et al., 2012), however the 
stability of these cells was not tested during inflammation or in the context of infection. 
Following our observations that the Treg and Th2 ratio shifts towards a Th2 response 
during a memory response to H. polygyrus, we hypothesised that Treg cells 
contributed to the pool of memory Th2 cells, losing their regulatory phenotype and 
converting to Th2 cells. To test whether Foxp3-RFP+ cells that develop following H. 
polygyrus infection could convert to Il4-GFP+ cells, we FACS-purified CD4+TCRβ+Il4-
GFP+Foxp3-RFP+ cells expressing high levels of CD25 (CD25high) (HpTR) from the 
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spleen and MLN of mice 14 days following infection with H. polygyrus, a time when the 
parasite has established a chronic infection correlating with the peak of the 
differentiation of Il4-GFP-expressing CD4+ T cells (Fig. 4.5 A). We hypothesised that a 
proportion of Treg cells developing in the face of a strong Th2 response would convert 
to Th2 cells following adoptive transfer (Fig. 4.5 A). We transferred these cells to T cell 
deficient (Tcra–/–) mice, transferring FACS-purified naïve T cells (nT) as a control 
population into separate Tcra–/– mice. We infected the recipient Tcra–/– mice with H. 
polygyrus on the day of transfer, drug-cured them on days 14 and 15 post-infection and 
re-infected them at day 28 (model; Fig. 4.5 B). After 14 days of secondary infection, a 
high proportion of transferred HpTR cells lost Foxp3-RFP expression and CD25 
expression. Furthermore, a proportion of transferred HpTR cells expressed Il4-GFP, as 
shown in representative FACS plots of transferred cells in the MLN (Fig 4.5 D). 
Approximately 10% of adoptively transferred HpTR cells (black bars) were Foxp3-RFP–
Il4-GFP+ in the spleen and MLN, in comparison to 20% of transferred nT cells (white 
bars) (Fig. 4.5 E). More strikingly in the PP, 25% of transferred HpTR were Foxp3-
RFP–Il4-GFP+, similarly to transferred nT cells (Fig. 4.5 E). In addition to expressing 
Il4-GFP, a proportion of transferred HpTR cells (black bars) secreted IL-4 protein in the 
MLN as measured by intra-cellular cytokine staining, to a similar extent as transferred 
nT cells (Fig. 4.6 A). Transferred HpTR cells failed to produce significant levels of IL-5 
or IL-13 in comparison to nT cells (Fig. 4.6 A) suggesting that converted cells had 
acquired some, but not all, characteristics of Th2 cells. Together, these data identified 
that CD25highFoxp3-RFP+ cells have the potential to convert to IL-4-expressing and -
secreting cells, to a similar extent as transferred naïve T cells, and suggest that 
differences in the tissue microenvironment may contribute to different levels of 
conversion.  
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4.2.3.2. MLN-derived Foxp3-RFP+CD25high Treg cells convert to the highest extent 
in the Peyer’s patches 
To test the impact of the tissue microenvironment on the ability of Foxp3-RFP+ 
cells to convert to Il4-GFP+ cells, we isolated HpTR cells from either the spleen or MLN 
of CD45.1 or CD45.2 congenically marked double-reporter mice and co-transferred 
CD45.1+Foxp3-RFP+ (spleen) or CD45.2+Foxp3-RFP+ (MLN) cells in equal proportions 
into the same Tcra–/– host. We infected the recipient Tcra–/– mice with H. polygyrus, 
drug-cured the mice and measured the proportion of Il4-GFP+ cells (model; Fig. 4.6 
B). We found that 10-12% of transferred HpTR cells were Foxp3-RFP–Il4-GFP+ in the 
spleen and MLN and 25-30% were Foxp3-RFP–Il4-GFP+ in the PP (Fig. 4.6 C), 
similarly to previous experiments (Fig. 4.5 D). Gating on the Il4-GFP+ cells in the PP, 
we identified that the majority (around 80%) of Il4-GFP+ cells originated from 
transferred MLN HpTR cells (white bars, Fig. 4.6 D), as did the majority of Il4-GFP– 
cells (data not shown), suggesting MLN cells proliferated more following adoptive 
transfer. In a separate analysis, gating on MLN (CD45.2) or spleen (CD45.1)-derived 
HpTR cells, we found a higher proportion of MLN-derived cells expressed Il4-GFP 
compared to spleen-derived cells (Fig. 4.6 E). These results suggest that MLN-derived 
Treg cells proliferate and convert to a larger extent than spleen-derived Treg cells, in 
particular in the Peyer’s patches.  
 
4.2.3.3. Foxp3-RFP+ cells convert to Il4-GFP+ cells in the absence of antigen and 
of high levels of CD25 expression 
Following the observation that a population of HpTR cells had the capacity to 
either co-express Il4-GFP or down-regulate Foxp3 and express Il4-GFP, we wanted to 
test whether the infection status of either the donor or recipient mouse influenced the 
ability of the cells to convert. To test this, we isolated CD25highFoxp3-RFP+ cells from 
naïve (nTR cells) or H. polygyrus infected double-reporter donor mice (HpTR cells) and 
adoptively transferred the purified Treg cells into either naïve (white bars) or H. 
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polygyrus infected (black bars) Tcra–/– recipient mice (Fig. 4.7 A). We observed a 
similar proportion of Il4-GFP+ cells in naïve or infected recipients following the transfer 
of CD25highFoxp3-RFP+ cells from naïve or infected donor mice, as shown in 
representative graphs of the Peyer’s patches (Fig. 4.7 A) suggesting that the antigen-
specificity of the donor or host may not influence Treg conversion in this adoptive 
transfer model. Furthermore, we wanted to test whether the levels of CD25 expression 
previously shown to correlate with Treg stability (Miyao et al., 2012) influenced their 
conversion to Il4-GFP expressing cells. To test this, we isolated either CD25highFoxp3-
RFP+ or CD25lowFoxp3-RFP+ cells from H. polygyrus infected double-reporter mice and 
adoptively transferred these cells to Tcra–/– mice. Adoptively transferred CD25high or 
CD25low HpTR cells expressed similar levels of Il4-GFP as shown in representative 
graphs of the Peyer’s patches (Fig. 4.7 B), suggesting that CD25 expression may not 
determine the degree of Treg conversion to Il4-GFP–expressing cells following 
adoptive transfer.  
 
4.2.3.4. Il4-GFP+ ex–Foxp3-RFP+ cells are transcriptionally re-wired 
To characterise the transcriptional profile of Il4-GFP+ ex-Foxp3 cells (HpTRà 
Il4-GFP+), we FACS-purified donor HpTR cells from double-reporter mice and 
compared them to Il4-GFP+ cells isolated following the adoptive transfer of HpTR 
(HpTRà Il4-GFP+) or nT cells (nTà Il4-GFP+). We performed a gene expression 
microarray on 3 biological replicates for each group and filtered significantly expressed 
genes that were 2-fold up-regulated compared to naïve T cell controls. We performed 
hierarchical clustering between HpTR, HpTRà Il4-GFP+ and nTà Il4-GFP+ 
populations and found that HpTRà Il4-GFP+ and nTà Il4-GFP+ were more closely 
clustered together than with HpTR cells (Fig. 4.8 A). Following this, we compared 
differentially expressed genes between the samples, presented as a Venn diagram 
(Fig. 4.8 B). A significant number of genes (913) were similarly expressed between all 
cell types (Fig. 4.8 B). Strikingly, very few genes (172 genes) were similarly expressed 
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between HpTR and HpTRà Il4-GFP+ cells, suggesting converted cells had significantly 
re-wired their transcriptional profile following adoptive transfer. Indeed, 907 genes were 
commonly expressed between HpTRà Il4-GFP+ and nTà Il4-GFP+ cells, which 
constitutes around 50% of the significantly expressed genes for both cell types. Few 
genes (297) were commonly expressed between HpTR and nTà Il4-GFP+ cells (Fig. 
4.8 B). Furthermore we selected a few candidate genes representative of Treg and 
Th2 cells and looked at their expression in the three subsets. HpTRà Il4-GFP+ and 
nTà Il4-GFP+ but not HpTR significantly expressed the Th2 hallmark cytokines Il4, Il13 
and Il2 and had downregulated Il4ra expression (Fig. 4.8 C). HpTRà Il4-GFP+ and 
nTà Il4-GFP+ had also downregulated the Treg-associated genes Foxp3, Il2ra, Ctla4 
and Il10 (Fig. 4.8a C), suggesting that HpTRà Il4-GFP+ had lost their Treg phenotype 
and acquired a Th2 effector phenotype. We confirmed loss of Foxp3 and gain of Il4 
expression by qRT-PCR (Fig. 4.8a D). In addition to the classical CD4+ T cell lineage 
genes listed above, we also saw high levels of Cxcr5 and Il21, typically associated with 
Tfh cells, expressed in HpTRà Il4-GFP+. In addition, the IL-33R (Il1rl1) was expressed 
on HpTR and nTà Il4-GFP+ but not on HpTRà Il4-GFP+ (Fig. 4.8a C). Computational 
analysis using Ingenuity Pathways Analysis software (IPA) (Kramer et al., 2014) was 
used to identify putative upstream signalling pathways that may contribute to the 
observed gene expression profile in HpTR, HpTRà Il4-GFP+ and nTà Il4-GFP+ cells. 
Il4 was predicted to be upstream of the transcriptional profile of the three populations 
(Fig. 4.8 E). Additionally, Csf2, Il1b, and Tnf were the most highly predicted cytokines 
responsible for regulating the transcriptional profile of HpTRà Il4-GFP+ cells (Fig. 4.8 
F). Il4 also featured as a highly significant upstream regulator when compared to all 
molecules upstream and featured in the 5 highest predicted regulators (bold, Fig. 4.8 
F). The transcriptional profiling of HpTR and HpTRà Il4-GFP+ suggested that loss of 
Foxp3-RFP expression correlated with broad transcriptional changes and the 
acquisition of T effector cell properties. To test whether the similarities in the 
transcriptional profile of HpTRà Il4-GFP+ and nTà Il4-GFP+ were a consequence of 
the lymphodeficient environment in Tcra–/– mice, we also compared the expression 
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profile of HpTR cells that had maintained Foxp3-RFP following adoptive transfer 
(HpTRà Foxp3-RFP+), and HpTR cells that had lost Foxp3-RFP expression but not 
upregulated Il4-GFP expression (HpTRà DN). We performed hierarchical clustering 
between HpTR, HpTRà Foxp3-RFP+, HpTRà DN and HpTRà Il4-GFP+ cells. From 
the dendogram, HpTR cells were the most distant, whereas the three groups isolated 
following adoptive transfer clustered together (Fig. 4.8b C). Of these, HpTRà HpTR 
and HpTRà DN clustered closest together. Interestingly, the HpTRà Il4-GFP+ 
samples clustered apart from HpTRà DN (Fig. 4.8b C), suggesting that neither the 
loss of Foxp3 or signals from the lymphodeficient environment were entirely 
responsible for driving the transcriptional profile of HpTRà Il4-GFP+. Instead, these 
results suggest that sorting ex-HpTR cells based on Il4-GFP expression cells led to the 
identification of a unique subset of cells.  
 
4.2.3.5. Il4-GFP+ ex–Foxp3-RFP+ cells retain a demethylated Foxp3 locus 
Foxp3 expression is essential for the development of CD4+ T regulatory cells 
(Fontenot et al., 2003), however recent studies identified an important group of proteins 
and TFs that cooperate with Foxp3 to maintain Treg function (Fu et al., 2012; Rudra et 
al., 2012) termed the Foxp3 interactome (Hori, 2012). Furthermore, commitment 
towards a Treg lineage correlates with the establishment of a unique demethylation 
pattern on the Foxp3 gene and on other genes associated with Treg function such as 
Il2ra and Ctla4 (Okada et al., 2014). As mentioned previously, CD25 expression on 
Foxp3-expressing cells correlated with the proportion of demethylated CpG islands 
both at the CD25 coding gene, Il2ra, as well as on the Foxp3 locus (Ohkura et al., 
2012). From our previous experiments, a proportion of Foxp3-RFP+CD25high cells were 
unstable in vivo and lost Foxp3 expression, which correlated with the re-wiring of their 
transcriptional profile. In light of this, we wanted to determine the methylation status of 
the Foxp3 locus in our donor Foxp3-RFP+CD25high cells and compare them to cells that 
had lost Foxp3-RFP and Foxp3 mRNA expression following adoptive transfer. We 
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hypothesised that converted cells would have re-methylated their Foxp3 locus. To 
quantify the methylation of the Foxp3 locus we performed bisulphite modification of 
DNA (Clark et al., 1994), which converts all unmethylated cytosines to uracils, and 
leaves methylated cytosines untouched.  We designed primers to amplify the CNS2 
region of the Foxp3 locus containing 12 CpG islands previously shown to be 
specifically demethylated in Foxp3+CD25+ cells (Floess et al., 2007). In addition, we 
designed primers for a control region of the Foxp3 locus containing 5 CpG islands 
previously shown to remain methylated in Treg cells (Floess et al., 2007) (Fig. 4.8 A). 
We PCR-amplified bisulphite modified DNA from our different populations and cloned 
the PCR products. We sent multiple clones from each sample for sequencing, and 
analysed the data using the online methylation analysis programme QUMA (Kumaki et 
al., 2008). We FACS-purified Foxp3-RFP+CD25high cells (HpTR), naïve T cells (nT) and 
HpTR cells that had lost Foxp3-RFP expression and unregulated Il4-GFP (HpTRà Il4-
GFP+) and assessed their methylation status. As expected, the majority of the CpG 
islands within the three populations were methylated at the control region of the Foxp3 
locus (as illustrated in Fig. 4.9 A and B). Furthermore, a high proportion of the CpG 
islands in the Foxp3 CNS2 of naïve T cells (nT) (95%) were methylated (white bars, 
Fig. 4.9 A and B) as previously described (Miyao et al., 2012). Conversely, only a 
small proportion (15-20%) of the CpG islands were methylated in HpTR cells (grey 
bars; Fig. 4.9 A and B), as expected. Surprisingly, this was also true in HpTRà Il4-
GFP+ cells that had lost Foxp3 expression, where a very low proportion (5-10%) of CpG 
islands were methylated (black bars, Fig. 4.9 A and B). We also FACS-purified Foxp3-
RFP+CD25high from naïve double-reporter mice (nTR) and Foxp3-RFP–Il4-GFP+ cells 
from double reporter mice infected with H. polygyrus for 14 days. As expected, a low 
proportion of CpG islands were methylated in the Foxp3 CNS2 (15-20%), but not the 
control region of nTR cells similarly to HpTR cells (Fig. 4.9 D). Conversely, a high 
proportion of CpG islands were methylated in both the Foxp3 CNS2 and control region 
of Foxp3-RFP–Il4-GFP+ cells, similarly to nT cells (Fig. 4.9 D).  In light of the surprising 
finding that HpTRà Il4-GFP+ cells had retained a demethylated Foxp3 CNS2, we 
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isolated HpTRà DN cells that had lost Foxp3 expression but not acquired Il4-GFP 
expression. In contrast to HpTRà Il4-GFP+, a high proportion of HpTRà DN cells had 
re-methylated their Foxp3 locus (Fig. 4.9 E). Lastly, we FACS-purified cells which had 
maintained Foxp3 expression following adoptive transfer (HpTRà Foxp3-RFP+) to 
account for the effects of the lymphodeficient environment on changes in methylation 
status. We found the majority of HpTRà Foxp3-RFP+ cells had maintained a 
demethylated Foxp3 locus, which correlated with the maintenance of Foxp3 expression 
(Fig. 4.9 E). Taken together, these experiments revealed that although HpTRà Il4-
GFP+ cells lost Foxp3 expression and were transcriptionally more similar to Th2 cells, 
they retained a demethylated Foxp3 locus, similar to Treg cells. 
Methylation of the Foxp3 TSDR has been shown to correlate with Treg 
suppressor function. We therefore wanted to test whether HpTRà Il4-GFP+ cells that 
maintained a demethylated Foxp3 locus (Fig. 4.9 A and B) had retained their 
suppressor function. To address this, we performed an in vitro Treg suppression assay 
by co-culturing CD4+TCRβ+CD25–CD44– nT cells alone or with an equal number of 
FACS-purified HpTRà Foxp3-RFP+, HpTRà DN or HpTRà Il4-GFP+ cells in the 
presence of TCR stimulation. A high proportion (~70%) of nT cells cultured alone or 
with HpTRà DN proliferated in vitro as assessed by CTV staining (Fig. 4.10 A). In 
comparison, we saw fewer nT cells proliferating when cultured with HpTRà Il4-GFP+ or 
HpTRà Foxp3-RFP+ cells, where proliferation was almost completely blocked (Fig. 
4.10 A). Together, these results suggest that the methylation status of the Foxp3 locus 
correlated with the suppressive capacity of the cells. 
 
4.2.3.6. Adoptive transferred Treg and nT cells are insufficient to mediate 
functional worm expulsion 
Although the population of HpTRà Il4-GFP+ cells maintained elements of their 
Treg past, including a demethylated Foxp3 locus, the above studies also highlighted 
fundamental changes in their transcriptional profile, including evidence of Th2 effector 
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function. To test whether the cells could function as Th2 effector cells in the adoptive 
transfer model, we measured their ability to stimulate downstream type-2 responses in 
Tcra–/– recipients following secondary infection with H. polygyrus. One of our first 
observations was that although the frequency of Il4-GFP+ cells originating from HpTR 
cells was similar to the frequency of Il4-GFP+ cells originating from naïve T cells (nTà 
Il4-GFP+), the absolute number of both populations was significantly different, with 
much fewer numbers of HpTRà Il4-GFP+ cells, suggesting they had a lower 
proliferative capacity (Fig. 4.10 B), although this needs confirming with labelling 
experiments. In addition, although we had previously detected IL-4 protein secretion by 
CD4+ T cells by intra-cellular cytokine staining, levels of IL-4 secreted by re-stimulated 
HpTRà Il4-GFP+ cells in vitro were undetectable by ELISA (Fig. 4.10 C). Furthermore, 
we could not detect serum IgE antibody levels in mice that received HpTR cells, in 
comparison to mice that received nT cells (Fig. 4.10 D). Similarly, mRNA expression of 
alternative macrophage activation-related genes, Arg1 and Chil3l3, was only marginally 
elevated in the small intestine of mice that received HpTR in contrast to mice that 
received nT cells (Fig. 4.10 E). Finally, we assessed the ability of transferred cells to 
promote the expulsion of H. polygyrus following secondary infection (as previously 
shown Fig. 4.1). Using this adoptive transfer system, neither nT or HpTR recipients 
eliminated a secondary infection with H. polygyrus (Fig. 4.10 F).  Collectively, these 
results suggested that the adoptive transfer model was a useful system to identify the 
ability of T cells to convert their phenotype, but was insufficient to test the functional 
consequences of this change in vivo, including their their ability to promote antibody 
class-switching as well as alternative activation of macrophages, possibly due to their 
limited ability to expand. In addition, although nTà Il4-GFP+ expanded and induced a 
type-2 effector response, they were also unable to promote functional expulsion of H. 
polygyrus. As a consequence of these observations, we concluded that this model was 
insufficient to test the ability of HpTRà Il4-GFP+ cells to functionally expel H. 
polygyrus. Nevertheless, we observed that a proportion of FACS-purified Foxp3-
RFP+CD25high HpTR cells had downregulated Foxp3-RFP reporter expression and 
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mRNA expression following adoptive transfer into H. polygyrus infected Tcra–/– mice. Of 
these ex-Foxp3 cells, a fraction upregulated Il4-GFP and Il4 mRNA expression 
(HpTRà Il4-GFP+ cells) and exhibited a unique transcriptional profile. 
 
4.2.4. ex-Foxp3 Il4-GFP+FP635+ cells develop in vivo and contribute to the 
memory Th2 response to H. polygyrus 
4.2.4.1. ex-Foxp3 Il4-GFP+FP635+ cells develop in vivo and expand in secondary 
responses to H. polygyrus 
We hypothesised that Il4-GFP+ ex-Foxp3 cells also developed in a wild-type 
setting in vivo. Following the observation that there was a strong shift from a regulatory 
to an effector response in secondary responses to H. polygyrus (Fig. 4.2), we further 
hypothesised that Il4-GFP+ ex-Foxp3 cells contributed to the Th2 memory population 
during H. polygyrus infection. To test whether Il4-GFP+ ex-Foxp3 cells developed in a 
lympho-complete mouse, we crossed existing fate-mapping and fluorescent cytokine 
reporter strains Foxp3YFP-Cre (Rubtsov et al., 2008), 4get (Mohrs et al., 2001) and 
R26RFP635 mice (Coomes et al., 2015) to generate Foxp3YFP-CreIl4-GFPR26RFP635 fate-
reporter mice. Using this mouse, we were able to track cells actively transcribing Il4 
(Il4-GFP+) and Foxp3 (Foxp3-YFP-Cre+FP635+) and cells that had previously 
expressed Foxp3 (Foxp3-YFP-Cre–FP635+). Thus, we could also identify whether any 
Il4-GFP+ cells had previously expressed Foxp3 (Il4-GFP+FP635+) in vivo in a lympho-
complete mouse. We infected Foxp3YFP-CreIl4-GFPR26RFP635 mice with H. polygyrus, 
drug-treated them and subsequently gave them a secondary infection (Hp 2°). At the 
same time, we infected naïve Foxp3YFP-CreIl4-GFPR26RFP635 mice with a primary H. 
polygyrus infection (Hp 1°) (model; Fig. 4.11 A). We harvested the mice at day 7 post-
infection, when we had previously seen a strong regulatory to effector shift in the CD4+ 
populations (Fig. 4.2). We saw a small reduction of Foxp3-YFP-Cre+Il4-GFP– Treg cells 
in Hp 2° mice compared to Hp 1° mice (Fig. 4.11 B) as previously described using the 
double-reporter mice (Fig. 4.2). This decrease correlated with an increase in the 
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proportion and total number of Il4-GFP+ Th2 cells (Fig. 4.11 C), as illustrated in 
representative FACS plots of the spleen (Fig. 4.11 B), confirming previously described 
results using the double-reporter mice (Fig. 4.2). As expected, all Foxp3-YFP-Cre+Il4-
GFP– Treg cells were fate-marked and expressed FP635+ (Fig. 4.11. B), highlighting 
the efficiency of the Cre-mediated recombination. Furthermore, a significant proportion 
of Il4-GFP+ cells were FP635+ (10%) (Il4-GFP+FP635+) demonstrating that ex-Foxp3 
Il4-GFP+ cells develop in wild-type mice. Both the proportion and absolute number of 
Il4-GFP+FP635+ cells increased in Hp 2° mice, with up to 20-25% of all the memory 
Th2 cells deriving from a Foxp3-expressing past (Fig. 4.11 D).  Furthermore, Il4-
GFP+FP635+ cells expressed similar levels of CD25, GITR and CD103 as Il4-GFP+ 
cells (Fig. 4.11 E) and lower than Foxp3-YFP+Il4-GFP– cells, suggesting that they were 
more functionally similar to Th2 cells than Treg cells. Intracellular CTLA-4 levels were 
marginally elevated on all cells and not different between groups (Fig. 4.11 F). 
 
4.2.4.2. ex-Foxp3 Il4-GFP+FP635+ cells exhibit Th2 effector function whilst 
maintaining characteristics of their Treg past  
Unlike the ex-Foxp3-RFP+Il4-GFP+ cells isolated following adoptive transfer in 
the previous section, FACS-purified fate-marked Il4-GFP+FP635+ from Hp 2° mice 
secreted high levels of IL-4, IL-13, IL-5 and IL-2 protein following re-stimulation in vitro, 
to similar levels as FACS-purified Il4-GFP+ Th2 cells (Fig. 4.12 A). IL-4, IL-13, IL-5 or 
IL-2 were undetectable in the supernatants of FACS-purified and re-stimulated Foxp3-
YFP-Cre+Il4-GFP– Treg cells (Fig. 4.12 A). We designed an assay to test whether T 
cell-derived IL-4 and IL-13 could alternatively activate macrophages (AAMΦ) in vitro, a 
process known to be dependent on either of these cytokines (Junttila et al., 2008). 
These cellular interactions are also thought to occur around the larvae during a 
secondary infection with H. polygyrus and were shown to be required for larval killing 
and immunity to secondary infection (Anthony et al., 2006). We FACS-purified Il4-
GFP+FP635+ cells from Hp 2° mice and co-cultured the cells with bone marrow derived 
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macrophages (BMDMs) in vitro overnight. Following this, we washed away the CD4+ T 
cells and measured Arg1 and Retnla expression in macrophages. Both Il4-GFP+ and 
Il4-GFP+FP635+ cells induced Arg1 and Retnla expression in BMDMs, to a better 
extent than recombinant IL-4 and IL-13, frequently used to differentiate AAMΦ in vitro 
(Fig. 4.12 B).  As expected, Foxp3-YFP-Cre+Il4-GFP– Treg cells did not induce 
detectable levels of Arg1 or Retnla expression (Fig. 4.12 B). Following the observation 
that ex-Foxp3 Il4-GFP+FP635+ were functionally similar to Th2 cells, we wanted to 
determine the methylation status of the Foxp3 locus and again hypothesised that Il4-
GFP+FP635+ cells had re-methylated their Foxp3 locus, similarly to previously 
described Il4-GFP+ cells (Fig. 4.9). We FACS-purified Foxp3-YFP-Cre+Il4-GFP– Treg, 
Il4-GFP+ Th2 and ex-Foxp3 Il4-GFP+FP635+ cells and performed bisulphite modification 
and methylation sequencing of the Foxp3 CNS2 and negative control region, as 
previously described (Fig. 4.9). As expected, the majority of Foxp3-YFP-Cre+Il4-GFP– 
Treg cells (98%) had a demethylated Foxp3 CNS2 and maintained a methylated 
control region (grey bars, Fig. 4.12 C), as we had previously shown in FACS-purified 
Foxp3-RFP+ cells from double-reporter mice (Fig. 4.8). In addition, a high proportion of 
Il4-GFP+ cells (90%) had a methylated Foxp3 CNS2, in accordance with the lack of 
Foxp3 expression (white bars, Fig. 4.12 C). Interestingly, a high proportion of Il4-
GFP+FP635+ cells (75-80%) also had a methylated Foxp3 CNS2 (black bars, Fig. 4.12 
C), in contrast to the methylation status of converted cells from the adoptive transfer 
system. There was a significant difference in the proportion of methylated Il4-
GFP+FP635+ compared to Il4-GFP+ cells, highlighting a potential heterogeneity in the 
populations and suggesting a small proportion of ex-Foxp3 Il4-GFP+FP635+ cells 
retained epigenetic memory (Fig. 4.12 C). To test whether this heterogeneity reflected 
the ability of ex-Foxp3 Il4-GFP+FP635+ cells to re-express Foxp3, we cultured ex-
Foxp3 Il4-GFP+FP635+ in inducible Treg (iTreg) polarising conditions in vitro and 
measured Foxp3-YFP expression. We FACS-purified Foxp3-YFP-Cre+, Il4-GFP+ and 
Il4-GFP+FP635+ cells and cultured them in the presence of TGF-β and IL-2 with TCR 
stimulation for 7 days. Firstly, we observed a significant proportion of ex-Foxp3 Il4-
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GFP+FP635+ cells lost Il4-GFP expression (black bars; Fig. 4.12 D) compared to Il4-
GFP+ cells cultured in the same conditions (white bars; Fig. 4.12 D) suggesting they 
were more unstable. Furthermore, a higher proportion of cultured Il4-GFP+FP635+ cells 
re-expressed Foxp3-YFP in comparison to cultured Il4-GFP+ cells (Fig. 4.12 D). Taken 
together, this data demonstrated that ex-Foxp3 Il4-GFP+FP635+ cells that had 
previously expressed Foxp3 could function as Th2 effector cells in vitro, similar to Il4-
GFP+ cells. In addition, these data highlighted heterogeneity in the methylation status 
of the cells as well as the ability of cells to re-express Foxp3, suggestive of true 
plasticity, albeit only in a small proportion of cells. These data also suggest that ex-
Foxp3 Il4-GFP+FP635+ cells may be a heterogeneous population of cells displaying 
some properties of their Treg past.  
 
4.2.5. Investigating a role for IL-4 signalling for the development of ex-Foxp3 Il4-
GFP+FP635+ cells 
IL-4 and IL-4Rα are critically required for the functional expulsion of H. 
polygyrus (Urban et al., 1991). Importantly, anti-IL-4 treatment administered around the 
time of a secondary H. polygyrus infection inhibited worm expulsion (Urban et al., 
1991), suggesting IL-4 was required for functional immune responses in a secondary 
infection rather than uniquely in the generation of Th2 memory cells. Using two 
separate approaches, we have shown that Il4-GFP+ cells can differentiate from Foxp3-
expressing cells in the context of a secondary infection with H. polygyrus. We therefore 
hypothesised that IL-4 was required for the development and expansion of ex-Foxp3 
Il4-GFP+FP635+ cells. We aimed to test this in two ways: 1) through antibody blockade 
of IL-4 during a secondary infection and 2) by specifically deleting Il4ra in Foxp3-
expressing cells.  
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4.2.5.1. IL-4 signals through STAT6 in CD25highFoxp3-RFP+cells and promotes 
their conversion to Il4-GFP+ cells in vitro 
Before testing whether IL-4 was contributing to the conversion of HpTR to Il4-
GFP+ cells, we first wanted to determine whether Treg cells were responsive to IL-4. As 
previously described, CD25highFoxp3-RFP+ cells express Il4ra to similar levels as naïve 
T cells (Fig. 4.8a). To test the signalling capacity of IL-4Rα on CD25highFoxp3-RFP+ 
cells, we FACS-purified CD25highFoxp3-RFP+ (HpTR) or naïve T cells (nT) from Il4-
GFPFoxp3-RFP double-reporter mice. We stimulated the FACS-purified cells with 
recombinant IL-4 for 15min in vitro (model; Fig. 4.13 A) and measured the 
phosphorylation of STAT6 (Kaplan et al., 1996; Takeda et al., 1996). IL-4 triggered the 
phosphorylation of STAT6 (pSTAT6) to a similar extent in nT cells and HpTR cells (Fig. 
4.13 B). Interestingly, we saw a basal level of pSTAT6 in the control HpTR cells that 
were cultured in media alone (Fig. 4.13 B), possibly reflecting the IL-4-rich 
environment in the spleen and MLN where HpTR cells were purified from. Following 
this observation, we wanted to test the impact of IL-4 signalling on the conversion of 
HpTR cells. We FACS-purified CD25highFoxp3-RFP+ (HpTR) or naïve T cells (nT) from 
Il4-GFPFoxp3-RFP double-reporter mice and cultured the cells in Th2 polarising 
conditions in vitro for 7 days (model; Fig. 4.13 A). After 7 days, the majority of nT cells 
had up-regulated Il4-GFP as shown in the representative FACS plots (Fig. 4.13 C). In 
addition, a high proportion (75-80%) of the cultured HpTR cells lost Foxp3-RFP 
expression with a substantial fraction (35-40%) up-regulating Il4-GFP (Fig. 4.13 C and 
D) indicating that IL-4 can drive conversion of HpTR to Il4-GFP+ cells in vitro.  
 
4.2.5.2. Foxp3+ cells are dispensable for the development of Th2 responses and 
functional immunity to H. polygyrus  
In light of the observation that HpTR cells were actively phosphorylating STAT6 
in a H. polygyrus infection, and that IL-4 could promote Treg to Th2 conversion in vitro, 
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we wanted to test the impact of IL-4 signalling in Treg cells on the development of 
memory Th2 responses in a secondary H. polygyrus infection. 
Our first broad approach was to determine whether Foxp3-expressing cells 
contributed to the Th2 response. Because Foxp3-deficient mice develop severe 
lymphoproliferative disease (Brunkow et al., 2001), we made use of “deletion of T 
regulatory cell” BAC transgenic (DEREG) mice that express a diphtheria toxin receptor 
(DTR) DTR-eGFP fusion protein under the control of the Foxp3 promoter. This allows 
for the identification of Foxp3-expressing cells using GFP, as well as the temporary 
and selective depletion of Foxp3-expressing cells upon diphtheria toxin injection (Lahl 
et al., 2007).  We hypothesised that the selective depletion of Foxp3-expressing cells 
at the time of H. polygyrus challenge infection would impair Th2 responses by 
depleting a potential pool of ex-Foxp3 Th2 cells. We infected DEREG mice with H. 
polygyrus, drug-treated them and subsequently gave them a secondary infection (Hp 
2°). We pre-treated mice with two rounds of diphtheria toxin before infection and once 
on the day of secondary infection (DEREG Hp 2° + Dtx) and left another group 
untreated (DEREG Hp 2°) (model; Fig. 4.14 A). In addition, we harvested treated or 
untreated naïve DEREG mice. We harvested the mice 7 days post-infection for FACS 
analysis and 14 days post-infection to measure intestinal worm burden. The proportion 
of Foxp3-GFP+CD25+ cells was significantly reduced in DEREG Hp 2° + Dtx mice as 
shown in representative FACS plots of the MLN (Fig. 4.14 B). Furthermore, Foxp3-
GFP+CD25+ depletion was effective in both naïve and infected mice (Fig. 4.14 C).  
Following this, we measured the impact of Treg depletion on the functional Th2 
response by assessing functional worm expulsion on day 14 post-infection. As 
previously described, drug-cured mice expel a challenge infection with H. polygyrus. 
Indeed, adult worms almost completely failed to mature in WT Hp 2° mice and control 
DEREG Hp 2° mice which were not given diphtheria toxin (white bars; Fig. 4.14 D) 
compared to mice given a primary infection (grey bars; WT Hp 1°) (Fig. 4.14 D). Worm 
expulsion was not compromised in DEREG Hp 2° + Dtx mice (black bar; Fig. 4.14 D). 
Indeed, depletion of Foxp3-expressing cells resulted in a significant increase in the 
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proportion of CD4+IL-4+ or CD4+IL-13+ cells as measured by intra-cellular cytokine 
staining (Fig. 4.14 E), suggesting that on a population level, a dominant functional role 
of Foxp3+ cells was to limit Th2 expansion, rather than contribute to the Th2 pool.  
The second approach we used to test the impact of IL-4 signalling in Treg cells 
on functional immunity to H. polygyrus followed the observation that IL-4 could 
stimulate the conversion of Treg cells to Th2 cells in vitro. We hypothesised that IL-4 
signalling could drive the conversion of Treg to Th2 cells and therefore contribute to the 
memory Th2 response. To test this, we used a mixed bone marrow approach to 
specifically delete Il4ra in Foxp3-expressing cells. We used lethally irradiated T-cell 
deficient Tcra–/– recipient mice and bone marrow from WT mice, Il4ra–/– mice and 
Scurfy (Foxp3–/–) pups that are deficient in Treg cells and develop fatal 
lymphoproliferative disease within a few weeks of birth (Fontenot et al., 2003). We 
reconstituted irradiated Tcra–/– mice with either WT, Il4ra–/–, WT:Foxp3–/– (20%:80%) or 
IL4ra–/–:Foxp3–/– (20%:80%) bone marrow. In the latter two groups, Foxp3+ Treg cells 
originated from either the WT or Il4ra–/– compartments. Although at this stage we 
couldn’t test the impact of IL-4 signalling on Treg conversion, using this chimeric 
system we could test whether the deletion of IL-4Rα on Treg cells would have any 
impact on the development of memory Th2 cells and functional expulsion of H. 
polygyrus. Following reconstitution, we infected the chimeric mice with H. polygyrus, 
drug-treated them and subsequently gave them a secondary infection. We harvested 
the mice 14 days post-infection for FACS and adult worm counts (Fig. 4.15 A). There 
were no significant differences in the proportion of Foxp3+CD25+ cells in the spleen of 
the different groups, and none of the mice developed wasting disease in the time-frame 
of the experiment, crudely demonstrating that the IL-4Rα was not required for the 
development or function of Treg cells (Fig. 4.15 B).  To test whether IL-4Rα expression 
on Treg cells contributed to the Th2 response, we measured IL-4 production by CD4+ 
T cells by intra-cellular cytokine staining. The development of CD4+IL-4+ cells was 
significantly impaired in mice fully reconstituted with Il4ra–/– bone marrow, compared to 
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WT reconstituted mice (Fig. 4.15 C), as previously described in Stat6–/– mice (Perona-
Wright et al., 2010) and in mice treated with anti-IL-4Rα antibody following secondary 
infection (Urban et al., 1991; Urban et al., 1995). Restricting IL-4Rα deficiency to 
Foxp3-expressing cells (IL4ra–/–:Foxp3–/–) did not significantly impact the development 
of CD4+IL-4+ cells compared to the WT control mice (WT:Foxp3–/–) (Fig. 4.15 C). As a 
consequence, immunity to H. polygyrus as assessed by luminal worm counts was 
impaired in complete Il4ra–/– mice but not in mice with a selective deficiency in IL-4Rα 
expression on Foxp3-expressing cells (Fig. 4.15 D).  These data suggest that IL-4Rα 
expression on Treg cells is not required for the development, or control, of Th2 memory 
responses and does not impact the expulsion of H. polygyrus. 
 
4.2.5.3. Generation of a conditional IL-4Rα-deficient mice to study the role of IL-4 
signalling on Treg conversion in vivo 
The above experiments suggest IL-4 signalling in Foxp3-expressing cells had 
no impact on the development of Th2 cells or functional expulsion of H. polygyrus. 
However, given that we knew a high proportion of Il4-GFP+ cells seen in a secondary 
H. polygyrus infection originated from a Foxp3-expressing past (Fig. 4.11), we wanted 
to test whether IL-4 signalling was required for the generation of Il4-GFP+FP635+ cells. 
Our first approach was to treat fate-reporter mice with anti-IL-4 monoclonal antibody 
during the course of a secondary infection and monitor the development of Il4-
GFP+FP635+ cells (model, Fig. 4.15 E). Preliminary data suggests that treatment of 
fate-reporter mice with anti-IL-4 over the course of the secondary challenge did not 
reduce the proportion or number of Il4-GFP+ Th2 cells in the spleen or MLN (Fig. 4.15 
F) or the proportion and total number of ex-Foxp3 Il4-GFP+ cells (Fig. 4.15 G). 
Our second approach is to directly test the role of IL-4 on Foxp3-expressing 
cells by generating a conditional knockout mouse. We have crossed our fate-reporter 
Foxp3YFP-CreIl4-GFPR26RFP635 mice with an Il4rafl/fl mouse harbouring a conditional Il4ra 
allele. Using this mouse, we will determine whether IL-4 signalling on Foxp3-
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expressing cells is required for the development of ex-Foxp3 Il4-GFP+FP635+ cells and 
whether IL-4-responsive Treg cells contribute or regulate Th2-mediated expulsion of H. 
polygyrus. 
 
4.3. Discussion 
Helminths have evolved to subvert host immune responses by stimulating the 
expansion of Treg cells (Grainger et al., 2010) and establishing chronic infections in the 
host. Despite helminth-elicited immune-modulation, functional immunity to intestinal 
helminths can occur, and is dependent on the development of a polarised type-2 
response, orchestrated by CD4+ Th2 cells (Urban et al., 1991; Urban et al., 1991). As 
we have shown, expulsion of the intestinal helminth H. polygyrus is associated with a 
shift from a regulatory to a Th2 effector response. Furthermore, recent work has 
demonstrated that Foxp3+ Treg cells can lose Foxp3 expression in the context of 
inflammation or infection and convert to pathogenic T helper cells (Coomes et al., 
2013). In this chapter, we tested the hypothesis that Treg cells convert to Th2 cells 
during secondary infection with H. polygyrus and contribute to protective immune 
responses to H. polygyrus. We hypothesise that IL-4 signalling contributed to Treg to 
Th2 conversion and finally, we will ask whether Treg to Th2 conversion is required for 
protective immune responses to H. polygyrus.  
Using double-reporter mice we found that a proportion of Foxp3-RFP+CD25high 
Treg cells could lose Foxp3 expression and up-regulate Il4-GFP following a secondary 
infection with H. polygyrus. Furthermore, using novel fate-reporter mice we identified 
ex-Foxp3 Il4-GFP+ cells in vivo that expanded during the development of protective 
immune responses. Finally, we generated novel fate-reporter mice with a specific 
deletion of the high affinity IL-4 receptor chain (IL-4Rα) on Foxp3-expressing cells to 
test whether IL-4 was required for Treg to Th2 conversion and whether ex-Foxp3 Il4-
GFP+ cells contribute to protective immunity to H. polygyrus. 
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4.3.1. Promoting effector responses for improved anti-helminth immunity 
H. polygyrus establishes chronic infections in C57BL/6 hosts, correlating with 
the early expansion (Rausch et al., 2008) and activation (Finney et al., 2007) of Treg 
cells that limit the development of a protective Th2 response (Rausch et al., 2009). 
Indeed, the early onset and strength of the immune response correlates with natural 
resistance to the parasite in genetically resistant hosts. Transient depletion of Treg 
cells in susceptible C57BL/6 hosts early following infection resulted in increased Th2 
responses, in particular in the Peyer’s patches (Mosconi et al., 2015) and increased 
pathology (Rausch et al., 2009), suggesting that a major function of Treg cells in the 
context of a primary infection is to limit host damage by suppressing the development 
of otherwise protective Th2 responses. Following drug-treatment, mice become 
resistant to re-infection and mount a protective immune response against the 
developing larvae upon re-infection, ultimately resulting in larval killing (Reynolds et al., 
2012). Immunity to secondary infection correlated with the development of a faster and 
stronger Th2 response (Anthony et al., 2006) as well as with reduced Treg expansion 
(Liu et al., 2010) highlighting the dynamic interplay between immune balance and 
immunity. Using Il4-GFPFoxp3-RFP reporter mice, we described increased proportions 
of both Foxp3-RFP+ Treg and Il4-GFP+ Th2 cells following primary infection, confirming 
previously published results on the individual responses using either Il4-GFP reporter 
mice (Mohrs et al., 2005) or Foxp3 intranuclear staining (Rausch et al., 2008). Upon 
secondary infection, we observed a shift in the ratio of Th2 to Treg cells to favour an 
effector response, correlating with increased type-2 responses and functional expulsion 
of H. polygyrus, as previously described (Reynolds et al., 2012). Collectively, these 
results demonstrate that a dominant Th2 response correlates with immunity to H. 
polygyrus. In support of this, treatment of mice with a complex of IL-4 and anti-IL-4 
antibody (IL-4c) to enhance IL-4 signalling was shown to promote the expulsion of H. 
polygyrus during a chronic infection by mimicking the expansion of IL-4-secreting Th2 
cells (Urban et al., 1995; Herbert et al., 2009). Similarly, IL-2c treatment has been 
shown to activate CD25-expressing cells including Treg (Boyman et al., 2006) and T 
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helper cells (Tang et al., 2008) and promote immunity to N. brasiliensis (Roediger et 
al., 2013) and H. polygyrus (chapter 3) in Rag-deficient mice. Although low-dose IL-2c 
has been shown to preferentially expand Treg cells in naïve mice and in the context of 
disease (Klatzmann and Abbas, 2015), high doses of IL-2c were shown to expand 
pathogenic Th1 cells and Treg cells, with a net result of exacerbated autoimmune 
progression (Tang et al., 2008). This suggests that treatment of mice with different 
doses of IL-2c can influence the Treg to T effector ratio in favour of an effector 
response. Indeed, we tested whether the treatment of mice with variable doses of IL-2c 
could impact the balance of effector cells over regulatory cells and promote immunity to 
H. polygyrus by stimulating Th2 expansion. We found that a high dose IL-2c treatment 
promoted both Th2 expansion and Treg expansion resulting in the maintenance of a 
balanced Treg to Th2 ratio, suggesting that immunity to H. polygyrus would not be 
altered. Given that IL-2c treatment expanded the absolute number of Th2 cells, it would 
be interesting to test whether additional treatments, or an altered treatment regimen 
could promote immunity despite the expansion of Treg cells. Conversely, it would be 
interesting to treat mice with low-dose IL-2c during a memory response and to restore 
Treg numbers to determine whether Treg expansion limits the protective Th2 
responses. The generation of IL-2c using different IL-2 antibody clones (Spangler et 
al., 2015) or the recent generation of IL-2 variants (Mitra et al., 2015) are thought to 
confer differing signalling potential to IL-2 and could be used to test preferential 
expansion of specific populations. However given the impact of IL-2c on the expansion 
of many CD25-expressing cells such as Treg, T effector and ILC2s, therapeutic 
applications of IL-2c will be limited and must be carefully controlled. 
 
4.3.1.1. Reporter mice: useful tool for studying Treg specialisation and 
conversion 
It has become clear that there is transcriptional heterogeneity between populations of 
Treg cells isolated from distinct locations (Feuerer et al., 2009; Feuerer et al., 2010). In 
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particular, Tregs express unique genes that are required for their maintenance and 
suppressor function in the tissue, such as Pparg in adipose tissue Treg cells (Cipolletta 
et al., 2012) and Il1rl1 (IL-33R) on colon-, spleen-, and adipose-tissue-derived Treg 
cells (Matta et al., 2014; Schiering et al., 2014; Molofsky et al., 2015; Vasanthakumar 
et al., 2015). Furthermore, the transcriptional specialisation of Tregs correlates with the 
ability of Tregs to specifically suppress helper cell subsets (Cretney et al., 2013). For 
example the micro-RNA miR-182 was highly expressed in Treg cells isolated from the 
liver of S. mansoni infected mice and required for Treg suppression of Th2 cells, but 
not Th1 cells, in vivo (Kelada et al., 2013). Furthermore, Treg expression of the Th2-
related TF Irf4 was required for their selective inhibition of Th2 inflammation (Zheng et 
al., 2009). In addition, many studies have described the spontaneous development of 
type-2 inflammation, upon reduced levels of Foxp3 (Wan and Flavell, 2007; Wang et 
al., 2010) or loss of Foxp3 expression in mice deficient in Foxp3-stabilising genesTraf6 
(Muto et al., 2013), Itch (Jin et al., 2013), Cbfb (Kitoh et al., 2009), Bcl6 (Sawant et al., 
2012) and Bach2 (Roychoudhuri et al., 2013). Together, these data suggest that Treg 
cells specialise to suppress different Th responses.  
 Using Il4-GFPFoxp3-RFP mice, we identified double-positive (DP) Il4-
GFP+Foxp3-RFP+ cells that expressed similar levels of lineage-defining TFs (Foxp3 
and Gata3) as Treg and Th2 cells, suggesting DP cells may represent a unique subset 
of Treg cells. In support of this hypothesis, we observed that DP cells, compared to 
Th2 or Treg cells, expressed higher levels of Il10, which is a dominant mechanism of 
Treg-mediated immune suppression (Rubtsov et al., 2008). DP cells may represent a 
population of specialised regulatory Tregs with the ability to potently control Th2 
responses. Further transcriptional profiling of DP cells would provide insight into 
potential molecular mechanisms, required for the specialisation of H. polygyrus-elicited 
Th2 cells including TF or miRNA usage, and identify novel therapeutic targets for 
limiting Treg suppression and improving Th2 responses. 
Previous studies have shown that Treg cells lose Foxp3 expression (Komatsu 
et al., 2009), convert to Tfh cells (Tsuji et al., 2009) and/or acquire the potential to 
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produce effector cytokines including TNFα, IL-17 (Duarte et al., 2009) and IFN-γ (Feng 
et al., 2011) following adoptive transfer into T-cell deficient mice. Furthermore, CD4+ 
cells with attenuated levels of Foxp3 have been shown to selectively secrete type-2 
cytokines (Wan and Flavell, 2007; Wang et al., 2010) and preferentially express Th2-
related TFs such as Gata3, Irf4 as well as secrete IL-4 (Muto et al., 2013). Finally, 
Foxp3-RFP+ cells were shown to co-express Il4-GFP (Wang et al., 2010) and secrete 
IL-4 (Duarte et al., 2009) following adoptive transfer into Rag2–/– mice. Following the 
adoptive transfer of HpTR cells to Tcra–/– mice, we also identified cells co-expressing 
Il4-GFP+ and Foxp3-RFP+, suggesting that DP cells identified in Il4-GFPFoxp3-RFP 
mice may be of Treg origin. In addition, we found that the majority of transferred HpTR 
cells lost Foxp3 expression and a proportion of these cells upregulated Il4-GFP in 
systemic, local and gut associated lymphoid organs demonstrating that Treg to Th2 
conversion can occur in the context of a secondary immune response to H. polygyrus. 
Given the role of B cells in supporting Th2 differentiation during memory responses to 
H. polygyrus (Wojciechowski et al., 2009), the development of single positive Il4-GFP+ 
cells in our model may be attributed to the presence of B cells in Tcra–/– recipient mice, 
not seen following Treg transfer to B- and T-cell deficient Rag2–/– recipients (Wang et 
al., 2010).  
 
4.3.1.2. Transcriptional re-wiring of ex-Foxp3 cells 
Transcriptional reprogramming of Treg cells has been described following the 
loss of Foxp3 expression (Williams and Rudensky, 2007), perhaps as a result of the 
associated loss of the complex network of TFs bound to Foxp3 (Rudra et al., 2012). 
Indeed, we observed dramatic changes in the transcriptional profile of HpTRàIl4-GFP+ 
cells that had lost Foxp3 expression. It is interesting to speculate that some of the 
genes upregulated in HpTRàIl4-GFP+ cells could be direct targets of Foxp3 normally 
suppressed during the differentiation program of Treg cells. For example Foxp3 was 
shown to directly bind to the Il4 locus (Kwon et al., 2008) and Il2 locus (Williams and 
Chapter 4 - Results 
 180 
Rudensky, 2007) to repress their expression, and both Il4 and Il2 were expressed in 
HpTRàIl4-GFP+ cells, suggesting loss of Foxp3 released a ‘molecular brake’. 
Furthermore, we found that HpTRàIl4-GFP+ cells had downregulated Bach2, a 
transcription factor required for the maintenance of Treg stability in vivo and a direct 
repressor of genes required for Th2 differentiation (Roychoudhuri et al., 2013). 
Together, these data suggest that the loss of Foxp3 has resulted in the spontaneous 
acquisition of a Th2-phenotype, and loss of Treg associated markers such as Ctla4 
(Walker and Sansom, 2015) and Il10 (Rubtsov et al., 2008). However we also 
observed significant changes in the transcriptional profile of cells that had maintained 
Foxp3 expression following adoptive transfer. This suggests that a fraction of 
transcriptional changes following adoptive transfer may also be caused by their 
response to the lympho-deficient environment in addition to the loss of Foxp3 
expression. Indeed, transferred Tregs are likely to be subject to increased homeostatic 
proliferation and limiting concentrations of IL-2, both of which which are important for 
Treg stability and are altered in lymphodeficient hosts (Fontenot et al., 2005). 
Furthermore, TCR activation was shown to modulate the transcriptional profile of Treg 
cells in vivo (Levine et al., 2014). It is therefore conceivable that adoptively transferred 
HpTR cells lose Foxp3 expression following changes in TCR activation with the 
appropriate antigen in their new host environment. To minimise the impact of 
lymphodeficiency, we could co-transfer naïve T cells with HpTR cells into 
lymphodeficient hosts, which was previously shown to limit Treg instability through by 
providing a source of IL-2 (Duarte et al., 2009) or transfer congenically marked HpTR 
cells into lymphocomplete Il4-GFPFoxp3-RFP mice. 
 
4.3.1.3. Influence of tissue environment and antigen on Treg instability 
Tissue microenvironments have been show to influence Treg stability (Murai et 
al., 2010). Indeed, adoptively transferred Tregs were most unstable in the Peyer’s 
patches, (Hirota et al., 2013) where they were also found to preferentially convert to 
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Tfh cells (Tsuji et al., 2009) suggesting that gut-specific cues may promote the 
instability of Tregs. Consistent with these results, we observed that adoptively 
transferred Tregs were most unstable and acquired the highest levels of Il4-GFP 
expression in the Peyer’s patches. This was surprising given the recent finding that 
Treg cells and not Th2 cells accumulate in the PP following H. polygyrus infection 
suggesting the PP environment supports immune regulation (Mosconi et al., 2015). 
Interestingly, a subset of myeloid-derived DCs enriched in the PP has been shown to 
preferentially prime IL-4 production by naïve T cells when compared to myeloid DCs 
from non-mucosal sites (Iwasaki and Kelsall, 2001) and could also be promoting 
increased Treg to Th2 conversion following H. polygyrus infection. In addition to testing 
the influence of the organ of migration on Treg plasticity, we tested the ability of Tregs 
isolated systemically or from tissue draining MLNs to convert to Il4-GFP+ cells. MLN-
derived Tregs formed the dominant population of CD4+ T cells in the PP following co-
transfer to H. polygyrus infected T-cell deficient recipients, suggesting they had a 
competitive advantage over splenic Treg cells. In addition, a higher proportion of MLN-
derived cells converted to Il4-GFP+ cells in all organs analysed, suggesting they were 
inherently more plastic at a population level, which may be a consequence of their 
increased proliferation, or reflect their proximity to the site of infection and antigen.  
Treg instability has been observed both at steady state as well as in the context 
of infection (Wohlfert and Belkaid, 2010) suggesting Treg to Th2 conversion following 
H. polygyrus infection could either be antigen-independent, or dependent on the 
presence of pathogen-derived signals, including signals from resident intestinal 
bacteria. Indeed, Tregs have been recently shown to accumulate in PP adjacent to H. 
polygyrus larvae (Mosconi et al., 2015), and H. polygyrus excretory/secretory proteins 
are known to directly stimulate Treg proliferation (Mosconi et al., 2015) and induction in 
vitro (Grainger et al., 2010). We tested whether H. polygyrus derived antigens could 
influence Treg conversion to Il4-GFP+ cells and found that Treg cells originating from 
either H. polygyrus infected or naïve double-reporter mice had a similar ability to 
convert when transferred to either to either naïve or H. polygyrus infected recipients, 
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suggesting the conversion of Treg to Th2 cells following adoptive transfer does not 
depend on H. polygyrus antigen. To test whether H. polygyrus antigens can promote 
Treg to Th2 conversion we could culture Tregs in the presence of HES and measure 
the loss of Foxp3-RFP and acquisition of Il4-GFP expression, similarly to the 
experiments performed testing the role of IL-4 on Treg to Th2 conversion. In addition, 
bacterial-derived metabolites have recently been shown to directly promote Treg 
development in the intestine (Arpaia et al., 2013; Furusawa et al., 2013). It is 
conceivable that microbiota-derived signals influence Treg conversion, especially in the 
PP where specialised M cells are permissive to antigen transfer (reviewed in (Siebers 
and Finlay, 1996)). Indeed, expression of activation markers on Treg cells 
accumulating in the PP following H. polygyrus infection were decreased following 
antibiotic treatment (Mosconi et al., 2015) suggesting microbial factors drive H. 
polygyrus elicited Tregs. To test whether microbiota-derived signals are required for 
Treg to Th2 conversion following adoptive transfer, we could pre-treat Tcra–/– recipients 
with antibiotics to temporarily deplete intestinal bacteria, or transfer Treg cells to germ-
free mice. Taken together, these results suggest that the tissue microenvironment can 
influence the stability of Treg cells. Kaede transgenic mice express the photo 
convertible Kaede protein that converts green fluorescence to red fluorescence 
following violet light exposure, enabling the visualisation of the migration of red 
fluorescent cells throughout the mouse (Tomura et al., 2008). It would be interesting to 
expose the MLN of Kaede+ Treg recipients to violet light and track the migration of 
MLN-derived photo-converted red cells to different organs. Furthermore it would be 
interesting to purify the Kaede+ MLN-derived cells following their migration to different 
organs and compare their transcriptional profile to MLN-resident Tregs to identify 
markers correlating with their migration and adaptation to different tissues which could 
be useful for targeting the migration of Treg cells to particular organs following adoptive 
transfer or in the context of Treg therapy.  
The adoptive transfer of Tregs has proved to be very useful for revealing the 
potential for Treg cells to lose Foxp3 expression. Given the differences in cellular 
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composition and cytokine environment between lymphodeficient hosts and wild-type 
hosts, the Treg instability following transfer into lymphodeficient hosts may not reflect 
the situation in lymphocomplete mice. 
 
4.3.2. Identification of functional Treg conversion in vivo using novel fate-
reporter mice 
To study Treg plasticity in a more physiological context, recent studies have 
made use of fate-mapping strategies that enable the identification of ex-Foxp3 cells in 
vivo. These studies have been entirely performed in models of autoimmune disease 
and inflammation (Bailey-Bucktrout et al., 2013; Komatsu et al., 2014; Noval Rivas et 
al., 2015). Ex-Foxp3 cells have been shown to secrete IFN-γ in the context of type-1 
diabetes (Zhou et al., 2009) and EAE (Bailey-Bucktrout et al., 2013) as well as IL-17 in 
the synovial fluid of arthritic joints (Komatsu et al., 2014). Furthermore, a recent study 
showed that transgenic Treg cells overexpressing the IL-4Rα could convert to Th2 cells 
following intestinal food allergy, however it is unclear whether this was true of wild-type 
Treg cells (Noval Rivas et al., 2015).  The development of ex-Foxp3 cells in the context 
of an infection remains unknown. Furthermore, the function and requirement for ex-
Foxp3 T helper cells in the pathogenicity of disease has not been tested. We 
generated novel fate-reporter mice by crossing Foxp3-fate reporter mice with Il4-GFP 
mice and characterised the Foxp3- and Il4-expressing cells following primary and 
secondary infection. We identified a substantial proportion of Il4-GFP+ cells that had 
previously expressed Foxp3 during memory immune responses to H. polygyrus. The 
proportion and number of ex-Foxp3 Il4-GFP+ cells expanded during the secondary 
immune response to H. polygyrus. Furthermore, they were secreting Th2 cytokines and 
could promote the activation of alternative macrophages in vitro and lost their Treg 
phenotype, suggesting they were functional Th2 memory cells. Taken together these 
results suggest Il4-GFP+ ex-Foxp3 cells could be participating in the functional immune 
response to secondary infection with H. polygyrus by promoting type-2 effector 
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mechanisms known to be required for immunity to H. polygyrus (Anthony et al., 2006). 
Interestingly, we found that a proportion of Il4-GFP+ ex-Foxp3 cells retained a 
demethylated locus, correlating with unstable maintenance of Il4-GFP+ expression in 
vitro and correlating with an increased potential to re-express Foxp3 in vitro. Taken 
together this data suggests that the majority of Il4-GFP+ ex-Foxp3 cells have converted 
to Th2 effector cells however a minority have maintained a demethylated Foxp3 locus 
and the ability to re-express Foxp3, which may represent a sub-population of truly 
plastic Treg cells that are able to function as effector cells whilst maintaining the 
potential to re-express Foxp3. 
It would be interesting to further characterise the heterogeneity of the Il4-GFP+ 
ex-Foxp3 population. To do this, we could perform genome-wide RNA sequencing on 
cells isolated from diverse tissues and time-points following infection and compare their 
transcriptional profiles. Furthermore, it would be interesting to study the heterogeneity 
within a unique population of Il4-GFP+ ex-Foxp3 cells by performing RNA sequencing 
on a single-cell level. This technique was recently used to identify a discrete sub-
population of steroidogenic Th2 cells within N. brasiliensis-elicited Il13-GFP+ cells with 
a unique immunoregulatory function (Mahata et al., 2014). In a similar way, single-cell 
RNA sequencing would allow the identification of sub-populations of Il4-GFP+ cells with 
more effector or regulatory properties. 
 
4.3.3. Dynamicity of DNA methylation at the Foxp3 locus 
The Foxp3 locus is composed of three conserved non-coding elements (CNS1-
3). Both the CNS1 and CNS3 were shown to be required for Foxp3 expression and 
Treg development (Zheng et al., 2010). TCR signalling in thymic CD4+ T cells led to the 
induction of the transcriptional activator c-rel and its positioning on the Foxp3 CNS3 
resulting in Foxp3 expression (Zheng et al., 2010). Furthermore, CNS1-deficient mice 
exhibited reduced proportions of iTreg cells in the MLN and gut associated lymphoid 
tissue suggesting CNS1 was required for peripheral Foxp3 induction (Zheng et al., 
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2010). In contrast, CNS2 was not required for Foxp3 induction but for the maintenance 
of Foxp3 expression in peripheral Treg cells and following adoptive transfer to T cell 
deficient mice (Zheng et al., 2010). The CpG islands on the CNS2 of the Foxp3 locus 
were shown to be specifically demethylated in CD25+Foxp3-expressing cells (Floess et 
al., 2007) and the maintenance of demethylated CpG islands on the Foxp3 CNS2 was 
required for Treg stability (Ohkura et al., 2012; Okada et al., 2014). Thus, the level of 
methylation of the Foxp3 CNS2 has been used to predict the function and stability of 
Treg cells.  
We performed bisulphite sequencing (Clark et al., 1994) to characterise the 
methylation status of the Foxp3 CNS2 region in ex-Foxp3 cells following adoptive 
transfer or isolated from fate-reporter mice infected with H. polygyrus. There are two 
distinctive quantitative advantages to this method. Firstly, we can interrogate modified 
sequences at a nucleotide level and characterise methylation patterns on individual 
CpG islands including heterogeneity between CpG clones islands. Secondly, we can 
characterise the heterogeneity of the population of cells by cloning separate PCR 
products, which in theory represent individual cells within a population, and get a 
representation of the methylation status of the whole Treg population.  
We found that the majority of our donor HpTR cells had a demethylated Foxp3 
CNS2, similar to Foxp3-YFP+ Tregs isolated form fate-reporter mice and Foxp3-RFP+ 
cells isolated from naïve double-reporter mice, as previously reported (Okada et al., 
2014). Although the majority of HpTR cells used as donor Tregs in our adoptive 
transfer model were exhibiting characteristics of bona fide Treg cells, we found they 
were unstable and lost Foxp3 expression following adoptive transfer, suggesting 
methylation does not confer stability to Treg cells when transferred into a 
lymphodeficient environment. A previous study described the re-methylation of Foxp3 
CNS2 in ex-Foxp3 cells generated in vitro or in vivo following their adoptive transfer 
into lymphopenic mice (Feng et al., 2014). We quantified the methylation of HpTR cells 
that had lost Foxp3 expression but did not upregulate Il4 (HpTRàDN) and found that 
they had re-methylated their Foxp3 locus. In contrast, cells that had lost Foxp3 
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expression and acquired Il4-GFP expression maintained a demethylated Foxp3 locus. 
This suggests HpTRàIl4-GFP+ cells may have developed directly from HpTR 
precursors rather than going through a double-negative stage. Furthermore, it supports 
the idea that HpTRàIl4-GFP+ originated from HpTR cells displaying a demethylated 
Foxp3 CNS2 and not from potentially contaminating and uncommitted or Foxp3– cells 
within the transferred HpTR pool. These data also suggest that HpTRàIl4-GFP+ cells 
form a unique population of plastic cells with epigenetic memory of their Treg past. 
Indeed, we found that HpTRàIl4-GFP+ but not HpTRàDN cells were able to suppress 
the proliferation of naïve T cells in vitro, confirming previous studies showing Foxp3 
methylation correlating with Treg suppressor function (Feng et al., 2014). However, 
their ability to suppress effector T cells was reduced compared to cells that had 
maintained Foxp3 expression, suggesting that HpTRàFoxp3-RFP+ cells had additional 
suppressor mechanisms. For example Il10, known to be an important mechanism of 
Treg suppression in vivo (Rubtsov et al., 2008), was highly expressed in 
HpTRàFoxp3-RFP+ cells but undetectable in HpTRàIl4-GFP+ cells. These results 
differ from previous methylation analysis showing the majority of ex-Foxp3 cells 
isolated from fate-reporter mice had a demethylated Foxp3 locus (Bailey-Bucktrout et 
al., 2013; Feng et al., 2014; Komatsu et al., 2014). Using our fate-reporter system, we 
also found that the vast majority of ex-Foxp3 Il4-GFP+ cells isolated from fate-reporter 
mice displayed a re-methylated Foxp3 CNS2 in contrast to HpTRàIl4-GFP+ cells, 
suggesting that signals present in wild-type mice promote the remethylation of Foxp3 
and potentially more stable conversion of Treg to Il4-GFP–expressing cells. 
Alternatively, it is conceivable that ex-Foxp3 Il4-GFP+ originate from DN cells displaying 
a methylated locus in both systems, whereas HpTRàIl4-GFP+ originate directly from 
Foxp3-expressing cells with a demethylated locus. Foxp3 methylation is thought to 
correlate with stability of Foxp3 expression, and only a small proportion of ex-Foxp3 
Il4-GFP+ cells could re-express Foxp3 following their culture in Treg conditions in vitro, 
correlating with the small proportion of cells displaying a demethylated Foxp3 locus. 
We hypothesise that HpTRàIl4-GFP+ displaying a demethylated Foxp3 locus would 
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readily convert back to Foxp3-expressing cells, however this remains to be tested. 
Finally, it would be interesting to interrogate other Treg specific demethylated regions 
(TSDRs) known to be specifically demethylated in Treg cells such as the Il2ra and 
Ctla4 loci to see whether changes in methylation patterns on the Foxp3 locus are 
reflected throughout and whether reduced Il2ra and Ctla4 mRNA expression correlates 
with changes in methylation at these sites, in contrast to the Foxp3 locus. 
Together, these results confirm discordance between Foxp3 mRNA expression 
and Foxp3 DNA methylation, and instead, highlight the correlation between Foxp3 
methylation and Treg suppressor function, suggesting the accessibility of the Foxp3 
locus is required for the binding of other TFs important for Treg function. Although the 
adoptive transfer of Tregs into lymphodeficient hosts has been invaluable for tracking 
and studying the fate of Treg cells, our results suggest that the lymphodeficient 
environment may not provide appropriate signals for the conversion of Treg to Th2 
cells, such as B- and T-cell derived cytokines. 
 
4.3.4. Investigating the role of cytokine signalling for Treg instability 
CD4+ T cells are dependent on cytokine signalling for their development, 
maintenance and differentiation. As a result, modulations in the cytokine environment 
can influence the balance in T helper cell subsets (Dardalhon et al., 2008; Veldhoen et 
al., 2008) as well as the stability of differentiated cells (Hegazy et al., 2010). For 
example IL-2 (Setoguchi et al., 2005) and IL-10 (Murai et al., 2009) are required for the 
development and maintenance of the Treg lineage in vivo, whereas IL-4 and IL-6 
promote instability of Foxp3 expression (Feng et al., 2014). Indeed, IL-4 has been 
shown to inhibit Foxp3 expression in vitro (Chapoval et al., 2010), in vivo (Noval Rivas 
et al., 2015) and limit Treg suppressor function during allergic lung inflammation 
(Dorsey et al., 2013). Furthermore, STAT6, phosphorylated downstream of the IL-4Rα, 
has been shown to directly bind to DNA methyl transferase Dnmt1 (Feng et al., 2014) 
required for the demethylation of the Foxp3 locus and maintenance of Foxp3 
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expression (Lee et al., 2001). As a consequence, IL-4 is thought to directly inhibit 
Foxp3 expression by recruiting Dnmt1 to the Foxp3 locus, resulting in CNS2 re-
methylation (Feng et al., 2014). Taken together, this data demonstrates that IL-4 
signalling promotes Treg instability. We found that Tregs isolated from a primary H. 
polygyrus infection expressed a functional IL-4Rα and were actively phosphorylating 
STAT6 ex vivo. Furthermore, we found that Treg cells lost Foxp3 expression following 
IL-4 stimulation in vitro, confirming studies describing a dominant inhibitory effect of IL-
4 on the function of Treg cells (Mantel et al., 2007; Wei et al., 2007; Feng et al., 2014).  
Emerging evidence suggests that IL-4 is required both for Treg instability as 
well as Treg to Th2 conversion. Indeed, Treg-specific overexpression of Il4ra and 
enhanced IL-4 signalling was shown to result in Treg acquisition of a Th2 phenotype 
however it was unclear whether wild-type Tregs expressing could convert to Th2 cells 
in this system (Noval Rivas et al., 2015). IL-4 and IL-1β were identified as two of the 
highest predicted regulators of converted HpTRàIl4-GFP+ cells, and have previously 
been shown to be significantly increased early following H. polygyrus infection (Urban 
et al., 1991; Zaiss et al., 2013). Interestingly, IL-4 was also predicted to be upstream of 
the transcriptional profile of donor HpTR cells. Given that HpTR cells were isolated 
from a polarised type-2 environment following H. polygyrus infection, this may suggest 
that IL-4 is actively signalling in HpTR and driving the expression of a unique set of IL-
4-related genes such as miR-182, previously shown to be upregulated following IL-4 
stimulation of Treg cells in vitro (Kelada et al., 2013). We also found that IL-4 
stimulation led to the conversion of Treg to Il4-GFP+ cells in vitro suggesting that IL-4 
signalling might be upstream of Treg conversion to Th2 cells in our study. In light of the 
recent evidence showing that strong IL-4 signalling was required for Treg 
reprogramming in the context of oral allergy (Noval Rivas et al., 2015), it is conceivable 
that there is a quantitative threshold of IL-4 signalling that dictates Treg specialisation 
or conversion. To test whether IL-4 signalling was required for Treg to Th2 conversion 
during H. polygyrus infection, we have generated fate-reporter mice with a Treg-
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specific deficiency in IL-4Rα that will allow us to measure the impact of IL-4Rα-
deficiency on the development of ex-Foxp3 Il4-GFP+ cells in vivo and their expansion 
following secondary H. polygyrus infection.  
Increased reprogramming of Treg to Th2 cells has been shown to correlate with 
exacerbated Th2-mediated disease following oral challenge with ovalbumin (OVA) 
(Noval Rivas et al., 2015). Similarly, increased proportions of ex-Foxp3 Il4-GFP+ cells 
following secondary H. polygyrus infection correlated with increased type-2 responses 
and functional immunity to H. polygyrus. However the functional relevance of Treg to 
Th2 conversion on disease outcome or immunity in both these models remains 
unclear. We hope to test the role of Treg to Th2 conversion for functional expulsion of 
H. polygyrus using the IL-4Rα-deficient fate-reporter mouse. While we haven’t had the 
opportunity to characterise the Il4ra–/– fate-reporter mice, we can speculate about 
functional outcomes following secondary infection with H. polygyrus (Figure 4.16).  
IL-4-deficient mice (Finkelman et al., 1997) have impaired type-2 responses 
and compromised worm expulsion following secondary infection with H. polygyrus. IL-4 
is required for the generation of a functional type-2 response following primary infection 
(Urban et al., 1991). Furthermore, mice treated with anti-IL-4 antibody at the time of 
secondary challenge had reduced type-2 responses and worm expulsion (Urban et al., 
1991) suggesting IL-4 is required at the time of secondary infection. However whether 
IL-4 is required for de novo differentiation of Th2 cells during a secondary challenge is 
unclear. We will test this hypothesis by measuring the number of Il4-GFP+ cells that 
have originated from a Treg past in the presence or absence of the IL-4Rα. We found 
that anti-IL-4 antibody treatment at the time of secondary challenge did not impair the 
differentiation of Th2 cells or ex-Foxp3 Il4-GFP+ cells, suggesting that the activation of 
memory Th2 cells is IL-4-independent. Previous studies showing impaired type-2 
responses following anti-IL-4 treatment were most likely blocking the wide variety of IL-
4 target cells and downstream effector pathways but not the re-activation of memory 
Th2 cells (Urban et al., 1991). 
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We hypothesise that IL-4 could be required for the generation of Il4-GFP+ ex-
Foxp3 cells in a primary infection. Consequently, Treg-specific IL-4Rα deficiency may 
reduce the conversion of Foxp3+ cells to Il4-GFP+ cells and impair the development of 
memory responses following primary infection, thereby resulting in the impaired 
development of Il4-GFP+ ex-Foxp3 memory cells seen following secondary infection 
with H. polygyrus (Figure 4.16 A). Since we have shown that a significant proportion of 
Il4-GFP+ cells originated from a Foxp3-expressing past during a secondary infection, 
we hypothesise that Treg-specific IL-4Rα deficiency would reduce the magnitude of the 
Th2 population (Figure 4.16 A) and impair functional worm expulsion. Our studies and 
others have shown that IL-4 signalling promotes Foxp3 instability in mature Treg cells 
in vitro (Noval Rivas et al., 2015). Therefore an alternative hypothesis is that IL-4Rα 
signalling could be reducing Foxp3 expression in mature Treg cells in vivo. It is 
therefore conceivable that IL-4Rα deficiency in Treg cells could lead to enhanced Treg 
differentiation, resulting in increased suppression of Th2 cells, and impaired memory 
Th2 responses (Figure 4.16 B). Preliminary data using a chimeric system suggested 
that Il4ra-deficiency in Treg cells does not significantly alter the ratio of Treg and Th2 
cells in a secondary infection with H. polygyrus. 
Alternatively, given that IL-4 was predicted to be upstream of the transcriptional 
profile of HpTR it is conceivable that IL-4 is required for the specialisation of HpTR 
cells and their ability to specifically suppress Th2 cells. Indeed, IL-4 was shown to 
induce cmaf and mir-182 expression and confer nTreg cells with the ability to suppress 
Th2 cells in vitro (Kelada et al., 2013). Furthermore, Irf4 bound by STAT6 following IL-4 
signalling (Gupta et al., 1999) was shown to confer HpTR with the specific ability to 
suppress Th2 cells (Zheng et al., 2009). Thus, inhibition of IL-4 signalling in HpTR cells 
compromise the ability of HpTR cells to specifically suppress Th2 cells and result in the 
enhanced development of Th2 responses (Figure 4.16 C), similarly to what we have 
seen following the transient depletion of Treg cells in DEREG mice during secondary 
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infection (Fig. 4.13). Of note, persistent Th2 responses may result in Th2-mediated 
immunopathology, such as the development of fibrosis.  
Alternatively, reduced type-2 responses following the inhibition of Treg to Th2 
conversion may result in impaired downstream type-2 responses and limit the 
expulsion of H. polygyrus, as seen following combined IL-4 and IL-4Rα antibody 
treatment during memory immune response (Urban et al., 1991). We will fully 
characterise the type-2 responses such as the activation of alternative macrophages, 
the stimulation of antibody class-switching to protective IgG1 and IgE, and worm 
expulsion (Figure 4.16). Preliminary results from the generation of bone-marrow 
chimeras indicate that functional expulsion of H. polygyrus may not be compromised in 
the absence of IL-4 signalling on Treg cells (Fig 4.15). 
It would be interesting to determine the temporal characteristics of conversion 
and determine whether Treg cells convert during a primary infection or a secondary 
infection. One way to do this would be to adoptively transfer congenically marked 
Foxp3-YFP+FP635+ Treg cells isolated from fate-reporter mice into wild-type hosts 
either in a primary or secondary infection and compare their conversion to Il4-GFP-
expressing cells. Alternatively, a recent study employed a tamoxifen inducible fate 
mouse model to study Th17 to Tr1 conversion (Gagliani et al., 2015). By selectively 
inducing Il17-Cre at baseline or during inflammation, the authors could show that Th17 
cells could reprogram to IL-10+ Tr1 cells during inflammation rather than proliferate 
from cells which had developed in steady-state (Gagliani et al., 2015). To identify 
whether ex-Foxp3 Th2 cells are generated de novo during memory Th2 responses to 
H. polygyrus or proliferate from a cell that was generated during a primary infection, it 
would be useful to use tamoxifen inducible Foxp3-Cre fate-reporter system. To date, 
the only conditional Foxp3 fate reporter mice harbours a DNA sequence which 
encodes a triple fusion protein containing eGFP, Cre and ERT2 (Foxp3-eGFP-Cre-
ERT2) (Rubtsov et al., 2010), limiting our ability to cross it to Il4-GFP mice. To test 
Foxp3 to Il4-GFP conversion we would need to generate knock-in mice harbouring an 
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IRES site followed by a triple fusion sequence containing YFP fluorescent protein 
instead of GFP.  
 
4.3.5. Advantages and limitations of transcriptional reporter mice 
Il4-GFP expression reflects Il4 transcription into mRNA but not translation into 
IL-4 protein (Mohrs et al., 2005). To better understand the relationship between mRNA 
and protein, Mohrs et al generated a double-reporter mouse by crossing 4get (Il4-GFP) 
mice (Mohrs et al., 2001) with KN2 mice in which the expression of surface huCD2 
faithfully reports IL-4 protein secretion (Mohrs et al., 2005). This previous study found 
that the correlation of Il4-GFP mRNA and huCD2 expression was highly dependent on 
the tissue and disease model (Mohrs et al., 2005). In the context of a H. polygyrus 
infection, they showed that Il4-GFP expression correlated with IL-4 protein in CD4+ T 
cells isolated from the gut associated lymphoid tissues (MLN, PP and LP) (Mohrs et al., 
2005). In concordance with these results, we found the highest proportion of converted 
HpTRàIl4-GFP+ cells in the MLN and PP, which suggested they were likely to be 
secreting IL-4 protein. Indeed, transferred HpTR cells expressed IL-4 protein ex vivo as 
assessed by flow cytometry, however IL-4 protein was undetectable following the re-
stimulation of purified HpTRàIl4-GFP+ cells compared to nTàIl4-GFP+ cells, 
suggesting there may be post-transcriptional or post-translational regulatory 
mechanisms inhibiting the secretion of IL-4 in ex-Foxp3 cells. Conversely, we found 
that ex-Foxp3 Il4-GFP+ cells isolated from fate-reporter mice secreted large amounts of 
IL-4 protein suggesting that these inhibitory mechanisms were absent in a 
lymphocomplete context, although it still remains unclear to what extent Il4-GFP 
expression correlates with protein in this context. To test this, we would ideally cross 
the Foxp3-RFP reporter or Foxp3 fate-reporter mice with KN2fl/wt mice to determine the 
correlation of Il4-GFP expression with IL-4 protein production in ex-Foxp3 cells. 
Alternatively, we could perform an IL-4 ELISPOT assay on purified ex-Foxp3 Il4-GFP+ 
cells re-stimulated with P+I. For example, if we plated 1000 Il4-GFP-expressing cells, 
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we could count the number of spots, illustrating single-cell IL-4 secretion, and in theory 
calculate the ratio of Il4-GFP-expressing cells with the number of spots. An additional 
method to test this, which has been used for correlating IL-17 production and reporter 
expression in IL-17 fate-reporter mouse (Hirota et al., 2011), IL-9 reporter mice 
(Wilhelm et al., 2011) and IL-22 fate-reporter mice (Ahlfors et al., 2014) would be to 
use a modified intra-cellular cytokine staining protocol, which would allow us to retain 
intra-cellular GFP expression and co-stain for Il4-GFP and IL-4 protein. Although this 
would be useful for correlating Il4-GFP and IL-4 protein at a single-cell level, it may be 
harder to detect cells secreting low levels of cytokine and therefore may 
underrepresent the true levels of IL-4 protein. 
A possible limitation of Foxp3 fate-reporter systems comes from evidence that 
CD4+ T cells can transiently up-regulate Foxp3 expression following their activation. 
Indeed, human (Pillai et al., 2007; Tran et al., 2007; Wang et al., 2007; Dorsey et al., 
2013) and murine (Miyao et al., 2012) naïve T cells have been shown to transiently 
express Foxp3 upon activation in vitro, however it’s unclear to what extent this 
happens in vivo during inflammation or infection (Hori, 2011; Miyao et al., 2012). In 
vivo, a small proportion of CD4+ T cells have been shown to express Foxp3 and low 
levels of the fate-reporter (Miyao et al., 2012). Furthermore, these cells were shown to 
have a partially methylated Foxp3 locus and to lose Foxp3 expression upon transfer 
into Rag1–/– recipients co-transferred with bulk CD4+ T cells suggesting they were not 
committed Treg cells and were more unstable in vivo (Miyao et al., 2012). Based on 
these results, the authors defined a Foxp3 heterogeneity model in which a small 
proportion of the Foxp3+ pool of Tregs express unstable Foxp3 expression and 
represent cells that were never fully committed Treg cells. This suggests that a 
proportion of Foxp3-expressing cells identified throughout our work may only be 
transiently expressing Foxp3. Alternatively, the identification of cells expressing Foxp3 
reporter but not fate-marked could also suggest that the Cre recombinase was 
inefficient and that the cells had not had the time to properly excise the loxP sites either 
side of the stop cassette inserted into the Rosa26 locus (Ohkura et al., 2012), which 
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we do not observe in our model. Furthermore, in our hands, the majority of HpTR cells, 
Foxp3-YFP+FP635+ cells and converted HpTRàIl4-GFP+ cells had a demethylated 
Foxp3 locus, suggesting they were not transiently expressing Foxp3. If a significant 
proportion of activated effector cells were transiently expressing Foxp3, we would 
expect to see a large proportion of Foxp3-RFP cells isolated from a H. polygyrus 
infection (HpTR) have a methylated Foxp3 CNS2. In contrast to HpTRàIl4-GFP+ cells, 
the majority of ex-Foxp3 Il4-GFP+ cells in fate-reporter mice had re-methylated their 
Foxp3 locus. This could either be due to de novo methylation in ex-Foxp3 Il4-GFP+ 
cells (as previously discussed). Alternatively, it suggests they could have originated 
from cells that transiently expressed Foxp3 and were consequently expressing FP635 
without displaying characteristic Foxp3 CNS2 demethylation. Instead, we found that a 
small but significant fraction of the ex-Foxp3 Il4-GFP+ cells displayed a demethylated 
Foxp3 locus compared to Il4-GFP+ cells, correlating with their ability to re-express 
Foxp3. It is conceivable that these cells represent a population of truly plastic ex-Treg 
Th2 cells. We could study the role of IL-4 signalling on methylation in vivo by 
comparing the methylation status of IL-4Rα-sufficient and Il4ra–/– Treg cells. 
In conclusion, we have shown that Foxp3-expressing cells can convert to Il4-
GFP+ cells in vivo in complete mice or following adoptive transfer into T-cell deficient 
mice. Furthermore, we have shown these cells are functional in the context of 
secondary immune responses to H. polygyrus. We have developed a fate-reporter 
mouse with a Treg specific deletion of the IL-4Rα to test the requirement of IL-4 
signalling for Treg to Th2 conversion and to test its impact on functional immune 
responses to H. polygyrus. 
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Figure 4.1. Secondary infection with H. polygyrus correlates with increased type-2 
responses and larval killing. (A) Schematic representation of the experimental model. Il4-
GFPFoxp3-RFP double-reporter mice were infected with 200 H. polygyrus larvae. Mice were 
drug-cured with the anthelminthic Pyrantel Embonate (PE) at days 14 and 15 post-infection and 
given a secondary infection (Hp 2°) at day 28. Naïve Il4-GFPFoxp3-RFP mice were given a 
primary (Hp 1°) infection at the same time-point. All groups were harvested 7 days post-
infection for FACS analysis and 14 days post-infection for worm counts. (B) Adult worms were 
counted in the intestinal lumen of Hp 1° and Hp 2° mice 14 days post-infection. (C) AB-PAS and 
H&E stained sections of the small intestine at day 7 post infection in Hp 1° and Hp 2° mice 
infection. The images depict larvae trapped in the intestinal wall. (D) Retnlb, Retnla, Arg1, and 
Gob5 gene expression in the small intestine of Hp 1° and Hp 2° mice 7 days post-infection, 
expressed as fold change relative to naïve mice. Data is representative of 2-3 independent 
experiments with 3-5 mice per group. Statistical test applied Mann-Whitney, two-tailed, * 
denotes p<0.05. 
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Figure 4.2. Shift from a regulatory to an effector immune response during secondary 
infection with Heligmosomoides polygyrus. Il4-GFPFoxp3-RFP reporter mice were infected 
with 200 H. polygyrus larvae. Mice were drug-cured with the anthelminthic Pyrantel Embonate 
(PE) at days 14 and 15 post-infection and given a secondary infection (Hp 2°) at day 28. Naïve 
Il4-GFPFoxp3-RFP mice were given a primary (Hp 1°) infection at the same time-point. The 
mice were harvested 7 days post-infection for FACS analysis. (A) Representative FACS dot plot 
showing Il4-GFP and Foxp3-RFP expression in the mesenteric lymph nodes (MLN) of naïve, Hp 
1º and Hp 2º mice. Graphical representation of the frequency of Il4-GFP+Foxp3-RFP– and Il4-
GFP–Foxp3-RFP+ cells (of the CD4+TCRβ+ cells) in the spleen (B), mesenteric lymph nodes 
(MLN) (C) and Peyer’s patches (PP) (D) of naïve, Hp 1º and Hp 2º mice. (E) Ratio of the 
frequency of Il4-GFP+ cells over Foxp3-RFP+ cells in the spleen, MLN and PP. Data is 
representative of 3 independent experiments with 3-5 mice per group. Statistical test applied 
Mann-Whitney, two-tailed, * denotes p<0.05. 
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Figure 4.3. IL-2c treatment expands Treg and Th2 cells. Il4-GFPFoxp3-RFP reporter mice 
were infected with 200 H. polygyrus larvae. Naïve or H. polygyrus-infected mice were treated 
with IL-2c or PBS at days 12, 14 and 16 post-infection and harvested at d21. (A) Graphical 
representation of the frequency of Il4-GFP–Foxp3-RFP+ and (B) Il4-GFP+Foxp3-RFP– cells (of 
the CD4+ cells) in the spleen of naïve (white bars), or infected mice (black bars). H. polygyrus-
infected mice were treated with either a high (IL2chigh) or a low (IL-2clow) dose of IL-2c at days 
12, 14 and 16 post-infection and harvested at d21. (C) Graphical representation of the 
frequency of Il4-GFP–Foxp3-RFP+ and Il4-GFP+Foxp3-RFP– cells (of the CD4+ cells) in the 
spleen.  CD4+TCRβ+Il4-GFP–Foxp3-RFP+CD25high (HpTR) Treg cells were FACS-purified from 
the spleen and MLN of Il4-GFPFoxp3-RFP reporter mice infected with H. polygyrus for 14 days 
and transferred to TCRα-deficient mice (Tcra–/–). Recipient mice were treated with IL-2c or PBS 
at days 12, 14 and 16 post-infection and harvested at d21.  (C) Representative FACS dot plots 
showing Foxp3-RFP, Il4-GFP and CD25 expression pre- and post-purification.  
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Figure 4.4. The Il4-GFPFoxp3-RFP reporter faithfully reports Il4 and Foxp3 expression. 
(A) Il4, Foxp3, IL4ra, Il2ra, Gata3 and Il10 expression in FACS-purified CD4+TCRβ+CD25–
CD44low naïve T cells (nT), CD4+TCRβ+Il4-GFP+Foxp3-RFP– Th2 cells (Il4-GFP+), 
CD4+TCRβ+Il4-GFP–Foxp3-RFP+ Treg cells (Foxp3-RFP+) and double-positive CD4+TCRβ+Il4-
GFP+Foxp3-RFP+ (DP) cells expressed relative to Hprt (x100). Data is representative of 3 
independent experiments. Cells were pooled from 3-4 mice.  
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Figure 4.5. A proportion of adoptively transferred Foxp3-RFP+CD25high Treg cells lose 
Foxp3 expression and express Il4-GFP. (A) Naïve Il4-GFPFoxp3-RFP mice were infected 
with H. polygyrus and harvested at days 0, 5, 7, 14, 21 and 21 post-infection. Graphical 
representation of the frequency of Il4-GFP+Foxp3-RFP–cells (of the CD4+TCRβ+ cells) in the 
spleen over the time-course. (B) Schematic representation of the adoptive transfer experimental 
set-up. CD4+TCRβ+Il4-GFP–Foxp3-RFP+CD25high (HpTR) Treg cells were FACS-purified from 
the spleen and MLN of Il4-GFPFoxp3-RFP reporter mice infected with H. polygyrus for 14 days. 
CD4+TCRβ+CD25–CD44low (nT) naïve T cells were FACS sorted from the spleen and MLN of 
naïve Il4-GFPFoxp3-RFP mice. HpTR cells or nT were transferred to TCRα-deficient mice 
(Tcra–/–). Recipient mice were infected with H. polygyrus, drug-cured with the anthelminthic 
Pyrantel Embonate (PE) at days 14 and 15 post-infection and given a secondary infection (Hp 
2°) at day 28. The mice were harvested 14 days post-infection for FACS analysis (d42). (C) 
Representative FACS dot plots showing Foxp3-RFP, Il4-GFP and CD25 expression pre- and 
post-purification. (D) Representative FACS dot plots showing CD25, Il4-GFP and Foxp3-RFP 
expression in the mesenteric lymph nodes (MLN) of Tcra–/– HpTR recipients at day 42 post-
transfer. (E) Frequency of Il4-GFP+Foxp3-RFP– cells (of CD4+TCRβ+ cells) in the spleen, MLN 
and Peyer’s patches (PP) of nT (white bars) or HpTR (black bars) recipients d42 post-transfer. 
Data are representative of at least 5 independent experiments with 3-5 mice per group. 
Statistical test applied Mann-Whitney, two-tailed, * denotes p<0.05. 
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Figure 4.6. MLN-derived Foxp3-RFP+CD25high Treg cells convert to the highest extent in 
the Peyer’s patches. (A) Adoptive transfer of HpTR cells was performed as described 
previously (Fig. 4.4 B). Frequency of IL-4+ and IL-5+IL-13+ CD4+CD44high cells in the spleen 
and mesenteric lymph nodes (MLN) of CD4+TCRβ+CD25–CD44low (nT) (white bars) and 
CD4+TCRβ+Il4-GFP–Foxp3-RFP+CD25high (HpTR) (black bars) recipients as measured by intra-
cellular cytokine staining. Data are representative of 2 independent experiments with 4 mice per 
group. (B) Schematic representation of the modified adoptive transfer experimental set-up. 
Congenically marked spleen (CD45.1) and MLN (CD45.2) HpTR cells were purified and co-
transferred to TCRα-deficient mice. Recipient mice were infected with H. polygyrus, drug-cured 
with the anthelminthic Pyrantel Embonate (PE) at days 14 and 15 post-infection and given a 
secondary infection (Hp 2°) at day 28. The mice were harvested 14 days post-infection for 
FACS analysis (d42). (C) Frequency of Il4-GFP+Foxp3-RFP– cells (of CD4+TCRβ+ cells) in the 
spleen, MLN and Peyer’s patches (PP) of HpTR recipients d42 post-transfer. (D) Frequency of 
CD45.1+ (spleen-derived) or CD45.2+ (MLN-derived) cells (within the Il4-GFP+ population) in the 
PP of HpTR recipients d42 post-transfer. (E) Frequency of Il4-GFP+ cells within the spleen-
derived (black bar) or MLN-derived (white bar) HpTR populations in the PP of HpTR recipients 
d42 post-transfer. Data are representative of 2 independent experiments with 5 mice.  
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Figure 4.7. Foxp3-RFP+ cells convert to Il4-GFP+ cells in the absence of antigen and of 
high levels of CD25 expression. (A) CD4+TCRβ+Il4-GFP–Foxp3-RFP+CD25high cells were 
purified from naïve (nTR) or H. polygyrus infected (HpTR) Il4-GFPFoxp3-RFP donor mice and 
transferred to TCRα-deficient mice. One group of recipient mice were left uninfected (naïve; 
white bars). Another group were infected with H. polygyrus, drug-cured with the anthelminthic 
Pyrantel Embonate (PE) at days 14 and 15 post-infection and given a secondary infection (Hp 
2°) at day 28 (Hp infected; black bars). The mice were harvested 14 days post-infection for 
FACS analysis (d42). Frequency of Il4-GFP+Foxp3-RFP– cells (within the CD4+TCRβ+ 
population) in the Peyer’s patches (PP) of nTR and HpTR recipients d42 post-transfer. (B) 
CD4+TCRβ+Il4-GFP–Foxp3-RFP+CD25high or CD4+TCRβ+Il4-GFP–Foxp3-RFP+CD25low cells 
were purified from H. polygyrus infected Il4-GFPFoxp3-RFP donor mice and transferred to 
TCRα-deficient mice. Recipient mice were infected with H. polygyrus, drug-cured with the 
anthelminthic Pyrantel Embonate (PE) at days 14 and 15 post-infection and given a secondary 
infection (Hp 2°) at day 28 (Hp infected; black bars). The mice were harvested 14 days post-
infection for FACS analysis (d42). Frequency of Il4-GFP+Foxp3-RFP– cells (within the 
CD4+TCRβ+ population) in the Peyer’s patches (PP) of CD25high and CD25low HpTR recipients 
d42 post-transfer.  
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Figure 4.8. HpTRà Il4-GFP+ cells are transcriptionally re-wired. CD4+TCRβ+CD25–CD44low 
(nT) naïve T cells were FACS sorted from the spleen of naïve Il4-GFPFoxp3-RFP mice. 
CD4+TCRβ+Il4-GFP–Foxp3-RFP+CD25high (HpTR) cells were FACS-purified from the spleen and 
mesenteric lymph nodes (MLN) of H. polygyrus infected mice day 14 post-infection. The 
adoptive transfer of HpTR cells was performed as described previously (Fig. 4.4 B). Adoptively 
transferred CD4+TCRβ+Il4-GFP+Foxp3-RFP– cells were FACS-purified from nT (nTà Il4-GFP) 
or HpTR (HpTRà Il4-GFP) recipient mice at day 42 post-transfer. Gene expression profiling 
was performed using microarray, and analysed using Genespring. (A) Heatmap depicting 
significantly expressed mRNA transcripts (p<0.05) in FACS-purified HpTR, nTà Il4-GFP+ and 
HpTRà Il4-GFP+ cells expressed as fold change relative to nT cells (> 2.0). Each heatmap lane 
represents the 3 biological replicates. (B) Venn diagram showing comparative analysis of 
common and unique mRNA transcripts between nT, HpTR, nTà Il4-GFP+ and HpTRà Il4-
GFP+ cells. (C) Graphical representation of microarray data showing fold change expression of 
selected Th2- and Treg-related mRNA transcripts. Data is representative of 1 experiment with 3 
biological replicates per group. For each biological replicate, cells were sorted from 3-4 mice. 
(D) Validation of Foxp3 and Il4 expression by real-time PCR. (E) Graph depicting the ingenuity 
pathways analysis (IPA) of the Il4 signalling pathway predicting the role for IL-4 signalling 
upstream of the transcriptional profile of nTàIl4-GFP+, HpTRàIl4-GFP+ and HpTR cells. (F) 
Table listing the top 20 genes predicted to be upstream of the transcriptional profile of 
HpTRàIl4-GFP+ cells as determined by IPA. (G) Heatmap depicting significantly expressed 
mRNA transcripts (p<0.05) in FACS-purified HpTR, HpTRàIl4-GFP+, HpTRàDN and 
HpTRàFoxp3-RFP+ cells expressed as fold change relative to nT cells (> 2.0). Each heatmap 
lane represents the 3 biological replicates. Data is representative of 2 experiments with 3-4 
biological replicates per group.  
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Figure 4.9. HpTRà Il4-GFP+ cells maintain a demethylated Foxp3 locus. (A) Schematic 
representation of the Foxp3 locus depicting 12 CpG islands within the conserved non-coding 
sequence 2 (CNS2) of intron 1 and 5 CpG islands within intron 7. Bisulphite modification of DNA 
was performed followed by the amplification of the CNS2 and control region of the Foxp3 locus. 
Amplified products were cloned and sequenced to determine their methylation status. (B) 
Diagram generated using QUMA (Kumaki et al., 2008) representing methylated (full circles) and 
demethylated (empty circles) CpG sites on the amplified CNS2 (1-12) and control region (1-5) of 
nT, HpTR and HpTRàIl4-GFP+ replicate clones (14-21 clones per sample). (C) Graphical 
representation of the frequency of methylated CpG islands in the CNS2 and control region of 
nT(white bars), HpTR (grey bars) and HpTRàIl4-GFP+ (black bars) cells. Data is pooled from 1-
2 independent experiments. Cells were pooled from 5 recipient mice for experiments. (D) 
Graphical representation of the frequency of methylated CpG islands in the CNS2 and control 
region of nTR and Il4-GFP+ cells. Data is pooled from 1-2 independent experiments. Cells were 
pooled from 5 recipient mice for experiments. (E) Graphical representation of the frequency of 
methylated CpG islands in the CNS2 and control region of HpTRàDN and HpTRàFoxp3-RFP+ 
(black bars) cells. Data is pooled from 1-2 independent experiments. Cells were pooled from 5 
recipient mice for experiments. All experiments were done in collaboration with Manolis 
Gialitakis. 
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Figure 4.10. The adoptive transfer model is insufficient to test effector function of 
HpTRà Il4-GFP+ cells. Treg suppression assay setup: nT (Teff) cells were isolated from naïve 
C57BL/6 mice. The adoptive transfer of HpTR cells was performed as described previously (Fig. 
4.4 B). HpTRàDN, HpTRàIl4-GFP+ and HpTRàFoxp3-RFP+ cells were FACS-purified 42 days 
post-transfer and cultured at a 1:1 ratio with Teff cells for 2.5 days. Proliferating Teff cells were 
measured by cell tracker violet (CTV) staining. (A) Representative FACS histogram plot 
depicting CTV dilutions in the cultured cells and graphical representation of CTV dilutions. Data 
is representative of 1 experiment. Cells were pooled from 4 mice. (B) Absolute cell number of 
Il4-GFP+ cells in the spleen and MLN of nT (grey bars) or HpTR (black bars) recipients day 42 
post-transfer. Data are representative of at least 3 independent experiments. (C) nTàIl4-GFP+, 
HpTRàIl4-GFP+ and HpTRàFoxp3-RFP+ cells were FACS-purified from nT or HpTR recipients 
day 42 post-transfer. Purified cells were re-stimulated with P+I in vitro for 24h. IL-4 protein 
production as assessed by Flow Cytomix. Data are representative of 3 independent 
experiments. Cells were pooled from 3-4 mice. (D) Total IgE levels in the serum of nT or HpTR 
recipients day 42 post-transfer. (E) Arg1 and Chil3l3 expression in the small intestine of nT or 
HpTR recipients day 42 post-transfer expressed as fold change relative to Tcra–/– mice having 
received no T cells. (F) Intestinal worm count in nT or HpTR recipients day 42 post-transfer (day 
14 post-infection, see model (Fig. 4.4 B).  
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Figure 4.11. Ex-Foxp3 Il4-GFP+FP635+ cells develop in vivo and expand following 
secondary infection with H. polygyrus. (A) Schematic representation of the experimental 
setup. Foxp3YFP-CreIl4GFPR26RFP635 fate-reporter mice were infected with 200 H. polygyrus 
larvae. Mice were drug-cured with the anthelminthic Pyrantel Embonate (PE) at days 14 and 15 
post-infection and given a secondary infection (Hp 2°) at day 28. Naïve Foxp3YFP-
CreIl4GFPR26RFP635 mice were given a primary (Hp 1°) infection at the same time-point. All 
groups were harvested 7 days post-infection for FACS analysis. (B) Representative FACS dot 
plots showing expression of Il4-GFP against Foxp3-YFP-Cre (within the CD4+TCRβ+ 
population) and expression of Il4-GFP against FP635 in the spleen of Hp 1° and Hp 2° mice. 
(C) Graphical representation of the frequency and absolute number of Foxp3-YFP-Cre–Il4-GFP+ 
cells in the spleen of Hp 1° and Hp 2° mice. (D) Graphical representation of the frequency and 
absolute number of Foxp3-YFP-Cre–Il4-GFP+FP635+ cells in the spleen of Hp 1° and Hp 2° 
mice. Data are pooled from 2 independent experiments with 3-4 mice per group. (E) Graphical 
representation of the frequency of CD25-, GITR- and CD103- expressing cells within the Foxp3-
YFP-Cre+ (grey bars), Il4-GFP+ (white bars) and Il4-GFP+FP635+ (black bars) populations. Data 
is representative of 1 experiment with 4 mice per group.  (F) Representative FACS histogram 
showing CTLA-4 surface expression on FACS purified populations and CTLA-4 mRNA 
expression in FACS-purified Foxp3-YFP-Cre+ (light grey bar), Il4-GFP+ (dark grey bar) and Il4-
GFP+FP635+ (black bars) populations. Data are representative of 1-2 independent experiments 
with 3-4 mice per group. 
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Figure 4.12. Ex-Foxp3 Il4-GFP+FP635+ cells are functional Th2 effector cells and maintain 
molecular elements of their Treg past. Foxp3YFP-CreIl4GFPR26RFP635 fate-reporter mice were 
infected with 200 H. polygyrus larvae. Mice were drug-cured with the anthelminthic Pyrantel 
Embonate (PE) at days 14 and 15 post-infection and given a secondary infection (Hp 2°) at day 
28. Naïve Foxp3YFP-CreIl4GFPR26RFP635 mice were given a primary (Hp 1°) infection at the same 
time-point. Foxp3-YFP-Cre+ (grey bars), Il4-GFP+ (white bars) and Il4-GFP+FP635+ (black bars) 
cells were FACS-purified from Hp 2° fate-reporter mice and re-stimulated with P+I in vitro for 24 
hours. (A) IL-4 protein in the cell-culture supernatants as assessed by Flow Cytomix. (B) FACS-
purified Foxp3-YFP-Cre+, Il4-GFP+ and Il4-GFP+FP635+ cells were cultured with bone marrow 
derived macrophages (BMDMs) in the presence of TCR stimulation for 24 hours. BMDMs were 
cultured in media or with recombinant IL-4 and IL-13 as a control. Arg1 expression was 
measured in co-cultured BMDMs. Data are representative of 2 independent experiments. T cells 
were sorted from 3-4 mice and pooled for in vitro assays. (C) Graphical representation of the 
frequency of methylated CpG islands in the CNS2 and control region of Foxp3-YFP-Cre+ (grey 
bars), Il4-GFP+ (white bars) and Il4-GFP+FP635+ (black bars) cells FACS-purified from Hp 2° 
fate-reporter mice. Data is pooled from 2 independent experiments. Cells were pooled from 4 
mice per experiment. Experiments were done in collaboration with Manolis Gialitakis. (D) 
Graphical representation of the frequency of Il4-GFP and Foxp3-YFP-Cre expression following 
in vitro culture of FACS-purified Il4-GFP+ (white bars) and Il4-GFP+FP635+ (black bars) cells in 
Treg polarising conditions (IL-2 and TGF-β) for 7 days.  
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Figure 4.13. IL-4 signals through STAT6 in CD25highFoxp3-RFP+ cells and promotes their 
conversion to Il4-GFP+ cells in vitro. (A) Schematic representation of the experimental setup. 
Il4-GFPFoxp3-RFP mice were infected with 200 H. polygyrus larvae. 
CD4+TCRβ+CD25highFoxp3-RFP+ (HpTR) cells were FACS-purified at day 14 post-infection. 
CD4+TCRβ+CD25–CD44low (nT) cells were FACS-purified from naïve reporter mice. Purified nT 
and HpTR cells were stimulated with recombinant IL-4 at 37°C for 15min or with media as a 
control followed by protein extraction. (B) Western blot representing pSTAT-6, STAT6 and 
alpha-tubulin protein levels in cultured cells. Data is representative of 3 independent 
experiments. Cells were pooled from 3-4 mice. Purified nT and HpTR cells were cultured in Th2 
polarising conditions (IL-4, IL-2 and anti-IFN-γ) for 7 days. (C) Representative FACS dot plots 
showing the expression of Il4-GFP and Foxp3-RFP in nT and HpTR cultures following 
polarisation. (D) Graphical representation of the frequency of Il4-GFP+ cells in nT and HpTR 
cultures following polarisation. Data are pooled from 3 independent experiments. Cells were 
sorted from 1-4 mice.   
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Figure 4.14. Foxp3+ cells are dispensable for the development of Th2 responses and 
functional immunity to H. polygyrus. (A) Schematic representation of the experimental setup. 
“Depletion of regulatory T cell” (DEREG) mice were infected with 200 H. polygyrus larvae. Mice 
were drug-cured with the anthelminthic Pyrantel Embonate (PE) at days 14 and 15 post-
infection and given a secondary infection (Hp 2°) at day 28. One group of mice was treated with 
diphtheria toxin (Dtx; black bars) at days 26, 28 and 30 (Hp 2°+Dtx). All groups were harvested 
7 days post-infection for FACS analysis and 14 days post-infection for worm counts. (B) 
Representative FACS plots showing the expression of Foxp3-GFP and CD25 in the MLN of Hp 
2° and Hp 2°+ Dtx mice 7 days post-infection. (C) Graphical representation of the frequency of 
Foxp3-GFP+CD25+ cells in the MLN of naïve and Hp 2° DEREG mice treated with Dtx (black 
bars) or with PBS (white bars) 7 days post-infection. (D) Intestinal worm count in WT Hp 1° and 
Hp 2° mice and in Dtx-treated (black bars) and PBS-treated (white bars) Hp 2° DEREG mice 
day 14 post-infection. (E) Graphical representation of the frequency of CD44+IL-4+ and 
CD44+IL-13+ (within the CD4+TCRβ+ population) in the MLN of naïve and Hp 2° DEREG mice 
treated with Dtx (black bars) or with PBS (white bars) 7 days post-infection. Data is 
representative of 1 experiment with 5 mice per group.     
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Figure 4.15. IL-4 is required for development but not re-activation of Th2 cells. (A) 
Schematic representation of the experimental setup. Tcra–/– mice were sub-lethally irradiated 
and reconstituted with T-depleted WT, Il4ra–/– or a mix of WT(20%):Foxp3–/–(80%) or Il4ra–/– 
(20%):Foxp3–/–(80%). Chimeric mice were infected with 200 H. polygyrus larvae 7 weeks after 
reconstitution. Mice were drug-cured with the anthelminthic Pyrantel Embonate (PE) at days 14 
and 15 post-infection and given a secondary infection (Hp 2°) at day 28. All groups were 
harvested 14 days post-infection for FACS analysis and worm counts. (B) Graphical 
representation of the frequency of Foxp3+CD25+ cells in the MLN of chimeric mice 14 days 
post-infection. (C) Graphical representation of the frequency of CD44+IL-4+ cells in the spleen 
14 days post-infection. (D) Intestinal worm counts 14 days post-infection. Data is representative 
of 1 experiment with 3-5 mice per group. (E) Graphical representation of experimental model. 
Foxp3YFP-CreIl4GFPR26RFP635 fate-reporter mice were infected with 200 H. polygyrus larvae. Mice 
were drug-cured with the anthelminthic Pyrantel Embonate (PE) at days 14 and 15 post-
infection and given a secondary infection (Hp 2°) at day 28. Naïve Foxp3YFP-CreIl4GFPR26RFP635 
mice were given a primary (Hp 1°) infection at the same time-point. Mice were treated with 
11B11 (anti-IL-4 antibody) or isotype control on days 1, 3 and 5 of the secondary challenge. (F) 
Graphical representation of the frequency and absolute number of Foxp3-YFP-Cre–Il4-GFP+ 
cells in the spleen and MLN of isotype (white bars) or antibody-treated (black bars) mice. Data 
is representative of 1 independent experiment with 4 mice per group. (G) Graphical 
representation of the frequency and absolute number of Foxp3-YFP-Cre–Il4-GFP+FP635+ cells 
in the spleen and MLN of isotype (white bars) or antibody-treated (black bars) mice. Data is 
representative of 1 independent experiment with 4 mice per group. 
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Figure 4.16. Illustration of the impact of IL-4 signalling on Treg cells during a secondary 
infection with H. polygyrus. (A) IL-4 signalling may promote Treg to Th2 conversion. (B) IL-4 
signalling may be required to limit the development of Treg cells. (C) IL-4 signalling may be 
required for Treg suppression of Th2 cells.  
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Chapter 5: General discussion 
Intestinal helminth infections modulate host immune responses and promote an 
immunoregulatory environment, primarily limiting anti-helminth immune mechanisms, 
and subsequently preventing immune-mediated pathology.  This modified immune 
response results in the long-term survival of the parasite and chronic infection. In 
humans, the chronicity of intestinal helminth infections has a significant impact on the 
health, development and morbidity of the host. Using laboratory models of infection, it 
has been shown that favouring the development of type-2 responses correlates with 
the functional expulsion of the parasite, either in genetically resistant hosts or following 
therapeutic intervention. It is within this context that we have identified a new cellular 
source and target of IL-4 that contributes to the development of Th2 cells, type-2 
immunity and anti-helminth immune mechanisms. 
 
5.1. Immunoregulation of type-2 responses by intestinal helminths  
Both ILC2s and their Th2 counterparts play important roles in anti-helminth 
immunity by secreting canonical cytokines required for the activation of downstream 
effector responses, ultimately resulting in the expulsion of the parasite. Given their 
functional similarities, understanding the relative contribution of ILC2s and their Th2 
cell counterparts to protective immune responses, as well as the interplay between the 
two cells has become an increasingly important objective in immunology. Although 
ILC2s are sufficient to drive anti-helminth immunity in a limited number of helminth 
infections, it is becoming clear that ILC2s also provide important differentiation cues for 
Th2 cells (Oliphant et al., 2014). However, the precise mechanisms of how ILC2s relay 
cues to the adaptive immune compartment remains unclear. Importantly, the role of 
ILC2s during anti-helminth immunity has mostly been studied in the context of 
infections with the lab-adapted helminth N. brasiliensis, and it remains unclear whether 
ILC2s play a role during an infection with other helminth parasites that reside in 
different tissues and require different immune mechanisms. Previous studies have 
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shown ILC2s expand following infection with the intestinal helminth H. polygyrus 
(Mackley et al., 2015) in parallel with the development of Th2 cells (Filbey et al., 2014), 
however the contribution of ILC2s to the initiation of type-2 responses was not 
addressed. In chapter 3, we identified that ILC2s promote the differentiation of Th2 
cells in vitro and are important for the development of Th2 cells in vivo following H. 
polygyrus infection. The magnitude of Th2 responses correlates with natural immunity 
to H. polygyrus (Filbey et al., 2014) suggesting that strategies designed to amplify 
ILC2s could indirectly promote Th2 responses and enhance immunity to infection. In 
the context of infections with complex intestinal helminths, immune responses need to 
be tightly regulated to limit excessive damage caused by inflammation. Many studies 
have characterised the ability of intestinal helminths to promote a regulatory 
environment for their survival and chronic establishment (McSorley et al., 2013). In 
particular, the establishment of H. polygyrus infection correlates with the early parasite-
driven (Grainger et al., 2010) expansion of Foxp3+ Treg cells (Finney et al., 2007; 
Rausch et al., 2008), and negatively correlates with the development of functional Th2 
responses (Rausch et al., 2009).  
Although Treg cells have been shown to directly (Huber et al., 2011) and 
indirectly (Fiorentino et al., 1991) suppress T helper cells, it remains unclear whether 
they play a role in regulating ILC2s. However recent transcriptional profiling of intestinal 
KLRG1+ ILC2s and CD127+NKP46+ ILC1s found that they expressed significantly 
higher levels of Il10ra than other ILC subsets (Robinette et al., 2015) suggesting they 
could be directly regulated by Treg-derived IL-10 as has been previously shown for the 
control of T helper cells (Huber et al., 2011). An indirect role for H. polygyrus 
suppression of ILC2s is emerging instead. H. polygyrus ES was shown to negatively 
regulate IL-33R expression in mouse epithelial cell lines (Buck et al., 2014) and IL-33 
release from the lung epithelium, leading to reduced ILC2 numbers (McSorley et al., 
2014). Similarly, the secretion of IL-1β by H. polygyrus-elicited innate cells was shown 
to inhibit IL-33 and IL-25 release from the intestinal epithelium and limit ILC2 expansion 
(Zaiss et al., 2013). In a separate model, the secretion of the fatty acid maresin-1 
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(MaR1) in allergic lungs was shown to directly inhibit ILC2 cytokine production and 
promote resolution of lung inflammation (Krishnamoorthy et al., 2015), suggesting that 
other tissue-derived factors can limit ILC2 effector function. In addition, ILC2s have 
been described to express high levels of KLRG1, an inhibitory c-type lectin shown to 
negatively regulate Gata3 expression and IL-5 and IL-13 secretion by human dermal 
ILC2s (Salimi et al., 2013). Together, these results provide evidence of potential 
regulatory pathways for the control of ILC2s, which suggests that H. polygyrus and 
other intestinal helminths may have evolved to subvert immune responses by limiting 
the expansion of Th2 cells as well as ILC2s. Indeed, it was recently reported that 
children infected with helminths have reduced proportions of ILC2s, which were 
restored following curative anthelminthic treatment (Nausch et al., 2015).  
 
5.2. Enhancing type-2 immune responses by stimulating ILC2s and Tregs 
Treg cells have recently been shown to lose their regulatory phenotype and 
contribute to Th responses in the context of inflammation, however whether Treg 
conversion contributes to protective immune responses in the context of an infection 
was unclear. In chapter 4, we tested whether Treg cells could convert to Th2 cells and 
play a protective role during memory Th2 responses. We found that Treg cells could 
convert to IL-4 expressing cells in vitro in response to IL-4 signalling and in vivo 
following adoptive transfer and identified that a significant proportion of functional Th2 
cells originate from a Foxp3-expressing past in vivo. We are currently testing the 
requirement for IL-4 in promoting Treg to Th2 conversion in vivo. Based on preliminary 
results, IL-4 may be redundant for the re-activation of memory Th2 cells during a 
secondary infection with H. polygyrus. Instead, an early source of IL-4 may be required 
to promote the conversion of Treg to Th2 cells during a primary infection. Basophils, 
eosinophils, mast cells and CCR2+ monocytes are redundant for the development of 
Th2 cells following a primary H. polygyrus infection (Smith et al., 2012) or vaccine-
mediated immunity (Hewitson et al., 2015). In light of and our data showing ILC2-
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derived IL-4 can promote Th2 differentiation, it is conceivable that ILC2s could be 
providing an important source of IL-4 in the tissue and promoting the conversion of 
Treg to Th2 cells during a primary infection. 
 Alternatively, ILCs may be important antigen presenting cells. Indeed, MHC 
Class II expression on ILC3s (Hepworth et al., 2013; Hepworth et al., 2015) and ILC2s 
(Neill et al., 2010) has been shown to be important for immune tolerance, T cell 
proliferation in vitro (Mirchandani et al., 2014) and functional expulsion of N. 
brasiliensis (Oliphant et al., 2014). Furthermore, previous studies found that ILC2s 
promote Th2 differentiation and proliferation in an MHC-dependent manner 
(Mirchandani et al., 2014; Oliphant et al., 2014). Finally, both ILC3s and ILC2s have 
the potential to migrate to the appropriate site for Th2 cell reactivation, as they were 
found to migrate to the MLN following primary H. polygyrus infection (Mackley et al., 
2015).  Taken together these studies suggest ILC2s could be providing antigen as well 
as IL-4 to support Treg to Th2 conversion (Fig. 5.1). 
Current experimental strategies to modulate the ratio of Th2 and Treg cell either 
amplify or inhibit Treg and Th2 cells using cytokines and antibodies (Klatzmann and 
Abbas, 2015). In some settings, shifting the ratio of Treg to Th2 cells was shown to 
limit pathogenic Th2 responses. For example, in vivo expansion of Treg cells following 
the administration of IL-2c (Wilson et al., 2008) or the stimulation of the TNF-
superfamily receptor DR3 (Schreiber et al., 2010) were shown to reduce allergic 
inflammation by reversing the ratio of Th2 to Treg cells. Conversely, in the context of 
helminth infections, therapeutic strategies aim to modify to promote the differentiation 
of Th2 cells for improved immunity to helminths. For example, depletion of Treg cells 
during a chronic infection with H. polygyrus (Rausch et al., 2009) and other intestinal 
helminths (Taylor et al., 2005) was shown to promote Th2 responses. Furthermore, 
enhanced Th2 responses following IL-4c treatment led to the expulsion of H. polygyrus 
(Urban et al., 1995; Herbert et al., 2009), however the targets of IL-4 following IL-4c 
treatment were unclear. Indeed, both CD4+ cells (Kopf et al., 1993) and ILC2s 
(Motomura et al., 2014) are activated in response to IL-4 signalling. Thus, treatment 
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with recombinant IL-4 may directly, or indirectly (via ILC2s) stimulate the conversion of 
Treg to Th2 cells as well as de novo Th2 differentiation. By simultaneously increasing 
Th2 differentiation, originating from two independent sources, and concomitantly 
reducing the number of Treg cells, low-dose IL-4 treatment may be sufficient to amplify 
Th2 responses without mediating excessive pathology. Given the ability of an anti-
helminth Th2 response to develop in the context of a strong regulatory environment, 
increasing numbers of studies are looking to identify helminth-associated molecular 
patterns that could be triggering the differentiation of protective immune responses 
(Loukas et al., 2011; Hotez et al., 2013) rather than the differentiation of Treg cells 
(Grainger et al., 2010). Indeed, preliminary data suggests that vaccination with 
helminth-derived excretory/secretory molecules, and in particular secreted venom-
allergen-like proteins (VALS 1, 2 and 3), can stimulate potent immunity to H. polygyrus 
(Hewitson et al., 2015) suggesting that specific helminth antigens can drive protective 
immune responses. Furthermore, both IL-25R (IL-17RA) and IL-4Rα were required to 
promote sterile immunity to H. polygyrus after vaccination with HES (Hewitson et al., 
2015). Hence, the authors suggested that IL-25-responsive cells, such as ILC2s, are 
required to drive Th2 differentiation and subsequent activation of antibody class-
switching in B cells, culminating in sterile immunity (Hewitson et al., 2015). Therefore, 
enhancing early type-2 immune responses to H. polygyrus through the activation of 
ILC2s may be particularly relevant in the context of vaccine development.  
In summary, we have identified new cellular targets for enhancing natural anti-
helminth immune responses. Thus, we propose that strategies to promote Th2 
differentiation could concomitantly expand ILC2s and promote Treg to Th2 conversion, 
shifting the balance of Treg and Th2 responses and ultimately improving anti-helminth 
immunity.  
 
Chapter 5 - General discussion 
 225 
5.3. Evidence for Treg to Th2 conversion in natural immunity 
An important continuation of this study will be to define unique characteristics of 
ex-Foxp3 Th2 cells in order to monitor their development in different models. For 
example, we could use a transcriptional approach to identify distinct surface receptor 
expression patterns combined with epigenetic analysis for the identification of markers 
of their Treg past. The significance of identifying markers unique to ex-Foxp3 Th2s 
would be two-fold. Firstly, they may provide mechanistic hints for the specific 
amplification or inhibition of the cells. In addition, they may serve as biomarkers for the 
identification of ex-Foxp3 Th2 cells in vivo in human patients.  
Throughout this study we have infected mice with a single dose of 200 L3 
larvae widely used in different laboratories (Reynolds et al., 2012), which may not 
represent infection rates in the wild. Furthermore, we studied functional immune 
responses in mice that developed immunity to re-infection following anthelminthic 
treatment (Urban et al., 1991). Although global deworming programs do exist, the 
global coverage of anthelminthic treatment for school children is estimated to be 
between 30-40%, and a high number of children are predicted to be chronically and 
repeatedly infected (WHO, 2015). Thus, both the dose and regimen of our infection 
model may not accurately model human infection. Instead, it would be interesting to 
study the role of ILC2s and Treg to Th2 conversion in the context of protective memory 
responses that develop following repeat trickle infections to H. polygyrus and to the 
human hookworm Ancylostoma ceylanicum (Brailsford and Behnke, 1992; Brailsford 
and Behnke, 1992). For example it would be interesting to cross our fate-reporter mice 
onto different genetic backgrounds that have varying degrees of resistance, and 
determine whether Treg to Th2 conversion correlates with natural immunity to H. 
polygyrus as well as increasing numbers of ILC2s (Filbey et al., 2014). Furthermore, 
infections with lower doses of H. polygyrus were shown to improve the rapidity of 
expulsion due to reduced immunomodulatory responses, suggesting that modifications 
in dose of H. polygyrus larvae inoculation may favour the development of Th2 cells 
over Treg cells, perhaps through Treg to Th2 conversion (Brailsford and Behnke, 1992) 
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or through the participation of ILC2s in ‘trained immunity’ as seen in monocyte 
populations following Candida infection (Netea, 2013). Together, these experiments 
would better model genetic variation and epidemiological diversity of human soil-
transmitted helminth infections. Based on these results and following the identification 
of appropriate biomarkers, it would be interesting to determine whether the proportion 
of ex-Foxp3 Th2 cells correlates with increased protective immunity to intestinal 
helminths in humans, as observed following repeated infections with S. mansoni 
(Karanja et al., 2002) and infections with Necator americanus (Quinnell et al., 2004). 
 
5.4. Lessons learnt and future applications 
Throughout these studies we have identified that H. polygyrus elicits multiple 
mechanisms of Th2 differentiation that can be enhanced to promote immunity to 
infection. Although this would seem detrimental to the parasite’s survival, Th2 cells also 
mediate important repair mechanisms that are crucial for the survival of the host. 
Indeed, it is increasingly thought that Th2 responses have evolved in response to 
helminth-infections to limit damage to the host in addition to immunity (Gause et al., 
2013; Allen and Sutherland, 2014). Therefore it is conceivable that helminth-derived 
molecules may promote the conversion of Treg to Th2 cells to enhance promote tissue 
repair following infection. Indeed, we identified Foxp3+IL-4+ cells that expressed high 
levels of the regulatory cytokine IL-10, and may be important for regulating damage-
mediated inflammation.  
Like in many immune responses, there may be a threshold at which IL-4-elicited 
specialised Treg cells convert to Th2 effector cells, which depending on the context 
may have protective or pathogenic roles. Treg cells may inadvertently adapt to the Th2 
immune responses in strong polarising environments. Indeed, only high levels of IL-4 
signalling were shown to promote Treg conversion to Th2 cells (Noval Rivas et al., 
2015). Thus, promoting ILC2 expansion and Treg reprogramming may have a 
beneficial role for anti-helminth immune responses, however it may also have negative 
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consequences on the development of pathogenic Th2-mediated diseases such as 
asthma and allergic inflammation, the global prevalence of which is steadily increasing 
(Weinberg, 2011), correlating with increased hygiene (Maizels, 2005) and changes in 
diets (Julia et al., 2015). Indeed, ILC2s have been implicated in the pathogenesis of 
oral and airway allergies (Licona-Limon et al., 2013) and may be playing an important 
role in driving innate type-2 responses at mucosal barriers. Furthermore, Treg 
reprogramming to Th2 cells correlated with the development of inflammation following 
oral allergy (Noval Rivas et al., 2015), suggesting that reprogrammed Tregs may 
contribute to disease. Current immunotherapies are looking at adoptively transferring 
Treg cells to control inflammatory diseases such as allergic asthma (Miyara et al., 
2014). Instability of cultured Tregs and their conversion to Th2, Th1 or Th17 cells in 
vitro pre-transfer or in vivo post-transfer could therefore exacerbate rather than 
regulate disease. Identifying mechanisms of Treg to Th2 conversion would therefore be 
vitally important for the inhibition of these pathways, resolution of disease, and 
enhancing the stability of Tregs. Finally, if ILC2-derived IL-4 provides an important 
source of IL-4 for Treg to Th2 conversion, inhibiting ILC2s in parallel with the inhibition 
of Treg to Th2 conversion may indirectly reduce Th2-mediated disease and 
inflammation. The generation of Foxp3YFP-Crell4GFP R26RFP635 fate-reporter mice will 
allow us to determine the prevalence of Treg to Th2 conversion in a diversity of 
settings where protective and pathogenic Th2 cells play a dominant role, including 
allergic inflammation, metabolic homeostasis and wound repair (Gause et al., 2013). 
Furthermore, if IL-4 stimulates Treg to Th2 conversion, we will be able to test the 
functional impact of inhibiting conversion by using Foxp3YFP-Crell4GFP R26RFP635Il4rafl/fl 
mice.  
In conclusion, we have identified a novel source and target of IL-4 in the context 
of immune responses to H. polygyrus. We have generated novel and sophisticated 
genetic tools to study the impact of Treg to Th2 conversion in diverse settings of 
immunity and disease. We hope these tools can help identify new targets to promote 
enhanced anti-helminth vaccine responses and to reduce type-2-mediated disease. 
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Figure 5.1. Working model: ILC2s promote the conversion of Treg to Th2 cells. Treg cells 
expand in response to a primary infection with H. polygyrus (Hp 1°). ILC2s expand 
concomitantly and provide a source of IL-4, which stimulates conversion of a proportion of 
tissue-resident Treg to Th2 cells. Furthermore, ILC2s and DCs migrate to the local MLN and 
promote the differentiation of nT cells in to Th2 cells, as well as further conversion of Treg to 
Th2 cells. Upon secondary infection (Hp 2°), re-activated Th2 and ex-Foxp3 Th2 cells expand 
and secrete high levels of IL-4, IL-13 and IL-5 that drive an early cascade of type-2 responses 
ultimately resulting in larval killing. Inhibition of Treg conversion to Th2 cells, or ILC2 secretion 
of IL-4 may impair the development of functional memory Th2 cells and immunity.  
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